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Total Synthesis of Cruentaren A and 
Analogues 
 
Introduction   1
1 Introduction 
 
The urgent need for the discovery and development of new pharmaceuticals for the 
treatment of cancer, AIDS, infectious diseases, as well as a host of other diseases demands that 
all approaches to drug discovery be exploited aggressively. Among the most important 
approaches, the one from natural products has made many unique and vital contributions to 
drug discovery. From the data presented by Newman et al.1, the utility of natural products as 
sources of novel structures, but not necessarily the final drug entity, is still alive and well. 
Thus, in the area of cancer, over the time frame from around the 1940s to 2007, of the 155 
small molecules, 47% are actually being either natural products or directly derived therefrom. 
 
Although many complex natural products are very interesting from a biological point of view, 
they are usually present in organisms in low quantities. This sometimes significantly hampers 
extensive clinical research of such compounds. Thus, alternative sources and in the first place, 
chemical synthesis must provide access to required amounts as well as modified analogues 
that may have improved biological activity.2 Another important role of total synthesis is to 
prove the assigned structure and determine absolute stereochemistry of complicated 
molecules.3 
The total synthesis of complex natural products remains the most difficult, daunting, and 
challenging endeavor in organic chemistry. It is also the most humbling, exhilarating, and 
formative enterprise in our science. The sizes and complexities of the natural products 
synthesized today bear no resemblance to the substrates that were targeted in the beginning.4 
The assembly of complex natural products has stimulated the development of powerful 
synthetic methodologies that enable organic chemists to build, in a shorter time and more 
efficient manner, structures of previously undreamed complexity. The desire to imitate nature 
has led to the discovery and establishment of powerful biomimetic approaches, as exemplified 
by the Johnson synthesis of steroids.5 
Benzolactones represent an important subclass of natural products among the polyketides.6 
They may be viewed as privileged structures in nature since there are so many of them and 
they do show a broad range of biological activity. From a biological point of view, 
benzolactones are secondary metabolites of bacteria, fungi, sponges, and small animals. They 
appear to be unnecessary for an organism’s internal functioning but can be used for the 
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purpose of defense and intercellular communication. Polyketide fragments are derived from 
the oligomerization of propionyl and acetyl subunits in a similar process to fatty acid 
synthesis. Such fragments can include double bonds, saturated chains or even heterocycles. 
Among the many benzolactones,7 the recently described cruentaren A (1-1)8 stands out due to 
its unique structural features and novel mode of action (Figure 1). It turned out that 1-1 is an 
inhibitor of mitochondrial F-ATPase from yeast.9 Against the L929 cell line cruentaren A 
shows strong cytotoxicity with an IC50 value of 1.2 ng mL–1. With its 12-membered 
macrolactone and a side chain that is terminated with an acylated amino function, cruentaren 
A has some resemblance to the well known benzolactone enamides.10 However, in contrast to 
cruentaren A, the benzolactone enamides target V-ATPase.11  
O
cruentaren A (1-1)
OH
MeO
HO
O
HO
N
H
O
HO
1
6 9
15
22
25
 
Figure 1. Structure of cruentaren A. 
Since mitochondrial ATPases play a crucial role in the pathophysiology of several human 
disorders including cancer, selective inhibitors of such transport proteins constitute promising 
leads in the quest for novel chemotherapeutic agents.12 It is therefore of considerable interest 
to evaluate the potential of cruentaren A in more detail. 
The fascinating structure combined with the potent biological activity prompted us to embark 
on a total synthesis of cruentaren A. Clearly, it would be of interest to identify key structural 
elements that are essential for its unique biological activity. On the other hand, before we 
started this project there was no synthesis of this molecule reported in the literature. Therefore, 
the total synthesis of cruentaren A would prove the absolute configuration of all eight 
stereogenic centers. 
The objective of our research was therefore aimed at the design of an efficient synthetic 
strategy, which would allow the total synthesis of cruentaren A itself, as well as other 
structural analogues of this novel natural product. 
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2 Literature Review 
 
2.1 Biological Activity of Cruentaren A 
The Gram-negative, fruiting body forming myxobacteria have emerged as a particularly rich 
source of secondary metabolites, which are characterized by a multitude of unrelated 
structures as well as by different biological activities with interesting mechanism of 
action.13,14 
Recently, two novel metabolites, namely cruentaren A (1-1) and B (2-1), have been isolated 
from the myxobacterium Byssovorax cruenta. With an IC50 value of 1.2 ng mL–1 against the 
L929 cell line 1-1 is among the most cytotoxic compounds found in myxobacteria. Notably, 
the isomeric δ-lactone cruentaren B turned out to be essentially inactive. Initially, cruentaren 
A was patented as a pesticide15 but in the meantime it turned out that it is an inhibitor of 
mitochondrial F-ATPase from yeast. Interestingly, it does not inhibit V-ATPase which is the 
molecular target of the benzolactone enamides.11 
O
MeO
OH O OH OH
N
H
O OH
cruentaren B (2-1)
1
9
15
 
Figure 2. Structure of cruentaren B (2-1). 
To explain the mode of action of cruentaren A, one should take a closer look at cell biology. 
As was mentioned previously, cruentaren A is a selective inhibitor of F-ATPase from the 
yeast. First we should consider the following questions: What is the role of F-ATPase? Why it 
is so important for living organisms? 
F-ATPase is a transmembrane protein found in bacterial plasma membranes, mitochondrial 
inner membranes and in chloroplast thylakoid membranes. It uses a proton gradient to drive 
ATP synthesis by allowing the passive flux of protons across the membrane down their 
electrochemical gradient and using the energy released by the transport reaction to synthesize 
ATP from ADP and inorganic phosphate. In some bacteria, sodium ions may be used instead. 
F-ATPase consists of two domains: F1, a peripheral enzyme complex which contains the 
catalytic activity of the synthase, and FO, an integral membrane protein complex (Figure 3). 
The F1 domain of the F-ATPase contains the binding sites for ATP and ADP and is involved 
in the catalytic reactions of the ATP synthesis. The FO domain is embedded in the membrane 
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and provides a channel for the translocation of protons across the membrane. The F1 domain 
of F-ATPase functions as a rotary molecular motor: in vitro its γ-subunit rotates16 against the 
surrounding α3β3 subunits, 17  hydrolysing ATP in three separate catalytic sites on the β-
subunits. It is widely believed that reverse rotation of the γ-subunit, driven by proton flow 
through the associated FO domain of ATP synthase, leads to ATP synthesis in biological 
systems.18  
 
Figure 3. A schematic view of F- and V-ATP synthase (Nelson et al.19) 
Boyer proposed that the coupling between F1 and FO domains is mechanical: FO is a motor or 
turbine, driven by the proton flow, and F1 is another motor driven by ATP hydrolysis.20 The 
two have a common shaft. Proton flow from bottom to top in Figure 3 drives the shaft in the 
unique direction, say clockwise. ATP hydrolysis in F1 drives the shaft in the opposite 
direction, counterclockwise. When the free energy obtained from the downward flow of 
protons is greater than the free energy of ATP hydrolysis, the FO motor rotates the common 
shaft in its genuine direction. The F1 motor is forced to rotate in its reverse direction, and thus 
ATP synthesized in its catalytic sites. If the energy obtained from ATP hydrolysis is higher, 
the F1 motor gains control and protons are pumped out. Boyer’s idea came from the analysis 
of the chemical reaction in the F1 part. The F1 portion can be isolated in solution, and then it 
only hydrolyses ATP. Hence, the isolated enzyme is called F1-ATPase. The F1-ATPase 
consists of five types of subunits in the stoichiometry of α3β3γδε. α3β3γ-subunits suffice for 
ATPase activity and for rotation. Each β-subunit contributes one catalytic site for the 
synthesis – hydrolysis of ATP (the catalytic site resides at the interface between a β-subunit 
and a α-subunit, and is in part contributed from residue of α). It was found that the three 
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catalytic sites are completely equivalent in steady-state ATP hydrolysis by F1-ATPase or in 
steady-state ATP synthesis – hydrolysis by the whole ATP synthase. 
As the protons bind to the subunits of the FO domains they cause parts of it to rotate. This 
rotation is propagated by a common shaft to the F1 domain. ADP and Pi (inorganic phosphate) 
bind spontaneously to the three β subunits of the F1 domain, so that every time it goes through 
a 120° rotation ATP is released. This can be explained with binding – change mechanism for 
proton driven ATP synthesis, which was proposed by Boyer. This proposal states that changes 
in the properties of the three subunits allow sequential ADP and Pi binding, ATP synthesis, 
and ATP release. 
 
One of the well known inhibitors of F-ATPase is the natural antibiotic oligomycin. It blocks 
the synthesis of ATP by preventing the movement of protons through the FO domain of ATP 
synthase. 21  It is primarily found to act as an inhibitor of mitochondrial respiration and 
swelling. This antibiotic is widely used as an inhibitor of oxidative phosphorylation. 22 
Because of its activity, it can also be used to reduce the number of parameters (such as ER 
Ca2+ release, exocytotoxicity and apoptosis) which are affected by mitochondrial 
depolarization.23 
Recently Juan et al. performed a proteomic analysis on human breast carcinoma tissues to 
investigate the tumor-specific protein expression in breast carcinoma.24 It was shown that ATP 
synthase was up-regulated in tumor tissues and was present on the plasma membrane of breast 
cancer cells. Furthermore, the breast cancer cells were treated with ATP synthase inhibitors and 
the inhibitory efficiency was examined. Aurovertin B, an ATP synthase inhibitor, was proved to 
have strong inhibition on the proliferation of several breast cancer cell lines, but little influence 
on the normal cell line MCF-10A. It was shown that aurovertin B inhibits proliferation of breast 
cancer cells by inducing apoptosis and arresting cell cycle at the G0/G1 phase and can be used as 
an antitumorigenic agent as well as may be exploited in cancer chemotherapy. 
 
In a recent publication of Kunze et al.25 it was shown that cruentaren A inhibits mitochondrial 
F-ATPases by targeting the catalytic F1-domain and not via interaction with the membrane 
bound FO-domain. As one can see from the Table 1, in contrast to cruentaren A, the FO-
targeting inhibitor oligomycin did not affect the F1-ATPase activity. 
Table 1. Inhibition of F1 ATPase solubilized from submitochondrial particles25 
Relative activity (%) Compound 
Beef heart S. cerevisiae 
Control without inhibitors 100 100 
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Oligomycin 1 μM 99.1±0.1 94.0±2.0 
Cruentaren A 1 μM 3.3±0.8 3.0±0.7 
Cruentaren A 0.1 μM 10.0±0.5 10.3±0.7 
 
Inhibitory efficacy of cruentaren A was also tested on the V-ATPase and Na+/K+-ATPase. 
The latter belongs to the family of P-ATPase and is responsible for the preservation of Na+ 
gradients across the plasma membrane. But even at a concentration of 1 μM in both cases no 
inhibition was observed. 
This outcome seems surprising in view of the effect of the related benzolactone enamides 
which operate on V-ATPases via the VO-complex. However, in spite of their planar structural 
similarity, conformation and spatial arrangement of functional groups are quite different, as 
has been shown by X-ray crystal structure analyses of apicularen A and cruentaren A. From 
this point of view it is conceivable that these compounds interact with different binding sites 
in related proteins.  
Furthermore, it turned out that cruentaren A inhibits the mitochondrial F1-ATPase from two 
evolutionarily rather distant eukaryotic organisms such as yeast and mammal but does not 
inhibit the F1-ATPase from Escherichia coli. Thus, one can speculate that it binds to the F1 
subunit ε which has no bacterial counterpart.26 
In addition, cruentaren A was checked for its impact on the growth of a variety of human 
cancer cell lines from different tissues (Table 2). The IC50 values were comparable with those 
described for other benzolactones such as apicularen A27 in the nanomolar range, even for the 
multi-drug-resistant cell line KB-V1. 
Table 2. Growth inhibition of different human cancer lines by cruentaren A and apicularen25 
IC50 (ng/ml) Cell line Origin 
Cruentaren A Apicularen A 
 KB-3-1  Cervix carcinoma 0.3 1.0 
 KB-V1  Multi-drug resistant KB line 0.6 10 
 K-562  Chronic myelogenous leukemia 0.6 1.0 
 U-937  Histiocytic carcinoma 0.1 1.5 
 A-549  Lung carcinoma 0.4 0.1 
 SK-V-3  Ovarian carcinoma 1.0 1.5 
 A-498  Kidney carcinoma 0.4 0.3 
 
Despite the fact that the exact binding site of cruentaren A remains undefined, the described 
results substantiate, that this unique benzolactone is the most potential inhibitor of 
mitochondrial F1-ATPases. Thus, future understanding of the interaction of cruentaren A with 
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its binding side may provide irreplaceable knowledge for the rational development of 
therapeutic agents for cancer treatment. 
 
2.2 Synthesis of Cruentaren A by Fürstner 
One should mention that the first total synthesis of cruentaren A was developed in our group, 
featuring a ring-closing alkyne metathesis and double Lindlar reduction.28 Recently, another 
RCAM based synthesis of cruentaren A was achieved by the Fürstner group.29 Similar to our 
approach they decided to divide the molecule into two main subunits, functionalized benzoic 
acid 2-2 and an aliphatic fragment containing a stereotetrad (2-3) (Figure 4). 
OOH
MeO
HO
O
HO
N
H
O
HO
9
15
22
esterification
RCAM/
Lindlar
MeO
MeO
CO2R
PO
+ HO
PO
2-2
2-3
17
acylation/
CBS reduction
MeO
MeO
CO2R
2-5
N
O
Me
OMe
Evans
aldol
asymmetric
propargylation
2-4
OP
1-1
 
Figure 4. Key retrosynthetic cuts for cruentaren A by Fürstner and co-workers.29 
Synthesis of fragment 2-2 started from silicon protected benzoic acid 2-8, which was acylated 
with Weinreb amide 2-5 via the corresponding benzyllithium derivative (Scheme 2). A 
subsequent Corey-Bakshi-Shibata (CBS) reduction afforded alcohol 2-11 in 95% yield but 
with relatively low diastereomeric purity (de 85%). Next, protection of the secondary 
hydroxyl function, followed by selective cleavage of the trimethylsilylethyl ester furnished 
acid 2-12 in 83% overall yield. The synthesis of Weinreb amide 2-5 commenced with the 
alkylation of 2-6 with 1-iodo-2-butyne. Removal of the oxazolidinone auxiliary and coupling 
of the obtained acid with N,O-dimethylhydroxylamine completed the synthesis of amide 2-5. 
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Scheme 1. Synthesis of Weinreb amide 2-5. 
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Scheme 2. Synthesis of acid 2-12. 
In a similar way for the introduction of the C18 methyl group they relied on the alkylation of ent-
2-6 with propargyl iodide 2-13 (Scheme 3). Reductive cleavage of auxiliary, followed by Lindlar 
reduction and Dess-Martin oxidation furnished aldehyde 2-15. Subjection of the latter to an Evans 
aldol reaction gave adduct 2-16 in good overall yield and high selectivity (≥96% de). Simple 
transformations, namely TBS-protection, cleavage of oxazolidinone auxiliary and Dess-Martin 
oxidation secured aldehyde 2-18. The last stereocenter was introduced using asymmetric 
propargylation methodology recently developed by Soderquist and co-workers.30 
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Scheme 3. Synthesis of alcohol 2-21. 
Exposure of aldehyde 2-18 to enantiopure allenylborane (S)-2-19 afforded propargyl alcohol 
2-20 in 75% yield and greater than 95% de. TES protection of the obtained hydroxyl function, 
followed by deprotonation of the terminal alkyne and subsequent treatment with methyl 
iodide established internal an alkyne fragment, required for RCAM reaction. Finally, selective 
TES deprotection mediated by HF·pyridine complex secured desired alcohol 2-21. 
 
After numerous attempts to couple acid 2-12 with alcohol 2-21, it was finally found that the 
desired ester can be obtained by reacting the sodium alcoholate derived from 2-21 with acid 
fluoride 2-23 (Scheme 4). The latter was best prepared by treatment of 2-12 with 2,4,6-
trifluoro-1,3,5-triazene (2-22) and pyridine. Ring closing of ester 2-24 was performed using the 
molybdenum complex 2-25, activated in situ by CH2Cl2. This key transformation proceeded 
smoothly and provided cycloalkyne 2-26 in excellent yield. Lindlar reduction, followed by THP 
ether deprotection, azide group introduction under Mitsunobu conditions and subsequent 
Staudinger reduction furnished amine 2-30 in respectable overall yield. 
  Literature Review 10 
OMe
MeO
TBDPSO
80 °C, (87%)
2-21
 THF (91%)
OMe
MeO
TBDPSO
O
O
TBSO
2-23
2-12
O
F
N
N
N
F
F F
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Scheme 4. Synthesis of amine 2-30. 
After coupling of amine 2-30 with acid 2-31, treatment of the obtained fully protected 
cruentaren A (2-32) with BCl3 led to selective cleavage of the C3 methyl ether as well as 
removal of the TBS ether in the amide portion of the molecule (Scheme 5). Deprotection of the 
two remaining silicon groups turned out to be rather difficult. The use of standard fluorine 
sources met with failure (TBAF with or without HOAc or NH4Cl; TASF/DMF, DMA or 
MeCN; HF·pyridine). This can be attributed to the tendency of the 9-OH group to engage in 
translactonization, which leads to cruentaren B. Finally, it was found that the crucial 
deprotection can be achived by using aqueous HF (pKa ≈ 3.14) in MeCN. This secured 
cruentaren A in 84% yield. 
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Scheme 5. Completion the synthesis of cruentaren A (1-1). 
Although Fürstner and co-workers achieved a quite convergent synthesis of cruentaren A with 
21 steps in the longest linear sequence, the final compound was obtained in only 3% overall 
yield. This can be attributed to the fact that in the final stage of the synthesis some steps 
turned out to be less efficient (transformation to azide 65%, amide coupling 64%). 
 
In addition, a total synthesis of essentially inactive δ-lactone cruentaren B was recently 
reported by Chakraborty.31 As key reactions for the establishment of chiral centers of the 
stereotetrad Mukaiyma and Evans aldol reaction were used. To fashion the anti-OH/Me 
pattern at C9/C10 a Brown’s asymmetric crotylboration came to use. For the creation of the 
C7-C8 bond they relied on a Stille coupling reaction. Required Z-allylamide fragment was 
attached using a Wittig olefination. 
O
MeO
OH O OH OH
N
H
O OH
cruentaren B (2-1)
Stille
coupling
Brown's
crotylboration
Mukaiyama
aldol
Evans
aldol
Wittig
SN2
9
15 18
 
Figure 5. Retrosynthetic analysis of cruentaren B by Chakraborty. 
Developed synthesis consists of 26 linear steps and provides cruentaren B in 7.1% overall yield. 
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2.3 Key Reactions and its Mechanisms 
For the synthesis of such complex molecules as cruentaren A one would need to apply a broad 
spectrum of well established and modern synthetic methodologies. Therefore, an overview of 
the most important reactions used for our cruentaren A synthesis is provided below. Since it is 
not possible to describe every method in detail in this thesis, for each reaction only the general 
information and the most representative examples of application are given. 
 
2.3.1 Ring closing alkyne metathesis 
Among the few limitations that infringe upon the superb overall application profile of ring-
closing olefin metathesis (RCM), the lack of control over the configuration of the newly formed 
double bond constitutes a significant handicap when applied to macrocyclic systems.32 The 
cycloalkenes formed are usually obtained as mixtures of E and Z isomers, with the E isomers 
dominating in most of the recorded examples. This constitutes a significant drawback in many 
natural product syntheses as can be clearly seen, for example in the epothilone case.33 
To avoid this inherent problem, recently a stereoselective approach to macrocyclic Z alkenes 
which comprises a ring-closing metathesis reaction of diyne substrates followed by semi-
reduction of the resulting cycloalkyne products was proposed by Fürstner (Scheme 6).34 The 
nature of the process allows for similar retrosynthetic logic as with RCM to be applied whilst 
having the additional benefit of introducing a predictable component for stereocontrol. 
X
R1
R2
X
R1
R2
+
RCAM
Semi-reduction
(Lindlar)
X
 
Scheme 6. Z-selective approach to macrocyclic systems using a RCAM/semi-reduction 
sequence. 
Alkyne metathesis refers to the mutual exchange of the alkylidyne units between a pair of (non-
terminal) acetylene derivatives. Whilst the nature of the catalytically active species formed in 
situ from suitable precursors remained elusive, Katz et al. proposed that metal carbynes likely 
account for the catalytic turnover in a sequence of formal [2+2] cycloaddition and 
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cycloreversion steps (Scheme 7).35 The proposed mechanism was later experimentally proven 
by Schrock using high valent metal alkylidynes. 36  As additional proof of this theory was 
isolation and characterization of several intermediate metallacyclobutadiene complexes formed 
by [2+2] cycloaddition of alkylidynes and alkynes.37 
R2
R1R1R1
M R2
M
R1 R1
R2
M
R1 R1
R2 M
R1
+ +
 
Scheme 7. Mechanism of alkyne metathesis. 
The first effective catalyst for alkyne metathesis was found by Mortreux et al.38 It was shown 
that the desired transformation is effected by a homogenous mixture of Mo(CO)6 (or related 
molybdenum sources) and simple phenol additives heated in high boiling solvents. The most 
widely used phenols for ‘instant’ activation of Mo(CO)6 are 4-chlorophenol and 4-
trifluormethylphenol. The simplicity and user-friendly nature of this catalyst system is offset 
somewhat by its rather limited tolerance of polar functional groups and the elevated 
temperatures (ca. 140–150 °C) required for initiating and maintaining catalytic activity. 
Recently, Grela et al. identified 2-fluorophenol and 2-fluoro-5-methylphenol as the optimal 
additives in various alkyne metatheses.39 
 
A major breakthrough in rational catalyst design for alkyne metathesis came with the 
development of well-defined tungsten alkylidyne complexes by the Schrock group, of which 
catalyst (tBuO)3W≡CCMe3 (2-34) is the most widely used. 40 It operates under fairly mild 
conditions, sometimes ambient temperature, effecting up to several hundred catalytic turnovers 
per minute. Although complex 2-34 has recently been made commercially available, it can be 
efficiently prepared in large scale from (tBuO)3W≡W(OtBu)3 and neoheptyne (Scheme 8).41 
W
OtBu
tBuO
OtBu
WCl4 4  LiNMe2 (Me2N)3W W(NMe2)31/2
tBuOH
(tBuO)3W W(OtBu)3
+
neoheptyne
2-34 
Scheme 8. Scaleable preparation of the tungsten alkylidyne complex 2-34. 
The first application of catalyst 2-34 in the synthesis of functionalized macrocycles was 
reported by Fürstner.34b It was shown that utilizing catalyst 2-34 cyclic products with ring sizes 
12 or greater can be obtained in good to excellent yield. Moreover, ether, ester, enoate, amide, 
silyl ether, sulfonamide, carbamate and sulfone functionalities were accommodated in the 
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RCAM process catalysed by complex 2-34.34c It should be noted, that due to incompatibility of 
terminal alkynes with catalyst 2-34 end-caped substrates with R = Me, Et are necessary for 
successful cyclization. At first RCAM was successfully employed in the synthesis of olfactory 
molecules: civetone, ambrettolide and yuzu lactone. 
RCAM of the acyclic diyne 2-35 at 80 °C with catalyst 2-34 afforded the desired cycloalkyne 
2-36 in good yield (Scheme 9). Subsequent Lindlar reduction furnished the valuable 
fragrance civetone.42 Interestingly, the carbonyl functions of the starting material and product 
are kinetically inert toward the tungsten alkylidyne. Furthermore it was shown that in situ 
generated catalyst from a Mo(CO)6/4-trifluormethylphenol mixture was also effective in 
metathesis reaction. 
O
O
W
OtBu
tBuO
OtBu 2-34
toluene, 80 °C  (65%)
or
Mo(CO)6 (5%), F3CC6H4OH
chlorobenzene, 140 °C  (59%)
Lindlar
(94%)
civetone
2-35 2-36
 
Scheme 9. Stereoselective synthesis of civetone by Fürstner et al.42 
Other representative examples of utilization of RCAM are the syntheses of the insect repellent 
alkaloid epilachnene and the cytotoxic sponge extract motuporamine C43 where the key ring 
closing could be achieved using either 2-34 or the ‘in situ’ Mortreux system (Scheme 10). 
W
OtBu
tBuO
OtBu 2-34
(62%)
or
Mo(CO)6/p-ClC6H4OH
(68%)
NFmoc
2-37
N
Fmoc
Motuporamine C
2-38
 
Scheme 10. Stereoselective synthesis of motuporamine C by Fürstner et al.43 
During the Fürstner synthesis of nakadomarin A it was shown that the rather labile furan 
moiety could be tolerated along with the sulfone and amide group under the reaction 
conditions (Scheme 11).34c 
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Scheme 11. Synthesis of the macrocyclic perimeter of nakadomarin A by Fürstner et al.34c 
A very interesting application for RCAM was found during the elegant synthesis of 
citreofuran, 44  which belongs to the curvularin family of natural products. As is shown in 
Scheme 12, the readily prepared diyne 2-41 underwent smooth macrocyclization within 1 hour 
upon the addition of catalyst 2-34 (10 mol%) to a solution of substrate in toluene at 85 °C to 
afford 12-membered benzolactone 2-42 in 78% yield. The relative ease of this cyclization is 
likely to be due to the presence of the preexisting aromatic ring, which restricts the 
conformational degrees of freedom available to the starting material 2-41. Treatment of 2-42 
under acidic conditions initiated a transannular cycloaromatization that led to the formation of 
the furan 2-43. Subsequent cleavage of both methyl ethers completed this concise synthesis of 
citreofuran. 
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Scheme 12. Total synthesis of citreofuran by Fürstner et al.44 
It is important also to recall the recent development of novel methodology for the conversion 
of alkynes into the corresponding E-alkene systems. A general and mild procedure based on a 
hydrosilylation/protodesilylation strategy was independently developed in both the Trost 
group, for acyclic substrates45, and Fürstner group with cyclic systems. 46 The use of the 
cationic ruthenium complex [Cp*Ru(MeCN)3]PF6 and (EtO)3SiH for hydrosilylation of the 
alkynes affords a highly chemo- and streoselective trans addition in decent to excellent yields 
with good compatibility with a host of functional groups (Scheme 13).47 
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Scheme 13. Stereoselective synthesis of macrocyclic alkenes via RCAM followed by trans-
selective hydrosilylation and protodesilylation. 
It was shown that the use of AgF led to rapid, quantitative and selective desilylation under 
mild conditions without damaging the configurational integrity of the double bond. AgF can 
also be used in sub-stoichiometric amounts (2–20%) provided that TBAF is added to the 
medium as a stoichiometric fluoride source. The overall set of conditions holds promise for 
the application of this three step sequence to complex molecules. 
Recently, the Fürstner group introduced the monochloro molybdenum complex 2-44 as a 
powerful precatalyst for alkyne metathesis. 2-44 is conveniently formed in situ by the 
activation of the corresponding trisamido complex 2-25 with CH2Cl2 as a chlorine source 
(Scheme 14).48 Notably, another halogen sources (CHCl3, CCl4, CH2Br2, CH2I2, C6H5CHCl2, 
C6H5CH2Cl, Me3SiCl) were successfully used for the activation of 2-25 in order to form 
metathesis active components.48a 
Mo
N
N N
tBu
tBu
tBu
CH2Cl2
Mo
N
N N
tBu
tBu
tBu
Cl
2-25 2-44  
Scheme 14. Activation of the molybdenum trisamido complex 2-25 to form metathesis active 
component 2-44. 
Importantly, this system not only effects the formation of macrocyclic cycloalkynes of 
different ring sizes (12–26 membered) but also tolerates functional groups which completely 
shut down the catalytic activity of the tungsten alkylidyne catalyst 2-34. Thus thioethers, 
basic nitrogen atoms and polyether chains survive conditions of the metathesis reaction. As a 
representative example one can mention the critical ring-closing step in the course of the total 
synthesis of cruentaren A,29 where the utilization of catalyst 2-34 led only to the cleavage of 
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the terminal THP acetal without inducing the macrolactone formation. In contrast to this 
unsuccessful attempt, the use of the molybdenum complex 2-44 activated in situ by CH2Cl2 
secured desired cycloalkyne in excellent yield. 
Similarly to complex 2-34, 2-25 is also compatible with a broad spectrum of functional 
groups (ester, isolated double bonds, silyl ethers, sulfones, aldehydes, nitro groups, ketones, 
alkyl chlorides, acetals and nitriles). However, ‘acidic protons’ such as those of secondary 
amides, which are tolerated by 2-34, could not be endured by catalyst 2-25, whereas tertiary 
amides are fully compatible. The enhanced functional group tolerance of 2-25 can be 
attributed to the big sterical demands of the molybdenum atom, preventing coordination of 
potential donor substrates onto the catalytically active template. 
In addition, this newly developed catalytic system 2-25 along with Lindlar reduction was 
efficiently applied for the stereoselective construction of the C12–C13 double bond of 
epothilone C. Fürstner and co-workers found that the desired macrocyclization could be 
affected in a pleasing 80% yield by treatment of substrate 2-45 with the trisamido 
molybdenum catalyst precursor 2-25 (10 mol%) in a toluene/CH2Cl2 solvent mixture at 80 °C 
for 8 h (Scheme 15).49 A subsequent Lindlar hydrogenation of the cycloalkyne established the 
required Z double bond. 
O
O
O
Me Me
TBSO Me N
S
O
O
O
Me Me
TBSO Me N
S
Complex 2-25
(10 mol%)
toluene/CH2Cl2
80 °C (80%)
2-45
2-46
O
O
O
Me Me
HO Me N
S
epothilone C
12
13
 
Scheme 15. RCAM in the total synthesis of epothilone C. 
Notably, the catalyst 2-25 rigorously distinguishes between the (reactive) alkyne moieties and 
the preexisting double bond of the precursor 2-45. Thus, a useful feature of alkyne metathesis 
is that alkene systems are generally inert toward the catalyst. The particular choice of the 
catalyst system in this case was important, owing to its tolerance of both the sulfur and basic 
  Literature Review 18 
nitrogen atoms of the thiazole ring, the presence of which would have been deleterious to the 
use of the Schrock catalyst 2-34. 
In conclusion, alkyne metathesis provides a widely applicable technology for the creation of 
alkyne system which thereafter can be used as branching set point for subsequent selective 
manipulations. In particular, the combination of alkyne ring-closing metathesis followed by 
stereoselective partial reduction of the triple bond offers an efficient, though indirect, method 
for the mild preparation of macrocyclic alkenes of well-defined E or Z stereochemistry. 
Application of classical tungsten alkylidyne complex 2-34 along with recently developed 
molybdenum trisamido precatalytic system 2-25 allows alkyne metathesis of highly 
functionalized substrates under mild conditions. 
 
 
 
2.3.2 Evans aldol reaction 
The aldol structural motif is one of the most frequently appearing in many natural products, 
especially in polyketides, from which many pharmaceuticals are derived, including the potent 
immunosuppressant FK506, the tetracycline antibiotics, and the antifungal agent amphotericin 
B. Extensive research on the aldol reaction has produced highly efficient methods which 
enable the otherwise challenging synthesis of molecules with complex architecture. 
The directed aldol reaction is widely recognized as one of the most powerful carbon – carbon 
bond forming reaction available for the regio-, diastereo-, and enantioselective construction of 
complex intermediates. 50  The utility of the asymmetric aldol addition has been amply 
demonstrated through a multitude of synthetic application. 51  Despite recent advances in 
organocatalytic routes to asymmetric aldol reactions,52 auxiliary based approaches remain 
steadfast as a principle means to achieve high yields of aldol adducts with reliably high 
stereocontrol. In addition, dibutylboron enolates of N-acyl oxazolidinones, pioneered by 
Evans, are the most commonly utilized enolates and are highly effective for the preparation of 
Evans syn products in asymmetric aldol additions. 
 
In theory, up to four different stereoisomers can be generated in aldol reactions since two new 
stereocenters can be created by the process. A major breakthrough in understanding the 
stereochemical outcome of aldol reactions came with the proposal of Zimmerman and Traxler, 
according to which some aldol reactions proceed through six-membered chair-like transition 
states. This statement is now well known as Zimmerman-Traxler model.53  
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The configuration of the aldol product strongly depends on the geometry of the boron enolates 
used in these reactions: E-enolates give anti aldols whereas Z-enolates give syn aldols. These 
results can be easily explained by the transition states shown in Figure 6. The aldol addition 
proceeds via a chairlike, six-membered transition state, which is more rigid than those of alkali 
metal enolates. This tight transition state arises from the shorter boron–oxygen bond, which 
maximizes the 1,3-diaxial interactions (R3↔L) in the transition state. This strong dependence of 
the configuration of the aldol adducts on the geometry of the enolates enables syn- as well as 
anti-configured aldols to be made as desired. 
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Figure 6. Aldol reactions of Z- and E-boron enolates with aldehydes. 
The simplest and most common method for accomplishing asymmetric induction in any type 
of reaction is to utilize a chiral element within one of the reactants to direct its interaction 
with another. In 1981 Evans reported the application of N-acyl oxazolidinones as chiral 
auxiliaries for diastereoselective syn aldol reactions.54 After pioneering, this strategy became 
a very important tool in the synthesis of a broad range of bioactive natural products. Since the 
acylated oxazolidinone is an imide, it can produce only Z-enolate upon treatment of 
dibutylboron triflate and a tertiary amine. As is known, boron forms a strong and short bond 
with oxygen and thus forms a tight six membered chair like transition state that leads to syn 
aldol adduct with high preference. Preferential formation of syn aldol arises from blockage of 
one side of the enolate by a bulky group in the oxazolidinone ring (Figure 7). In the reaction 
transition state, the carbonyl group of the oxazolidinone and the C–O bond of enolate arrange 
in an anti fashion to each other in order to minimize dipole-dipole repulsions. In this 
arrangement the aldehyde approaches the enolate from the less hindered side of the chiral 
auxiliary. 
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Figure 7. Favored transition state for Evans aldol reaction. 
Extremely high diastereoselectivity (diastereomeric ratios up to 600:1 for matched cases and 
more then 20:1 for mismatched case with aldehydes bearing a stereogenic center at the α-
position) and a broad spectrum of possible chemical transformation of obtained aldol adduct 
make this reaction an irreplaceable synthetic tool for modern organic synthesis. In order to 
increase the selectivity and simplify the procedure of purification of the obtained aldol 
adducts a huge number of oxazolidinones and thiazolidinethiones were prepared, most of 
which became commercially available in both enantiomeric forms (Figure 8). 
X NH
X
R4R3
R1
R2
R1= R2= R3= H; R4= Bn, iPr, Ph, tBu; X = O, S
R1= R2= Ph; R3= H, R4= iPr; X = O, S
R1= Ph; R3= Me; R2= R4= H; X = O, S
 
Figure 8. Structure of auxiliaries used for aldol reactions. 
Due to its efficiency this methodology is widely used in the synthesis of polyketide natural 
products, and pharmaceuticals.55 One of the first representative examples was a convergent 
synthesis of ionomycin56 developed by Evans and co-workers. Other elegant applications of 
the boron enolate method can be found in the total synthesis of macrolide antibiotics 
rutamycin A,57 cytovaricin,51a and macbecin.58 The Novartis’ large-scale synthesis of (+)-
discodermolide showed that this reaction can be conducted in multigram amounts (up to 50 
kg). 
It is important to mention, that Evans efficiently extended his aldol methodology introducing 
a versatile approach to the assemblage of polypropionate systems. Depending on the Lewis 
acid used for β-keto imide enolisation one can assemble three of the four possible 
stereoarrays: anti-syn, syn-syn59 and anti-anti60 (Scheme 16). 
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Scheme 16. Application of Evans’ extended aldol methodology.59,60 
This approach was successfully applied by Smith and Brandt during the asymmetric synthesis 
of the potent cytotoxic agent (–)-callystatin A.61 
 
One of the most important modifications of Evans’ auxiliary was done by Crimmins and co-
workers. It was shown that asymmetric aldol additions using chlortitanium enolates of N-
acyloxazolidinone, oxazolidinethione, and thiazolidinethione propionates can proceed with 
high selectivity for the Evans or non-Evans syn product depending on the nature and amount 
of the base used to generate the enolates. 62 The change in facial selectivity in the aldol 
additions was proposed to be a result of switching of mechanistic pathways between chelated 
and nonchelated transition states. The reaction with boron enolates proceeds via the non-
chelated transition state 2-49 and provides ‘Evans’ syn adducts 2-50. However, the use of 
titanium tetrachloride for the enolisation allows the formation of the chelated transition state 
2-51, which leads to ‘non Evans’ syn adducts 2-52. 
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Figure 9. Non-chelated (2-49) and chelated (2-51) transition states in the asymmetric aldol 
addition using chlortitanium enolates of N-acyloxazolidinone, N-acyloxazolidinethiones and 
thiazolidinethiones. 
 
The obtained experimental results were in full accordance with the proposed mechanism. The 
Evans syn products were obtained, via the non-chelated transition state 2-49, when titanium 
enolates were formed in the presence of two equivalents of (–)-sparteine. It can be attributed 
to the coordination of second equivalent of amine to the metal center which prevents further 
coordination of the imide or thioimide carbonyl to the titanium. However, using only one 
equivalent of amine in the enolisation step resulted in preferential formation of non-Evans syn 
products. In this case the imide carbonyl or the thiocarbonyl coordinated to the metal center to 
produce the highly ordered chelated transition state 2-51. Coordination of the imide carbonyl 
or thiocarbonyl to the metal center led to reversal of the π-facial orientation of the enolate in 
the transition state. In addition, N-acyloxazolidinethiones and thiazolidinethiones are 
significantly easily to remove. 
 
Recently, Crimmins communicated a paper devoted to highly diastereoselective acetate aldol 
additions using chlorotitanium enolates of mesityl-substituted N-acetyloxazolidinethione and 
N-acetylthiazolidinethione auxiliaries.63 These additions proceed in high yields and diastereo-
selectivities (93:7 to 98:2) for aliphatic, aromatic, and α,β-unsaturated aldehydes. 
 
Most auxiliary-based aldol reactions require a stoichiometric addition of metal salt (B, Ti, Si 
etc.) to form the required enolate derivative. Lately, Evans and co-workers reported the first 
examples of metal-catalyzed aldol reactions by using both standard oxazolidinone ent-2-664 
Literature Review   23
and thiazolidinethione 2-4865 based auxiliaries. The addition of a magnesium halide (0.1–0.2 
equiv.) to a EtOAc solution of the auxiliary and aldehyde in the presence of NEt3 and TMSCl 
yielded ‘non-Evans’ 2-53 and ‘Evans’ anti aldol adduct 2-54 in high yield and with 
respectable selectivity (Scheme 17). However, this potentially valuable anti-aldol route was 
shown to be restricted to nonenolizable aldehydes under these conditions. 
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Scheme 17. Magnesium halide catalyzed anti-aldol reactions. 
 
2.3.3 Addition of chiral allenylzincates to aldehydes (Marshall-Tamaru reaction) 
Polyketide natural products have played a major role in the development of synthesis 
methodology for acyclic stereocontrol. The most common synthetic approach for constructing 
the various stereotriad66 and higher subunits of these compounds involves diastereo- and 
enantioselective carbon–carbon bond forming reaction related to variants of the aldol reaction. 
Allylborane and boronate, allylsilane, and allyltitanate additions have also been applied with 
great success. Many of these approaches utilize a chiral auxiliary or substrate to effect 
stereochemical control. One of the most problematic tasks in stereotriad synthesis is 
introduction of the moiety with anti oriented methyl and hydroxyl groups. The most 
frequently used methods for this purpose are Brown asymmetric crotylboration and Abiko 
aldol reaction. 
Addition of chiral nonracemic allenylmetal reagents to chiral aldehydes have also proven 
useful for the assembly of stereotriad and stereotetrad segments of polyketide natural 
products. 67  These reagents rely upon allene chirality to favor one of the two possible 
diastereomeric transition states in the addition and thus differ in fundamental way from the 
aforementioned methods in which a chiral auxiliary or catalyst provides the control element. 
 
First insights in the application of allenylzinc compounds for the stereoselective synthesis 
were made by Tamaru and coworkers. 68  In 1996 they found that propargylpalladium 
complexes can undergo a nucleophilic addition to carbonyl compounds to provide 
homopropargyl alcohols 2-56 selectively (Scheme 18). 
  Literature Review 24 
R1
OBz
Ph
R1
OH
Pd(PPh3)4 (5 mol%)
Et2Zn, 2.4-3.6 equivR2
2-55
+ PhCHO
R2
R1
R2
OH
Ph+
2-56
2-57
Et
R1
2-58
R2R1 = H, Me, Ph
R2 = H, Me, Ph, TMS
(52-80%), syn:anti = 1:1
major product
 
Scheme 18. Addition of propargylpalladium complexes to carbonyl compounds. 
The propargylation of benzaldehyde proceeded smoothly at room temperature by stirring a 
solution of a propargyl benzoate 2-55 (1.2 equiv.), a carbonyl compound (1 equiv.), 
diethylzinc (2.4–3.6 equiv.), and tetrakis(triphenylphosphine)palladium (5 mol%) in THF 
under nitrogen. 
The outcome of this palladium-catalyzed propargylation of carbonyl compounds may be 
rationalized according to Scheme 19, under the assumption that both the transformation of II 
to a mixture of III and IV and the reactions of these two with benzaldehyde proceed much 
faster than the reductive elimination of II to provide 2-58. The selective formation of the 
alcohols 2-56 may be attributed to the preponderance of III (with Csp2-M bonding) over IV 
(with Csp3-M bonding) in the equilibrium shown in Scheme 19. 
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Scheme 19. Mechanistic rationale for the propargylation and allenylation of benzaldehyde. 
Significant improvement in the additions of in situ generated chiral allenylzinc reagents to 
aldehydes was achieved by the Marshall group. 69  They reported that enantioenriched 
propargylic mesylates can be efficiently converted to chiral allenylzinc reagents via transient 
allenylpalladium species by treatment with Pd(0)-phosphine catalyst in the presence of excess 
Et2Zn. These zinc reagents undergo SE2’ additions to various aldehydes to yield mainly the 
anti homopropargylic alcohol adducts of high ee. As a result of detailed investigation of this 
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reaction they found that the best leaving group is mesylate, the reaction is most efficient in 
THF with Pd(OAc)2·PPh3 as the catalyst system, and the best diastereoselectivity can be 
achieved when the reaction was carried out at –20 °C. The reaction proceeds via a distorted 
transition state (Scheme 20). The preference for anti over syn adducts can be attributed to an 
unfavourable eclipsing interaction between the allenyl Me and the aldehyde substituent in the 
transition state B leading to the syn adduct. 
MsOZn
R1 Me
H
O
H
H
R2
OMs
MsOZn
R1
H
R2
Me
OH
Me
R2
HHO H
HMe
Pd(PPh3)4
Et2Zn, THF
–78 to –20°CR1
2-59
R1
R1
MsOZn
R1
H
O
H
A
2-60
H
Me
R2
unfavorable
eclipsing
interaction R
2
Me
OH
Me
R1
anti
syn
CHOR2
B  
Scheme 20. Possible cyclic transition states for allenylzinc additions to aldehydes. 
Interestingly, high diastereoselectivity was observed in additions to both enantiomers of α-
methyl propanal derivatives to afford the anti,anti and anti,syn adducts. Thus, the preference 
for the anti transition state overrides Felkin–Anh considerations in these additions with a 
resulting absence of mismatching.70 The suggested catalytic cycle for the metal exchange 
process was based on the previous investigations of the Tamaru71 and Knochel72 groups. A 
key feature of a possible catalytic cycle for the Pd–Zn exchange reaction involves reductive 
regeneration of the active Pd(0) catalyst from a Pd(II) intermediate through extrusion of 
ethylene (Figure 10). The SN2’ reaction with Pd(0) catalyst results in formation of 
allenylpalladium intermediate A which subsequently reacts with diethylzinc to give the 
allenylzincate C. The latter undergoes SE2’ additions to aldehyde which results in elimination 
of a Pd(II) intermediate. The palladation of propargylic mesylates was shown to take place 
with inversion,73 and the predominant formation of anti adducts 2-60 strongly implicate a syn 
addition process which can be attributed to the cyclic transition state. Therefore, it can be 
assumed that the zincation reaction proceeds with retention of configuration. 
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Figure 10. Possible catalytic cycle for Pd(0) catalyzed zincation of propargylic mesylates. 
Although (R) and (S)-3-butyn-2-ol, precursors for corresponding mesylates are commercially 
available, their high cost limits widespread or large-scale application. Thus, an efficient 
synthetic route to the desired enantiomeric alcohols was developed. It is based on a kinetic 
resolution of 4-(TMS)-3-butyn-2-ol (R,S)-2-61 mediated by Amano AK lipase in the presence 
of vinyl acetate. This enantioselective acetylation affords unchanged (S)-TMS-3-butyn-2-ol 
((S)-2-61) and the corresponding (R)-acetate 2-62, both with high ee (Scheme 21).74 The two 
are readily separated through treatment of the mixture with succinic anhydride and extraction 
of the (S)-succinate 2-63 with aqueous NaHCO3. Reduction of each ester with DIBAL-H 
affords the enantiomeric butynols (S)- and (R)-61 of high ee. 
Alternatively, the acetate (R)-2-62 or the succinate (S)-2-63 can be cleaved with hydrazine 
hydrate in ethanol. 75  The acyl hydrazides formed in this reaction are water soluble and 
washed out by extraction. 
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Scheme 21. Kinetic resolution of racemic 4-(TMS)-3-butyn-2-ol with Amano AK lipase. 
This chiral allenylzincate methodology provides access to all isomers of the homopropargylic 
alcohol stereodiad and stereotriad adducts with excellent diastereo- and enantioselectivity. 
The overall utility of the methodology is reflected in applications in the total synthesis of 
natural products such as zincosporin,76 discodermolide,77 (–)-callistatin A,78 aplyronine A,79 
tautomycin,80 leptofuranin D,81 cytostatin.82 
In addition, the acetylenic grouping of the adducts can be further elaborated, both functionally 
and for chain extension by a variety of protocols. It was shown that homopropargylic alcohol 
2-64 can be converted to the unsaturated lactone (pentenolide) 2-67 through carboxylation of 
the lithiated alkynes with CO2 followed by partial hydrogenation of triple bond and thermal 
lactonization (Scheme 22). The 4-alkylpentenolide moiety of 2-67 is found in a number of 
biologically active polypropionate natural products.83 
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Scheme 22. Conversion of homopropargylic alcohols to unsaturated ketones. 
Catalytic hydrogenation of the obtained triple bond followed by oxidative degradation will 
lead to corresponding aldehyde 2-68, whereas hydroboration with dicyclohexylborane 
followed by in situ oxidation of the obtained vinylborane intermediate provides 
homoaldehyde 2-69 (Scheme 23). In addition, intermediate vinyl- or alkylboranes can be 
efficiently used in cross-coupling reactions.84 
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Scheme 23. Possible transformation of homopropargylic alcohols. 
Other synthetic utilisation of the triple bond includes alkylation, 85 addition to aldehydes, 
epoxide opening, cross-coupling etc. 
 
2.3.4 Synthesis of enamides via copper-catalyzed coupling of amides with vinyl 
halides 
Enamides are important synthetic intermediates,86 as well as a structural component of many 
natural products. The most commonly used protocols for their preparation include direct 
addition of amides to alkynes, 87 acylation of imines, 88 the Curtius rearrangement of α,β-
unsaturated acyl azides,89 and the olefination of amides.90 Although these protocols provide 
access to enamides, they suffer from either low yield or lack of stereocontrol on the double 
bond geometry. Transition metal-catalyzed C–N bond formation has been an area of intensive 
research during the past 15 years. 
 
In 1991 Ogawa at al. reported the copper iodide-promoted substitution of vinyl bromides and 
potassium amides (1 equiv. of CuI, HMPA, 130 °C) to afford enamides in low to moderate 
(38–45%) yields.91 More recently, using CuTC (TC = thiophene-2-carboxylate) as a catalyst, 
Porco described a copper catalyzed amidation of vinyl iodides to give enamides in moderate 
yields.92 Developed methodology was applied to the synthesis of O-methyloxime enamide 
side chains related to the natural products lobotamides A-F, oximidine I and II, and CJ-12950. 
Also a possible mechanism of copper-catalyzed enamide formation was proposed.92 
According to scenario A, a cesium carboxamide may react with CuTC to afford a cuprate-like 
intermediate which forms the enamide after four-centered ipso-substitution of the vinyl 
iodide. In a second scenario (B), oxidative addition of the vinyl iodide to CuTC occurs which 
may be favored because of the carboxylate ligand (Scheme 24). Displacement of a copper 
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iodide intermediate by the cesium carboxamide would be followed by reductive elimination to 
afford the enamide product. 
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Scheme 24. Mechanistic scenarios for copper-catalyzed enamide formation.92 
This methodology was successfully employed by Fürstner et al. in the total synthesis of 
salicylihalamide.86b Reaction of 2-70 with amide 2-71 (3 equiv) in the presence of CuTC (50 
mol%) and Rb2CO3 (3 equiv) afforded a mixture of salicylhalamide A and B in 57% yield 
(Scheme 25). Notably the use of Cs2CO3 failed to afford any of the desired product under 
otherwise identical conditions. 
HO
CuTC, Rb2CO3
DMA 90 °C 
(57%)
O
O
OH
I
O
H2N HO
O
O
OH
O
HN
2-70
2-71
Salicylihalamide A: 17(E)
Salicylihalamide B: 17(Z)
17
 
Scheme 25. Synthesis of salicylihalamide A and B by Fürstner et al.86b 
During the total synthesis of oximidine II by Porco et al. it turned out that amidation of 2-72 
using conditions earlier reported for (E)-vinyl iodides92 led to low yield due to competitive 
elimination under basic conditions. After a model study involving evaluation of various ligands 
and bases they found that 2-72 coupled smoothly with 2-73 employing stoichiometric amounts 
of CuTC–N,N’-dimethyl-ethylendiamine and K2CO3 as a base (Scheme 26).93 
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Scheme 26. Synthesis of oximidine II by Porco et al.93 
Other examples of CuTC-catalyzed amidation of vinyl iodides include total synthesis of 
oximidine III94 as well as synthesis of apicularen A95 and its analogues.96 
More recently Buchwald and co-workers developed a general and efficient copper-catalyzed 
method for the amination of vinyl bromides and iodides.97 This protocol uses a combination 
of 5 mol% copper iodide and 20 mol% N.N’-dimethyl ethylendiamine in the presence of 
K2CO3 or Cs2CO3 as a base. Substrates bearing ester, silyl ether and amino groups were 
successfully coupled under the reaction conditions (Scheme 27). Both cyclic amides and 
acyclic amides could be combined with vinyl halides in excellent yields. It was shown that the 
coupling reaction of vinyl bromides required higher temperatures (110 °C) and longer stirring 
(15–30 h). In addition, di- and trisubstituted vinyl bromides were efficiently converted to the 
corresponding enamides in excellent yield. 
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Scheme 27. Scope of the copper-catalyzed amidation of vinyl halides.97 
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Importantly, the double bond geometry of the vinyl halides was retained under the reaction 
conditions. 
The Buchwald copper-catalyzed protocol found its application in the total synthesis of the 
marine macrolide palmerolide A98 and alkaloid ageladine A. 99 After all, due to the mild 
reaction conditions, broad scope, the operational simplicity and the functional group 
compatibility this methodology becomes a valuable synthetic tool for the installation of the 
structurally important enamide moiety. 
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3 Results and Discussion 
 
3.1 Retrosynthetic Analysis 
 
The target molecule, cruentaren A (1-1), features the following distinct fragments: 
a) 12-memebered benzolactone; 
b) Z-double bond in the ring; 
c) Z-allylamide side chain. 
As a key step for macrolactone formation, a ring closing alkyne metathesis (RCAM) followed 
by Lindlar reduction was deemed appropriate. As an option ring closing metathesis and 
classical macrolactonization strategies (Yamaguchi, Mitsunobu) might also be considered. 
Accordingly, we divided the target molecule into two main subunits: functionalized benzoic 
acid 3-1 and a stereotetrad containing fragment 3-2 (Figure 11). 
O
cruentaren A (1-1)
OH
MeO
HO
O
HO
N
H
O
HO
4
9
13
15
18
Wittig
esterification
aldol reaction
RCAM
or RCM
P1O
MeO
CO2H
P2O
+
Marshall- 
Tamaru
HO
P3O
OP4
3-1
3-2
 
Figure 11. Retrosynthetic analysis for cruentaren A. 
Alternatively, the C12–C13 bond could be secured by opening of epoxide 3-4 with the lithium 
salt of alkyne 3-3. Lindlar reduction of the obtained triple bond could be done after or before 
the macrolactonization step (Figure 12). 
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Figure 12. Alternative retrosynthetic analysis for cruentaren A. 
The required functionalized benzoic acid 3-1 might be synthesized using an Evans aldol 
reaction of aldehyde 3-5 with pentynyloxazolidinone 3-6. To provide the internal triple bond 
simple methylation of the corresponding acetylide was considered (Figure 13). 
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Figure 13. Retrosynthetic analysis for fragment 3-1. 
Fragment 3-2 logically originates from opening of epoxide 3-4 with the lithium salt of 
propyne or TMS-acetylene (Figure 14). 
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Figure 14. Retrosynthetic analysis for fragment 3-2. 
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Obviously, epoxide 3-4 should result from diol 3-7, which can be easily obtained from 
acetonide 3-8. Compound 3-8 can be derived from alkyne 3-9 using a hydroboration – 
reduction sequence. As a key step in the synthesis of the alkyne 3-9 containing the 
stereotetrad, a Marshall-Tamaru reaction of known aldehyde 3-10100 was envisioned in order 
to fashion the anti-configuration at C17/C18 (Figure 15). 
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Figure 15. Retrosynthetic analysis for epoxide 3-4. 
Results and Discussion   35
3.2 Ring Closing Metathesis Model Study 
 
3.2.1 Synthesis of diene 3-11 
According to the retrosynthetic analysis, one of the options to create the macrolactone ring is 
a ring closing metathesis (RCM) reaction.101 However, it is required that this reaction should 
provide the Z-alkene. Thus, our first goal en route to cruentaren A was to test the RCM 
strategy on a model substrate 3-11 to check for the Z/E ratio (Figure 16). The isopropyl group 
replaces the extended side chain. In order to prevent unwanted lactonization to the δ-lactone, a 
keto function can be used instead. Retrosynthetic analysis of terminal diene 3-11 shows that it 
might be obtained via an acylation of the benzylic anion derived from 3-12 with the Weinreb 
amide 3-13 using conditions, recently published by Winssinger et al.102 Logically, ester 3-12 
derives from the 2,4-dimethoxy-6-methylbenzoic acid 3-14 and commercially available 
alcohol 3-15. 
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Figure 16. Retrosynthetic analysis for RCM precursor 3-11. 
Synthesis of acid 3-14 was done in accordance with published procedures. At first, methyl 
acetoacetate was subjected to a self-condensation reaction in the presence of NaH and nBuLi103 
(Scheme 28). The obtained 2,4-dihydroxy-6-methylbenzoate was methylated with Me2SO4 in the 
presence of K2CO3 as a base.104 Subsequently, the methyl ester was saponified with KOH and the 
obtained acid was coupled with commercially available alcohol 3-15.102 This ester was 
deprotonated with freshly prepared LDA which was followed by addition of Weinreb amide 3-13. 
Unfortunately, the desired ketone 3-11 was obtained only in 27% yield. All our attempts to 
optimize the conditions of this reaction previously described by Winnsinger et al.102 were not 
successful. 
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Scheme 28. Synthesis of diene 3-11. 
Synthesis of Weinreb amide 3-13 started with enantioselective alkylation of Evans 
oxazolidinone 2-6 with allylbromide, following a previously described procedure105 (Scheme 
29). The obtained product was subjected to oxidative cleavage of the auxiliary using lithium 
peroxide in a THF/H2O mixture. This resulted in the formation of acid 3-17, which was 
subsequently converted to Weinreb amide 3-13 via formation of the corresponding mixed 
anhydride106. 
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Scheme 29. Synthesis of Weinreb amide 3-13. 
 
3.2.2 Ring closing metathesis of diene 3-11 
With sufficient amount of diene 3-11 in hand we started to investigate RCM conditions. 
Following a general procedure, substrate 3-11 was heated at 80 °C in degassed toluene in the 
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presence of 10 mol% of Grubbs 2nd catalyst. This resulted in the formation of a separable 
mixture of E- and Z-macrolactones in a ratio of 6:1 (Scheme 30). 
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Scheme 30. Ring closing metathesis of diene 3-11. 
Both of the macrolactones were crystalline solids. This allowed us to make an X-Ray analysis 
of the major product 3-18a. As on can see from Figure 17, the alkene protons are oriented in 
different directions, which confirms that the major product has the undesired E-configuration 
of the double bond. 
 
Figure 17. X-Ray analysis for the macrolactone 3-18a. 
One of the possible explanations of this outcome might be the fact, that the formation of the 
undesired E-isomer is thermodynamically more favorable. These disappointing results 
induced us to switch to the alternative strategy which is based on epoxide opening followed 
by classical macrolactonization. In this case the desired Z-alkene can be easily obtained from 
the corresponding alkyne via Lindlar reduction. 
 
 
 
 
E-configuration 
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3.3 Epoxide Opening Strategy 
 
3.3.1 Synthesis of alkyne 3-30 
The synthesis of a benzoic acid building block 3-30 was started with commercially available 
2,4-dimethoxybenzoic acid which was allylated via the dianion107 followed by methylation.108 
Degradation of the terminal double bond to an aldehyde function was achieved by a 
dihydroxylation/periodate cleavage sequence109 in good overall yield (Scheme 31). The OsO4 
required for this reaction was prepared from cheaper and relatively less toxic K2OsO4·2H2O in 
accordance with a literature procedure.110 
MeO
MeO
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O 1. sBuLi, TMEDA,
THF, –90 °C, 1.5 h
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–78 °C, 1.5 h
MeO
MeO
OH
O
MeO
MeO
OMe
O
MeI, DBU,
RT, 24 h
(51% 2 steps)
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tBuOH/H2O, RT, 24 h
2. NaIO4, MeOH, RT,
2 h (85% for 2 steps)
MeO
MeO
OMe
O
O
3-19 3-20
3-21 3-22  
Schema 31. Synthesis of aldehyde 3-22. 
Obtained aldehyde 3-22 was combined with pentynyloxazolidinone 3-25 via an Evans aldol 
reaction using the standard boron enolate.111 Trying different conditions, we have found that 
the highest yield (85%) of aldol adduct 3-26 could be obtained carrying the reaction in 
toluene. In comparison, the use of CH2Cl2 as solvent resulted in formation of 3-26 only in 
55% yield. The required alkyne 3-25 was obtained through acylation of lithiated 
oxazolidinone 3-24 with commercially available pentynoic acid 3-23, employing the mixed 
anhydride method106 (Scheme 32). Protection of the secondary hydroxyl function of aldol 
adduct 3-26 as tert-butyldimethylsilyl ether using TBS triflate and proton sponge as base, 
furnished the corresponding TBS ether 3-27 in excellent yield. Interestingly, applying 
classical condition for TBS protection (TBS triflate, 2,6-lutidine) we were able to get the 
desired product only in 35–40% yield. This can be attributed to possible δ-lactone formation. 
NaBH4 mediated reductive cleavage of the chiral auxiliary proceeds smoothly and produced 
the corresponding primary alcohol 3-28 in 91% yield.112 Conversion of the primary alcohol to 
the corresponding methyl group was achieved by tosylation of the hydroxyl function followed 
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by treatment of the intermediate tosylate with zinc/sodium iodide.113 This resulted in the 
formation of the required alkyne 3-30 in almost quantitative yield. 
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Scheme 32. Synthesis of alkyne 3-30. 
After having the desired alkyne 3-30 in hand we started the synthesis of the required epoxide 
fragment 3-4. 
 
3.3.2 Synthesis of epoxide 3-42 
Aldehyde 3-9, the substrate for the Marshall reaction was prepared in accordance with a 
published procedure. The aldol adduct obtained by Evans aldol reaction between 
oxazolidinone 2-6 and benzyloxyacetaldehyde was subjected to hydrogenolysis conditions in 
PPTS–2,2-dimethoxypropane–acetone, to afford an acetonide directly, which was 
transformed to alcohol 3-33 via reductive removal of the chiral auxiliary (Scheme 33). Swern 
oxidation of alcohol 3-33 proceeded smoothly and provided us with the corresponding 
aldehyde 3-9. 
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Scheme 33. Synthesis aldehyde 3-9. 
Due to possible epimerization, aldehyde 3-9 is chemically unstable and was immediately 
introduced in the Marshall-Tamaru reaction.81 Reaction of aldehyde 3-9 with propargylic 
mesylate (S)-3-3474a in the presence of PPh3, palladium(II) acetate and diethylzinc resulted in 
formation of alkyne 3-35 with excellent diastereoselectivity (22:1) and good yield (Scheme 
34). The only drawback of this reaction is the relatively long time required for complete 
consumption of aldehyde (72 h). 
After silyl protection of the hydroxyl function, the triple bond of 3-36 was hydroborated with 
Cy2BH. The vinylborane intermediate was in situ oxidized to aldehyde 3-37.81 Sodium boro-
hydride reduction of the aldehyde gave primary alcohol 3-38, which was protected using 4-
methoxybenzyltrichloroacetimidate114 leading to ether 3-39 in excellent yield. Cleavage of the 
acetonide moiety under mild conditions (CuCl2·2H2O, acetonitrile, –5 °C)115 afforded diol 3-
40. Other attempts to cleave the acetal of 3-39 (AcOH in THF at 50 °C, TFA in CH2Cl2, 
FeCl3/SiO2 in CHCl3) were unsuccessful – deprotection of the acetonide moiety was always 
accompanied by unwanted TBS ether cleavage. Finally, diol 3-40 was converted to epoxide 3-
42 via an efficient one-flask Fraser-Reid transformation.116 At the beginning substrate 3-40 
was deprotonated with sodium hydride which was followed by treatment of the obtained bis-
alcoholate with trisimidazole 3-41. This resulted in almost quantitative formation of the 
desired fragment 3-42. 
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Scheme 34. Synthesis of epoxide 3-42. 
 
3.3.3 Coupling of alkyne 3-30 with epoxide 3-42 
After the successful synthesis of alkyne 3-30 and epoxide 3-42 our next task was to combine 
these two big fragments. Deprotonation of alkyne 3-30 proved to be the most efficient with 
tert-butyllithium. All other attempts to perform this deprotonation, using nBuLi, LDA or 
mesityllithium were not successful because of decomposition (nBuLi was undergoing 
nucleophilic addition to the carboxyl function) or low reactivity (LDA, mesityllithium) of 
alkyne 3-30. The obtained acetylide was treated with boron trifluoride-diethylether complex 
which was followed by addition of epoxide 3-42 (Scheme 35). Despite numerous attempts to 
optimize the conditions of this reaction, the desired product 3-43 was obtained only in 
moderate yield (44%). One of the explanations for the low yield could be the C17O–TBS 
group cleavage enhanced by neighbouring group participation of the 15-OH. 
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Scheme 35. Coupling of alkyne 3-30 with epoxide 3-42. 
Our next challenging task was to saponify ester 3-43 in order to get the seco-acid required for 
macrolactonization. This simple transformation in our case turned out to be rather difficult. 
The cleavage of the methyl ester of the substituted benzoic acid was attempted under various 
saponification conditions. Applying such mild reagents as LiOH in THF/MeOH/H2O, 
TMSOK in THF,117 Me3SnOH in 1,2-dichlorethane118 no product was observed even after 
several days of stirring at ambient temperature or at 60 °C. Such a low reactivity of methyl 
benzoate 3-43 can be attributed to the presence of two electron-donating methoxy groups in 
the aromatic ring, which significantly deactivate the carboxylic function. This finding 
prompted us to use more hard conditions. But unfortunately, reaction of ester 3-43 with KOH 
in EtOH at 80 °C resulted in cleavage of TBS ether at C9 and formation of the corresponding 
isocoumarin 3-44 (Scheme 36). This was judged by LC-MS analysis of the crude reaction 
mixture, where the most intensive peak in the UV 254 nm corresponds to the mass [M+Na]+ = 
705.38, that is perfectly matching with the mass of δ-lactone 3-44. 
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Scheme 36. Attempted cleavage of methyl ester. 
These disappointing results persuade us to switch to another alternative strategy, namely ring-
closing alkyne metathesis. This seemed promising since a model study revealed that the 
RCAM strategy might be feasible.119 Having in hand useful building blocks 3-42 and 3-30 
and concise routes for their preparation we started the synthesis of the required precursors. 
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3.4 Ring Closing Alkyne Metathesis Strategy 
 
3.4.1 Synthesis of functionalized benzoic acid 3-50 
This time the secondary hydroxyl function derived from the aldol reaction was intentionally 
protected as rather robust TIPS ether in order to survive the ester hydrolysis in the course of 
the synthesis of acid 3-50 and to prevent unwanted δ-lactone formation on the activated acid. 
All transformations described for TBS ether 3-27 were transferred to TIPS-protected aldol 3-
45 (Scheme 37). After alcohol protection, the oxazolidinone auxiliary was cleaved with 
NaBH4 and the obtained primary alcohol 3-46 subjected to tosylation. Intermediate tosylate 3-
47 was treated with zinc/sodium iodide in refluxing 1,2-dimethoxyethane. This provided us 
with alkyne 3-48. After saponification of the methyl ester 3-48, the obtained alkynoic acid 3-
49 was converted to the dianion which was alkylated at the acetylide using MeI. Gratifyingly, 
no unwanted δ-lactone formation was observed during the potassium hydroxyde mediated 
ester cleveage. This way, the acid 3-50 containing an internal alkyne required for the RCAM 
could be obtained in a concise manner. 
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Scheme 37. Synthesis of acid 3-50. 
With synthesis of benzoic acid fragment 3-50 completed we started the synthesis of the 
second necessary fragment for the esterification, namely alcohol 3-60. 
 
3.4.2 Synthesis of alcohol 3-60 
Although, the way to epoxide 3-42 was well established we decided to change some 
protective groups in order to avoid difficulties which might appear on the later stage of the 
synthesis. Thus, primary alcohol 3-38 was protected using 3,4-
dimethoxybenzyltrichloroacetimidate leading to ether 3-51 in excellent yield.120 It is known 
that DMB ethers, in comparison to PMB analogues, are less stable against oxidative agents 
such as DDQ and CAN.121 This should allow us to perform a selective deprotection of the 
primary DMB group in presence of a secondary PMB ether. Thus, the TBS group was cleaved 
using TBAF in THF. This reaction proceeds smoothly and provided us with alcohol 3-52 in 
95% yield (Scheme 38). Deprotonation of the secondary hydroxyl function with potassium 
hydride, followed by treatment of the alcoholate with freshly prepared 4-methoxybenzyl 
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bromide secured acetonide 3-53 in good yield. Subsequently, the acetonide moiety was 
cleaved under the same conditions as was described for compound 3-39 (CuCl2·2H2O, 
acetonitrile, –5 °C). This afforded diol 3-54, which was easily transformed to oxirane 3-55 
using the one-pot procedure. 
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Scheme 38. Synthesis of epoxide 3-55. 
With epoxide 3-55 in hand we started to investigate the introduction of the internal alkyne 
necessary for the RCAM. As it was previously mentioned, the desired fragment can be 
established using an epoxide opening reaction with acetylide derived from propyne or silicon 
monoprotected acetylene. In the last case additional methylation of the terminal triple bond is 
required. A possible short-cut from epoxide 3-55 to the alkyne 3-60 was attempted by direct 
opening of the epoxide with propynyllithium. Unfortunately, the major product in this 
reaction using propynyllithium prepared in-situ from 1-bromopropene122 turned out to be the 
corresponding bromohydrin. Opening of epoxide 3-55 with lithium triisopropylsilylacetylide 
resulted in formation of alcohol 3-56 (Scheme 39). Cleavage of the carbon-silicon bond 
proceeded smoothly and resulted in formation of alcohol 3-57 in almost quantitative yield. 
Subsequent protection of the hydroxyl function with TBSOTf afforded alkyne 3-58 which 
then could be deprotonated with n-butyllithium and treated with methyl iodide to give 
propyne deriviative 3-59. A final treatment of the silyl ether 3-59 with TBAF furnished 
alcohol 3-60 in excellent yield. Although this sequence includes five chemical steps, all of 
them are highly efficient and require short reaction time, thus, all operations can be done in 
two days. Moreover, the desired alcohol 3-60 was obtained in 70% overall yield. 
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Scheme 39. Synthesis of alcohol 3-60. 
 
3.4.3 Esterification of acid 3-50 with alcohol 3-60 
On this stage of our synthesis we faced one of the most challenging tasks of this project. 
Formation of an ester bond between acid 3-50 and alcohol 3-60 turned out to be rather 
difficult. Using standard Mitsunobu-,123 Yamaguchi-,124 or Trost125 esterification no trace of 
product was observed. Also, attempts to make the desired ester using peptide coupling 
reagents like DCC/DMAP, or BOP were not successful. Another option for esterification of 
sterically hindered acids and alcohols relies on the reaction of an acid chloride with a sodium 
alcoholate. However, attempted conversion of acid 3-50 to the corresponding acid chloride 
was not possible. Instead, formation of the six-membered lactone 3-62 was observed (Scheme 
40). 
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Scheme 40. Attempted esterification of acid 3-50. 
Eventually we found that the desired ester 3-64 could be obtained by reaction of the 
imidazolidine derivative126,127 of acid 3-50 with the putative sodium alcoholate of alcohol 3-
60, prepared by stirring the alcohol with 1.2 equiv of NaH in DMF. Unfortunately this 
reaction proceeded very slowly (3 days) and ester 3-64 was obtained in only 35% yield. Very 
interesting is that the imidazolide derivative was found to be very stable and could be 
recovered from the reaction (Scheme 41). 
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Scheme 41. Synthesis of ester 3-64. 
As the main reason for such unfavorable esterification, big sterical demands of the secondary 
hydroxyl function as well as the functionalized benzoic acid can be considered. Keeping this 
  Results and Discussion 48 
in mind, we decided to make the corresponding secondary hydroxyl function more accessible. 
An initial idea was to remove the PMB protecting group. 
 
3.4.4 Synthesis of diol 3-71 
As one can see, the desired diol can be obtained from epoxide 3-66. The latter is easily 
accessible from one of the key intermediates used in the synthesis of epoxide 3-55 (Figure 
18). 
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Figure 18. Retrosynthetic analysis for diol 3-71. 
Hence, as the previously described DMB ether 3-51 was still available in gram amounts it was 
immediately subjected to react with CuCl2·2H2O in acetonitrile at –5 °C (Scheme 42). This 
furnished diol 3-65 in excellent yield. Thereafter, diol 3-65 was converted to epoxide 3-66. 
Opening of epoxide 3-66 with lithium trimethylsilylacetylide resulted in formation of alcohol 
3-67. Cleavage of the carbon-silicon bond and protection of the hydroxyl function with 
TBSOTf afforded alkyne 3-69 which then was methylated to give propyne deriviative 3-70. A 
final treatment of the bis-silyl ether 3-70 with TBAF furnished diol 3-71 in excellent yield. 
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Scheme 42. Synthesis of diol 3-71. 
 
3.4.5 Esterification of acid 3-50 with diol 3-71 
Having in hand sufficient amounts of acid 3-50 and diol 3-71 our next task was to make their 
coupling using already developed methodology. Formation of activated intermediate 3-63 was 
achieved by stirring acid 3-50 with CDI at 50 °C for 4 h (monitoring by LC-MS). Obtained 
derivative was allowed to react with the putative disodium alcoholate of diol 3-71, prepared 
by stirring the diol with 2.5 equiv of NaH in DMF (Scheme 43). This reaction resulted in 
formation of only one regioisomer. It is important to mention, that the rate and yield of 
esterification are highly dependent on the concentration of the substrates. Trying different 
conditions, we have found that the optimal concentrations of imidazolide intermediate 3-63 
and diol 3-71 are 0.76 M and 0.54 M, respectively. If the concentration of the substrates is 
lower this reaction might proceed less efficient. The obtained hydroxyester 3-72 was 
protected as TBS ether to give ester 3-73 in 65% overall yield. 
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Scheme 43. Synthesis of ester 3-73. 
At this stage the regiochemistry of the ester formation could be inferred from the COSY 
spectrum of ester 3-73. Most revealing in this context were cross peaks of the ester methine 
hydrogen Hb to the vicinal methylene hydrogen atoms Hc,d (Figure 19). 
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Figure 19. H-H Cosy spectrum (400 MHz, CDCl3) of ester 3-73. 
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As can be seen, we obtained the required precursor for RCAM in a very efficient manner. Our 
next task was to make the ring closure of compound 3-73 in order to reach the macrolactone 
core of cruentaren A. 
 
3.4.6 Ring closing metathesis reaction and synthesis of the core structure of 
cruentaren A 
The crucial RCAM reaction of ester 3-73 proceeded smoothly and resulted in the formation of 
macrolactone 3-74 in 91% yield (Scheme 44). Thus, addition 10 mol% of the tungsten 
carbine complex 2-3441 to a solution of the diyne 3-73 (0.009 M in degassed toluene!) and 
stirring the mixture for 2 h at 85 °C induced an efficient cyclization.44 It was found that the 
tungsten carbine complex 2-34 is extremely moisture and oxygen sensitive. Thus, to obtain 
satisfactory results some precautions should be taken. We used the following technique: a 
freshly bought batch of the catalyst (100 mg from Strem Chemicals) was transferred into a 
glowbox and then weighted into 20–25 mg portions. Each portion was secured in a tightly 
closed brown glass vial with rubber septum cap and used when necessarily as a whole. The 
catalyst was introduced into the reaction as a solution in 0.5–1.0 ml of degassed toluene. 
Creation of the Z-double bond was achieved using Lindlar reduction (H2, Pd on CaCO3, 
poisoned with lead, EtOAc/quinoline) on the alkyne 3-74 leading to lactone 3-75. Under these 
conditions, no overreduction was observed. Finally, deprotection of the DMB group with 
DDQ led to macrolactone 3-76, the core structure of cruentaren A. 
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Scheme 44. Synthesis of the core structure of cruentaren A. 
After the synthesis of the macrolactone core was accomplished we made some test reactions 
in order to check the possibility of TIPS ether cleavage. Preliminary studies on a derivative of 
lactone 3-76 to cleave the silicon protecting groups with the HF·pyridine complex 
unfortunately led to the corresponding δ-lactone. As a way out of this dilemma, we relied on 
the triple bond in the macrolactone hoping that it would prevent this unwanted intramolecular 
translactonization due to steric reasons. The introduction of the two double bonds we decided 
to make at the final stage of the synthesis. Accordingly, the synthetic route was devised with 
this in mind. 
 
3.4.7 Connection of the propargyl amide side chain 
For the introduction of the Z-allylamine moiety Lindlar reduction of corresponding alkyne 
derivative was envisioned. Accordingly, to introduce the required propargylamine fragment 
we relied on the Bestmann one carbon elongation sequence. Later simple functional group 
manipulation followed by coupling of the obtained amide with hexanoic acid derivative 2-31 
should lead to the carbon skeleton of cruentaren A (Figure 20). 
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Figure 20. Retrosynthetic analysis for the installation of the Z-allylamide side chain. 
First, the dimethoxybenzyl (DMB) group of 3-74 was removed under oxidative conditions121 
using DDQ in a pH 7 buffer/dichloromethane mixture128 (Scheme 45). It is interesting to 
note, that already after 30 minutes stirring at ambient temperature TLC indicated complete 
consumption of starting material. A subsequent oxidation of the resulting primary alcohol 3-
77 with the Dess-Martin periodinane 129 furnished aldehyde 3-78. The aldehyde 3-78 was 
extended to the alkyne 3-80 by reacting it with the diazophosphonate 3-79130 in methanol in 
presence of potassium carbonate.131 With alkyne 3-80 in hand a one carbon homologation was 
performed via deprotonation of the alkyne followed by addition of dried paraformaldehyde. In 
this step it is very important that prior to use paraformaldehyde it should be dried in vacuo (in 
a dessicator) over P2O5 for 2 days and then suspended in absolute THF and dried with 
molecular sieves (4 Å) for 1 day. This way the propargylalcohol 3-81 was obtained in good 
yield. For the introduction of the azide, Mitsunobu conditions were used.132 Thus, reaction of 
alcohol 3-81 with PPh3, diethyl azodicarboxylate (DEAD) and diphenylphosphoryl azide 
provided the azide 3-82 in excellent yield. Reduction of the azide function to the 
corresponding amine 3-83 was accomplished with triphenylphenylphosphine followed by 
hydrolysis of intermediate phosphinimine. 133  Due to high polarity of the corresponding 
propargyl amine, column chromatography was done using a DCM/MeOH/NH4OH = 9:1:0.01 
mixture as eluant. 
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Scheme 45. Synthesis of propargylamine 3-83. 
Condensation of the amine 3-83 with the hexanoic acid derivative 2-31 using HBTU in 
presence of HOBT in DMF as solvent proceeded smoothly and secured the amide 3-84 in 
85% yield. 
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Scheme 46. Synthesis of cruentaren A skeleton 3-84. 
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Synthesis of acid 2-31 started with an Evans aldol reaction of oxazolidinone 2-6 with 
butyraldehyde.134 Subsequent protection of the secondary hydroxyl with TBS triflate in the 
presence of 2,6-lutidine as a base resulted in formation of TBS ether 3-86 (Scheme 47). 
Lithium peroxide mediated cleavage of the oxazolidinone auxiliary secured the required 
hexanoic acid derivative 2-31. 
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Bn
O O 1. nBu2BOTf, NEt3
DCM, 0 °C, 2 h
2. nPrCHO, –78  to 
0 °C, 4 h (80%)
O N
Bn
O O OH
DCM, –50 to 
0 °C, 2 h (95%)
8 h (89%)
LiOH, H2O2
2-6 3-85
TBSOTf,
O N
Bn
O O OTBS
3-86
THF/H2O, 0 °C
HO
O OTBS
2-31
2,6-lutidine
 
Scheme 47. Synthesis of acid 2-31. 
 
3.4.8 Completion of the synthesis of cruentaren A 
After the full skeleton of cruentaren A was established, our next tasks were: selective 
cleavage of the methyl ether next to the carboxyl function, global silyl removal and selective 
reduction of two triple bonds. 
Accordingly, we set out to cleave the methyl ether at C3 in macrolactone 3-84. This was 
achieved with boron trichloride in dichloromethane at –80 °C (Scheme 48).135,136 Besides 
cleavage of the methyl ether, we also observed some cleavage of the silyl ether in the β-
hydroxy amide part. One possible explanation for this can be coordination of boron trichloride 
to the carboxylic function of the propargylamide side chain. The mixture of the two 
compounds 3-87a and 3-87b was then subjected to the HF·pyridine complex 137 in THF, 
warming the mixture from – 80 °C to – 5 °C. Gratifyingly, we were able to isolate the tetraol 
3-88 in almost quantitative yield. None of the unwanted δ-lactone was formed! The methine 
proton of lactone 3-88 resonates at δ = 5.34 ppm which is typical for the macrolactone. Thus, 
the triple bond in the lactone nicely served as a lock against translactonization. In the final 
step, a Lindlar reduction on the diyne 3-88 provided cruentaren A (1-1). Notably, no 
overreduction had occurred. The synthetic material was identical in all respects with natural 
cruentaren A. 
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Scheme 48. Completion of the synthesis of cruentaren A (1-1). 
As one can see, an efficient synthesis of the novel macrolide cruentaren A was developed. We 
were able to produce 46 mg of the final compound in 7% overall yield with the longest linear 
sequence in 25 steps (starting from described alcohol 3-33). Our approach features a ring 
closing alkyne metathesis reaction to form the macrolactone. After extension of the side chain 
to the propargyl amine 3-83, condensation with the protected β-hydroxy acid 2-31 provided 
amide 3-84. During the following two steps, that is cleavage of the C3 methyl ether and the 
silicon protecting groups, the triple bond in the ring served as a lock that prevented the 
unwanted translactonization to the δ-lactone. The final step of the synthesis was a Lindlar 
reduction of two triple bonds. The sequence is quite concise featuring many high yielding 
steps and should allow for the synthesis of various analogues. 
 
3.5 Synthesis and Biological Evaluation of Cruentaren A Analogues 
 
3.5.1 Synthesis of 3-OMe cruentaren (3-90) 
As was mentioned previously, cruentaren A is a selective inhibitor of mitochondrial F-
ATPase from yeast. Against the L929 cell line cruentaren A shows strong cytotoxicity with an 
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IC50 value of 1.2 ng mL–1. Since mitochondrial ATPases play a crucial role in the 
pathophysiology of several human disorders including cancer, cruentaren A or synthetic 
derivatives thereof could form the basis of future therapeutic strategies. As confirmation are 
results recently reported by Kunze and Sasse.25 In this paper the influence of cruentaren A and 
apicularen A on the growth of a variety of human cancer cell lines from different tissues was 
studied. It was found that the IC50 values for cruentaren A are comparable with those 
described for other benzolactones such as apicularen A, in the nanomolar range, even for the 
multi-drug-resistant cell line KB-V1. 
With its 12-membered macrolactone and a side chain that is terminated with an 
acylated amino function, cruentaren A has some resemblance to the well known benzolactone 
enamides.10 However, in contrast to cruentaren A, the benzolactone enamides target V-
ATPase.11 Clearly, it would be of interest to identify key structural elements that are essential 
for its biological activity. 
With regard to the design of analogues we wanted to use the available stereotetrad 
building blocks and stick to the proven RCAM reaction. We intended to answer the following 
questions: How important is the carboxylic acid part of the amide? How important is the free 
OH at C3? Can we make enamides instead of Z-allylamides? While quite speculative, it could 
be that the allylamide isomerizes to an enamide that then might form a highly electrophilic 
acyliminium ion upon protonation (Figure 21).138 
lactone
HO
N
H
O
HO
lactone
HO
N
H
O
HO
enamideallylamide  
Figure 21. Possible isomerisation of allylamide to enamide. 
First, we decided to study the importance of free OH at C3. For the preparation of the desired 
analogue we turned back to the fully protected amide 3-84. Omitting the cleavage of the C3 
methyl ether and instead treating the lactone 3-84 with the HF·pyridine complex led to the 
triol 3-89 (Scheme 49). Similar to the synthesis of cruentaren A, a final Lindlar reduction 
delivered 3-OMe cruentaren 3-90 in excellent yield. 
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Scheme 49. Synthesis of 3-OMe cruentaren (3-90). 
 
3.5.2 Modification of the carboxylic acid part of the amide 
Another key intermediate of the total synthesis, the propargyl amine 3-83, presented itself for 
derivatization reactions. Accordingly, the amine 3-83 was condensed with the acids 3-91a – 
3-91d using HBTU in the presence of HOBt and Hünig’s base in DMF (Scheme 50). These 
acylation reactions proceeded in quite good yields (Table 3). For these derivatives we chose 
to generate the original aromatic part with the 3-OH group. Selective ether cleavage on the 
lactones 3-92a – 3-92d using the well established boron trichloride mediated reaction 
furnished the corresponding 3-hydroxy compounds 3-93a – 3-93d, again in excellent yields. 
Treatment of the foregoing phenols with HF·pyridine complex provided corresponding triols 
3-94a – 3-94d in almost quantitative chemical yields. The Lindlar reduction of the diynes 3-
94b and 3-94c proceeded as expected to give the analogues 3-95b and 3-95c. Due to a 
possible overreduction the reaction was monitored by LC-MS. Unfortunately, in some cases 
product of overreduction was observed already after 30% conversion of starting diyne. As a 
result, from the reduction of diyne 3-94a the analogue 3-95a (74% yield) was obtained, but 
we also isolated the dihydro compound 3-95e (24% yield), resulting from hydrogenation of 
the cinnamoyl double bond. In the case of the hept-2-en-4-ynamide 3-94d we were able to 
isolate only the product 3-95f, resulting from complete hydrogenation. The internal Z-double 
bond survived as in the other amide analogues. 
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Scheme 50. Synthesis of analogues with modified carboxylic acid part. 
  Results and Discussion 60 
Table 3. Yields for the various steps for the synthesis of amide analogues 3-95 of cruentaren A 
 
 Transformation 
acid used acylation BCl3 HF·py Lindlar 
3-91a 87 92 95 74a 
3-91b 88 86 93 93 
3-91c 91 83 85 87 
3-91d 85 89 92 73b 
 
a by-product dihydro derivative 3-95e  
b only the saturated heptanoyl derivative 3-95f was formed under the Lindlar conditions  
 
3.5.3 Synthesis of the enamide analogue 3-100 
As a further branching point for the synthesis of analogues we indentified the lactone 3-80 
with a propynyl terminus. We thought that the derived vinyl iodide might be useful for the 
synthesis of enamide derivatives. With this in mind, diyne 3-80 was subjected to 
hydrozirconation with the Schwartz reagent followed by addition of iodine to the intermediate 
vinylmetal species (Scheme 51). This secured required vinyl iodide 3-96 in excellent yield.139 
Notably, the introduction of the vinyl iodide moiety was also tried using Takai conditions on 
aldehyde 3-78. But unfortunately this resulted in formation of an inseparable 4:1 mixture of 
E- and Z-vinyl iodides. Thereafter, a copper catalysed cross-coupling reaction of vinyl iodide 
3-96 with the amide 3-97 under Buchwald conditions97 was performed resulting in enamide 3-
98 in high yield. Due to the expected sensitivity of the enamide to harsh acidic conditions the 
demethylation step was omitted. Nevertheless, the enamide survived the conditions 
(HF·pyridine complex) for global deprotection of the silyl ethers. A Lindlar reduction on 
diyne 3-99 completed the synthesis of enamide analogue 3-100. 
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Scheme 51. Synthesis of the enamide analogue 3-100. 
The required amide 3-97 was derived from the previously described carboxylic acid 2-31. In 
order to avoid unwanted TBS ether cleavage formation of intermediate acid chloride was 
achieved using the Ghosez chloroenamine 3-61 (N-(1-chloro-2-methyl-1-propenyl)-N,N-
dimethylamine) (Scheme 52).140 This was followed by bubbling gaseous ammonia through 
the reaction mixture and secured amide 3-97 in high yield. 
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Scheme 26. Synthesis of amide 3-97. 
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3.5.4 Synthesis of the oxazinan-4-one analogue 3-102 
To get more information about structure-activity relationship of the obtained derivatives we 
attempted to generate the original aromatic part with the 3-OH group. If however, the 
enamide 3-98 was treated with boron trichloride to cleave the C3 O-methyl ether, followed by 
global silyl removal with HF·pyridine complex, a compound (3-101) lacking the enamide 
signals in the 1H NMR spectrum was isolated (Scheme 53). According to LC-MS analysis the 
mass was the same as expected for the enamide. The signal at δ = 5.02 ppm in the 1H NMR 
pointed to the presence of the 1,3-oxazinan-4-one. The formation of this heterocyclic ring 
system can easily be explained via the corresponding acyliminium ion. While we were not 
able to unambiguously assign the stereochemistry at the aminal carbon we assume a 2,6-cis-
configuration (oxazinone-4-numbering). Chem3D calculations on 2,5,6-trimethyl-1,3-
oxazinan-4-one showed the cis-2,6-diastereomer to be 5.65 kJ mol–1 more stable than the 
corresponding 2,6-trans isomer. Lindlar reduction of the triple bond led to the oxazinan-4-one 
analogue 3-102. It can be assumed that oxazinanone formation occurs upon treatment of the 
enamide 3-98 with BCl3, since the HF·pyridine complex seems not to affect the enamide as 
could be shown with the deprotection of 3-98 to enamide 3-99. 
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Scheme 53. Synthesis of the oxazinan-4-one analogue 3-102. 
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3.5.5 Synthesis of the vinyl iodide 3-119 
To further probe the potential biological relevance of a cruentaren A enamide, the 
homologated enamide derivative of analogue 3-100 was targeted. In this case we could have 
used macrolactone 3-80, with a propyne terminus, as starting material but instead we began 
with the stereotetrad containing building block 3-36 (Scheme 54). This compound which 
originated from a Marshall-Tamaru reaction was extended to the propargyl alcohol 3-103. A 
hydrogenation reaction provided the propanol derivative 3-104. Protection of the hydroxyl 
function with dimethoxybenzyl imidate to give 3-105 was followed by cleavage of the 
isopropylidene group using aqueous copper(II) chloride to provide diol 3-106. The 1,2-diol 
was converted to the epoxide 3-107 using the arylsulfonyl derivative 3-41. The stage was now 
set for epoxide opening with lithium trimethylsilylacetylide in presence of BF3·OEt2. 
Silylation of 3-108 and removal of the acetylenic silyl group from 3-109 furnished alkyne 3-
110. In preparation for the RCAM reaction, the terminal alkyne 3-110 was converted to the 
inner alkyne 3-111 using nBuLi followed by MeI. Thereafter treatment of bis-silyl ether 3-
111 with TBAF delivered diol 3-112. 
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Scheme 54. Synthesis of diol 3-112. 
As we had found during the synthesis of the core structure 3-76, esterification of benzoic acid 
3-50 was best done with the diol 3-112 itself. After conversion of the acid to the 
corresponding carbonylimidazolide 3-63, esterification with the sodium alcoholate of 3-112 
proceeded smoothly and in a regioselective manner (Scheme 55). Silylation of the free 
hydroxyl function of 3-113 gave rise to the ester 3-114, the substrate for the alkyne metathesis 
reaction. Based on the diol 3-112 the yield for the ester 3-114 amounted to 67%. The RCAM 
reaction of 3-114 with the Schrock catalyst 2-34 proceeded in excellent yield furnishing 
lactone 3-115. In order to set up an (E)-vinyl iodide at the side chain terminus, the DMB 
protecting group was removed under oxidative conditions. The resulting primary alcohol 3-
116 was oxidized to the aldehyde 3-117. Extension of the aldehyde 3-117 to the alkyne was 
accomplished with the Bestmann-Ohira reagent 3-79 in presence of K2CO3. Finally, 
hydrozirconation and iodination provided the vinyl iodide 3-119. 
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Scheme 55. Synthesis of vinyl iodide 3-119. 
 
3.5.6 Synthesis of the homologated enamide 3-122 
Synthesis of enamide 3-122 was accomplished applying conditions already developed for the 
analogue 3-100. Accordingly, a cross-coupling reaction of vinyl iodide 3-119 with the amide 
3-97 under the Buchwald conditions came to use in order to set up the enamide functionality 
(Scheme 56). HF·pyridine complex mediated global silicon ether cleavage on 3-120 secured 
alkyne 3-121. Finally, Lindlar reduction of the triple bond furnished analogue 3-122. 
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Scheme 56. Synthesis of enamide 3-122. 
 
3.5.7 Synthesis of the oxazinan-4-one analogue 3-124 
If the enamide 3-120 was treated with BCl3, cleavage of the C3 OMe ether was accompanied 
by the formation of the oxazinan-4-one 3-123 (Scheme 57). As was shown before, global 
deprotection of all silicon ethers proceeded cleanly by treatment with HF·pyridine complex in 
THF. Subsequently, Lindlar reduction of corresponding intermediate triol derived 
corresponding analogue 3-124. 
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Scheme 57. Synthesis of the oxazinan-4-one analogue 3-124. 
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Characteristic peaks for the oxazinanone part of 3-124 are as follows: 2-H (22-H) 4.71, N-H 
6.40; 13C NMR C-2 (C-22) 83.8, C-4 (C-23) 174.6, C-5 (C-24) 38.8, C-6 (C-25) 72.9 ppm. 
 
3.5.8 Biological testing 
The described analogues as well as the diyne 3-88 were tested for cytotoxicity against the 
L929 cell line, and the inhibitory efficacy on F-ATPase in mitochondrial preparations of 
bovine heart. The obtained IC50 values in the cell culture assay as well as the percentage of F-
ATPase inhibition of the compounds at a concentration of 0.1 and 1.0 µM, respectively, are 
listed in Table 4. The analogues are ordered according to increasing IC50 values against the 
L929 cell line. 
Table 4. IC50 values for cruentaren A and analogues against the L929 cell line 
 
entry comp. IC50  [μg mL–1] IC50 [μM] 
Inhibition of F-
ATPase activity [%][a] description 
    1 μM 0.1 μM  
1 1-1 0.0004±5×10-5 0.0007±8×10-5 94 78 cruentaren (synthetic)[b]
2 1-1 0.0012±4×10-5 0.002±1.9×10-5 93 84 cruentaren (natural) 
3 3-90 0.017±0.004 0.028±0.007 80 42 3-OMe-crue 
4 3-124 0.085±0.02 0.14±0.03 34 2 7C-oxazinanone-crue 
5 3-95c 0.3±0.01 0.56±0.02 44 30 isobutanoyl-crue 
6 3-95e 2.4±0.1 4.0±0.2 47 32 dihydro-cinnamoyl-crue
7 3-95b 2.5±0.1 4.5±0.2 47 27 hexanoyl-crue 
8 3-95f 2.9±0.3 5.0±0.5 67 48 heptanoyl-crue 
9 3-122 3.0±0.4 5.0±0.7 47 8 7C-enamide-crue 
10 3-100 3.0±1.1 5.1±1.9 51 15 6C-enamide-crue 
11 3-95a 6.1±0.7 10.3±1.2 40 30 cinnamoyl-crue 
12 3-88 6.5±0.4 11.1±0.7 21 10 diyne-crue 
13 3-102 7.5±0.9 13.0±1.6 18 12 6C-oxazinanone-crue 
 
[a] The inhibition values are the mean values of at least two independent assays. The 
deviations did not exceed a range of ±10% inhibition. [b] The natural cruentaren A displayed 
a slightly lower activity (IC50= (0.002±0.0019) μM, F-ATPase inhibition=93% at 1 μM). This 
might be attributed to different purity values. The value for the synthetic product does lie 
within the deviation of the natural material. 
 
According to the table there are highly effective compounds. In most cases cytotoxicity and 
inhibitory activity against F-ATPase in vitro run parallel. However, there are some exceptions 
in this regard. For example, 3-95c and analogues 3-95e, 3-95b, and 3-95f differ in their 
cellular activity by a factor of almost 10 but display similar effects on the F-ATPase. This 
might be explained by differences in cellular uptake. The highest effective compound is 
cruentaren A itself (entry 1), followed by 3-OMe cruentaren (3-90) (entry 3). Furthermore, the 
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oxazinanone derivative with a 7 carbon side chain can be considered as highly cytotoxic, but 
it showed only low inhibitory efficacy in the F-ATPase assay (entry 4). Then there are 
compounds of intermediate cytotoxicity and F-ATPase activity, namely the cruentaren 
derivatives with modified carboxylic part in the side chain (3-95c, 3-95e, 3-95b; entries 5-7). 
In particular 3-95c and 3-95b make clear that the OH-group of the carboxylic acid part is 
extremely important as well as methyl group in α position to the carboxyl function. Finally, 
there are compounds that are essentially non toxic, starting with compound 3-95f. 
Surprisingly, both enamides show neither a high cytotoxicity, nor significant inhibition of F-
ATPase. One hypothesis in the design of the enamide analogues was that with a structural 
resemblance to typical V-ATPase inhibitors like apicularen A or salicylihalamide A these 
analogues would show corresponding activity. Because it could be supposed that an V-
ATPase inhibitor would be highly cytotoxic, this shows that the enamide side is not sufficient 
to convert the F-ATPase inhibitor cruentaren A into an V-ATPase inhibitor. The most 
puzzling observation is the relatively high cytotoxicity of the oxazinanone 3-124 which shows 
only low inhibition of F-ATPase. We also checked for inhibitory effects on V-ATPase with 
PtK2 potoroo cells. But when we investigated treated cells by fluorescent techniques, we did 
not observe the characteristic changes in the endoplasmatic reticulum that are typical for V-
ATPase inhibitors. One explanation for the cytotoxicity of 3-124 could be that the 
heterocyclic ring is opened to an electrophilic acyliminium ion when taken up by the cells. 
The lack of activity for diyne cruentaren 3-88 can be attributed to conformational effects. 
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4 Conclusion I 
 
In summary, we developed an efficient synthesis of the novel macrolide cruentaren A. 
The key steps in this synthesis were a ring closing alkyne metathesis reaction to form the 
macrolactone, a Marshall–Tamaru anti-selective allenylzincate addition to establish the 
stereotetrad at C15-C18 and an Evans aldol reaction to fashion the anti-OH/Me pattern at 
C9/C10. 
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Scheme 58. Key intermediates in the synthesis of the propargylamine 3-83. 
Marshall reaction of the described aldehyde 3-9 allowed us to introduce two additional chiral 
centres as well as a four carbon building fragment in one chemical step. Simple functional 
group manipulations and introduction of an internal alkyne moiety secured fragment 3-71 in a 
highly efficient manner. Synthesis of acid 3-50 was based on an Evans aldol reaction between 
aldehyde 3-22 and pentynyloxazolidinone 3-25 using the standard boron enolate. 
Macrolactonization was performed by a very simple protocol using commercially available 
Schrock catalyst 2-34. Application of a Bestmann one carbon elongation sequence furnished 
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propargyl amine 3-83 which was subsequently coupled with the protected β-hydroxy acid 2-
31. During the cleavage of the C3 methyl ether and the silicon protecting groups, the triple 
bond in the ring served as a lock that prevented the unwanted translactonization to the δ-
lactone. The final step of the synthesis was a Lindlar reduction of two triple bonds. The 
sequence is quite concise and proceeded in 25 linear steps with overall yield of 7%. All chiral 
centers were essentially obtained via highly enantioselective methods. 
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Scheme 59. End game of the synthesis of cruentaren A. 
Using the well established strategy a range of cruentaren A analogues were prepared. 
Structure activity relationship study proved that the OH and α-Me group of the carboxylic 
acid part are extremely important for the activity. Despite our expectations, two enamide 
analogues 3-100 and 3-122, prepared via cross-coupling (amination) of the corresponding 
vinyl iodides were not active (Figure 22). The most puzzling observation was the relatively 
high cytotoxicity (IC50 140 nM) of the oxazinanone 3-124 which might be a metabolite of 1-1. 
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Figure 22. Structure of cruentaren A analogues. 
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5 Introduction 
The marine environment, arguably the original source of all life, is a rich source of bioactive 
compounds. More than 70 percent of our planet’s surface is covered by the oceans, and some 
experts feel that the potentially available biodiversity on the deep seafloor or coral reefs is 
greater than that existing in the rainforests.141 
 
Considering the fact that many marine organisms have soft bodies and lead a sedentary 
lifestyle, a chemical system of defence becomes almost essential for survival. Marine 
organisms have evolved the ability to synthesize such toxic compounds or extracts or convert 
pertinent compounds from other marine microorganisms. Natural products from marine 
organisms might be released into the water and therefore rapidly diluted, accordingly they 
must be very potent materials to have the desired effect. The simplest sea animals like corals, 
sponges and plankton produce the most complex and toxic non-peptide substances ever 
known, such as palytoxin, brevetoxin and maitotoxin. Only 5 micrograms of these cytotoxic 
compounds can kill a human being within a few minutes. The richly available marine 
biodiversity that is available to us has to this point only been explored to an extremly limited 
extend. Furthermore, the primary chemical diversity available from marine organisms is most 
likely capable of delivering an even greater abundance of secondary metabolites for research 
use. For all of these reasons it is believed that the natural products that are available from the 
seas and oceans provide a tremendous opportunity for the discovery of novel therapeutic 
agents. 
 
Marine organisms, particularly sponge invertebrates and associated bacteria, are an 
enormously rich source of structurally diverse secondary metabolites with unique molecular 
architectures. 142  These marine natural products often possess unusual and sometimes 
unexpected biological activities, making them valuable molecular probes for the investigation 
of biochemical pathways. Among these fascinating and eye-catching structures, a prominent 
class is the marine macrolides – highly oxygenated and stereochemically elaborate polyketides 
having a macrocyclic lactone as a conformational constrain. 143  Many marine macrolides 
demonstrate potent cell growth inhibition (antiproliferative properties) and offer considerable 
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promise as lead structures for the development of new anti-cancer chemotherapeutic agents, 
provided the supply issue can be resolved. 
In general, the low natural abundance of marine macrolides coupled with the unsustainable 
and unacceptable ecological impact of large-scale isolation of the producting organisms 
preclude detailed biological evaluations, thus hampering their possible clinical development 
and exploitation in human medicine. These factors, combined with the impressive molecular 
architectures themselves, present compelling and formidable challenges to contemporary 
organic synthesis with regard to both strategy and methodology for their total synthesis in the 
laboratory. Furthermore, synthesis is also important for structure elucidation, including 
determination of the full absolute configuration, where spectroscopic methods may not have 
permitted a full assignment. 
 
In 2007 the group of A. E. Wright described a novel macrolide named neopeltolide (5-1).144 
The producing deep-water sponge of the family Neopeltidae was collected off the north 
Jamaican coast. Neopeltolide turned out to be a very potent antitumor agent, inhibiting the 
proliferation of various cell lines in the low nanomolar range. The structural features of 
neopeltolide include a 14-membered macrolactone ring which contains an ether bridge 
forming a tetrahydropyran subunit. The hydroxyl group at C5 is acylated with an oxazole- and 
a carbamate-containing side chain which is identical to the one in the macrolide 
leucascandrolide (5-2).145,146 Thus, one can assume the same biological targets for these two 
compounds. 
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Figure 23. Structures of neopeltolide and leucascandrolide. 
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Two recent total syntheses, one by Panek 147  and the other by Scheidt 148  corrected the 
stereochemical assignment at C11 and C13. Two additional reports on the total synthesis of 
neopeltolide have appeared to date.149,150 
 
As a consequence of the natural supply of neopeltolide (5-1) being extremely limited (4×10–
3% of frozen weight), a flexible and efficient synthesis is essential for further biological 
studies, while also opening access to de novo analogues. Moreover, the challenging and 
unusual polyketide structure combined with the potent biological activity prompted us to 
embark on a synthesis of 5-1. 
 
Our intention was to develop a strategy that would be flexible enough to access analogues and 
derivatives which might help to identify the biological target. Furthermore, analogues which 
could illuminate key structural features important for the activity were planned. 
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6 Literature Review 
 
6.1 Isolation and Biological Activity of Neopeltolide 
Lithistid sponges are renowned among marine organisms for their ability to produce a diverse 
array of biologically active metabolites.151 Representative compounds include polyketides, 
cyclic peptides, alkaloids, pigments, and novel sterols. This extreme diversity of metabolites 
defied simple chemotaxonomic rationalization until it was shown that symbiotic 
microorganisms were responsible for the production of some representative compounds. In 
modern times lithistid sponges are predominantly found in deeper waters, which presents the 
collector with considerable logistical problems, and which has resulted in chemical 
investigations being concentrated on those genera that can be found at normal scuba depths. 
Lithistid sponges of the family Neopeltolidae include the genera Callipelta, Daedalopelta, 
Homophymia, and Neopelta. Neopeltolide was isolated from the sponge of the genus 
Daedalopelta, which was collected at depths of 442 and 443 m off the north Jamaican cost. 
Extraction of frozen sponge, followed by vacuum-column chromatography and finally by 
preparative reversed-phase HPLC provided neopeltolide in 4×10–3% yield of frozen weight.144 
The macrolide portion of neopeltolide shows similarities to the macrolide ring seen in the 
callipeltoside, 152  lyngbyaloside, 153  and polycarvenoside. 154  Moreover, In addition 
neopeltolide also shows strong similarities to leucascandrolide A isolated from the calcareous 
sponge Leucascandra caveolata.145 Leucascandrolide A has a 16-membered macrolide ring 
with a tetrahydrofuran ring, rather than the hemiketal, and the same oxazole-containing side 
chain found in neopeltolide. Tan et al. have hypothesized that the true biosynthetic origin of 
the callipeltosides and polycavernoside may be cyanobacteria that either live in association 
with the microorganisms or are derived from dietary sources. 155 D’Ambrosio et al. have 
proposed a microbial origin for the leucascandrolides, which are structurally unprecedented 
for calcareous sponges.145 It is interesting to note the presence of neopeltolide, a structurally 
related compound in a lithistid sponge that occurs in deep-water habitats where limited if any 
light is present, and one might speculate that heterotrophic (organic compounds are used as 
carbon sources) cyanobacteria may be responsible for the biosynthesis of at least some of the 
metabolites found in deep-water lithistid sponges. 
In preliminary biological studies, leucascandrolide A exhibited potent cytotoxic activity in 
vitro against KB oral epidermoid carcinoma and P388 leukemia cell lines (IC50 = 0.05 and 
0.25 μg/mL respectively), as well as significant inhibition of the pathogenic fungus Candida 
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albicans.145 Additionally, following hydrolysis of the C5 ester linkage, biological testing of 
the 18-membered macrocyclic core and the separated side-chain demonstrated that the 
macrocyclic domain is solely responsible for the cytotoxicity, while the oxazole-containing 
unsaturated side chain appears to be responsible for the antifungal activity. 
 
As was shown by Wright and co-workers,144 neopeltolide is a potent inhibitor of the growth of 
the fungal pathogen Candida albicans. It showed a growth inhibitory zone of 17 mm when 
tested at concentration of 25 μg/disk in the C. albicans disk diffusion assay and a minimum 
inhibitory concentration (MIC) in liquid culture of 0.625 μg/mL. 
Neopeltolide is also potent inhibitor of tumor cell proliferation in vitro. In the MTT assay to 
determine effects of 5-1 on cell proliferation, IC50 values of 1.2 nM against the A549 human 
lung adenocarcinoma, 5.1 nM against the NCI/ADR-RES ovarian sarcoma, and 0.56 nM 
against the P388 murine leukaemia were observed.144 In the PAC-1 pancreatic cancer cell line 
and the DLD-1 colorectal adenocarcinoma cell line, both of which have p53 mutations, 
neopeltolide showed strong inhibition of cell proliferation at nanomolar concentration but did 
not give the typical sigmoidal curve, and instead showed 50% cell kill over an extended dose 
range. Accordingly it was assumed that 5-1 may be cytostatic (inhibition or suppression of a 
cellular growth and multiplication) to these cell lines rather than cytotoxic (cell-killing, cell-
toxic). In addition, cell cycle analysis by flow cytometric methods indicated that neopeltolide 
caused a block of the cell cycle at the G1 phase at doses of 100 nM in the A549 lung 
adenocarcinoma cell line (Table 5). 
Table 5. Effects of Neopeltolide on the Cell cycle of A549144 
treatment Dose (nM) cells in G1 phase (%) 
cells in S 
phase (%) 
cells in 
G2/M phase
nontreated control  47.13 39.05 13.82 
vehicle control  46.55 36.46 13.99 
paclitaxel 100 1.56 0.00 98.44 
neopeltolide 100 63.03 22.02 14.95 
 10 59.66 30.27 10.07 
 1 46.11 39.95 13.94 
 0.1 46.4 40.01 13.59 
 
Preliminary investigation into the mechanism of action of neopeltolide suggests that it does 
not act via interaction with tubulin or actin.144 
Due to the promising biological activity of neopeltolide and its unknown mode of action 
further biological evaluation is very important. 
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6.2 Previous Neopeltolide Syntheses 
Due to its promising biological profile and fascinating structure, neopeltolide attracted 
considerable synthetic attention from several group. The first two syntheses, one by Panek,147 
the other by Scheidt et al.148 showed the original structural assignment to be partially wrong. 
As a result, the stereocenters at C11 and C13 had to be revised. Recently two more total 
syntheses of neopeltolide were achieved in the research groups of Lee149 and Sasaki.150 
 
6.2.1 Synthesis of Neopeltolide by Panek and co-workers147 
Paneks’ retrosynthetic strategy features a disconnection of the C19-C20 double bond to reveal 
the macrolide 6-1 and the oxazole side chain 6-2. For the creation of the macrolactone ring 
they relied on Yamaguchi macrolactonization. Installation of the tetrahydropyran unit was 
based on an [4+2] annulation strategy between allylsilane 6-3 and aldehyde 6-4. The latter 
was then traced back to dithiane 6-5 and epoxide 6-6. 
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Figure 24. Retrosynthetic analysis of neopeltolide (5-1) by Panek and co-workers.147 
Synthesis of aldehyde 6-4 was started from commercially available, but relatively expensive 
(R)-(+)-3-methylglutarate 6-7 (Scheme 60). Chemoselective reduction of the carboxylic acid 
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followed by TBDPS protection provided ester 6-8. Reduction of the ester function with 
subsequent dithioacetalization furnished dithiane 6-5. Coupling of dithiane 6-5 with epoxide 
6-6 followed by removal of the dithioketal group yielded ketone 6-9. A modified Evans–
Tishchenko reduction established the 1,3-anti-diol fragment. Protection of the secondary 
hydroxyl function, followed by silyl ether cleavage and Swern oxidation provided aldehyde 6-
4. 
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Scheme 60. Synthesis of the C7–C16 fragment 6-4. 
Aldehyde 6-4 was combined with allylsilane 6-3 to access dihydropyran 6-10 (Scheme 61). 
The sulfonate group was replaced with a nitrile moiety followed by DIBAL-H mediated 
cleavage of the acyl protecting group. Reduction of the nitrile to an aldehyde, followed by 
Pinnik oxidation provided the seco acid which afterwards was cyclized using the Yamaguchi 
protocol. Selective oxymercuration of the pyran double bond yielded the axial C5 alcohol 6-
12, which was subsequently transformed to phosphonoacetate 6-13. 
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Scheme 61. Completion of neopeltolide (5-1) synthesis. 
Deprotonation of 6-13 with KHMDS, followed by treatment with aldehyde 6-2 provided a 7:1 
mixture of neopeltolide (5-1) and the corresponding E olefin in 62% overall yield. 
The developed synthesis is based on the [4+2]-allylsilane annulation, and required a time-
consuming preparation of building block 6-3. Moreover, the longest linear sequence consist of 
19 steps, starting from costly (R)-(+)-3-methylglutarate 6-7, and provided neopeltolide in only 
1.3% overall yield. 
 
 
6.2.2 Synthesis of Neopeltolide by Scheidt and co-workers148 
Scheidt and co-workers divided the molecule in two distinct fragments, namely macrolactone 
6-14, and oxazole-containing acid 6-15 (Figure 25). Their plan was to utilize a recently 
developed Lewis-acid catalyzed cyclization. 156  The linear precursor (6-16) to this 
macrolactonization was available from dioxinone acid 6-17 and alcohol 6-18. 
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Figure 25. Retrosynthetic analysis of neopeltolide (5-1) according to Scheidt and co-workers.148 
The synthesis of acid 6-17 began with the Ti(IV)-(R)-BINOL catalyzed aldol reaction 
between dienoxy silane 6-20 and protected saturated aldehyde 6-19 to afford secondary 
alcohol 6-21 (Scheme 3). Protection of the hydroxyl function was followed by deprotection 
and oxidation of the primary alcohol function furnishing dioxinone acid 19. 
The synthesis of the alcohol 6-18 commenced with the two-step conversion of β-hydoxy ester 
6-22 to Weinreb amide 6-23. Acylation of the alkyl lithium derived from 6-24 with amide 6-
23 furnished ketone 6-25. Removal of the PMB group followed by Evans-Tischenko 
reduction provided alcohol 6-26. Methylation of free hydroxyl function with subsequent 
hydrolysis of benzoate secured alcohol 6-18. 
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Scheme 62. Synthesis of acid 6-17 and alcohol 6-18. 
Acid 6-17 was coupled with alcohol 6-18 using the Yamaguchi protocol. Deprotection of both 
silyl ethers followed by selective oxidation of the primary alcohol afforded acyclic aldehyde 
6-16. The crucial Sc(OTf)3 promoted macrocyclization provided macrolactone 6-27, albeit 
only in moderate yield (25%). The tricyclic dioxinone was converted to alcohol 6-14 by 
heating in wet DMSO followed by a selective reduction of the ketone with NaBH4. 
Mitsunobu reaction of the obtained alcohol 6-14 with acid 6-15 furnished neopeltolide (5-1). 
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Scheme 63. Completion of the neopeltolide (5-1) synthesis. 
Although the aforementioned synthesis is quite convergent, due to the poor yield of the key 
macrolactonization step, the final product was obtained in only 0.5% overall yield. This is 
significantly limiting the application of the developed strategy to the synthesis of neopeltolide 
analogues. 
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6.2.3 Synthesis of Neopeltolide by Lee and co-workers149 
According to this retrosynthetic analysis the pyran fragment as well as macrolactone ring 
could be prepared via intramolecular Prins cyclization of aldehydic homoallylic alcohol 6-29. 
The latter can be derived from alcohol 6-30. 
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Figure 26. Retrosynthetic analysis of neopeltolide (5-1) by Lee et al.149 
Asymmetric crotyl transfer reaction from 6-31 to butanal, followed by protection and 
ozonolysis afforded aldehyde 6-32 (Scheme 64). Subsequent TiCl4 mediated methallylation 
of 6-32 and esterification of the obtained alcohol with acid 6-33 secured ester 6-34. A 
substrate-directed hydroformylation of 6-34 provided aldehyde 6-35 in a 5:1 ratio. 
Dimethylacetal formation, hydrolysis and O-methylation furnished dimethyl acetal 6-36. 
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Scheme 64. Synthesis of dimethyl acetal 6-36. 
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The aldehyde derived from 6-36 was introduced in a Brown allylation reaction, which 
furnished homoallylic alcohol 6-37 in a 5.5:1 diastereomeric ratio (Scheme 65). Subsequent 
TBS protection, followed by benzyl group cleavage and esterification with 3,3-
diethoxypropanoic acid provided intermediate 6-38. The crucial intramolecular Prins 
cyclization of 6-38 afforded macrolactone 6-14, albeit only in 47% yield and with 9:1 
selectivity. 
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Scheme 65. Synthesis of macrolactone 6-14. 
Due to the low yield of pyran 6-14 the Lee group developed an alternative Prins cyclization 
approach. The required substrate 6-41 was derived from aforementioned dimethyl acetal 6-36. 
Deprotection of the benzyl ether, followed by esterification with acid 6-40 and prolonged 
exposure to DDQ produced intermediate 6-41 (Scheme 66). This time, the Prins cyclization 
proceeded more efficiently and provided macrolide 6-14 in reasonable yield. Mitsunobu 
esterification of alcohol 6-14 with acid 6-15 led to neopeltolide (5-1). 
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Scheme 66. Completion of the neopeltolide (5-1) synthesis. 
After all, Lee and co-workers developed a quite convergent synthesis of neopeltolide, which 
consist of 15 linear steps and provides the final compound in 6.7% overall yield. 
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6.2.4 Synthesis of Neopeltolide by Sasaki and co-workers150 
Following the general trend,148,149 neopeltolide (5-1) was divided into macrolactone 6-14 and 
the oxazole-containing carboxylic acid 6-15. Yamaguchi macrolactonization required the 
preparation of tetrahydropyran intermediate 6-42. For the construction of the fragment 6-42, 
in turn, they relied on a Suzuki–Miyaura coupling of enol phosphate 6-43 and alkylborate 6-
44 (generated in situ from iodide 6-45) and subsequent RCM. 
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Figure 27. Retrosynthetic analysis of neopeltolide (5-1) by Sasaki and co-workers.150 
The two stereocenters of 6-43 are based on an asymmetric allylation and a Sharpless 
asymmetric epoxidation. Asymmetric allylation of aldehyde 6-46 followed by PMB 
protection and olefin cross-metathesis provided enoate 6-47 in 57% yield (Scheme 67). After 
reduction of 6-47 to the corresponding allylic alcohol, Scharpless asymmetric epoxidation 
delivered epoxide 6-48. An iodination/reductive ring-opening sequence on substrate 6-48, 
followed by BOM protection and oxidative cleavage of the PMB ether led to alcohol 6-49 in 
good overall yield. The obtained alcohol was transformed to the corresponding acetate, which 
was subjected to enolization in the presence of (PhO)2P(O)Cl. This resulted in formation of 
enol phosphate 6-43. 
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1. I2, PPh3, imidazole
2. Zn, AcOH, EtOH
3. BOMCl, iPr2NEt
4. DDQ, DCM/pH 7 buf.
(54% 4 steps)
6-48
CHO
TIPSO
1. (+)-Ipc2BOMe
allylMgBr (98%)
2. PMB-imidate, La(OTf)3
3. Methyl acrylate
Grubbs II (58% 2 steps)
6-46
CO2Me
OPMB
TIPSO 1. DIBAL-H, DCM
(80%)
2. (–)-DET, Ti(OiPr)4,
tBuOOH (97%)
OPMB
TIPSO
OHO
6-43
6-47
OH
TIPSO
BOMO
1. Ac2O, NEt3,
DMAP (99%)
2. KHMDS,
(PhO)2P(O)Cl6-49
 
Scheme 67. Synthesis of enol phosphate 6-43. 
The synthesis of iodide 6-45 commenced with nitrile 6-50 (Scheme 68). DIBAL-H reduction of 
6-50 followed by asymmetric allylation and methylation of the resulting secondary hydroxyl 
function secured alkene 6-51. Ozonolysis of the double bond provided the corresponding 
aldehyde, which was allylated to alcohol 6-52. The next sequence, which includes 
hydrogenation, PMB protection, desilylation and iodination, furnished required iodide 6-45. 
1. H2, Pd/C, (100%)
2. PMB-imidate, La(OTf)3
3. TBAF (65% 2 steps)
4. I2, PPh3, imidazole (76%)
6-50
1.O3, then PPh3
(85%)
2. (–)-Ipc2BOMe
allylMgBr (96%)
6-45
1. DIBAL-H, DCM
2. (+)-Ipc2BOMe
allylMgBr (82% 2 steps)
3. MeOTf, 
2,6-di-tert-butylpyridine
(88%)
ORNC
R = TBDPS
6-51
OR
OMe
OR
OMeOH
I
OMePMBO
6-52  
Scheme 68. Synthesis of iodide 6-45. 
Transformation of iodide 6-45 to alkylborate 6-44 was followed by treatment with Cs2CO3, 
[Pd(PPh3)4] and enol phosphate 6-43. This resulted in formation of diene 6-53, which was 
subjected to RCM with subsequent stereoselective hydrogenation (Scheme 69). 
6-45
6-45, B-MeO-9-BBN 
tBuLi, then
3M aq. Cs2CO3
[Pd(PPh3)4], 6-43
O
OBOM6-53
OMe
PMBO6-43
+
OR
R = TIPS
O
OBOM6-42
OMe
PMBO
OR
1. Grubbs II
10 mol%
2. H2, Pd/C
(63%, for 
3 steps)
H H
 
Scheme 69. Synthesis of tetrahydropyran intermediate 6-42. 
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Notably, transformation of obtained intermediate 6-42 to the neopeltolide core 6-14 required 
8 steps, which make this synthesis quite long (Scheme 70). Finally, alcohol 6-14 was coupled 
with acid 6-15 under Mitsunobu conditions. 
6-42
1. TBAF, THF
2. SO3·Py, NEt3, DMSO
3. NaClO2, NaH2PO4
4. TMSCHN2 
5. DDQ, DCM/pH 7 buf.
6. TMSOK (79% overall)
HO2C
O
OBOM6-54
OMe
HO
H H
1. TCBC,
Et3N (100%)
2. H2, Pd/C
(100%)
6-14 5-1
6-15, DIAD
PPh3, C6H6
(61%)
 
Scheme 70. Completion of the neopeltolide (5-1) synthesis. 
In summary, the developed synthesis required 25 steps (longest linear sequence) and provided 
neopeltolide (5-1) in 8.3% overall yield, starting from relatively expensive (R)-(–)-3-hydroxy-
2-methylpropionate. These facts are significantly hampering the application of the 
aforementioned strategy to the large-scale synthesis of neopeltolide or its analogues thereof. 
 
6.3 Key Reactions and its Mechanisms 
For the synthesis of such complex molecules as neopeltolide one would need to apply a broad 
spectrum of well established and modern synthetic methodologies. Therefore, an overview of 
the most important reactions used for our neopeltolide synthesis is provided below. Since it is 
not possible to describe every method in detail in this thesis, for each reaction only the general 
information and the most representative examples of application are given. 
 
6.3.1 Prins cyclization 
A large number of natural products and medicinally useful agents contain substituted 
tetrahydropyran rings; correspondingly a variety of methods have been developed for their 
stereocontrolled synthesis.157 One of the most powerful transformations to generate highly 
substituted tetrahydropyrans with excellent stereoselectivity is the Prins cyclization.158 
 
As with any reaction creating new stereogenic centers, the utility of the Prins cyclization is 
highly dependent on the degree of stereoselectivity associated with the transformation. Prins 
cyclizations are typically highly selective for the all-cis tetrahydropyran. Several factors are 
involved when rationalizing the stereochemical outcome for Prins cyclization reactions. The 
first rationale for the all-cis stereoselectivity has been set forth by computational work from 
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Alder.159Alder suggested that ring closure of an alkene into an oxocarbenium ion through a 
chair transition states leads to tetrahydropyranyl cation intermediate 6-56 (Figure 28). 
Tetrahydropyranyl cation 6-56 has increased stability due to delocalization. In the ring closure 
step, the C2 substituent lies in a favorable equatorial position and the (E)-oxocarbenium ion 
geometry is preferred 160  over the (Z)-oxocarbenium ion geometry. Therefore, chirality is 
transferred from C2 to the newly formed carbon–carbon bond. The stereocenter formed at C4 
is controlled by the extensive delocalization of tetrahydropyranyl cation 6-56. Favorable 
orbital overlap places the hydrogen at C4 in a pseudoaxial geometry, and, therefore 
nucleophilic attack occurs along an equatorial trajectory to deliver tetrahydropyran 6-57. In 
this way, four stereogenic centers of the tetrahydropyran ring can be formed with high 
stereoselectivity from one initial stereocenter and defined alkene geometry. 
O
R1
R2 R4
R3
O
R1
R2 R4
R3 H
:Nu
O
R1
R2 R4
R3
Nu
6-55 6-56 6-57
O 2
3
4
5
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Figure 28. Stereochemical outcome for Prins cyclizations. 
Recently Rychnovsky and co-workers reported Prins cyclizations that are not consistent with 
this rationale.161 Acetoxy ethers 6-58 upon treatment with bromotrimethylsilane (TMSBr), 
cyclize to produce 2,6-cis-4-trans tetrahydropyrans 6-59 (Scheme 71). 
OR1
OAc
R2
TMSBr
O
Br
R1 R2
CH2Cl2
R1 = Alk
R2 = Alk
6-58 6-59  
Scheme 71. Axial-selective Prins cyclization. 
Another important feature for a synthetically useful transformation is the ability to convert 
optically active starting materials into optically active products. Although typically 
proceeding with high stereochemical fidelity, the Prins reaction sometimes leads to partial or 
complete racemization.162 
Oxonia Cope rearrangement is a competitive process in Prins cyclization and proceeds rapidly 
even at –78 °C. Rychnovsky et al. reported that treatment of optically enriched alcohol 6-60 
(ee = 87%) with BF3·Et2O in the presence of hydrocinnamaldehyde and acetic acid led to 
tetrahydropyran 6-61 in 67% ee along with symmetric tetrahydropyrans 6-62 and 6-63 
(Scheme 72).163 The mechanism of racemization in this case can be attributed to an allyl 
transfer process. Alcohol (R)-6-60 can condense with hydrocinnamaldehyde to generate 
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oxocarbenium ion 6-64 and liberate a molecule of water. 2-Oxonia Cope rearrangement of 6-
64 will lead to oxocarbenium ion 6-65 which will undergo water mediated fragmentation to 
benzaldehyde and alcohol (R)-6-66. 
OHPh
PhCH2CH2CHO
(R)-6-60
BF3·Et2O, AcOH
TMSOAc, CyH
25 °C
OPh R
OAc
6-61
+
OPh Ph
OAc
OR R
OAc
+
67% ee
6-62 6-63
R = CH2CH2Ph6-61 : 6-62 : 6-63
4.0 :  1.2  : 1.0Allyl Transfer Mechanism:
OHPh
(R)-6-60
+ PhCH2CH2CHO
-H2O
OPh
6-64
Ph
2-Oxonia Cope
OPh Ph
+H2O
PhCHO
HO Ph
6-65(R)-6-66
+
 
Scheme 72. Racemization of Prins cyclization products by 2-oxonia Cope rearrangement.163 
The formation of benzaldehyde and alcohol (R)-6-66 allows for a symmetric 2-oxonia Cope 
rearrangement. Initial alcohol (R)-6-60 can condense with benzaldehyde, undergo 2-oxonia 
Cope rearrangement, and then fragment with the addition of water to generate epimeric (S)-6-
60 (Scheme 73). Likewise, alcohol (R)-6-66 can generate epimeric (S)-6-66. In this way, allyl 
transfer processes can lead to racemization in Prins cyclization reactions. It should be noted 
that this mechanism relies on the presence of water, which is generated upon direct Prins 
cyclizations between homoallylic alcohols and aldehydes. 
OHPh
(R)-6-60
PhCHO
PhHO
(S)-6-60
OHR
(R)-6-66
PhCHO
RHO
(S)-6-66
R = CH2CH2Ph  
Scheme 73. Racemization by symmetric 2-oxonia Cope rearrangement. 
Another example of racemization during Prins cyclization was reported by Willis et al. It was 
shown that Prins cyclization of benzylic alcohols can lead to an extensive loss in enantiomeric 
excess due to a solvolysis mechanism.164 Reacting of optically enriched alcohol (R)-6-67 with 
propanal in the presence of BF3·Et2O and acetic acid led to tetrahydropyran 6-68 in less then 
5% ee (Scheme 74). This outcome can be attributed to the generation of stabilized benzylic 
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cation 6-70 by a solvolysis reaction of initial alcohol 6-67 or oxocarbenium ion 6-69. This 
stabilized, achiral benzylic cation then recombines with propanal, providing racemic 
tetrahydropyran 6-68. In general, Prins cyclization reactions utilizing electron-rich aromatic 
substrates often proceed with low stereochemical fidelity. 
AcOH
TMSOAc OEt
OAc
rac-6-68
<5% ee
HO
OMe
EtCHO
BF3·Et2O
OMe(S)-6-67
EtCHO
O
OMe
Et
OMe6-69 6-70  
Scheme 74. Racemization in Prins cyclization by solvolysis mechanism.164 
In order to minimize racemization during Prins cyclization and increase its compatibility to 
sensitive substrates many useful modifications of this reaction were developed. Rychnovsky 
reported that α-acetoxy ethers are ideal precursors to the oxocarbenium ion of the Prins 
cyclization due to regioselective solvolysis of the acetate upon treatment with Lewis acid.165 
The α-acetoxy ethers can be prepared by reductive acetylation of acyclic esters 6-72, which 
allows the application of this methodology in the synthesis of complex structures (Scheme 
75). Lewis acid or protic acid induced cyclizations of unsaturated α-acetoxy ethers substrates 
6-73 lead to cis-2,6-dialkyltetrahydropyrans 6-74 with an equatorial halide or acetate at the 4-
position. 
R1 OH
R2CO2H
coupling
agent R1 O R2
O
1. DIBAL-H
2. Ac2O,
DMAP, pyr. R1 O R2
OAc
Lewis
acid
O
X
R1 R2
6-71 6-72 6-73 6-74
X = Hal, OAc  
Scheme 75. Utilization of α-acetoxy ethers in the Prins cyclization.165 
The stereoselectivity of the Prins cyclization with α-acetoxy ether substrates is consistent with 
an E-oxocarbenium ion intermediate adopting a chair conformation (Figure 29). The 
oxocarbenium ions prefer an E-geometry with the hydrogen atom roughly eclipsing the 
hydrogen atom of the methine across the ether link, and this preference results in the 
formation of cis-2,6-dialkyl tetrahydropyran products. 
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R = Alkyl  
Figure 29. Stereochemical outcome for Prins cyclizations of α-acetoxy ethers.165a 
In general, the Prins cyclization of substrates 6-73 are carried out using either SnBr4 in 
CH2Cl2 at –78 °C or BF3·Et2O and HOAc in hexanes.165 
Notably, cyclizations of dienes and enynes often take place with useful levels of 
regioselectivity (Scheme 76). 
O
OAc
A
O
OAc
84%
O
OAc
A
O
OAc
82 %
O
OAc
A
O
OAc
89% O
OAc
A
O
OAc
80 %
Ph Ph
Condition A: BF3·Et2O, HOAc, hexane, 0 °C  
Scheme 76. Prins cyclization of dienes and enynes.165a 
This methodology has been applied to a synthesis of the C22–C26 166  and C3–C19 167 
segments of phorboxazole B, C18-C25 segment of Lasonolide A168 and to the total synthesis 
of gambierol.169 
During the total synthesis of (–)-centrolobine Rychnovsky and co-workers have found that the 
Prins cyclization of α-acetoxy ether 6-75, promoted by SnBr4 is much faster than promoted by 
BF3·Et2O and HOAc and thus suppresses the competing 2-oxonia Cope process (Scheme 77). 
–78 °C (84%)
SnBr4
CH2Cl2
TsO
O
OAc
OBn TsO
O
Br
OBn6-75 6-76  
Scheme 77. Application of SnBr4 mediated Prins cyclization.163 
Another useful modification of Prins cyclization was developed in the Panek group. It was 
shown that syn-(E)- and anti-(E)-crotylsilanes react with aldehydes in the presence of Lewis 
acid to generate the 2,6-cis- and 2,6-trans-THP ring, respectively (Scheme 78). 170  This 
methodology was employed in the total synthesis of herboxidiene, 171  bistramide A, 172 
leucascandrolide146m and kendomycine.173 
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Scheme 78. Chiral crotylsilanes for the synthesis of THP rings.170 
Recently, Yadav et al. reported a new approach, based on the Prins cyclization, for the 
stereoselective synthesis of polyketid precursors containing anti-1,3-diols, flanked by a 
variety of alkyl branches and functional groups (Scheme 79).174 After the Prins cyclization 
that generates three new stereocenters, the pyran ring is opened under reductive conditions to 
provide acyclic structures. 
OHR1
R2
R3O+
1. TFA,
CH2Cl2
O
OP
R2
R3R1
OP
R4
R2
R3
OH
R1, R3 = Alkyl
R2 = H, Alkyl
R4 = Alkenyl,
        Alkynyl
Li or Na
NH3(liquid)
P = protecting group
 
Scheme 79. Approach for the stereoselective synthesis of anti-1,3-diol fragments.174 
After all, nowadays the application of the Prins reaction to the synthesis of natural products 
has become commonplace, undoubtedly because of the convergent and efficient nature of the 
reaction for the formation of tetrahydropyran rings. The most recent examples of its 
utilization include total synthesis of calyxin, 175  clavosolide A, 176  dactylolide, 177  ratjadone 
A,178 briarellins E and F,179 and polycavernoside A.180 
 
6.3.2 Asymmetric hydrogenation of β-keto esters (Noyori reduction) 
Optically active β-hydroxy carboxylic esters are an extremely important class of intermediates 
for synthesis of different natural products and pharmaceuticals. Until the end of 1980 access 
to such compounds has relied mainly on biological or biochemical transformations.181  
A major breakthrough in this field came with the fundamental work of Noyori. 182  In his 
pioneering paper he reported screening of different BINAP-Ru(II) complexes in the reduction 
of methyl 3-oxobutanoate to methyl 3-hydroxybutanoate.183 As a result it was found that the 
Literature Review 93
halogen-containing complexes having an empirical formula RuX2(BINAP) (X = Cl, Br or I), 
served as excellent catalyst precursors. The enantioselective hydrogenation using less than 0.1 
mol% of catalyst proceeded smoothly in methanol under an initial hydrogen pressure of 50–100 
atm.184 A variety of prochiral β-keto esters were hydrogenated in nearly quantitative yields 
and with extremely high (up to 100%) enantioselectivities (Scheme 80). Esters of methyl, 
primary, secondary, and tertiary alcohols were equally employable. 
O
R1
O
OR2
H2 (50-100 atm)
RuX2(BINAP)
MeOH
OH
R1
O
OR2
R1 = Me, Et, iPr, nBu, Ph
R2 = Me, Et, iPr, tBu
BINAP S or R
X = Cl, Br, I
93 - 99.5% yield
up to 100% ee
*
 
Scheme 80. RuX2(BINAP) catalyzed asymmetric hydrogenation of β-keto esters.183 
To explain the mechanism of RuX2(BINAP) catalyzed asymmetric hydrogenation of β-keto 
esters, one should take a closer look at its structure. 
BINAP, 2,2’-Bis(diphenylphosphino)-1,1’-binaphtyl, is a chiral ligand commonly used in 
formation of catalytic reagents. It is one of the most important commercially available catalyst 
ligand and has been widely used to achieve asymmetric catalysis under a variety of 
conditions.185 This catalytic ligand is a fully aromatic and conformationally flexible atropo-
isomeric C2 diphosphine (Figure 30). The barrier to racemization is high due to steric 
hindrance that limits rotation about the bond linking the naphtyl groups. The dihedral angle is 
approximately 90°. Because the rotation about the binaphtyl C1-C1’ pivot and C2- or C2’-P 
bonds is possible without seriously increasing the torsional strain, it can accommodate a range 
of transition metals, mainly of the second and third rows, such as Ru(II), Rh(I), palladium and 
iridium.186 The axially dissymmetric C2 chiral diphosphine exerts strong steric and electronic 
influences on transition metals complexes. Many of these species promote various 
asymmetric transformations such as hydrogenation, hydrosilylation, hydroboration, allylic 
alkylation and isomerization. 
P
P
MX2L2
Ar2
Ar2
P
P
M = transition metal
X = halogen
Ru
Ar2
Ar2
Cl
Cl
S
S
[RuCl2(binap)S2]
S = solvent or other ligand
A
 
Figure 30. Structure of (S)-BINAP based metal complex. 
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BINAP-Ru dichloride catalysts have a very wide scope for the hydrogenation of β-keto esters. 
Scheme 81 illustrates the mechanistic model for the (S)-(BINAP)-Ru-catalyzed 
hydrogenation of β-keto esters. The halide ligand in the Ru complex, which generates a strong 
hydrochloric acid and a RuHCl species by the action of H2, is important to facilitate the 
hydride transfer from the Ru centre to the carbonyl carbon. 187  Intermediate B interacts 
reversibly with the β-keto ester to form the σ-type chelate complex C, in which metal-to-
carbonyl hydride transfer is geometrically difficult. Then protonation occurs at the oxygen to 
increase the electrophilicity of the carbon and convert the geometry from σ to π, thereby 
facilitating the hydride migration. The hydroxy ester ligand compex in the resulting product D 
is liberated by solvent molecules. Reaction of the cationic Ru complex E with H2 results in 
regeneration of catalytic intermediate B. Enantioselection with a ratio of >99:1 is generally 
achieved in the hydride transfer step from C to D. Here, the key is the carbonyl protonation in 
C, which is mediated by HCl188 generated in the induction step A to B. 
[RuCl2(binap)S2]
A
H2 -HCl
[RuHCl(binap)S2]
B
O
OR2
O
R1
(binap)ClHRu
O
OR2
O
R1
(binap)ClRu
H
H
+
[RuCl(binap)Sn]+
C
D
E
O
R1
O
OR2
S
H+
S
OH
R1
O
OR2
H2
H+, S
S = solvent  
Scheme 81. Mechanism of (S)-BINAP-Ru catalyzed hydrogenation of β-keto esters.185,186 
The chirality of BINAP is transmitted to other metal coordination sites through the chelate 
structure. The δ or λ geometry is highly skewed and determines the chiral disposition of the P-
pnenyl rings that is crucial for generating outstanding chirality-discriminating ability at the 
reactive coordination sites. The transition states (TSs) in the hydride transfer step are 
stabilized by the ligation of the ester C–O to the Ru center. 
In addition, the presence of the ester moiety interacting with the Ru center is crucial for both 
high reactivity and enantioselectivity. Due to the excellent chiral recognition ability of 
BINAP, the two stereo-determining transition states (TSs) are well differentiated with the 
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assistance of the oxygen-Ru interaction. According to Figure 31, the second and fourth 
quadrants are more crowded than the first and third quadrants because of shielding by the 
equatorial phenyl groups. The S-directing TS is highly favored over the R-generating 
diastereomer, which suffers from the substantial R/P-phenyl repulsive interaction.186,189 The 
oxygen–Ru dative bond exerts a pivotal function in the acceleration of hydrogenation as well. 
β-Keto esters are hydrogenated smoothly even in acetone, containing a small amount of water. 
Although, BINAP-Ru dihalide catalyst have a very broad scope, they are not suitable for 
hydrogenation of simple, unfunctionalized ketones. 
Ru P
P
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equatorial
1
3
2
4 RuS2[(S)-BINAP]
HO
R1
O
OR2
Ru
Cl
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O
R2O
OH
R1
H
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this carbon to P
atom of BINAP O
R2O
OH
R1
Ru
Cl
favored TS
H
steric hindrance
R/Phenyl repulsion
backbone of phosphane is not depicted
 
Figure 31. Stereochemical outcome for (S)-BINAP-Ru catalyzed hydrogenation of β-keto esters. 
In addition, the halogen-containing BINAP-Ru complexes are efficient catalysts for the 
asymmetric hydrogenation of a range of functionalized ketones, wherein coordinative 
nitrogen, oxygen, and halogen atoms near C=O functions direct the reactivity and 
stereochemical outcome in an absolute sence. 190 A wide variety of achiral ketones were 
hydrogenated in an enantioselective manner to the corresponding chiral alcohols in 90–100% 
ee (Figure 32). In general, the reaction can be performed in alcohols, as a solvent, with up to 
50% substrate concentration under 4–100 atm at room temperature with an substrate:catalyst 
ratio of up to 10 000:1 on any scale, even using >100 kg of the substrate. 
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Figure 32. Scope of asymmetric hydrogenation of functionalized ketones. 
Although the Ru(II)-BINAP system provides very high enantioselectivity over a wide range 
of substrates with remarkable turnover, in some cases temperatures greater than 80 °C or 
hydrogen pressures greater than 1000 psi (80 atm) are required to achieve high selectivities 
and yields. 
 
In 1992 King and co-workers reported that in the presence of 0.1 mol% of strong acid and 
using 0.02–0.05 mol% of [RuCl2(BINAP)]2NEt3 complex, asymmetric hydrogenation can be 
conducted in a standard Parr shaker apparatus at low temperatures and readily attainable 
pressures (40 °C/30 psi H2).188a In addition, they developed a simple and reproducible 
procedure for the preparation of purified catalyst. 
 
Another valuable improvement of the original Noyori procedure was achieved by Genêt and 
co-workers.191 It was shown that asymmetric hydrogenation of β-keto esters can be carried out 
at atmospheric pressure using chiral Ru(II) catalysts of general formula [RuBr2(L)], where L = 
BINAP, MeO-BIPHEP, Me-DUPHOS. These catalysts were easily prepared in situ by 
treatment of commercially available (COD)Ru(2-methylallyl)2 in the presence of the 
appropriate chiral ligands. 
 
Because of outstanding selectivity and efficiency, BINAP-Ru(II) catalyzed reductions have 
found wide application in the syntheses of complicated natural products, pharmaceuticals and 
fine chemicals. The most representative examples of its utilization include total syntheses of 
(–)-roxaticin,192 (+)-mycoticin A,193 taurospongin A,194 roflamycoin,195 and (+)-codaphniphylline.196 
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6.3.3 Enantioselective allylation of aldehydes using strained silacycles (Leighton 
allylation) 
Due to the prevalence of secondary alcohols in bioactive natural products, many moderately 
to highly enantioselective chiral reagents and catalytic system for the allylation of aldehydes 
have been developed. 197  The most reliable reagents in this regard are based on chiral 
allylmetal derivatives. For example, as was shown by H. C. Brown and co-workers, chiral 
allyldiisopinocampheylborane (6-77), derived from the hydroboration of pinene turned out to 
give high ee-values in the addition to prochiral aldehydes (Figure 33).198 However, the main 
drawback of this methodology is requirement of salt-free conditions and low temperatures (–
100 °C), which is significantly limiting its application in a large scale synthesis. Other 
allylation reagents are derived from monocyclopentadienylchlorotitanium complexes 
containing two chiral alkoxy ligands, which in turn can be obtained from tartrate ester acetals 
by Grignard addition.199 Although allyltitanation reactions generally proceed with respectable 
selectivity, the preparation of reagents 6-78 is rather complicated and time consuming process. 
B
6-77
(+)-Ipc2BAll
Ti O
O
O
O
R
R
R
R
6-78
R = Alkyl, Aryl 
Figure 33. Structure of (+)-Ipc2BAll (6-77) and cyclopentadienyldialkoxyallyltitanium 
complexes (6-78). 
Thus, the development of new reagents for enantioselective allylation of aldehydes was 
undertaken by various groups. In terms of practically utility, an ideal reagent should be easily 
and inexpensively prepared in both enantiomeric forms; can be prepared in bulk and 
employed by using only trivial procedure; will allow easy separation and purification of the 
homoallylic alcohol products; and finally, be generally effective in terms of both efficiency 
and enantioselectivity. 
Significant progress in this field has been achieved by Leighton and co-workers. They 
reported that simply by constraining silicon in five-membered rings with 1,2-diols, 1,2-
diamines, and 1,2-amino alcohols, sufficient Lewis acidity for uncatalyzed allylation reactions 
are obtained.200 Because both enantiomers of pseudoephedrin are available and inexpensive it 
was chosen for initial study. Reaction of (1S,2S)-pseudoephedrine with allyltrichlorsilane and 
NEt3 in CH2Cl2 allowed the isolation of allylsilane (S,S)-6-79 in 88% yield (Scheme 82). 
Reaction of (S,S)-6-79 with benzaldehyde in benzene at room temperature gave alcohol (S)-6-
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80 with 66% ee. After optimization of reaction conditions it was found that the best yields and 
ee-values can be achieved when reactions are carried out in toluene at –10 °C and with 0.2–
0.4 M silane concentration. In order to investigate the scope of this reaction several different 
aldehydes were allylated under optimized conditions. As one can see, whereas 
enantioselectivities for aliphatic aldehydes are good (87–96%), they are unacceptably low for 
aromatic and conjugated aldehydes (78–81%). 
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Scheme 82. Enantioselective allylation of different aldehydes with allylsilane reagent (S,S)-6-79.200 
In the same paper were also reported preliminary data regarding reagent 6-81, which was 
found to provide improved enantioselectivity, but also low reactivity (Scheme 83). 
Allylsilane 6-81 was prepared by reacting (1R,2R)-N,N’-dibenzylcyclohexane-1,2-diamine 
with allyltrichlorsilane in the presence of DBU as a base. 
Cl3Si
+ DBU
CH2Cl2
RCHO
PhCH3
72 h
OH
R
NHBn
NHBn N
Si
N
Bn
Bn
Cl
R = Ph, 46%, 90% ee
R = PhCH2CH2,
58%, 95% ee
6-81
 
Scheme 83. Enantioselective allylation with allylsilane reagent 6-81.200 
Using obtained results as a starting point, they conducted a full investigation into the potential 
of the diamine-based system. During the optimization of the performance of reagent 6-81 it 
turned out that the use of CH2Cl2 as a solvent led to a significant increase in both the 
efficiency and enantioselectivity. In order to identify role of the benzyl substituent, the bis-(p-
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methoxybenzyl) and bis-(p-bromobenzyl) analogues of 6-81 were prepared and screened for 
any effect on efficiency and selectivity. 201  As a result, the bis-(p-bromobenzyl)-diamine 
system was identified as most effective and convenient. Thus, it was used to optimize 
conditions and to examine the scope of the reaction. Allylation of aliphatic aldehydes with 1 
equiv. of (R,R)-6-82 at –10 °C in CH2Cl2 proceeded smoothly and provided the corresponding 
homoallylic alcohols in good to excellent yields and with excellent enantioselectivities 
(Scheme 84). Reactions at room temperatures were found to be slightly less selective, but the 
yields were significantly lower due to partial decomposition of the reagent. 
Reacting aromatic aldehydes with reagent (R,R)-6-82 resulted in formation of chiral benzylic 
alcohols in respectable yields and with high ee-values. However, conjugated aldehydes 
proved still less efficient, but when the reaction was carried out at 8 °C for 72 h good yields 
and excellent enantioselectivities were obtained as well. 
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Scheme 84. Scope of the enantioselective allylation with allylsilane reagent (R,R)-6-82.201 
In addition, it was shown that the developed methodology can be successfully transferred to 
chiral aldehydes. Subjection of aldehyde 6-83 to the standard allylation conditions with (R,R)-
6-82 secured protected syn-alcohol 6-84 in 86% yield and 95:5 d.r. (Scheme 85). In a similar 
way, reaction of 6-83 with enantiomeric reagent (S,S)-6-82 led to protected anti-alcohol 6-85 
in 86% yield and 98:2 d.r. 
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Ph
OBn OH
Ph
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PhCH2Cl2
–10 °C
20 h
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6-84 6-83 (98% ee) 6-85
86%; 95:5 d.r. 86%; 98:2 d.r.  
Scheme 85 Asymmetric allylation of chiral aldehydes.201 
Notably, reagent 6-82 is a readily prepared stable solid that may be briefly handled in air with 
no apparent decomposition, and may be stored in a freezer under N2 for long periods of time. 
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The cyclohexane diamine (R,R)-6-86 was prepared via reductive amination from p-
bromobenzaldehyde and (1R,2R)-(+)-1,2-diaminocyclohexane·L-tartrate (Scheme 86). 
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Scheme 86. Synthesis of allylsilane reagent (R,R)-6-82.201 
As was mentioned before, allylsilanes 6-79, 6-81, 6-82 react without any additives with 
aldehydes because of ring-strain-release Lewis acidity, which still remains in such five-
membered silacycles due to the long Si–N bonds and short C–N bonds. Originally, it was 
assumed that complexation of the aldehyde to the silane to give a trigonal bipyramidal 
intermediate is followed by allyl transfer. Recently Leighton and co-workers communicated a 
paper, devoted to detailed investigations of mechanism and stereoselectivity of asymmetric 
aldehyde allylations employing the strain-release activated silane reagents based on 
computational methods.202 Some strain release is realized by reducing the Si–N-bond angle to 
roughly 90° in the trigonal bipyramidal arrangement. In this study the transition states for the 
stereoselective strain-release allylations have been located. Using the model based on these 
transition states the following components important for the stereoselectivity of diazasilane 
reagents were suggested: (a) attack of aldehyde oxygen on an apical position of the Si center 
(anti to an N); (b) an antiperiplanar arrangement of an O lone pair and the Si–Cl bond in the 
chair transition state; (c) location of the chlorine with the lone pair anti to the lone pair of 
apical N. 
N
N
Si O
Cl
R
H
Ar Ar 1. aldehyde oxygen on an apical position
2. trigonal bipyramidal molecular geometry
 
Figure 34. Possible transition state for Leighton allylation. 
In addition, it was shown that strained silacycles can be successfully used for enantioselective 
allylation of acylhydrazones 203  and highly diastereo- and enantioselective crotylation of 
aldehydes.204 
The developed methodology was efficiently employed in the total syntheses of dolabelide 
D,205 apicularen A,206 gigantecin,207 anamarine,208 and 10-epi-anamarine.209 
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More recently, it was demonstrated that even sterically hindered and functionalized aryl 
ketones can be allylated and crotylated with high enantioselectivities to provide access to 
unusual tertiary carbinol structures.210 
 
6.3.4 Asymmetric alkyl cuprate addition to α,β-unsaturated thioesters (Feringa–
Minnaard reaction) 
Due to the occurrence of polydeoxypropionate chains in numerous biologically relevant 
compounds many methods for their stereocontroled synthesis were developed. Many of these 
approaches utilize a chiral auxiliary (enolate alkylations, 211  conjugate additions, 212  allylic 
alkylations213) or substrate to effect stereochemical control. Recently, an attractive iterative 
catalytic asymmetric procedure was disclosed by Negishi and co-workers. 214  This 
methodology provides access to α,ω-diheterofunctional reduced polypropionates via ‘one-pot’ 
Zr-catalyzed asymmetric carboalumination–Pd-catalyzed cross-coupling tandem process. 
 
Other options for the introduction of the methyl bearing stereocenter are based on the use of 
commercially available and, usually, very costly chiral substrates, like Roche ester, 3-
methylglutarate etc. Therefore, development of simple and efficient enantioselective methods 
for the construction of deoxypropionate subunits with absolute stereocontrol always was 
desirable goal for many chemists. 
 
A major breakthrough in this area came with the pioneering work of Feringa and Minnaard.215 
Initially, it was reported that chiral Josiphos ligands216,217 were very effective in promoting 
the Cu-catalyzed conjugate addition (CA) of alkyl Grignard reagents to α,β-unsaturated 
esters.218 A broad range of β-substituted chiral esters was obtained in good yields and with 
excellent enantioselectivities (Scheme 87). Importantly, the use of sterically hindered esters, 
which usually help to avoid undesired 1,2-additions was not required. As was proved by X-ray 
analysis, reacting stoichiometric amounts of ligand Josiphos (6-87) with CuBr·SMe2 resulted 
in formation of dinuclear copper catalyst complex 6-88. Interestingly, complex 6-88 could also 
be recovered from the crude reaction mixture. While linear aliphatic Grignard reagents provided 
excellent results in the CA to α,β-unsaturated esters 6-89, affording the products 6-90 with 
excellent region- and enantioselectivities, the addition of MeMgBr to methyl (2E)-hex-2-
enoate showed the limitation of the methodology. Although the product was formed with high 
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enantioselectivity (93% ee), the reaction rate was prohibitively low because of decreased 
reactivity of MeMgBr. 
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Scheme 87. Scope of the enantioselective CA of Grignard reagents to α,β-unsaturated esters.218 
In order to make this methodology applicable to the synthesis of 1,3-dimethyl arrays, Feringa 
and co-workers switched to the more reactive but equally readily accessible α,β-unsaturated 
thioesters. The reduced electron delocalization in the thioester moiety, compared to oxoesters, 
results in a higher reactivity toward conjugated addition reactions, while the presence of 
thioester in the chiral product offers additional synthetic versatility. Gratifyingly, the addition 
of Grignard reagents to unsaturated thioesters 6-91 revealed the success of the approach.219 
The complex prepared in situ from CuBr·SMe2 (5 mol%) and (R,S)-Josiphos (6 mol%) 
catalyzed the CA of R2MgBr, providing the β-alkyl-substituted thioesters 6-92 in high yields 
and with excellent regio- and enantioselectivities (Scheme 88). Bulky Grignard reagents, such 
as iPrMgBr and iBuMgBr, however, gave poor enantioselectivities under these conditions. It 
was assumed, that drastically higher yields obtained for the methyl adducts from α,β-
unsaturated thioesters, compared to the oxoester analogues, were due to their inherent 
electronic properties which are close to those of enones. 
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Scheme 88. Enantioselective CA of Grignard reagents (R2MgBr) to α,β-unsaturated thioesters (6-91).219 
Based on the optimized procedure, an iterative method to provide access to optically active 
syn- and anti-1,3-dimethyl arrays as well as deoxypropionate subunits was devised. The 
approach relies on sequential enantioselective CAs to unsaturated thioesters (Scheme 89). 
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Scheme 89. Synthesis of syn- and anti-1,3-dimethyl arrays.219 
In order to clarify the mechanism of these Cu-catalyzed reactions extensive kinetic and 
spectroscopic studies were conducted. According to these studies a possible reaction pathway 
was proposed (Scheme 90).220 Reaction of the Grignard reagent converts the dimeric complex 
6-98 to the reactive Cu-complex 6-99. This will combine with the enoate to a π-complex 6-
100. In this entity Mg is bound to the oxygen, thereby activating it. In addition, one of the 
bromine atoms coordinates to the Cu center. The π-complex 6-100 rearranges to the σ-
complex 6-101 which then collapses by reductive elimination to the enolate. A new Grignard 
reagent RMgBr regenerates the active catalytic intermediate 6-99. The proposed catalytic 
cycle was proved to be in full accordance with the results of the kinetic study. The 
dependence of the reaction rate on the substrate and Grignard reagent indicated that both 
reactants are involved in the rate determining step. This step is preceded by fast equilibrium 
between substrate-bound σ-complex 6-101 and π-complex 6-100 and substrate unbound 
complex 6-99. 
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Scheme 90. Proposed catalytic cycle for Cu-catalyzed conjugate additions.220 
Optimized semiempirical calculations indicate that π-complex 6-102 adopts a square 
pyramidal geometry, which is stabilized via π-complexation of the alkene moiety to the Cu 
and, importantly, through the interactions between Mg and the carbonyl moiety of the 
thioester. Formation of the transition structure with the chairlike seven-membered ring 
conformation was proposed in the next step, where Cu forms a σ-bond approaching from the 
bottom side of the β-carbon leading to the CuIII intermediate 6-103 with the absolute 
stereochemistry shown (Figure 35). To avoid steric interactions with the dicyclohexyl 
moieties at the nearby phosphorous, the final transfer of methyl group occurs as shown in 
Figure 35. 
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Figure 35. Working model for the enantioselective CA of Grignard reagents.220 
The synthetic utility of the developed iterative catalytic protocol and the versatility of β-methyl-
substituted thioesters were demonstrated in asymmetric total syntheses of multi-methyl-
branched natural products. One can mention total syntheses of lardolure,219 β-D-mannosyl 
phosphomycoketide (6-106),221 phthioceranic (6-107)222 and mycocerosic (6-108)223 acids. 
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Figure 36. Structures of multi-methyl-branched natural products (6-106, 6-107, 6-108). 
More recently, Feringa and co-workers reported, that the Tol-BINAP/CuI catalytic system 
allows for the enantioselective addition of a wide variety of Grignard reagents, including 
relatively unreactive MeMgBr and bulky Grignard reagents, to aliphatic α,β-unsaturated 
thioesters. 224 Moreover, it was shown that Tol-BINAP/CuI is a more active catalyst than 
Josiphos/CuBr in the conjugate addition of MeMgBr to cinnamic acid thioesters, giving 
excellent selectivities for these reactions (Scheme 91). 
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Scheme 91. Tol-BINAP/CuI-catalyzed CA of Grignard reagents to α,β-unsaturated thioesters.224 
 
6.3.5 Yamaguchi macrolactonization 
The macrocyclic framework is one of the most basic structures for natural and unnatural 
organic molecules. With the advent of modern isolation techniques, numerous large-ring 
lactones that possess interesting biological activity have been isolated. Natural macrocyclic 
lactones present a large spectrum of interesting properties from perfumery, to phytotoxicity, 
to pheromone or insecticide activity to medicinal (antibiotic, cytotoxic, antiangiogenesis) 
properties. The most representative examples of clinically useful macrolactones include the 
macrolide antibiotic erythromycin, 225  the cyclodepsipeptide FK228, which is currently in 
phase II clinical trials as anticancer drug, the antifungal agent roxaticine,226 20-membered 
apoptolidin, which selectively induces apoptosis in rat glia cells transformed with adenovirus 
E1A oncogenin the presence of normal cells, and promising the anti-cancer drugs 
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epothilones,227 with a mode of action similar to Taxol® and the potential to overcome drug 
resistance. 
Recently, several effective C–C bond forming methods such as olefin and alkyne metathesis, 
transition metal-promoted coupling (Nozaki-Hiyama-Kishi), Horner-Wadsworth-Emmons 
reactions have been widely studied for producing cyclic compounds.228,229 However, macro-
lactonization is still the most popular method for producing cyclic compounds including 
carboxylic ester moieties since there are some effective methods for constructing the ester 
linkage.230 Due to entropic or enthalpic factors direct cyclization is generally not possible 
without activation of either the alcohol or the carboxylic acid terminal group (Scheme 92). 
O
OH
OH
O
[Act]
OH
(a)
O
O
(b)
X
O
On>7
X – leaving group
 
Scheme 92. Two different approaches to macrocyclic compounds. 
The need for relyable methods of forming large-ring lactones in the presence of sensitive 
functionality has led to the development of numerous methodologies. The most recognized of 
these is the Yamaguchi cyclization,124 where the acid is activated as a mixed anhydride and 
esterification is facilitated by a high concentration of the acylation promoter 4-
(dimethylamino)pyridine (DMAP). Due to the mild conditions and, generally, good yields, 
the Yamaguchi protocol and variations are widely used by synthetic chemists. The reaction 
sequence involves the formation of mixed anhydride 6-113 using the so-called Yamaguchi 
reagent i.e 2,4,6-trichlorobenzoyl chloride (TCBC) 6-112 in the presence of triethylamine or 
Hünig’s base (Scheme 93). The use of THF as a solvent enables easy separation from 
obtained NEt3-HCl, and subsequent concentration of the reaction mixture. Thereafter, the 
mixed anhydride is dissolved in toluene and slowly added by syringe pump to a highly diluted 
solution of DMAP (2–10 equiv) at high temperature (80 °C or reflux). Sometimes the desired 
macrolactonization proceeds smoothly even at ambient temperatures. Interestingly, the 2,6-
dichloro derivative turned out to be also effective in this reaction. Regarding DMAP, the use 
of pyrolidinopyridine as a supernucleophilic catalyst has also been described.231 In addition, a 
Yamaguchi macrolactonization, using polymer-supported DMAP was successfully employed 
in the total synthesis of epothilone C.232  
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Scheme 93. Mechanism of Yamaguchi macrolactonizations. 
From the many variations and modifications of the original Yamaguchi procedure, two very 
relevant ones were developed in the Yonemitsu group during the total synthesis of 
erythonolide derivatives. 233 In the first of these two modifications (‘modified Yamaguchi 
conditions’), the beneficial effect of direct additions of a large amount of DMAP to the 
preformed mixed anhydride, generally at room temperature and without the need for slow 
dilution was found. This protocol was successfully utilized in the total syntheses of 
oleandolide, 234  and bryostatin. 235  According to the second Yonemitsu modification 
(‘Yonemitsu conditions’), the mixed anhydride is not preformed and DMAP is directly 
introduced at room temperature from the beginning. This protocol was successfully employed 
in the total synthesis of rutamycin B,236 where utilization of Keck, Mukaiyama and Corey 
procedures completely failed. Although, there is still no rule about the best conditions to 
realize a Yamaguchi macrolactonization on a particular substrate, generally, the Yonemitsu 
conditions are proved to be more effective for rather large macrocycles, and classical 
Yamaguchi conditions on medium ring lactones. 
During the total synthesis of leucascandrolide by Carreira237 it was demonstrated that the 
lactonization of the seco-acid 6-114 under the usual conditions leads mainly to 
oligomerization, probably due to unfavorable hydrogen bonds (Scheme 94). To disrupt these 
interactions, the reaction was carried out in DMF, giving the 14-membered lactone in 49% 
yield. Notably, none of the 8-membered lactone was observed. 
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Scheme 94. Synthesis of leucascandrolide macrolactone by Carreira.237 
The use of the highly basic DMAP and high temperature on base-sensitive substrates such as 
unsaturated acids, can often lead to α/β to β/γ and Z/E isomerisation238 of conjugated double 
bonds, as well as epimerization of sensitive chiral centers. During the total synthesis of 
Pamamycin-607 by Jeong 239  et al., it was found that the high temperature Yamaguchi 
esterification leads to complete epimerization at C2, which is in α position to a carboxylic 
function (Scheme 95). 
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Scheme 95. Epimerization during Yamaguchi esterification.239 
In order to avoid undesired isomerisation of conjugated double bonds, macrolactonization can 
be performed on ynoic seco-acids with subsequent reduction of obtained triple bond. This 
methodology was successfully applied in the total syntheses of phorboxazole B, 240 
laulimalide,241 and pateamine A analogues.242 
Despite the aforementioned drawbacks, the Yamaguchi protocol still remains the most 
popular and reliable method for performing macrolactonization. This methodology and its 
variations have been successfully used in more than 250 synthetic applications. 243  Some 
representative examples of its utilization include total syntheses of tartrolon B, 244 
callipeltoside,128a bafilomycin,245 dictyostatin,246 44-membered swhinholide,247 polycavernoside 
A248 amphidinolides249 etc. 
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7 Goal of Research 
When we started this project there was no synthesis of neopeltolide reported in the literature. 
However, in the meantime, two total syntheses with the correct revised structure were almost 
simultaneously completed by the Panek147 and Scheidt148 groups. After we published a formal 
total synthesis of neopeltolide, two additional reports on the synthesis of this molecule were 
communicated by the Lee149 and Sasaki150 groups. After reviewing the total syntheses of 
neopeltolide from various groups, we could notice some significant drawbacks of their 
approaches. 
 
Although the synthesis of Panek and co-workers being quite convergent, it needs too many 
steps, and provides the final compound in only 1.3% overall yield. The overall number of 
steps for constructing the natural product is 35, while the longest linear sequence consists of 
19 steps, starting from expensive (R)-(+)-3-methylglutarate. Due to the poor overall yield and 
the presence of several low-yielding transformations, Panek’s approach hardly can be used for 
the preparation of large amounts of neopeltolide and its analogues thereof. 
 
In the Scheidt synthesis of neopeltolide, the tetrahydropyran ring and macrocycle were 
generated concurrently, albeit in only 25% yield. Although the longest linear sequence 
consists of only 18 steps, neopeltolide was obtained in very poor overall yield (0.5%). In 
addition, some key transformations proceed with acceptable yields (50–60%). Most likely, 
this synthesis was done just to demonstrate the application of the recently developed Scheidt 
methodology (Lewis acid-catalyzed Prins-type cyclization).156 
 
According to the preliminary study, reported by Amy Wright, neopeltolide is two to three 
orders of magnitude more potent for some cancer cells than Taxol®, a common chemotherapy 
drug. In addition, the side chain of neopeltolide is identical to the one in the macrolide 
leucascandrolide, which is also highly cytotoxic. Thus, one can assume the same biological 
targets for these two compounds. 
 
Neopeltolide is composed of the structural combination of the hydrophobic macrolactone core 
A and polar oxazole- and carbamate-containing side chain B (6-15). The interest for the 
construction of neopeltolide, as well as different analogues and derivatives, lies in the 
synthesis of the macrolide fragment. Although this fragment is quite compact, it contains six 
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stereogenic centers and a 2,4,6-trisubstituted tetrahydropyran ring, which makes the synthesis 
a challenging task. 
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Figure 37. Retrosynthetic analysis of neopeltolide. 
The promising biological activity combined with the fascinating structure prompted us to 
embark on a synthesis of neopeltolide. The objective of our study is the development of 
simple and reliable procedures for the synthesis of neopeltolide. The discovery of practical 
and useful new strategies requires that the key idea meet the important criteria: the devised 
approach should be flexible enough to access stereogenic and structural analogues that might 
help to identify the biological target. It means the strategy should involve efficient enantio- or 
diastereoselective reactions to generate each of the stereocenters independently, offering 
maximum flexibility. In this regard, we aimed to investigate the utility of recently developed 
reactions and methodologies. In addition, due to the modular built of neopeltolide, it was 
particularly interesting to prepare a range of analogues with different side chains at C5, which 
in turn should help to figure out whether the macrolactone or the oxazole-containing side 
chain are crucial for cytotoxicity as well as to identify in vivo biological targets and elucidate 
its mode of action. 
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8 Results and Discussion 
 
8.1 Retrosynthetic Analysis 
 
The target molecule, neopeltolide (5-1), features the following major fragments: 
a) oxazole- and carbamate-containing side chain; 
b) 14-memebered macrolactone ring that is bridged by an ether function; 
c) 2,4,6-trisubstituted tetrahydropyran. 
At first, we decided to make a disconnection of the oxazole-containing side chain 6-15 from 
the macrolactone core 6-14. Opening of the lactone 6-14 would lead to the seco acid 8-1, 
containing a substituted pyran. From a synthetic point of view one of the biggest challenges 
was a creation of desired pyran ring in a highly selective manner. For this reason we rely on a 
well developed Prins cyclization. Accordingly, the Prins strategy will require preparation of 
an aldehyde 8-2 and a homoallylic alcohol 8-3. The TFA promoted Prins reaction would 
secure an equatorial 5-OH group. Thus, a Mitsunobu reaction would have to be used for the 
attachment of the side chain (Figure 38). 
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Figure 38. Key retrosynthetic cuts for neopeltolide (5-1). 
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A key question relates to the introduction of the subunit with the methyl group. In this 
regards, we chose a facial selective Michael addition using the Feringa-Minnaard reaction 
(Figure 39). Obviously the unsaturated thioester 8-4, required for the previous reaction could 
be obtained from the corresponding aldehyde 8-5 via Wittig olefination. The necessary anti-
1,3-diol fragment, in turn, should result from a Leighton allylation and a highly 
enantioselective Noyori reduction thereof. As one can see the homoallylic alcohol 8-3 
necessary for the Prins reaction could be available by allylation of the known aldehyde 8-8250 
applying aforementioned Leighton methodology. 
HOP OMe
11 O
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OOP OMe
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Figure 39. Retrosynthetic anylysis for the aldehyde 8-2. 
Although, more than six different synthesis of the oxazole bearing side chain, identical to that 
found in leucascandrolide were published,146 we decided to develop our own approach. 
Following the general trend of previous described syntheses we rely on Still-Gennari 
olefination to establish the cis-enoate moiety of the side chain as a key step. Required 
aldehyde 8-9 could be derived from ester 8-10 (Figure 40). Introduction of cis-allylcarbamate 
subunit can be done using a classical Sonogashira coupling with subsequent Lindlar 
reduction. Triflate 8-12 logically originates from readily available oxazolone 8-14. 251 The 
necessary alkyne 8-13,146a in turn, should result from propargylamine and methyl 
chloroformate. 
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Figure 40. Retrosynthetic anylysis for the side chain 6-15. 
As one can see, we conceived a strategy that would be flexible enough to access structural 
analogues which might help to identify the biological target. Furthermore, analogues which 
could illuminate key structural features important for the activity were planned. 
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8.2 Synthesis of the Neopeltolide Macrolactone 
 
8.2.1 Synthesis of aldehyde 8-24 
The synthesis began with 3-ketoester 8-7 which was subjected to an enantioselelctive Noyori 
hydrogenation182 using (S)-BINAP-Ru(II) as chiral catalyst (Scheme 96). Required chiral 
complex was in situ prepared from commercially available (S)-BINAP and [RuCl2(benzene)]2 
in full accordance with an Organic Synthesis procedure.184 Reduction was carried out in a 
Parr hydrogenation vessel under pressure of hydrogen (5 bar) at 90 °C during 24 hours. This 
secured desired hydroxy ester 8-15 in 93% yield and with excellent selectivity (98% ee). The 
enantiomeric excess of the isolated hydroxyester was determined by chiral GC (Figure 41). 
Silylation of the alcohol 8-15 produced ether 8-16 in almost quantitative yield. This was 
followed by ester reduction using DIBAL-H 252 at –80 °C in dichloromethane leading to 
aldehyde 8-17. Chain extension was performed with the Leighton reagent (R,R)-6-82,201 
containing (R,R)-1,2-diaminocyclohexane moiety. Remarkably, we were able to recover the 
chiral diamine in 90% yield that makes this method very attractive for large-scale allylations. 
Furthermore, in the 13C NMR spectrum of 8-18 there was no other diastereomer visible, 
indicating the excellent selectivity in the allylation reaction. The alcohol function in the 1,3-
anti-diol 8-18 was protected using Meerwein’s salt in presence of proton sponge.253 Under 
other conditions (NaH, MeI, THF, 0 °C) partial migration of the silyl group was observed. 
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Scheme 96. Synthesis of alkene 8-19. 
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Figure 41. Chiral GC of methyl (3S)-3-hydroxyhexanoate (8-15), minor isomer tR = 18.07, 
major isomer tR = 19.17. Resolution was done using chiral column: 30% Lipodex E (octakis-
(2,6-di-n-pentyl-3-butyryl)-γ-cyclodextrin) in dimethyl polysiloxane PS 255 (70%). 
Synthesis of the required (R,R)-Leighton reagent 6-82 started from the resolution of racemic 
trans-1,2-diaminocyclohexane (Scheme 97). This was performed via crystallization of 
diamine with L-(+)-tartaric acid in full accordance to a published procedure. 254 Obtained 
tartrate was subjected to reductive amination reaction with p-bromobenzaldehyde, which 
proceeds via formation of corresponding intermediate diimine.201 Subsequent treatment of 
foregoing bis-(p-bromobenzyl)-diamine 6-86 with allyl trichlorosilane in the presence of 
DBU as a base furnished the desired reagent (R,R)-6-82. It should be noted that all steps of 
this sequence are experimentally simple, the final product does not require additional 
purification and can be directly introduced in the allylation reaction. All this together allowed 
us to produce the required reagent (R,R)-6-82 in up to 25 g scale. 
NH2
NH2
(±)-trans
L-(+)-Tartaric
acid, AcOH, H2O
NH3+
NH3+ OH
OH-OOC
-OOC 1. p-BrC6H4CHO, MsOH, EtOH, DCM, 80 °C, 12 h
2. NaBH4, MeOH, 65 °C
NH
NH
p-BrC6H4
p-BrC6H4
N
N
Si
Cl
p-BrC6H4
p-BrC6H4
DCM, 0 °C to RT
AllylSiCl3,DBU
90 °C to 5 °C
4 h (78%) 1 h (81%)
14 h (91%)
6-86 (R,R)-6-82
R
R
 
Scheme 97. Synthesis of the Leighton reagent (R,R)-6-82. 
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With the desired anti-1,3-diol in hand we started the introduction of the subunit bearing the 
methyl group. Degradation of the terminal double bond to an aldehyde function was achieved 
using a well established a dihydroxylation/periodate cleavage sequence in excellent overall 
yield (93%) (Scheme 98). Obtained aldehyde 8-20 was efficiently extended to the unsaturated 
thioester 8-22 using the stabilized Wittig reagent 8-21.255 The latter can be prepared in two 
steps, starting from bromoacetic acid and ethanethiol. The resulting S-ethyl 
bromoethanethioate was allowed to react with PPh3 which was followed by treatment of 
obtained triphenylphosphonium salt with an aqueous solution of NaHCO3. This provided 
sufficient amounts of required ylide 8-21. 
A conjugate addition reaction of methylmagnesium bromide (1.2 equiv) to 8-22 in presence of 
CuBr·SMe2 (3.4 mol%) and the chiral diphosphine (S,R)-Josiphos (ent-6-87)216,217 (4 mol%) 
produced the decanoate 8-23 in high yield. Only one set of signals was observed for 8-23 in 
the 13C NMR spectrum. Reduction of the thioester with Et3SiH in presence of Pd/C gave an 
almost quantitative yield of aldehyde 8-24. 
OR OMe 1. OsO4, NMO
tBuOH/H2O, RT, 20 h
2. NaIO4, MeOH
RT, 1 h (93%)
OR OMe O
H
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Scheme 98. Synthesis of aldehyde 8-24. 
 
Results and Discussion 117
8.2.2 Synthesis of homoallylic alcohol 8-26 
The homoallylic alcohol 8-26 required for the Prins reaction was available by allylation of the 
aldehyde 8-8 with the Leighton reagent (S,S)-6-82 (Scheme 99). Foregoing aldehyde was 
prepared by DIBAL-H reduction of the nitrile 8-25,256 resulting from Michael addition of 
benzylalcohol to acrylonitrile. Synthesis of (S,S)-6-82 was accomplished in the same way as 
was described for (R,R)-6-82. 
CN CNBnO
DIBAL-H, PhCH3
–80 °C, 2h (78%)
BnO H
O
CH2Cl2, –10 °C
24 h (84%) BnO
OH(S,S)-6-82
8-8 8-26
8-25
PhCH2OH, NaOH
RT, 14 h (95%)
 
Scheme 99. Synthesis of homoallylic alcohol 8-26. 
Remarkably, both substrates for the key Prins reaction were prepared in high yield and with 
excellent selectivity using the recently developed Leighton allylation methodology as key 
step. 
 
8.2.3 Synthesis of pyran 8-27 via Prins cyclization 
For the crucial Prins reaction the homoallylic alcohol 8-26 and aldehyde 8-24 were reacted in 
dichloromethane in presence of trifluoroacetic acid (Scheme 100). Trying different 
conditions, we have found that the highest yield (72%) of pyran 8-27 could be obtained 
carrying the reaction at –5 °C with 10 equiv. of trifluoroacetic acid. This can be explained by 
significant TBDPS ether cleavage at higher temperatures. Besides the major product 8-27 the 
formation of a small amount of another isomer (major/minor = 8:1) was observed. 
Unfortunately, the isomers could not be separated by column chromatography. The formation 
of the desired tetrahydropyran can be envisioned to proceed via oxonium ion A with an all 
equatorial orientation of the substituents in the chair-like transition state (Figure 42). In the 
ring closure step, the C2 substituent lies in a favorable equatorial position and the (E)-
oxocarbenium ion geometry is preferred over the (Z)-oxocarbenium ion geometry. Therefore, 
chirality is transferred from C2 to the newly formed carbon–carbon bond. The stereocenter 
formed at C4 is controlled by the extensive delocalization of tetrahydropyranyl cation B. 
Favorable orbital overlap places the hydrogen at C4 in a pseudoaxial geometry, and, therefore 
nucleophilic attack occurs along an equatorial trajectory to deliver tetrahydropyran 8-27. The 
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minor product turned out to be the C5 epimer of the trifluoroacetat 8-27. There was no 
erosion of stereochemistry at C3 and C7, respectively. 
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Scheme 100. Prins reaction between aldehyde 8-24 and alcohol 8-26. 
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Figure 42. Proposed chair-like transition state A. 
 
8.2.4 Completion the synthesis of the neopeltolide core structure 6-14 
At first, the labile trifluoroacetate was cleaved under basic conditions and the resulting 
alcohol 8-28 was protected as MOM ether using MOMCl and Hünig’s base in DMF at 
ambient temperature (Scheme 101). The MOM group was chosen in order to make possible a 
selective cleavage of benzyl and TBDPS ether respectively. Subsequent debenzylation under 
reductive conditions (H2, Pd/C) led to primary alcohol 8-30. Oxidation of 8-30 using a well 
established sequence consisting of Dess-Martin and sodium chlorite oxidation257 furnished 
acid 8-31 in high overall yield. Fluoride-induced cleavage of the silylether led to seco-acid 8-
32. Employing classical Yamaguchi conditions,124,243 the acid cyclized in high yield to 
macrolactone 8-33a. At this stage the minor isomer (8-33b) resulting from the Prins reaction 
could be separated. A final cleavage of the MOM-protecting group completed the synthesis of 
the neopeltolide core structure 6-14 {[α]20D = +18.4 (c 0.1, CHCl3)}. The NMR spectra of 6-
14 perfectly matched the one reported by Scheidt et al.148 
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Scheme 101. Synthesis of neopeltolide core 6-14. 
After all, starting from keto ester 8-7, the synthesis of neopeltolide core 6-14 required 17 
steps in the longest linear sequence and produced lactone 6-14 in 23% overall yield. In this 
regard it compares favorably with the other known routes.147,148,149,150 
 
8.3 Synthesis of Oxazole-Containing Acid 6-15 
With the core structure of neopeltolide in hand, attention was now focused on the preparation 
of the oxazole-containing side chain 6-15 in order to explore the viability of our planned 
endgame to deliver neopeltolide and its analogues thereof. As shown in Scheme 102, the key 
step in the preparation of the side chain 6-15 was a Sonogashira coupling, where the required 
oxazole triflate 8-12 was derived from known oxazolone 8-14 – the condensation product of 
ethyl 3-bromopyruvate with methyl carbamate in the presence of p-TSA and AgOTf.251 
Reaction of oxazolone 8-14 with Tf2O in the presence of 2,6-lutidine provided the 
corresponding triflate 8-12, which was immediately subjected to react with alkyne 8-13 under 
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Sonogashira coupling conditions (Pd(PPh3)4, CuI, 2,6-lutidine, 1,4-dioxane) developed by 
Panek and co-workers,258 to provide the important side-chain precursor 8-11. Triflate 8-12 
may be for several days stored in a freezer (–20 °C) and used as needed. Pd(PPh3)4 was 
prepared accordingly to the literature procedure, 259  and immediately introduced in the 
coupling reaction. Thereafter, the Z-double bond was created using Lindlar reduction (H2, Pd 
on CaCO3, poisoned with lead EtOAc/quinoline) on the foregoing alkyne 8-11 leading to ester 
8-10. 
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Scheme 102. Synthesis of ester 8-10. 
The next task was to realize a two carbon extension to aldehyde 8-9, required for Still-
Gennari olefination. Reduction of ester 8-10 with DIBAL-H in DCM furnished aldehyde 8-34 
along with some amounts of corresponding alcohol 8-35, which was easily converted back to 
8-34 via Dess-Martin oxidation (Scheme 103). In order to introduce a two carbon building 
block, aldehyde 8-34 was subjected to Wittig olefination with (methoxycarbonylmethylene)-
triphenylphosphorane 8-36. This resulted in formation of unsaturated ester 8-37. The next 
challenging task was conjugate reduction of the obtained unsaturated ester. Our initial attempt 
was to use the Mg – methanol system as the most efficient and reliable method in this 
regard.260 Unfortunately, despite numerous efforts to optimize condition for this reaction, we 
were not able to conduct the desired reduction selectively. Using other described methods 
(NiCl2, NaBH4 in MeOH; 261 CuCl2, NaBH4 in MeOH;262 ZnCl2, Mg in H2O263) was not 
successful as well. According to LC-MS analysis, besides the desired product always 
significant amounts of overreduction products derived from the Z-alkene were obtained. 
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Scheme 103. Attempted synthesis of ester 8-38. 
After unsuccessful attempts to perform a selective reduction of the conjugated double bond 
we revised our strategy and decided to make the two carbon homologation using methodology 
recently developed by Kozmin.264,146d Thus, aldehyde 8-34 was reduced to alcohol 8-35146a 
using sodium borohydride in THF/MeOH mixture (Scheme 104). Transformation of the 
hydroxyl function to the corresponding bromide 8-39 was achieved using well established 
Appel methodology (CBr4, PPh3 and 2,6-lutidine in CH3CN at ambient temperature).265 It 
should be noted that CBr4 must be very pure (Fluka), and without any trace of water. 
Afterwards, conversion of acetaldehyde to the corresponding cyclohexyl imine 8-40, followed 
by lithiation266 with lithium diethylamide and alkylation with freshly prepared bromide 8-39, 
afforded aldehyde 8-9 in 74% yield. Z-Selective olefination using Still-Gennari reagent 8-
41 267  proceeded with excellent selectivity (Z:E = 11:1) and in good yield. Finally, 
saponification of obtained ester 8-42 completed the assembly of the side chain subunit 6-15. 
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Scheme 104. Completion of the synthesis of the side chain 6-15. 
 
8.4 Completion of the Neopeltolide Synthesis 
Designed to invert the relative stereochemistry at the C5, the end game entailed a Mitsunobu 
esterification of alcohol 6-14 with oxazole-containing acid 6-15 (Scheme 105). Gratifyingly, 
treatment of the two coupling fragments with PPh3 and DIAD afforded neopeltolide (5-1) in 
80% yield. {[α]20D = +23.8 (c 0.24, MeOH)}. The NMR spectra of 5-1 were in excellent 
agreement with those reported in the literature.144,147,148 
PPh3, DIAD
6-15, benzene
O
O
Me
MeO
O
H
H
O
N
O
NH
OMe
O
O
neopeltolide (5-1)
6-14
RT, 1 h, (80%)
 
Scheme 105. Completion of the neopeltolide (5-1) synthesis. 
We have hence completed a convergent total synthesis of this potent antitumor agent, which 
favourably compares with the previous approaches in terms of all usual empirical indices (ca. 
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18% overall yield, 18 steps in the longest linear sequence). The developed strategy is very 
efficient and should allow for the preparation of further neopeltolide analogues. 
 
8.5 Synthesis of Neopeltolide Analogues 
 
8.5.1 Synthesis of 11-epi neopeltolide (8-57) 
Due to the potent biological activity of neopeltolide and its structure similarity to another 
cytotoxic natural product leucascandrolide, which in addition might have the same mode of 
action it would be of interest to identify key structural elements that are essential for its 
cytotoxicity. Furthermore, because of its modular built, a range of analogues with different 
side chains at C5 are conceivable, which in turn should help to figure out which parts of the 
macrolactone or oxazole-containing side chain are crucial for cytotoxicity as well as to 
identify in vivo biological targets and elucidate its mode of action. 
 
In order to delineate the role of the C11 methyl ether for the interaction with an active site, we 
decided to find out how important is the stereochemistry at C11. Keeping this in mind, for the 
Leighton allylation of aldehyde 8-17 reagent (S,S)-6-82 came to use (Scheme 106). This 
resulted in exclusive formation of 1,3-syn-diol 8-43 in 85% yield. Further transformations to 
the aldehyde 8-48 were done in full accordance with procedures described for 8-24. Thus, 
protection of the free hydroxyl function in the 1,3-syn-diol 8-43 using Meerwein’s salt in 
presence of proton sponge followed by oxidative degradation of the terminal double bond led 
to aldehyde 8-45 in excellent overall yield. Extension of obtained aldehyde 8-45 to the 
substrate for the Feringa–Minnard reaction 8-46 was achieved using the stabilized Wittig 
reagent 8-21. A conjugate addition of in situ preformed methyl cuprate in the presence of 
chiral diphosphine (S,R)-Josiphos ent-6-87 (4 mol%) secured the decanoate 8-47 in 85% 
yield. According to 13C NMR spectrum of thioester 8-47, exclusively one diastereomer was 
obtained. Reduction of the thioester with Et3SiH in presence of Pd/C gave an almost 
quantitative yield of aldehyde 8-48. For the crucial Prins reaction the previously described 
homoallylic alcohol 8-26 and aldehyde 8-48 were reacted in dichloromethane at –5 °C in 
presence of trifluoroacetic acid (10 equiv). This furnished desired pyran 8-49 in 71% yield. 
As in the case of compound 8-27, besides the major product 8-49 the formation of a small 
amount of another isomer (major/minor = 8:1) was observed. 
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Scheme 106. Synthesis of pyran 8-49. 
A few simple functional group manipulations: basic cleavage of the trifluoroacetate, MOM 
protection of the resulting alcohol 8-50, and debenzylation led to primary alcohol 8-52 
(Scheme 107). Oxidation of 8-52 using the well established sequence consisting of Dess-
Martin and sodium chlorite oxidation furnished acid 8-53. TBAF mediated cleavage of the 
silylether led to seco-acid 8-54 which was subsequently subjected to the Yamaguchi 
macrolactonization protocol. This way macrolactone 8-55 was obtained in 85% yield. At this 
stage the minor isomer resulting from the Prins reaction could be separated (9%). A final 
cleavage of the MOM-protecting group provided us with secondary alcohol 8-56, which was 
introduced in the Mitsunobu estrefication with oxazole-containing acid 6-15. This resulted in 
formation of 11-epi neopeltolide (8-57) in 86% yield. 
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Scheme 107. Completion of the synthesis of 11-epi neopeltolide (8-57). 
As one can see, this concise synthesis of 11-epi neopeltolide (8-57) once more proves the high 
efficiency of our approach. 
 
8.5.2 Synthesis of 5-epi neopeltolide (8-59) 
As a further branching point for the synthesis of analogues we identified the lactone 8-33b, 
the minor isomer resulting from the Prins reaction and separated at the macrolactonization 
stage. Analysis of the NOESY spectrum of lactone 8-33b indicated that hydrogens at C3 and 
C5 of the pyran ring are in cis-orientation to each other. Acid promoted cleavage of the MOM 
ether secured macrolactone 8-58 (Scheme 108). Finally, Mitsunobu esterification with 
oxazole-containing acid 6-15 furnished 5-epi neopeltolide 8-59. 
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Scheme 108. Completion of the synthesis of 5-epi neopeltolide (8-59). 
 
8.5.3 Synthesis of analogues with modified side chains 
In order to shed light on the importance of the oxazole-containing side chain for the biological 
activity of neopeltolide we aimed at the synthesis of some analogues with different oxazole-
containing acids (Figure 43). With regard to the design of modified acids we wanted to use 
some of the key intermediates from the synthesis of fragment 6-15. 
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Figure 43. Structures of designed oxazole-containing acids. 
At first, subjection of aldehyde 8-9 to the classical Wittig olefination with phosphorane 8-36 
resulted in formation of trans-enoate 8-60 (Scheme 109). Subsequent treatment of ester 8-60 
with lithium hydroxide secured the first configurational analogue 8-61. 
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Scheme 109. Synthesis of acid 8-61. 
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Continuing with the synthesis of analogues, saponification of ester 8-10 with potassium 
hydroxide provided acid 8-62, in which the four carbon bridge between the oxazole ring and 
carboxylic function was lacking (Scheme 110). In a similar way, lithium hydroxide mediated 
methyl ester cleavage of 8-37 produced corresponding acid 8-63. The latter is two carbons 
shorter than the previously synthesized acid 8-61. 
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Scheme 110. Synthesis of acids 8-62 and 8-63. 
To access further configurational analogues of the original acid 6-15 we continued to use the 
synthetic potential of unsaturated ester 8-37. Thus, we attempted to reduce the methyl ester to 
the aldehyde function in order to accomplish further derivatization. Unfortunately, it was 
rather difficult to conduct this reaction selectively. Even using 1 equivalent of DIBAL-H, 
along with desired aldehyde significant amounts of the corresponding alcohol were observed. 
Therefore, ester 8-37 was completely reduced to the alcohol by treatment with 2.5 equivalents 
of DIBAL-H, which was followed by Dess-Martin oxidation (Scheme 111). This sequence 
provided required unsaturated aldehyde 8-64 in 85% overall yield. Direct subjection of this 
aldehyde to the Still-Gennari olefination protocol secured (E,Z)-dienoate 8-65. On the other 
hand, reaction of aldehyde 8-64 with phosphorane 8-36 established the (E,E)-dienoate moiety. 
Both esters were subsequently saponified with lithium hydroxide in a THF/H2O mixture. This 
provided us with two other valuable oxazole-containing acids 8-67 and 8-68. In comparison to 
the original side chain 6-15, introduction of additional double bond between C4 and C5 will 
make the structure more rigid which, in turn, might be crucial for the ligand–receptor 
interaction. 
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Scheme 111. Synthesis of acids 8-67 and 8-68. 
After all, a number of different oxazole-containing acid were synthesized using methodology 
applied for the synthesis of acid 6-15. Next, coupling of these acids with the neopeltolide core 
should provide a set of configurational analogues. 
 
8.5.4 Coupling of oxazole-containing acids with the neopeltolide core 
Neopeltolide alcohol 6-14 was coupled with the oxazole-containing acids 8-61 – 8-63, 8-67 
and 8-68 applying classical Mitsunobu conditions (PPh3, DIAD in benzene or benzene/THF 
mixture) (Scheme 112). In order to increase the solubility of the carboxylic acid sometimes 
coupling reactions were conducted in benzene/THF mixture. Notably, all these reactions 
required only one hour to go to completion and furnished the desired analogues 8-69 – 8-73 in 
good yields. 
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Scheme 112. Synthesis of neopeltolide analogues 8-69 – 8-73. 
 
8.5.5 Biological testing 
The described analogues as well as macrolactones 6-14 and 8-56 were tested for cytotoxicity 
against the L929 cell line. The obtained IC50 values in the cell culture assay are listed in 
Table 6. The analogues are ordered according to increasing IC50 values against the L929 cell 
line. 
Table 6. IC50 values for neopeltolide and analogues against the L929 cell line 
 
entry comp. IC50 [ng·mL–1] IC50 [nM] description 
1 8-72 0.094 0.16 neo-diene-ZE 
2 5-1 0.15 0.25 neopeltolide 
3 8-73 1.2 2.0 neo-diene-EE 
4 8-57 1.3 2.2 11-epi-neo 
5 8-69 2.6 4.4 neo-trans 
6 8-59 5.0 8.5 5-epi-neo 
7 8-71 630 1120 neo-short 
8 8-70 2400 4473 neo-oxazole 
9 6-14 4000 12195 neo-macrolactone 
10 8-56 4000 12195 11-epi-neo-macrolactone 
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According to the Table there are highly effective compounds. Surprisingly, the most cytotoxic 
compound is neo-diene-ZE (8-72) (entry 1), which is almost two times more active than 
neopeltolide (5-1) itself. This increase of activity might be the result of constraining an original 
flexible bridge between the oxazole ring and Z-enoate moiety, leading to the fixation of one of 
the most favorable conformations. The next active compound after neopeltolide is neo-diene-
EE (8-73) (entry 3). But in this case we can observe some drop of activity, in comparison to 
neopeltolide. Obviously, this fact can be explained by the crucial role of the configuration of 
the unsaturated ester. Inversion of the stereochemistry at C11 also resulted in decrease of 
cytotoxicity (entry 4). Hence, one can assume that the corresponding methoxy group is 
important for lipophilic interaction with protein receptor. Analogue neo-trans (8-69) (entry 5) 
serves as an additional proof for the significant influence of the double bond configuration on 
the efficiency of ligand–receptor interaction. Expressly, conversion of neopeltolide to the 
corresponding 5-epi analogue 8-59 (entry 6) resulted in more than 33 times decrease of 
activity. Finally, there are compounds that are essentially non toxic, starting with compound 
8-71. According to this data we can conclude that the four carbon bridge between the oxazole 
ring and carboxylate moiety is necessary for high activity. Moreover, removal of the oxazole-
containing side chain leads to complete lack of activity (entry 9, 10). 
In conclusion, the obtained results proved that the oxazole-containing side chain, 
conformation, configuration and length of carbon linkage between carboxylate and oxazole 
ring as well as absolute configuration of stereocenters at C5 and C11 are crucial for the 
biological activity of neopeltolide. The further away from the side chain are the changes in the 
core, the less dramatic are the changes in activity (entry 4 vs. entry 6). 
 
First hints about the target came from observation of the phenotype of L929 mouse fibroblast 
cells treated with neopeltolide. Under the microscope a so-called fried-egg phenotype was 
observed. Other natural products with a similar phenotype turned out to be inhibitors of 
mitochondrial function. These compounds include antimycin A, myxothiazole, stigmatellin 
and crocacin. This hypothesis was confirmed in experiments with submitochondrial particles 
(SMP) from bovine heart. It was observed that neopeltolide inhibits NADH oxidation with 
SMP from bovine heart at very low concentrations (IC50 = 7 ng·mL–1). Accordingly, one can 
conclude that neopeltolide is a specific inhibitor of eukaryotic respiratory chain. More 
detailed investigation revealed that neopeltolide is targeting complex III in mitochondria, 
while the preceeding complex I is still being reduced in presence of neopeltolide. 
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9 Conclusion II 
 
In summary, we developed an efficient synthesis of the complex macrolide 
neopeltolide (5-1). The key steps in this synthesis are a Prins cyclization to fashion the pyran 
ring, a Leighton allylation to establish the stereocenters at C11 and C3 and a Feringa– 
Minnaard asymmetric methyl cuprate addition to introduce the methyl group at C9. 
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Scheme 113. Key intermediates in the synthesis of neopeltolide (5-1). 
Noyori reduction of keto ester 8-7 efficiently adjusted the first stereocenter. Subsequent 
Leighton allylation, followed by simple functional group manipulations and Wittig olefination 
extended aldehyde 8-17 to unsaturated thioester 8-22. A facial selective Feringa–Minnaard 
conjugate addition, followed by reduction of the resulting thioester secured aldehyde 8-24, 
which was conveniently combined with homoallylic alcohol 8-26 using a Prins cyclization. 
After the pyran core was established, a few simple transformations led to the seco-acid 8-32. 
Cyclization of acid 8-32, employing classical Yamaguchi conditions with subsequent 
deprotection accomplished the synthesis of the neopeltolide core 6-14. Finally, Mitsunobu 
esterification of alcohol 6-14 with oxazole-containing acid 6-15 produced neopeltolide (5-1). 
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It should be noted, that our synthesis favourably compares with the previous approaches in 
terms of all usual empirical indices (ca. 18% overall yield, 18 steps in the longest linear 
sequence). In addition, all chiral centers were essentially obtained via catalytic and highly 
enantio-selective methods. 
The synthesis of acid 6-15 involved 8 steps and proceeded in 18% overall yield from known 
oxazolone 8-14. Our strategy was based on a Sonogashira coupling reaction, Lindlar reduction 
and Still–Gennari olefination. Moreover, application of key intermediates of this route allowed 
us to prepare a range of different oxazole-containing acids (8-61 – 8-63, 8-67, 8-68), which 
afterwards were successfully employed for the preparation of neopeltolide analogues. 
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Scheme 114. Key intermediates in the synthesis of acid 6-15. 
According to cellular assays analogue 8-72 was almost two times more active that neopeltolide 
(5-1) itself, that was explained by fixation of the active conformation via introduction of 
additional double bond. Drop of activity in cases of compound 8-69, 8-70 and 8-71 was 
attributed to the crucial role of the conformation and length of the four carbon linkage 
between carboxylate and oxazole ring. In addition, complete lack of activity of macrolactones 
6-14 and 8-56 one more time confirms that oxazole-containing fragment is important for 
cytotoxicity. 
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Figure 44. Structures of neopeltolide analogues 8-69 – 8-72. 
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10 Experimental Section 
 
10.1 General Remarks 
 
10.1.1 Chemicals and working techniques 
 
The chemicals were purchased from the firms Acros, Aldrich, Fluka, Lancaster, Avocado and 
Merck. All reagents were obtained from commercial suppliers, and were used without further 
purification unless otherwise stated. All solvents were distilled and/or dried prior to use by 
standard methodology except for those, which were reagent grades. The applied petroleum 
ether fraction had a boiling point of 40–60 °C. Anhydrous solvents were obtained as follows: 
THF, diethyl ether and toluene by distillation from sodium and benzophenone; 
dichloromethane and chloroform by distillation from calcium hydride; acetone by distillation 
from phosphorous pentoxide. Absolute triethylamine and pyridine and diisopropylethylamine 
were distilled over calcium hydride prior to use. Unless and otherwise mentioned, all the 
reactions were carried out under a nitrogen atmosphere and the reaction flasks were pre-dried 
by heat gun under high vacuum. All the chemicals, which were air or water sensitive, were 
stored under inert atmosphere. Compounds that are not described in the experimental part 
were synthesized according to the literature. 
 
10.1.2 NMR-spectroscopy 
 
All the spectra were measured on a Bruker Avance 400 spectrometer, which operates at 400 
MHz for 1H and 100 MHz for 13C nuclei, respectively. The spectra of some final compounds 
were measured at 600 MHz (Bruker AMX 600 MHz). 1H (400 MHz, 600 MHz) and 13C NMR 
(100 MHz, 150 MHz) spectra were recorded at 295 K either in CDCl3 or CD3OD; chemical 
shifts are calibrated to the residual proton and carbon resonance of the solvent: CDCl3 (δH = 
7.25 ppm, δC = 77.0 ppm), CD3OD (δH = 3.30 ppm, δC = 49.0 ppm). Data are reported as 
follows: chemical shift (multiplicity: s = singlet, d = doublet, t = triplet, ddd = doublet of 
doublet of doublet, dt = doublet of triplet, td = triplet of doublet, m = multiplet, br = 
broadened, J = coupling constant (Hz), integration, peak assignment in italic form). 
10.1.3 Mass Spectrometry 
 
Mass spectra were recorded on a Finnigan Triple-Stage-Quadrupol Spectrometer (TSQ-70) 
from Finnigan-Mat. High-resolution mass spectra were measured on a modified AMD Intectra 
MAT 711 A from the same company. The used mass spectrometric ionization methods were 
electron-impact (EI), fast-atom bombardment (FAB) or field desorption (FD). FT-ICR-mass 
spectrometry and HR-FT-ICR mass spectra were measured on an APEX 2 spectrometer from 
Bruker Daltonic with electrospray ionization method (ESI). Some of the mass spectra were 
also measured on an Agilent 1100 series LC-MSD. Analytical HPLC-MS: HP 1100 Series 
connected with an ESI MS detector Agilent G1946C, positive mode with fragmentor voltage 
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of 40 eV, column: Nucleosil 100–5, C-18 HD, 5 mm, 70 × 3 mm Machery Nagel, eluent: NaCl 
solution (5 mM)/acetonitrile, gradient: 0/10/15/17/20 min with 20/80/80/99/99% acetonitrile, 
flow: 0.6 mL min–1. High resolution mass (HRMS) are reported as follows: (ESI): calcd mass 
for the related compound followed by found mass. 
 
10.1.4 Polarimetry 
 
Optical rotations were measured on a Perkin-Elmer Polarimeter Model 341. They are reported 
as follows: [α]temperatureD (concentration, solvent). The unit of c is g/100 mL. Anhydrous 
CH2Cl2, CHCl3 or MeOH was used as a solvent. For the measurement the sodium D line = 589 
nm was used. 
10.1.5 Melting Points 
 
Melting points were determined with a Büchi Melting point B-540 apparatus and were not 
corrected. 
 
10.1.6 Chromatographic Methods 
 
Flash column chromatography was performed using flash silica gel (40-63 μm, 230-400 mesh 
ASTM) from Macherey-Nagel. 
Gas chromatography was performed on a CHROMPACK CP 9000 using a flame ionization 
detector, and carrier gas H2. Chiral gas chromatographic analyses were carried out on 13.5 m × 
0.25 mm column filled with deactivated fused silica with 30% 6-TBDMS-2,3-diacetyl-β-
cyclodextrin in PS 086 (df = 0.13 μm) and carrier gas H2 at 50 kPa and 30 °C. 
For GC-MS coupled chromatography, a GC-system series 6890 with an injector series 7683 
and MS-detector series 5973 from Hewlett Packard was used, with EI method, and carrier gas 
He. Analytical HPLC was performed on a Hewlett Packard HP 1100 system.  
Analytical thin layer chromatography (TLC) was performed on precoated with silica gel 60 
F254 plates (Merck) or Polygram Sil G/UV254 (Macherey Nagel). The compounds were 
visualized by UV254 light and the chromatography plates were developed with an aqueous 
solution of molybdophosphorous acid or an aqueous solution of potassium permanganate 
(heating with the hot gun). For preparation of the molybdate solution 20 g ammonium 
molybdate [(NH4)6Mo7O24·4H2O] and 0.4 g Ce(SO4)2·4H2O were dissolved in 400 mL of 10% 
H2SO4. The potassium permanganate solution was prepared from 2.5 g KMnO4 and 12.5 g 
Na2CO3 in 250 mL H2O. 
 
10.2 Experimental Procedures 
 
All the experimental procedures are arranged to reflect the synthetic sequences shown in the 
schemes. 
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Methyl 2,4-dihydroxy-6-methylbenzoate103 
 
OH
HO
OMe
O
 
 
Methyl acetoacetate (20.0 g, 172.2 mmol, 1 equiv) was added dropwise to a stirred suspension 
of NaH (6.2 g, 258.4 mmol, 1.5 equiv; previously washed with hexane) in 100 ml of absolute 
THF at 0 °C. The solution was cooled to –80 °C and a 2.5M solution of nBuLi (65.5 ml, 163.6 
mmol, 0.95 equiv) was added dropwise. The reaction mixture was warmed to ambient 
temperature, stirred overnight and refluxed for 24 h. After the reaction was cooled to 0 °C, it 
was acidified to pH = 1–2 with 6N HCl, strirred for additional 1 h, and extracted with EtOAc 
(4 × 200 mL). The combined organic extracts were washed with brine, dried over Na2SO4 and 
concentrated in vacuo. The residue was purified by flash chromatography (hexane/EtOAc, 3:1) 
to give 10.2 g (65% yield) of methyl 2,4-dihydroxy-6-methylbenzoate (methyl orsellinate) as a 
colorless solid. Rf = 0.70 (petroleum ether/EtOAc, 1:1); m.p. 137–139 °C, Lit.103 136–138 °C; 
1H NMR (400 MHz, CDCl3): δ = 2.47 (s, 3H, Ar-CH3), 3.91 (s, 3H, OCH3), 6.22 (d, J = 2.3 
Hz, 1H, aryl H), 6.27 (d, J = 2.3 Hz, 1H, aryl H), 11.77 (s, 2H, OH); 13C NMR (100 MHz, 
CDCl3): δ = 24.3 (Ar-CH3), 51.9 (OCH3), 101.2 (C-3), 105.6 (C-5), 111.4 (C-1), 144.0 (C-6), 
160.3 (C-2), 165.2 (C-4), 172.1 (CO2Me). 
 
 
Methyl 2,4-dimethoxy-6-methylbenzoate104 
 
MeO
MeO
OMe
O
 
 
To the mixture of methyl 2,4-dihydroxy-6-methylbenzoate (5.0 g, 27.4 mmol, 1 equiv), 
anhydrous K2CO3 (9.5 g, 68.5 mmol, 2.5 equiv) in absolute acetone (100 ml) was added 
Me2SO4 and the reaction was refluxed for 16 h. Then the reaction mixture was cooled to 
ambient temperature, K2CO3 was filtered off, and the filtrate was concentrated in vacuo. The 
residue was redissolved in Et2O (300 ml) and washed with 4M aqeous NaOH (3 × 100 mL). 
The combined organic extracts were dried over MgSO4, concentrated in vacuo and the 
obtained residue was purified by flash chromatography (hexane/EtOAc, 4:1) to give 5.1 g 
(88% yield) of methyl 2,4-dimethoxy-6-methylbenzoate as a colorless solid. Rf = 0.37 
(hexane/EtOAc, 4:1); m.p. 43–44 °C, Lit.104 44–45 °C; 1H NMR (400 MHz, CDCl3): δ = 2.27 
(s, 3H, Ar-CH3), 3.78 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 6.30 (s, 2H, 
aryl H); 13C NMR (100 MHz, CDCl3): δ = 19.9 (Ar-CH3), 52.0 (CO2CH3), 55.3 (OCH3), 55.9 
(OCH3), 96.1 (C-3), 106.6 (C-5), 116.3 (C-1), 138.3 (C-6), 158.2 (C-2), 161.3 (C-4), 168.7 
(CO2Me). 
 
 
2,4-Dimethoxy-6-methylbenzoic acid (3-14)268 
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A solution of methyl 2,4-dimethoxy-6-methylbenzoate (3.55 g, 16.9 mmol) in a 10% solution 
of KOH in a mixture of ethanol/water (130 mL, 95:5) was refluxed for 16 h. After cooling, 
most of the ethanol was removed in vacuo. The residue was diluted with water (60 mL), 
acidified (pH ~ 1) by slow addition of aqueous hydrochloric acid (6N) and extracted with 
EtOAc (3 × 150 mL). The combined organic extracts were washed with saturated NaCl 
solution, dried over MgSO4, filtered, and concentrated in vacuo to afford acid 3-14 (3.1 g, 
93% yield) as colorless crystals. Rf = 0.31 (petroleum ether/EtOAc, 1:1); m.p. 141–143 °C, 
Lit.268 140–142 °C; 1H NMR (400 MHz, CDCl3): δ = 2.53 (s, 3H, Ar-CH3), 3.82 (s, 3H, 
OCH3), 3.92 (s, 3H, OCH3), 6.37 (s, 1H, aryl H), 6.41 (s, 1H, aryl H); 13C NMR (100 MHz, 
CDCl3): δ = 22.5 (Ar-CH3), 55.4 (OCH3), 56.5 (OCH3), 96.5 (C-3), 109.0 (C-5), 112.3 (C-1), 
143.9 (C-6), 159.5 (C-2), 162.2 (C-4), 168.6 (CO2Me). 
 
 
(1R)-1-Methylbut-3-enyl 2,4-dimethoxy-6-methylbenzoate (3-12)102 
 
MeO
MeO
O
O
2
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Oxalyl chloride (1.0 mL, 11.5 mmol, 1.3 equiv) was added at 0 °C to a solution of acid 3-14 
(2.24 g, 11.5 mmol, 1.3 equiv) in anhydrous CH2Cl2 (45 mL) and catalytic DMF (50 µL). The 
solution was then stirred at 25 °C. After 1 h, the reaction was recooled at 0 °C, and treated 
sequentially with Et3N (3.6 mL, 26.1 mmol, 2.9 equiv), (2R)-pent-4-en-2-ol 3-15 (0.90 ml, 8.8 
mmol, 1 equiv) and a solution of DMAP (70 mg, 0.57 mmol) in anhydrous CH2Cl2 (5 mL). 
The reaction was followed by TLC until consumption of the starting material (ca 4 h). It was 
then diluted with CH2Cl2 (150 mL), washed with saturated NH4Cl aqeous (100 mL), dried 
over MgSO4 and concentrated under reduced pressure. Flash chromatography of the residue 
(petroleum ether/EtOAc, 10:1) provided ester 3-12 (1.84 g, 79% yield) as a colorless oil. Rf = 
0.36 (petroleum ether/EtOAc, 10:1); [α]20D = –1.8 (c 2.0, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 1.32 (d, J = 6.3 Hz, 3H, 1’-CH3), 2.28 (s, 3H, Ar-CH3), 2.30–2.40 (m, 1H, 2’-H), 
2.41–2.50 (m, 1H, 2’-H), 3.77 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 5.06–5.15 (m, 2H, 4’-H), 
5.16–5.26 (m, 1H, 1’-H), 5.77–5.89 (m, 1H, 3’-H), 6.29 (s, 2H, aryl H); 13C NMR (100 MHz, 
CDCl3): δ = 19.5 (1’-CH3), 19.8 (Ar-CH3), 40.2 (C-2’), 55.3 (OCH3), 55.8 (OCH3), 70.8 (C-
1’), 96.2 (C-3), 106.5 (C-5), 117.1 (C-1), 117.6 (C-4’), 133.9 (C-3’), 137.8 (C-6), 158.0 (C-2), 
161.2 (C-4), 167.8 (CO2R); 
HRMS (ESI): calcd for C15H20NaO4 [M+Na]+: 287.12538, found 287.12541. 
 
 
(4R)-4-Benzyl-3-[(2S)-2-methylpent-4-enoyl]-1,3-oxazolidin-2-one (3-16)105 
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A solution of NaHMDS (2.0M in THF, 13.6 mL, 27.1 mmol) was added via syringe pump 
over 25 min to a solution of compound 2-6 (5.6 g, 24.0 mmol) in THF (70 mL) at −78 °C and 
the resulting mixture was stirred at that temperature for 2 h. Allylbromide (9.0 mL, 103.4 
mmol) was then introduced and stirring was continued at –78 °C for 1 h and at 0 °C for 16 h. 
The reaction was quenched with saturated aqeous NH4Cl (100 mL) and diluted with EtOAc 
(200 mL). The aqueous phase was extracted with EtOAc (3 × 100 mL), the combined organic 
layers were washed with brine (100 mL), dried (Na2SO4), filtered and evaporated, and the 
crude product was purified by flash chromatography (petroleum ether/EtOAc, 8:1) to yield the 
corresponding allylation product 3-16 (4.1 g, 62% yield) as a colorless oil which crystallized 
upon standing. Rf = 0.25 (petroleum ether/EtOAc, 8:1); m.p. 29–30 °C, Lit.105 28 °C; [α]20D = 
–42.6 (c 1.2, CHCl3), Lit.105 [α]20D = –41.7 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 
1.18 (d, J = 6.8 Hz, 2’-CH3), 2.19–2.28 (m, 1H, 3’-H), 2.48–2.57 (m, 1H, 3’-H), 2.69 (dd, J = 
13.4, 9.9 Hz, 1H, PhCH2), 3.28 (dd, J = 13.4, 3.3 Hz, 1H, PhCH2), 3.86 (q, J = 6.8 Hz, 1H, 2’-
H), 4.12–4.21 (m, 2H, 5-H), 4.64–4.72 (m, 1H, 4-H), 5.03–5.13 (m, 2H, 5’-H), 5.76–5.88 (m, 
1H, 4’-H), 7.18–7.35 (m, 5H, Ph); 13C NMR (100 MHz, CDCl3): δ = 16.4 (2’-CH3), 37.1 (C-
2’), 37.9 (PhCH2), 38.0 (C-3’), 55.4 (C-4), 66.0 (C-5), 117.2 (C-5’), 127.3 (pCH ar Ph), 128.9 
(mCH ar Ph), 129.4 (oCH ar Ph), 135.2 (C-4’), 135.3 (iCH ar Ph), 153.1 (C-2), 176.5 (C-1’); 
HRMS (ESI): calcd for C16H19NNaO3 [M+Na]+: 296.12626, found 296.12639. 
 
 
(2S)-2-Methylpent-4-enoic acid (3-17) 
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To a solution of allylation product 3-16 (3.4 g, 12.3 mmol) in THF/H2O (36 mL/9 mL) at 0 °C 
was slowly added H2O2 (30 % aq., 5.60 mL, 50.0 mmol) followed by a solution of LiOH·H2O 
(1.03 g, 24.6 mmol) in water (8 mL). The reaction was stirred at 0 °C for 1 h before it was 
quenched with saturated aqeous Na2SO3 to destroy excess H2O2. Most of the THF was 
evaporated and the pH of the aqueous phase was adjusted to 12–13 upon addition of NaOH 
(1M). Extraction with CH2Cl2 (3 × 50 mL) removed the chiral auxillary. The aqueous phase 
was then acidified with HCl (2M) until pH = 1–2 was reached and extracted with EtOAc (3 × 
75 mL). The combined organic phases were washed with brine (50 mL), dried (MgSO4), 
filtered and evaporated to yield acid 3-17 (1.17 g, 84% yield) as a pale yellow oil. Rf = 0.32 
(petroleum ether/EtOAc, 1:1); [α]20D = +9.0 (c 2.0, CHCl3), Lit. 269 [α]20D = +9.2 (c 1.9, 
CHCl3); 1H NMR (400 MHz, CDCl3): δ = 1.17 (d, J = 6.8 Hz, 2-CH3), 2.14–2.24 (m, 1H, 3-
H), 2.38–2.47 (m, 1H, 3-H), 2.49–2.60 (m, 1H, 2-H), 5.02–5.11 (m, 2H, 5-H), 5.69–5.81 (m, 
1H, 4-H), 9.72 (br s, 1H, COOH); 13C NMR (100 MHz, CDCl3): δ = 16.3 (2-CH3), 37.4 (C-2), 
39.1 (C-3), 117.2 (C-5), 135.1 (C-4), 182.5 (C-1’); 
HRMS (ESI): calcd for C6H11NaO2 [M–H]–: 113.06080, found 113.06073. 
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(2S)-N-Methoxy-N,2-dimethylpent-4-enamide (3-13)106 
 
N
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To a solution of acid 3-17 (0.96 g, 8.4 mmol) in CH2Cl2 (30 mL) was added N-
methylpiperidine (4.4 mL, 36.1 mmol) followed by isobutylchloroformate (2.3 mL, 18.1 
mmol) at –15 °C. The mixture was stirred at –15 °C for 1 h followed by addition of N,O-
dimethylhydroxylamine hydrochloride (2.13 g, 21.8 mmol). After being stirred at –15 °C for 
15 min, the mixture was allowed to warm to room temperature overnight. The reaction 
mixture was poured into saturated NaHCO3 aqueous solution, and the aqueous layer was 
extracted twice with CH2Cl2. The combined organic layers were dried over Na2SO4, filtered 
and concentrated in vacuo. The crude product was purified by flash column (petroleum 
ether/EtOAc, 4:1) to give Weinreb amide 3-13 (0.99 g, 75% yield) as a colorless oil. Rf = 0.40 
(petroleum ether/EtOAc, 4:1); [α]20D = +17.3 (c 3.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 1.11 (d, J = 6.8 Hz, 2-CH3), 2.06–2.15 (m, 1H, 3-H), 2.36–2.45 (m, 1H, 3-H), 2.86–2.98 (m, 
1H, 2-H), 3.17 (s, 3H, NCH3), 3.67 (s, 3H, OCH3), 4.97–5.08 (m, 2H, 5-H), 5.68–5.81 (m, 1H, 
4-H); 13C NMR (100 MHz, CDCl3): δ = 17.0 (2-CH3), 35.1 (C-2), 37.8 (C-3), 61.5 (OCH3), 
116.4 (C-5), 136.2 (C-4); 
HRMS (ESI): calcd for C8H15NNaO2 [M+Na]+: 180.09950, found 180.09958. 
 
 
(1R)-1-Methylbut-3-enyl 2,4-dimethoxy-6-[(3S)-3-methyl-2-oxohex-5-enyl]benzoate (3-
11)102 
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A solution of ester 3-12 (244 mg, 0.92 mmol) in anhydrous THF (2 mL) was treated at –78 °C 
with freshly made LDA (1.84 mL 1M in THF, 1.84 mmol). After 5 min of stirring, a solution 
of Weinreb amide 3-13 (144 mg, 0.92 mmol) in THF (1.0 mL) was added dropwise. The 
resulting mixture was then stirred for 15 min at –78 °C and quenched by addition of saturated 
aqueous NH4Cl. Upon warming to room temperature, the reaction mixture was diluted with 
EtOAc, washed several times with saturated aqeous NH4Cl, brine and dried over MgSO4. 
Concentration under reduced pressure, followed by flash chromatography afforded ketone 3-
11 (90 mg, 27% yield) as a colorless oil. Rf = 0.55 (petroleum ether/Et2O, 1:1); [α]20D = +32.1 
(c 2.2, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 1.06 (J = 6.8 Hz, 3H, 3’-CH3), 1.32 (d, J = 
6.3 Hz, 3H, 1’’-CH3), 2.02–2.11 (m, 1H, 4’-H), 2.29–2.45 (m, 3H, 2’’-H, 4’-H), 2.65–2.74 (m, 
1H, 3’-H), 3.68–3.84 (m, 8H, OCH3, 1’-H), 4.96–5.19 (m, 5H, 4’’-H, 6’-H, 1’’-H ), 5.62–5.74 
(m, 1H, 5’-H), 5.77–5.89 (m, 1H, 3’’-H), 6.26 (d, J = 2.0 Hz, 1H, aryl H), 6.36 (d, J = 2.0 Hz, 
1H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 16.0 (3’-CH3), 19.4 (1’’-CH3), 19.8 (Ar-CH3), 
37.0 (C-4’), 40.2 (C-2’’), 44.8 (C-3’), 46.4 (C-1’), 55.3 (OCH3), 55.7 (OCH3), 71.0 (C-1’’), 
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97.6 (C-3), 107.0 (C-5), 116.8 (C-6’), 117.0 (C-1), 117.5 (C-4’’), 133.9 (C-3’’), 134.9 (C-6), 
135.6 (C-5’), 158.7 (C-2), 161.4 (C-4), 167.4 (CO2R), 209.8 (C-2’); 
HRMS (ESI): calcd for C21H28NaO5 [M+Na]+: 383.18344, found 383.18339. 
 
 
(E)-Macrolactone 3-18a and (Z)-macrolactone 3-18b 
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To a solution of ester 3-11 (80 mg, 0.22 mmol) in degassed toluene (22 mL) was added a 
solution of Grubbs 2nd catalyst (17.0 mg, 0.02 mmol) in toluene (0.5 mL) and the mixture was 
stirred at 80 °C for 23 h. For workup, the solvent was evaporated and the residue purified by 
flash chromatography (petroleum ether/Et2O, 1:1) to give (E)-macrolactone 3-18a (51 mg, 
70% yield) as a colorless solid. For the X-Ray analysis compound 3-18a was recrystallized 
from diisopropyl ether. Besides 3-18a some of (Z)-isomer 3-18b (9 mg, 12% yield) was 
isolated. 
 
Compound 3-18a 
Rf = 0.35 (petroleum ether/Et2O, 1:1); m. p. 147–148 °C; [α]20D = +82.4 (c 0.5, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 1.10 (J = 6.8 Hz, 3H, 10-CH3), 1.31 (d, J = 6.6 Hz, 3H, 15-
CH3), 2.05–2.20 (m, 2H, 11-H, 14-H), 2.25–2.33 (m, 1H, 11-H), 2.45–2.52 (m, 1H, 14-H), 2.81–
2.90 (m, 1H, 10-H), 3.50 (d, J = 18.2 Hz, 1H, 8-H), 3.74 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 
3.95 (d, J = 18.2 Hz, 1H, 8-H), 5.15–5.23 (m, 1H, 15-H), 5.38–5.51 (m, 2H, 12-H, 13-H ), 6.21 
(d, J = 2.0 Hz, 1H, aryl H), 6.35 (d, J = 2.0 Hz, 1H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 
16.8 (10-CH3), 20.2 (15-CH3), 36.6 (C-11), 38.8 (C-14), 45.9 (C-10), 47.7 (C-8), 55.3 (OCH3), 
55.7 (OCH3), 70.4 (C-15), 97.5 (C-4), 107.8 (C-6), 117.9 (C-2), 128.2 (C-13), 129.6 (C-12), 
133.3 (C-7), 157.5 (C-3), 160.8 (C-5), 168.1 (C-1), 210.0 (C-9); 
HRMS (ESI): calcd for C19H24NaO5 [M+Na]+: 355.15159, found 355.15156. 
 
Compound 3-18b 
Rf = 0.27 (petroleum ether/Et2O, 1:1); m. p. 132–133 °C; [α]20D = +64.1 (c 2.2, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 1.14 (J = 6.8 Hz, 3H, 10-CH3), 1.29 (d, J = 6.3 Hz, 3H, 15-
CH3), 1.98–2.12 (m, 2H, 11-H), 2.39–2.50 (m, 2H, 14-H), 2.65–2.75 (m, 1H, 10-H), 3.56 (d, J = 
18.4 Hz, 1H, 8-H), 3.77 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.95 (d, J = 18.4 Hz, 1H, 8-H), 
5.28–5.38 (m, 1H, 15-H), 5.55–5.65 (m, 2H, 12-H, 13-H ), 6.14 (d, J = 2.3 Hz, 1H, aryl H), 6.37 
(d, J = 2.3 Hz, 1H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 17.2 (10-CH3), 20.9 (15-CH3), 
33.5 (C-11), 34.5 (C-14), 45.1 (C-10), 50.0 (C-8), 55.3 (OCH3), 55.8 (OCH3), 71.0 (C-15), 
97.6 (C-4), 107.4 (C-6), 117.7 (C-2), 128.4 (C-13), 129.3 (C-12), 133.8 (C-7), 158.2 (C-3), 
161.1 (C-5), 167.1 (C-1), 209.7 (C-9); 
HRMS (ESI): calcd for C19H24NaO5 [M+Na]+: 355.15159, found 355.15164. 
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Methyl 2-allyl-4,6-dimethoxybenzoate (3-21) 
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2-Allyl-4,6-dimethoxybenzoic acid (3-20):107 A 1-L three-necked round bottom flask, 
equipped with a digital thermometer, a mechanical stirrer, and a dropping funnel, was charged 
with TMEDA (40 mL, 260 mmol, 2.2 equiv) and dry THF (100 mL), flushed with argon, and 
cooled to –90 °C with 2-propanol/liquid N2. To this solution was added sBuLi (200 mL, 260 
mmol, 1.3 M in cyclohexane, 2.2 equiv) slowly, maintaining the temperature below –90 °C. 
The resulting pale yellow solution was stirred for an additional 30 min followed by the 
dropwise addition of a solution of 2,4-dimethoxybenzoic acid 1 (21.8 g, 120 mmol, 1.0 equiv) 
in dry THF (120 mL) over 30 min, maintaining the internal temperature at –90 °C. The 
reaction mixture was stirred further, while warming to –78 °C until an orange colored and 
nearly clear solution was obtained (approximately 1 h). After addition of allyl bromide (40 
mL, 470 mmol, 4.1 equiv) over 1 h at –78 °C, the resulting mixture was stirred for another 30 
min and then treated slowly with water (100 mL) and warmed to room temperature. After 
separation of the layers, the aqueous layer was washed twice with Et2O (100 mL), and then the 
organic layers were discarded. The aqueous layer was acidified with 6 N HCl (150 mL) and 
extracted with CH2Cl2 (3 × 500 mL). The organic layer was dried over MgSO4, filtered, and 
concentrated in vacuo to provide 21.0 g of crude acid (3-20), which was used in next step 
without additional purification. 
 
Methyl 2-allyl-4,6-dimethoxybenzoate (3-21):108 To a cooled (0 °C) solution of 2-allyl-4,6-
dimethoxybenzoic acid (3-20) (21.0 g, 94.6 mmol) in THF (500 mL) were added 1,8-
diazabicyclo-[5.4.0]undec-7-en (DBU) (14.1 mL, 14.3 g, 94.6 mmol) and iodomethane (17.7 
mL, 40.2 g, 93.6 mmol), successively. After the mixture was stirred for 24 h at room 
temperature, the precipitate was removed by filtration over celite. The filter cake was rinsed 
with Et2O (300 mL). The filtrate was washed with H2O (100 mL), dried (MgSO4), filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 9:1) to yield 14.45 g (51% for 2 steps) of methyl ester 3-21 as a colorless oil. Rf 
= 0.37 (petroleum ether/EtOAc, 8:1); 1H NMR (400 MHz, CDCl3): δ = 3.28 (d, J = 6.6 Hz, 
2H, ArCH2CH=CH2), 3.73 (s, 6H, OCH3, CO2CH3), 3.79 (s, 3H, OCH3), 4.96–4.98 (m, 1H, 
ArCH2CH=CH2), 4.99–5.02 (m, 1H, ArCH2CH=CH2), 5.77–5.87 (m, 1H, ArCH2CH=CH2), 
7.19 (s, 2H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 37.8 (ArCH2CH=CH2), 51.7 
(CO2CH3), 55.0, 55.6 (OCH3), 96.3 (C-5), 105.6 (C-3), 115.9 (C-1), 116.0 (ArCH2CH=CH2), 
135.9 (ArCH2CH=CH2), 139.9 (C-2), 157.9 (C-6), 161.2 (C-4), 168.2 (CO2CH3); 
HRMS (ESI): calcd for C13H16NaO4 [M+Na]+: 259.2535, found 259.2534. 
 
 
Methyl 2,4-dimethoxy-6-(2-oxoethyl)benzoate (3-22)109 
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To a solution of alkenoic ester 3-21 (7.38 g, 31.3 mmol) in a mixture of THF/tBuOH (200/30 
mL) was added 4-methyl-morpholine-N-oxide (8.76 g, 62.6 mmol) and an aqueous solution of 
OsO4 (20 mL of a 0.032 M solution, 0.64 mmol, 2 mol%, prepared from K2OsO4·2H2O (236 
mg, 0.64 mmol))110 at 0 ºC. After being stirred at room temperature for 24 h, 10% Na2S2O3 
solution was added to the mixture. After 30 min, the diol was extracted with EtOAc and the 
combined organic extracts were washed with water, saturated NaCl solution, dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was filtered through a short pad of 
silica gel followed by rinsing the pad with EtOAc. Removal of the solvent from the combined 
filtrate gave the crude diol.  
NaIO4 (10.1 g, 47.0 mmol, 1.5 equiv) was added to a solution of crude diol in 90% MeOH 
(300 mL). After stirring at room temperature for 2 h, most of the methanol was removed in 
vacuo and the residue extracted with EtOAc (3 × 150 mL). The combined organic extracts 
were washed with water, saturated NaCl solution, dried over MgSO4, and filtered. After 
concentration, the residue was purified by flash chromatography (CH2Cl2/EtOAc, 9:1) to give 
aldehyde 3-22 as a colorless oil (6.3 g, 85%). Rf = 0.45 (CH2Cl2/EtOAc, 9:1); 1H NMR (400 
MHz, CDCl3): δ = 3.63 (s, 2H, ArCH2CHO), 3.81 (s, 3H, CO2CH3), 3.82, 3.84 (2 s, 3H each, 
OCH3), 6.31 (s, 1H, aryl H), 6.42 (s, 1H, aryl H), 9.67 (s, 1H, CHO); 13C NMR (100 MHz, 
CDCl3): δ = 48.9 (ArCH2CHO), 52.1 (CO2CH3), 55.4, 56.0 (OCH3), 97.9 (C-3), 107.5 (C-5), 
116.1 (C-1), 133.6 (C-6), 159.3 (C-2), 162.1 (C-4), 167.7 (CO2CH3), 198.7 (CHO). 
 
 
(4S)-4-Benzyl-3-pent-4-ynoyl-1,3-oxazolidin-2-one (3-25) 
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To a solution of 4-pentynoic acid (3-23) (4.48 g, 45.7 mmol) in THF (180 mL) were added 
NEt3 (8.1 mL, 55 mmol) and PivCl (6.15 mL, 48 mmol) at –78 °C. The resulting mixture was 
stirred for 15 min at –78 °C, allowed to warm up to room temperature, stirred for 30 min and 
recooled to –78 °C. Now, a precooled (–90 °C) solution of lithiated (S)-(-)-4-benzyl-2-
oxazolidinone (3-24) (8.90 g, 50.3 mmol), generated by treatment of the oxazolidinone 
solution in THF (100 mL) at –78 °C with nBuLi (2.5 M solution in hexane, 20.0 mL, 50.0 
mmol) was cannulated to the mixed anhydride solution. After 15 min at –78 °C, the resulting 
suspension was warmed to room temperature within 2 h. The reaction mixture was treated 
with saturated aqueous NH4Cl solution and extracted with EtOAc (3 × 200 mL). The 
combined organic layers were washed with saturated NaCl solution, dried over MgSO4, 
filtered, and concentrated in vacuo. Purification of the residue by flash chromatography 
(EtOAc/petroleum ether, 1:4) afforded oxazolidinone 3-25 (11.20 g, 95%) as colorless 
crystals. Rf = 0.35 (petroleum ether/EtOAc, 4:1); m.p. = 88–89 °C; [α]20D = +98.6 (c 1.8, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 2.00 (dd, J = 2.5, 2.5 Hz, 1H, C≡CH), 2.57–2.61 
(m, 2H, 3’-H), 2.78–2.81 (m, 1H, PhCH2), 3.11–3.24 (m, 2H, 2’-H), 3.28–3.32 (m, 1H, 
PhCH2), 4.17–4.24 (m, 2H, 2-H), 4.66–4.72 (m, 1H, 4-H), 7.19–7.21 (m, 2H, aryl H), 7.27–7.35 
(m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 13.8 (C-3’), 35.1 (C-2’), 38.1 (PhCH2), 
55.5 (C-4), 66.7 (C-5), 69.3 (CH2C≡CH), 82.9 (CH2C≡CH), 127.7 (pCH ar), 129.3 (mCH ar), 
129.7 (oCH ar), 129.7 (iC ar), 153.2 (C-2), 171.6 (C-2). 
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Methyl 2-((2R,3S)-3-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]carbonyl}-2-hydroxyhex-5-
ynyl)-4,6-dimethoxybenzoate (3-26)111 
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To a stirred solution of pentynoyloxazolidinone 3-25 (9.3 g, 36.2 mmol) in absolute toluene 
(250 mL) was added nBu2BOTf (40 mL, 1M in CH2Cl2) dropwise to maintain the internal 
temperature at –10 °C. After stirring for 5 min at –10 °C, iPr2NEt (7.2 ml, 43.4 mmol) was 
added dropwise, while maintaining the internal temperature at –10 °C. The solution turned 
from dark orange to light yellow after this addition. The reaction mixture was stirred for 2 h at 
0 °C and then cooled to –78 °C before a solution of aldehyde 3-22 (9.50 g, 40.0 mmol) in 
toluene (50 mL) was added at –78 °C. The reaction mixture was stirred at this temperature for 
1 h and then allowed to warm to 0 °C. After stirring at 0 °C for 3 h, the reaction was quenched 
by addition of phosphate buffer pH = 7, (120 mL), and methanol (100 ml). The mixture was 
cooled to an internal temperature at –5 °C followed by the addition of 30% H2O2 (80 mL). The 
reaction mixture was stirred at 0 °C for 1 h. All volatiles were removed in vacuo and the 
residue was extracted with EtOAc (3 × 300 mL). The combined organic layers were washed 
with H2O (100 mL), saturated NaCl solution (100 mL), dried (MgSO4), and filtered. The 
filtrate was concentrated in vacuo to give the crude aldol product, which was purified by flash 
chromatography (CH2Cl2/EtOAc, 85:15) to give aldol product 3-26 (15.21 g, 85%) as a 
colorless solid. Rf = 0.45 (CH2Cl2/EtOAc, 85:15); m.p. = 47–48 °C; [α]20D = +67.3 (c 2.1, 
CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 2.02 (dd, J = 2.5, 2.5 Hz, 1H, C≡CH), 2.68–2.96 (m, 5H, 4’-
H, 1’-H, PhCH2), 3.62–3.65 (m, 1H, PhCH2), 3.78 (s, 3H, CO2CH3), 3.80, 3.90 (2 s, 3H each, 
OCH3), 4.12–4.24 (m, 4H, 5’’-H, 4’’-H, 3’-H), 4.70–4.76 (m, 1H, 2’-H), 6.35 (d, J = 2.0 Hz, 
1H, aryl H), 6.42 (d, J = 2.0 Hz, 1H, aryl H), 7.23–7.35 (m, 5H, Ph); 13C NMR (100 MHz, 
CDCl3): δ = 16.8 (CH2C≡CH), 37.8 (PhCH2), 38.9 (C-1’), 48.3 (C-3’), 52.7 (CO2CH3), 55.4 
(OCH3), 55.9 (2 C, OCH3, C-4’’), 66.1 (C-5’’), 70.1 (C≡CH), 81.5 (C≡CH), 97.5 (C-5), 106.4 
(C-3), 116.2 (C-1),127.3 (pCH ar Ph), 128.9 (2 C, mCH ar Ph), 129.5 (2 C, oCH ar Ph), 135.2 
(iC ar Ph), 139.5 (C-2), 153.2 (C-2’’), 158.6 (C-4), 162.0 (C-6), 169.7 (CO2CH3), 172.9 
(C=O); 
HRMS (ESI): [M+Na]+ calcd for C27H29NNaO8: 518.1785, found 518.1784. 
 
 
Methyl 2-((2R,3S)-3-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]carbonyl}-2-{[tert-
butyl(dimethyl)silyl]oxy}hex-5-ynyl)-4,6-dimethoxybenzoate (3-27) 
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A solution of aldol adduct 3-26 (3.0 g, 6.0 mmol) in CH2Cl2 (50 mL) was cooled to –60 °C 
and protone sponge (3.34 g, 15.6 mmol) was added, followed by TBSOTf (1.8 ml, 7.8 mmol). 
The reaction mixture was allowed to warm to room temperature and stirred overnight. After 
complete reaction (monitoring by TLC) water was added and the mixture extracted with 
CH2Cl2. The combined organic extracts were washed with 1N HCI, saturated NaHCO3 and 
saturated NaCl solution, dried over MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography of the residue (petroleum ether/EtOAc, 4:1) afforded silyl ether 3-27 (3.30 g, 
89% yield) as a colorless oil. Rf = 0.25 (petroleum ether/EtOAc, 4:1); [α]20D = +55.2 (c 2.0, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = –0.35 (s, 3H, Si(CH3)2), 0.01 (s, 3H, Si(CH3)2), 
0.86 (s, 9H, Si(C(CH3)3)), 2.00 (s, 1H, C≡CH), 2.57–2.66 (m, 1H, 4’-H), 2.71–2.94 (m, 4H, 
1’-H, 4’-H, PhCH2), 3.21–3.27 (m, 1H, PhCH2), 3.74 (s, 3H, CO2CH3), 3.78 (s, 3H, OCH3), 
3.87 (s, 3H, OCH3), 4.08–4.20 (m, 3H, 4’’-H, 5’’-H), 4.29–4.34 (m, 1H, 2’-H), 4.59–4.64 (m, 
1H, 3’-H), 6.32 (d, J = 2.0 Hz, 1H, aryl H), 6.51 (d, J = 2.0 Hz, 1H, aryl H), 7.20–7.34 (m, 5H, 
Ph); 13C NMR (100 MHz, CDCl3): δ = –5.2 (Si(CH3)2), 17.6 (CH2C≡CH), 17.9, 25.9 
(Si(C(CH3)3)), 37.6 (C-1’), 39.5 (PhCH2), 47.6 (C-3’), 52.3 (CO2CH3), 55.4 (OCH3), 55.6 
(OCH3), 55.9 (C-4’’), 66.0 (C-5’’), 70.2 (C≡CH), 81.5 (C≡CH), 97.4 (C-5), 107.6 (C-3), 117.2 
(C-1),127.2 (pCH ar Ph), 128.8 (2 C, mCH ar Ph), 129.5 (2 C, oCH ar Ph), 135.4 (iC ar Ph), 
138.0 (C-2), 152.8 (C-2’’), 158.0 (C-4), 161.1 (C-6), 168.4 (CO2CH3), 172.2 (C=O); 
HRMS (ESI): [M+Na]+ calcd for C33H43NNaO8Si: 632.26501, found 632.26578. 
 
 
Methyl 2-[(2R,3R)-2-{[tert-butyl(dimethyl)silyl]oxy}-3-(hydroxymethyl)hex-5-ynyl]-4,6-
dimethoxybenzoate (3-28)112 
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To a stirred solution of compound 3-27 (3.03 g, 5.0 mmol) in THF (185 mL) was added a 
solution of NaBH4 (1.0 g, 25.0 mmol) in H2O (35 mL) at 0 °C. The reaction mixture was 
stirred at 0 °C for 1 h and then 2 d at room temperature until TLC analysis showed complete 
consumption of starting material 3-27. The mixture was treated with saturated NH4CI solution 
and stirred for 1 h. After separation of the layers, the H2O phase was extracted with EtOAc (3 
× 150 mL). The combined organic extracts were washed with saturated NaHCO3 and NaCl 
solution, dried over MgSO4, filtered, and concentrated in vacuo. Flash chromatography 
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(CH2Cl2/EtOAc, 9:1) of the residue afforded primary alcohol 3-28 (1.99 g, 91% yield) as 
colorless crystals. Rf = 0.74 (CH2Cl2/EtOAc, 85:15); m.p. = 61–63 °C; [α]20D = +17.6 (c 3.5, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = –0.35 (s, 3H, Si(CH3)2), 0.02 (s, 3H, Si(CH3)2), 0.86 
(s, 9H, Si(C(CH3)3)), 2.03 (s, 1H, C≡CH), 2.11–2.29 (m, 3H, 3’-H, 4’-H), 2.68 (dd, J = 13.6, 9.1, 
1H, 1’-H), 2.89 (dd, J = 13.6, 4.5, 1H, 1’-H), 3.74–3.80 (m, 8H, CH2OH, CO2CH3, OCH3), 3.88 
(s, 3H, OCH3), 4.13–4.19 (m, 1H, 2’-H), 6.34 (d, J = 2.0 Hz, 1H, aryl H), 6.37 (d, J = 2.0 Hz, 1H, 
aryl H); 13C NMR (100 MHz, CDCl3): δ = –5.3 (Si(CH3)2), –5.1 (Si(CH3)2), 16.8 (CH2C≡CH), 
17.8, 25.8 (Si(C(CH3)3)), 37.1 (C-1’), 44.7 (C-3’), 52.2 (CO2CH3), 55.3 (OCH3), 56.0 (OCH3), 
63.3 (CH2OH), 69.7 (C≡CH), 74.0 (C-2’), 82.7 (C≡CH), 97.1 (C-5), 108.0 (C-3), 116.7 (C-1), 
139.0 (C-2), 158.4 (C-4), 161.1 (C-6), 168.7 (CO2CH3); 
HRMS (ESI): [M+Na]+ calcd for C23H36NaO6Si: 459.21734, found 459.21719. 
 
 
Methyl 2-[(2R,3R)-2-{[tert-butyl(dimethyl)silyl]oxy}-3-({[(4-
methylphenyl)sulfonyl]oxy}methyl)hex-5-ynyl]-4,6-dimethoxybenzoate (3-29) 
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To a cooled to 0 °C solution of alcohol 3-28 (1.8 g, 4.12 mmol) in CH2Cl2 (65 mL) were 
added DMAP (50 mg, 0.41 mmol), Et3N (2.9 mL, 20.6 mmol) and ptoluenesulfonyl chloride 
(1.57 g, 8.24 mmol). The mixture was stirred for 24 h at room temperature. Then H2O was 
added, and the aqueous layer extracted with CH2Cl2. The organic extracts were washed with 
1N HCI, saturated NaHCO3 and NaCl solution, dried over MgSO4, filtered, and concentrated 
in vacuo. Flash chromatography (CH2Cl2) of the residue afforded tosylate 3-29 (2.19 g, 90% 
yield) as a colorless oil. Rf = 0.27 (CH2Cl2); [α]20D = +3.8 (c 1.4, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = –0.33 (s, 3H, Si(CH3)2), –0.10 (s, 3H, Si(CH3)2), 0.76 (s, 9H, Si(C(CH3)3)), 
1.92–1.99 (m, 1H, 3’-H), 2.03 (s, 1H, C≡CH), 2.17–2.32 (m, 2H, 4’-H), 2.43 (s, 3H, CH3 of 
Ts), 2.53 (dd, J = 13.6, 8.3 Hz, 1H, 1’-H), 2.79 (dd, J = 13.6, 5.3 Hz, 1H, 1’-H), 3.78 (s, 3H, 
CO2CH3), 3.78 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 4.04–4.15 (m, 3H, CH2OTs, 2’-H), 6.28 (d, 
J = 2.0 Hz, 1H, aryl H), 6.33 (d, J = 2.0 Hz, 1H, aryl H), 7.31 (d, J = 8.1 Hz, 2H, ar of Ts), 7.76 
(d, J = 8.1 Hz, 2H, ar of Ts); 13C NMR (100 MHz, CDCl3): δ = –5.2 (Si(CH3)2), –5.1 
(Si(CH3)2), 15.8 (CH2C≡CH), 17.8, 21.6 (CH3 of Ts), 25.8 (Si(C(CH3)3)), 37.7 (C-1’), 42.7 (C-
3’), 52.3 (CO2CH3), 55.4 (OCH3), 56.0 (OCH3), 69.2 (CH2OTs), 70.1 (C≡CH), 71.2 (C-2’), 
81.7 (C≡CH), 97.1 (C-5), 107.5 (C-3), 116.7 (C-1), 128.0 (2 C, C-2, C-6 of Ts), 129.8 (2 C, C-
3, C-5 of Ts), 132.8 (C-1 of Ts), 138.4 (C-2), 144.7 (C-1 of Ts), 158.4 (C-4), 161.1 (C-6 ar), 
168.5 (CO2CH3); 
HRMS (ESI): [M+Na]+ calcd for C30H42NaO8SSi: 613.22619, found 613.22662. 
 
 
Methyl 2-((2R,3S)-2-{[tert-butyl(dimethyl)silyl]oxy}-3-methylhex-5-ynyl)-4,6-
dimethoxybenzoate (3-30)113 
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A mixture of tosylate 3-29 (2.14 g, 3.6 mmol), NaI (2.70 g, 18.2 mmol), activated zinc dust 
(2.84 g, 36.3 mol) and glyme (180 ml) was refluxed for 4 h under stirring. Then the reaction 
mixture was cooled to ambient temperature and filtered through a pad of celite. The filtrate 
was washed with H2O (50 mL) and the H2O fraction extracted with Et2O (2 × 200 mL). The 
combined organic layers were washed with saturated NaCl solution, dried over MgSO4, 
filtered, and concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc, 10:1) of 
the residue afforded ester 3-30 (1.47 g, 96% yield) as colorless oil. Rf = 0.26 (CH2Cl2); [α]20D 
= +19.5 (c 1.3, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = –0.34 (s, 3H, Si(CH3)2), –0.05 (s, 
3H, Si(CH3)2), 0.82 (s, 9H, Si(C(CH3)3)), 1.00 (d, J = 6.8 Hz, 3H, 3’-CH3), 1.78–1.87 (m, 1H, 3’-
H), 1.95 (t, J = 6.8 Hz, 1H, C≡CH), 2.04–2.12 (m, 1H, 4’-H), 2.21–2.31 (m, 1H, 4’-H), 2.54 
(dd, J = 13.6, 8.3 Hz, 1H, 1’-H), 2.77 (dd, J = 13.6, 4.6 Hz, 1H, 1’-H), 3.78 (s, 3H, CO2CH3), 
3.79 (s, 3H, OCH3), 3.84-3.90 (m, 4H, OCH3, 2’-H), 6.32 (d, J = 2.0 Hz, 1H, aryl H), 6.37 (d, J 
= 2.0 Hz, 1H, aryl H); 13C NMR (100 MHz, CDCl3): δ = –5.0 (Si(CH3)2), –5.0 (Si(CH3)2), 15.0 
(3’-CH3), 18.0, 21.2 (C-4’), 25.9 (Si(C(CH3)3)), 37.2 (C-1’), 38.2 (C-3’), 52.2 (CO2CH3), 55.3 
(OCH3), 56.0 (OCH3), 69.1 (C≡CH), 75.3 (C-2’), 83.7 (C≡CH), 96.8 (C-5), 107.9 (C-3), 116.8 
(C-1), 139.5 (C-2), 158.2 (C-4), 161.0 (C-6), 168.7 (CO2CH3); 
HRMS (ESI): [M+Na]+ calcd for C23H36NaO5Si: 443.22242, found 443.22255. 
 
 
(2S,3R,4R)-2-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-4-methylhex-5-yn-3-ol (3-35) 
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a) Preparation of (2R)-2-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]propanal (3-9): To a 
cooled (–78 °C) solution of oxalyl chloride (5.0 mL, 56.5 mmol) in dry CH2Cl2 (150 mL) was 
added a solution of dimethylsulfoxide (9.0 mL, 92.0 mmol) in CH2Cl2 (50 mL) and the 
mixture was stirred at –78 °C for 30 min. Then, a solution of (2S)-2-[(4R)-2,2-dimethyl-1,3-
dioxolan-4-yl]propan-1-ol100 (3-33) (6.05 g, 37.5 mmol) in CH2Cl2 (50 mL) was added and 
after additional stirring at –78 °C for 30 min, triethylamine (26.5 mL, 180 mmol) was added 
and the reaction mixture allowed to warm to room temperature over 4 h. The mixture was 
diluted with CHCl3 and then mixed with water. The organic layer was washed with 1N HCl, 
saturated NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered, and concentrated 
under reduced pressure. Concentration must be carried out with special care because of the 
high volatility of the aldehyde. The crude aldehyde 3-9 (5.72 g, 97% yield) was used in the 
next reaction without further purification. 
b) (2S,3R,4R)-2-[(4R)-2,2-Dimethyl-1,3-dioxolan-4-yl]-4-methylhex-5-yn-3-ol (3-
35):81 To a stirred solution of Pd(OAc)2 (163.0 mg, 0.73 mmol, 0.050 equiv) in THF (240 mL) 
at –78 °C were added PPh3 (191 mg, 0.73 mmol, 0.050 equiv), aldehyde 3-9 (5.72 g, 36.3 
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mmol), and mesylate (S)-3-3474a (7.95 g, 54.0 mmol, 1.50 equiv). Thereafter, diethylzinc (109 
mL, 1 M in hexane, 3.00 equiv) was added over 20 min, and after stirring for 5 min, the 
mixture was warmed to –20 °C and stirred for 3 d at this temperature. The reaction mixture 
was treated with NH4Cl/Et2O (1:1) and the layers were separated. The Et2O layer was washed 
with saturated NaCl solution and stirred with MgSO4 and norite decolorizing charcoal. The 
mixture was filtered and concentrated in vacuo, followed by purification of the residue by 
flash chromatography (EtOAc/hexanes, 10:1) to give 5.54 g (72%) of alkyne 3-35 as a 
separable 96:4 mixture of diastereomers as a light yellow oil. Rf = 0.65 (petroleum 
ether/EtOAc, 4:1); [α]20D = +2.9 (c 2.7, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.99 (d, J = 
6.8 Hz, 3H, 1-H), 1.16 (d, J = 6.8 Hz, 3H, 4-CH3), 1.32 (s, 3H, C(CH3)2), 1.39 (s, 3H, C(CH3)2), 
1.72–1.81 (m, 1H, 2-H), 2.13 (s, 1H, C≡CH), 2.20–2.38 (br s, 1H, OH), 2.60–2.71 (m, 1H, 4-H), 
3.37–3.46 (m, 1H, 3-H), 3.70 (dd, J = 7.6, 7.6 Hz, 1H, 5’-H), 4.03 (dd, J = 7.8, 7.8 Hz, 1H, 5’-
H), 4.19 (dd, J = 12.6, 6.3 Hz, 1H, 4’-H); 13C NMR (100 MHz, CDCl3): δ = 8.2 (C-1), 17.3 (4-
CH3), 25.2 (C(CH3)2), 26.4 (C(CH3)2), 30.7 (C-4), 38.0 (C-2), 67.3 (C-5’), 70.8 (HC≡C), 75.7 
(C-3), 78.2 (C-4’), 85.8 (HC≡C), 108.8 (C(CH3)2); 
HRMS (ESI): [M+Na]+ calcd for C12H20NaO3: 235.1305, found 235.1303. 
 
 
(4S)-4-[(1S,2R,3R)-2-{[tert-Butyl(dimethyl)silyl]oxy}-1,3-dimethylpent-4-ynyl]-2,2-
dimethyl-1,3-dioxolane (3-36) 
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A solution of alcohol 3-35 (3.18 g, 15.0 mmol) in CH2Cl2 (50 mL) was cooled to –50 °C and 
2,6-lutidine (5.20 ml, 45.0 mmol) was added, followed by TBSOTf (4.50 mL, 19.5 mmol). 
The reaction mixture was allowed to warm to room temperature and stirred overnight. Then it 
was diluted with water and extracted with CH2Cl2. The combined organic extracts were 
washed with 1N HCl, saturated NaHCO3 and saturated NaCl solution, dried over MgSO4, 
filtered and concentrated under reduced pressure. Flash chromatography (petroleum 
ether/EtOAc, 20:1) afforded silyl ether 3-36 (4.65 g, 95% yield) as a colorless oil. Rf = 0.27 
(petroleum ether/EtOAc, 20:1); [α]20D = +1.2 (c 2.25, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 0.06 (s, 3H, Si(CH3)2), 0.07 (s, 3H, Si(CH3)2), 0.90 (s, 9H, Si(C(CH3)3)), 1.01 (d, J = 6.8 Hz, 
3H, 1’-CH3), 1.18 (d, J = 7.0 Hz, 3H, 3’-CH3), 1.33 (s, 3H, C(CH3)2), 1.38 (s, 3H, C(CH3)2), 
1.88–1.95 (m, 1H, 1’-H), 2.07 (s, 1H, C≡CH), 2.62–2.68 (m, 1H, 3’-H), 3.49–3.53 (m, 1H, 2’-
H), 3.66–3.72 (m, 1H, 5-H), 4.04–4.17 (m, 2H, 5-H, 4-H); 13C NMR (100 MHz, CDCl3): δ = 
–4.2 (Si(CH3)2), 11.9 (1’-CH3), 17.4 (3’-CH3), 18.3 (Si(C(CH3)3)), 25.6 (C(CH3)2), 26.0 
(Si(C(CH3)3)), 26.8 (C(CH3)2), 31.3 (C-3’), 40.4 (C-1’), 68.4 (C-5), 70.6 (HC≡C), 75.6 (C-2’), 
78.0 (C-4), 86.6 (HC≡C), 108.3 (C(CH3)2); 
HRMS (ESI): [M+Na]+ calcd for C18H34NaO3Si: 349.2169, found 349.2166. 
 
 
(3R,4R,5R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-
methylhexanal (3-37)81 
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To a cooled (0 °C) solution of BH3·SMe2 (94%, 1.44 mL, 13.82 mmol, 1.3 equiv) in dry 1,2-
dimethoxyethane (90 mL) was added freshly distilled cyclohexene (2.91 mL, 28.7 mmol, 2.7 
equiv). After 15 min, the mixture was warmed to room temperature. The resultant cloudy 
suspension was stirred for 1 h then cooled to 0 °C, before and alkyne 3-36 (3.47 g, 10.63 
mmol, 1.0 equiv) in 1,2-dimethoxyethane (25 mL) was added. After 5 min the reaction 
mixture was warmed to room temperature when it eventually became clear in color. After 
stirring for 3 h, the solution was cooled to 0 °C and treated with 1N NaOH (250 mL) followed 
by dropwise addition of H2O2 (80 mL, 30% solution in H2O). The mixture was stirred for 5 
min at 0 °C and 20 min at room temperature, then recooled to 0 °C and the residual peroxide 
was quenched by careful dropwise addition of saturated aqueous Na2S2O3 solution. The 
mixture was allowed to warm to room temperature and diluted with ether (200 mL). The ether 
layer was washed with saturated NaCl solution and water, and the combined aqueous layers 
were extracted with ether (3 × 100 mL). The extracts were dried over MgSO4, filtered, and 
concentrated under reduced pressure. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 4:1) to give 3.11 g (85%) of aldehyde 3-37 as slightly yellow oil. Rf 
= 0.55 (petroleum ether/EtOAc, 4:1); [α]20D = –9.3 (c 1.4, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.05 (s, 3H, Si(CH3)2), 0.06 (s, 3H, Si(CH3)2), 0.89 (s, 9H, Si(C(CH3)3)), 0.94–
1.00 (m, 6H, 6-H, 3-CH3), 1.31 (s, 3H, C(CH3)2), 1.37 (s, 3H, C(CH3)2), 1.70–1.75 (m, 1H, 3-
H), 2.13–2.21 (m, 1H, 2-H), 2.27–2.37 (m, 1H, 5-H), 2.60–2.67 (m, 1H, 2-H), 3.42–3.46 (m, 
1H, 4-H), 3.58 (dd, J = 7.6, 7.6 Hz, 1H, 5’-H), 3.97 (dd, J = 7.6, 7.6 Hz, 1H, 5’-H), 4.13 (dd, J 
= 6.6, 6.0 Hz, 1H, 4’-H), 9.74 (s, 1H, CHO); 13C NMR (100 MHz, CDCl3): δ = –4.2 
(Si(CH3)2), –3.9 (Si(CH3)2), 11.1 (C-6), 18.2 (3-CH3), 18.3 (Si(C(CH3)3)), 25.4 (C(CH3)2), 
26.0 (Si(C(CH3)3)), 26.6 (C(CH3)2), 31.7 (C-3), 40.0 (C-5), 47.0 (C-2), 67.9 (C-5’), 76.4 (C-4), 
76.7 (C-4’), 108.7 (C(CH3)2), 202.8 (CHO). 
 
 
(3R,4R,5R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-3-
methylhexan-1-ol (3-38) 
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To a cooled (0 °C) solution of aldehyde 3-37 (3.11 g, 9.0 mmol) in a mixture of THF/MeOH 
(3:1, 50 mL) was added sodium borohydride (0.5 g, 13.5 mmol) and the reaction mixture was 
stirred at this temperature for 1 h. Then it was treated with saturated NH4Cl solution and all 
volatiles were removed in vacuo. The aqueous residue was extracted with CH2Cl2, and the 
combined organic extracts were washed with saturated NaCl solution, dried over MgSO4, 
filtered and concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc, 2:1) 
afforded alcohol 3-38 (2.96 g, 95% yield) as a colorless oil. Rf = 0.48 (petroleum ether/EtOAc, 
2:1); [α]20D = +4.2 (c 2.75, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.03 (s, 3H, Si(CH3)2), 
0.05 (s, 3H, Si(CH3)2), 0.89 (s, 9H, Si(C(CH3)3)), 0.94 (d, J = 7.1 Hz, 3H, 6-H), 0.96 (d, J = 
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7.1 Hz, 3H, 3-CH3), 1.33 (s, 3H, C(CH3)2), 1.38 (s, 3H, C(CH3)2), 1.70–1.78 (m, 3H, 3-H, 2-
H), 1.83–1.91 (m, 1H, 5-H), 1.95 (br s, 1H, OH), 3.43–3.47 (m, 1H, 4-H), 3.54–3.63 (m, 2H, 
5’-H, 1-H), 3.68–3.75 (m, 1H, 1-H), 3.98 (dd, J = 7.6, 7.6 Hz, 1H, 5’-H), 4.18 (dd, J = 6.8, 6.8 
Hz, 1H, 4’-H); 13C NMR (100 MHz, CDCl3): δ = –4.3 (Si(CH3)2), –4.0 (Si(CH3)2), 11.2 (C-6), 
17.6 (3-CH3), 18.3 (Si(C(CH3)3)), 25.4 (C(CH3)2), 26.0 (Si(C(CH3)3)), 26.6 (C(CH3)2), 33.5 
(C-3), 35.2 (C-2), 39.8 (C-5), 60.9 (C-1), 68.0 (C-5’), 76.7 (C-4), 77.1 (C-4’), 108.8 
(C(CH3)2); 
HRMS (ESI): [M+Na]+ calcd for C18H38NaO4Si: 369.2432, found 369.2428. 
 
 
tert-Butyl({(1R,2R)-1-{(1R)-1-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]ethyl}-4-[(4-
methoxybenzyl)oxy]-2-methylbutyl}oxy)dimethylsilane (3-39)120c 
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To a solution of alcohol 3-38 (1.86 g, 5.4 mmol) in CH2Cl2 (50 mL) were added 4-
methoxybenzyltrichloroacetimidate (4.56 g, 16.2 mmol) and PPTS (1.36 g, 5.4 mmol) at 0 °C. 
The resultant mixture was stirred for 3 d at room temperature before saturated aqueous 
NaHCO3 solution was added. After separation of the layers, the aqueous phase was extracted 
with CH2Cl2. The combined organic layers were washed with saturated NaCl solution, dried 
over MgSO4, filtered and concentrated in vacuo. Flash chromatography (petroleum 
ether/EtOAc, 4:1) afforded ether 3-39 (2.34 g, 93% yield) as a colorless oil. Rf = 0.57 
(petroleum ether/EtOAc, 20:1); [α]20D = –2.0 (c 1.3, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 0.03 (s, 3H, Si(CH3)2), 0.04 (s, 3H, Si(CH3)2), 0.87–0.93 (m, 12H, Si(C(CH3)3), 2’-H), 0.98 
(d, J = 6.8 Hz, 3H, 2-CH3), 1.32 (s, 3H, C(CH3)2), 1.37 (s, 3H, C(CH3)2), 1.65–1.83 (m, 4H, 
1’-H, 3-H, 2-H), 3.40–3.51 (m, 3H, 1-H), 4-H), 3.57 (dd, J = 7.3, 7.3 Hz, 1H, 5’’-H), 3.79 (s, 
3H, OCH3), 3.94–4.06 (m, 2H, 5’’-H, 4’’-H), 4.36–4.46 (m, 2H, CH2 of PMB), 6.86 (d, J = 
8.4 Hz, 2H, aryl H), 7.24 (d, J = 8.4 Hz, 2H, aryl H); 13C NMR (100 MHz, CDCl3): δ = –4.4 
(Si(CH3)2), –3.8 (Si(CH3)2), 11.6 (C-2’), 16.3 (2-CH3), 18.3 (Si(C(CH3)3)), 25.5 (C(CH3)2), 
26.0 (Si(C(CH3)3)), 26.7 (C(CH3)2), 32.7 (C-2), 35.4 (C-3), 39.3 (C-1’), 55.2 (OCH3), 68.1 (C-
5’’), 68.5 (C-4), 72.5 (CH2 of PMB), 76.2 (C-1), 78.3 (C-4’’), 108.4 (C(CH3)2), 113.7, 113.9, 
129.2, 129.7, 130.6, 159.1 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C26H46NaO5Si: 489.30067, found 489.30042. 
 
 
(2R,3R,4R,5R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-7-[(4-methoxybenzyl)oxy]-3,5-
dimethylheptane-1,2-diol (3-40)115 
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CuCl2·2H2O (6.14 g, 36.0 mmol, 10 equiv) was added to a solution of acetal 3-39 (1.68 g, 3.6 
mmol) in CH3CN (100 mL) at –10 °C. The reaction mixture was stirred for 20 h at –5 °C, 
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treated with saturated NH4Cl solution (20 mL), and extracted with EtOAc (3 × 100 mL). The 
combined organic layers were washed with water, saturated NH4Cl solution and saturated 
NaCl solution, and dried over MgSO4. After filtration, the solvent was removed under reduced 
pressure, and the residue purified by flash chromatography (petroleum ether/EtOAc, 2:1→1:1) 
to give diol 3-40 (1.46 g, 95%) as a colorless oil. Rf = 0.56 (petroleum ether/EtOAc, 1:2); 
[α]20D = +1.3 (c 1.6, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.06 (s, 6H, Si(CH3)2), 0.87–
0.95 (m, 15H, Si(C(CH3)3), 3-CH3, 5-CH3), 1.28–1.38 (m, 1H, 6-H), 1.65–1.73 (m, 1H, 5-H), 
1.74–1.86 (m, 1H, 6-H), 1.87–1.95 (m, 1H, 3-H), 2.52 (br s, 2H, OH), 3.38–3.56 (m, 5H, 7-H, 
4-H, 1-H, 2-H), 3.62–3.67 (m, 1H, 1-H), 3.81 (s, 3H, OCH3), 4.45 (dd, J = 18.4, 11.6 Hz, 2H, 
CH2 of PMB), 6.89 (d, J = 8.4 Hz, 2H, aryl H), 7.26 (d, J = 8.4 Hz, 2H, aryl H); 13C NMR 
(100 MHz, CDCl3): δ = –4.3 (Si(CH3)2), –3.9 (Si(CH3)2), 10.4 (3-CH3), 17.5 (5-CH3), 18.2 
(Si(C(CH3)3)), 26.0 (Si(C(CH3)3)), 32.6 (C-5), 34.1 (C-6), 38.7 (C-3), 55.2 (OCH3), 65.4 (C-
1), 68.4 (C-7), 73.1 (CH2 of PMB), 77.8 (C-2), 113.7, 129.4.1, 130.2, 159.72 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C23H42NaO5Si: 449.26937, found 449.26882. 
 
 
tert-Butyl[((1R,2R)-4-[(4-methoxybenzyl)oxy]-2-methyl-1-{(1R)-1-[(2R)-oxiran-2-
yl]ethyl}butyl)oxy]dimethylsilane (3-42)116 
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To a solution of diol 3-40 (152 mg, 0.356 mmol) in THF (12 mL) at 0 °C was added NaH 
(60% wt. in mineral oil, 44 mg, 1.07 mol, 3.0 equiv). The resulting mixture was warmed to 
room temperature and stirred for 40 min. The mixture was cooled to 0 °C before N-(2,4,6-
triisopropylbenzenesulfonyl)imidazole (3-41) (125 mg, 0.377 mmol, 1.1 equiv) was added in 
one portion. The reaction mixture was then allowed to warm to room temperature and stirred 
for 1 h. The mixture was diluted with water (10 mL) and extracted with Et2O (3 × 50 mL). The 
combined organic layers were washed with saturated NaCl solution (30 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. Flash chromatography (ethyl acetate/petroleum 
ether, 1:10) provided epoxide 3-42 (131 mg, 90% yield) as a colorless oil. Rf = 0.70 
(petroleum ether/EtOAc, 4:1); [α]20D = +3.6 (c 2.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
0.06 (s, 3H, Si(CH3)2), 0.08 (s, 3H, Si(CH3)2), 0.89–0.94 (m, 12H, Si(C(CH3)3), 2’-H), 1.07 (d, J 
= 6.6 Hz, 3H, 2-CH3), 1.27–1.40 (m, 2H, 3-H, 1’-H), 1.76–1.85 (m, 2H, 3-H, 2-H), 2.52–2.56 
(m, 1H, 3’’-H), 2.71–2.75 (m, 1H, 3’’-H), 2.80–2.85 (m, 1H, 2’’-H), 3.40–3.58 (m, 3H, 
CH2OPMB, CH(OTBS)), 3.82 (s, 3H, OCH3), 4.43 (dd, J = 18.6, 11.6 Hz, 2H, CH2 of PMB), 
6.89 (d, J = 8.6 Hz, 2H, aryl H), 7.26 (d, J = 8.6 Hz, 2H, aryl H); 13C NMR (100 MHz, CDCl3): 
δ = –4.1 (Si(CH3)2), –3.8 (Si(CH3)2), 13.1 (C-2’), 16.8 (2-CH3), 18.3 (Si(C(CH3)3)), 26.0 
(Si(C(CH3)3)), 32.1 (C-3), 34.6 (C-2), 40.3 (C-1’), 47.7 (C-3’’), 55.3 (C-2’’), 56.0 (2C, 
OCH3), 68.5 (CH2OPMB), 72.6 (CH2 of PMB), 77.9 (CH(OTBS)), 113.7, 129.2, 130.7, 159.1 
(aryl C); 
HRMS (ESI): [M+Na]+ calcd for C23H40NaO4Si: 431.25881, found 431.25852. 
 
 
Alcohol 3-43 
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tBuLi (140 µL, 1.5 M in pentane, 0.21 mmol) was added to a solution of alkyne 3-30 (90 mg, 
0.21 mmol) in THF (3.5 mL) at –78 °C in a dropwise fashion. The acetylide solution was 
stirred at –78 °C for 1 h before a solution of BF3·OEt2 (30 µL, 0.21 mmol) was added. Stirring 
was continued for 15 min at –78 °C. Then, a solution of epoxide 3-42 (58 mg, 0.14 mmol) in 
THF (0.5 mL) was added dropwise. The reaction was stirred at –78 °C for 3 h and then 
quenched with saturated NH4Cl solution. The layers were separated and the aqueous layer was 
extracted twice with Et2O. The combined organic extracts were dried (MgSO4), filtered, and 
concentrated in vacuo to afford an oil, which was purified by flash chromatography 
(petroleum ether/EtOAc, 10:1→5:1) to furnish alcohol 3-43 (52 mg) in 44% yield. Rf = 0.37 
(petroleum ether/EtOAc, 4:1); [α]20D = +8.0 (c 1.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
–0.37 (s, 3H, Si(CH3)2), –0.07 (s, 3H, Si(CH3)2), 0.05 (s, 6H, Si(CH3)2), 0.81 (s, 9H, 
Si(C(CH3)3)), 0.85–0.94 (m, 15H, 18-CH3, 16-CH3, Si(C(CH3)3), 0.97 (d, J = 6.8 Hz, 3H, 10-
CH3), 1.12–1.27 (m, 2H, 19-H), 1.30–1.40 (m, 1H, 18-H), 1.72–1.92 (m, 4H, 10-H, 11-H, 16-
H, 14-H), 2.00–2.08 (m, 1H, 11-H), 2.17–2.24 (m, 1H, 8-H), 2.32–2.36 (m, 2H), 2.46–2.54 
(m, 1H, 14-H), 2.58–2.61 (m, 1H, 8-H), 2.72–2.78 (m, 1H, 15-H), 3.38–3.51 (m, 2H, 20-H), 
3.63–3.67 (m, 1H, 17-H), 3.75–3.81 (m, 9H, OCH3), 3.84–3.90 (m, 4H, 9-H, OCH3), 4.36–
4.46 (m, 2H, CH2 of PMB), 6.32 (s, 1H, H-6), 6.37 (s, 1H, H-4), 6.86 (d, J = 8.6 Hz, 2H, aryl 
H), 7.24 (d, J = 8.6 Hz, 2H, aryl H); 13C NMR (100 MHz, CDCl3): δ = –5.1 (Si(CH3)2), –5.0 
(Si(CH3)2), –4.3 (Si(CH3)2), –3.7 (Si(CH3)2), 9.2 (16-CH3), 14.8 (10-CH3), 16.4, 17.9, 18.3 
(18-CH3), 21.8 (C≡CCH2), 25.5 (C≡CCH2), 25.9 (Si(C(CH3)3)), 26.0 (Si(C(CH3)3)), 32.6 (C-
19), 35.1 (C-18), 37.0 (C-16), 38.8 (C-8), 39.4 (C-10), 55.1 (OCH3), 55.2 (OCH3), 55.3 
(OCH3), 55.9 (OCH3), 68.4 (C-20), 72.5 (CH2 of PMB), 72.7 (C-15), 75.3, 77.7 (C-17), 77.9 
(C-9), 81.4 (CH2C≡C), 96.8 (C-3), 108.1 (C-6), 113.7 (ar of PMB), 116.8 (C-2), 129.2 (ar of 
PMB), 130.6 (ar of PMB), 139.7 (C-7), 158.1 (C-5), 159.1 (ar of PMB), 160.9 (C-3), 168.7 
(CO2R); 
HRMS (ESI): [M+Na]+ calcd for C46H76NaO9Si2: 851.49201, found 851.49172. 
 
 
(Methyl 2-{(2R,3S)-3-{[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]carbonyl}-2-
[(triisopropylsilyl)oxy]hex-5-ynyl}-4,6-dimethoxybenzoate (3-45) 
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A solution of aldol adduct 3-26 (9.42 g, 19.0 mmol) in CH2Cl2 (100 mL) was cooled to –60 °C 
and protone sponge (14.58 g, 67.8 mmol) was added, followed by TIPSOTf (6.64 ml, 24.7 
mmol). The reaction mixture was allowed to warm to room temperature and stirred overnight. 
After complete reaction (monitoring by TLC) water was added and the mixture extracted with 
CH2Cl2. The combined organic extracts were washed with 1N HCI, saturated NaHCO3 and 
saturated NaCl solution, dried over MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography of the residue (petroleum ether/EtOAc, 4:1) afforded silyl ether 3-45 (11.77 
g, 95% yield) as a colorless oil. Rf = 0.43 (petroleum ether/EtOAc, 4:1); [α]20D = +59.6 (c 2.4, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 1.05–1.09 (m, 21H, Si(CH(CH3)2), 2.03 (s, 1H, 
C≡CH), 2.57–2.69 (m, 2H, 4’-H), 2.76–2.92 (m, 2H, 1’-H), 2.99–3.04 (m, 1H, PhCH2), 3.19-
3.23 (m, 1H, PhCH2), 3.73 (s, 3H, CO2CH3), 3.80 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 4.02–
4.04 (m, 1H, 4’’-H), 4.08–4.19 (m, 2H, 5’’-H), 4.46–4.49 (m, 1H, 2’-H), 4.61–4.66 (m, 1H, 
3’-H), 6.32 (s, 1H, aryl H), 6.65 (s, 1H, aryl H), 7.18–7.32 (m, 5H, Ph); 13C NMR (100 MHz, 
CDCl3): δ = 13.0 (CH(CH3)2), 18.0 (CH2C≡CH), 18.2 (CH(CH3)2), 37.6 (C-1’), 39.4 (PhCH2), 
46.8 (C-3’), 52.4 (CO2CH3), 55.4 (OCH3), 55.6 (OCH3), 55.9 (C-4’’), 65.9 (C-5’’), 70.2 
(C≡CH), 81.5 (C≡CH), 97.5 (C-5), 106.7 (C-3), 117.1 (C-1),127.1 (pCH ar Ph), 128.8 (2 C, 
mCH ar Ph), 129.5 (2 C, oCH ar Ph), 135.6 (iC ar Ph), 137.3 (C-2), 152.6 (C-2’’), 157.9 (C-4), 
161.2 (C-6), 168.4 (CO2CH3), 172.0 (C=O); 
HRMS (ESI): [M+Na]+ calcd for C36H49NNaO8Si: 674.3120, found 674.3123. 
 
 
Methyl 2-{(2R,3R)-3-(hydroxymethyl)-2-[(triisopropylsilyl)oxy]hex-5-ynyl}-4,6-
dimethoxybenzoate (3-46) 
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To a stirred solution of compound 3-45 (9.5 g, 14.6 mmol) in THF (400 mL) was added a 
solution of NaBH4 (3.24 g, 87.6 mmol) in H2O (60 mL) at 0 °C. The reaction mixture was 
stirred at 0 °C for 1 h and then 3 d at room temperature until TLC analysis showed complete 
consumption of starting material 3-45. The mixture was treated with saturated NH4CI solution 
and stirred for 1 h. After separation of the layers, the H2O phase was extracted with EtOAc (3 
× 300 mL). The combined organic extracts were washed with saturated NaHCO3 and NaCl 
solution, dried over MgSO4, filtered, and concentrated in vacuo. Flash chromatography 
(CH2Cl2/EtOAc, 9:1) of the residue afforded primary alcohol 3-46 (6.56 g, 94% yield) as 
colorless crystals. Rf = 0.41 (CH2Cl2/EtOAc, 9:1); m.p. = 110–111 °C; [α]20D = +6.9 (c 2.6, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.98–1.02 (m, 21H, Si(CH(CH3)2), 1.97 (s, 1H, 
C≡CH), 2.00–2.02 (m, 1H, 3’-H), 2.20–2.23 (m, 2H, 4’-H), 2.81–2.85 (m, 2H, 1’-H), 3.76–
3.81 (m, 8H, CH2OH, CO2CH3, OCH3), 3.88 (s, 3H, OCH3), 4.39–4.41 (m, 1H, 2’-H), 6.33 (s, 
1H, aryl H), 6.40 (s, 1H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 12.8 (CH(CH3)2), 16.2 
(CH2C≡CH), 18.0 (CH(CH3)2), 18.1 (CH(CH3)2), 37.7 (C-1’), 44.3 (C-3’), 52.2 (CO2CH3), 
55.3 (OCH3), 56.0 (OCH3), 63.4 (CH2OH), 69.6 (C≡CH), 73.9 (C-2’), 83.1 (C≡CH), 97.1 (C-
5), 107.2 (C-3), 116.9 (C-1), 138.5 (C-2), 158.4 (C-4), 161.2 (C-6), 168.7 (CO2CH3); 
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HRMS (ESI): [M+Na]+ calcd for C26H42NaO6Si: 501.2643, found 501.2645. 
 
 
Methyl 2,4-dimethoxy-6-{(2R,3R)-3-({[(4-methylphenyl)sulfonyl]oxy}methyl)-2-
[(triisopropylsilyl)oxy]hex-5-ynyl}benzoate (3-47) 
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To a cooled to 0 °C solution of alcohol 3-46 (4.32 g, 9.00 mmol) in CH2Cl2 (150 mL) were 
added DMAP (245 mg, 2.0 mmol), Et3N (6.30 mL, 45 mmol) and ptoluenesulfonyl chloride 
(3.43 g, 18 mmol). The mixture was stirred for 24 h at room temperature. Then H2O was 
added, and the aqueous layer extracted with CH2Cl2. The organic extracts were washed with 
1N HCI, saturated NaHCO3 and NaCl solution, dried over MgSO4, filtered, and concentrated 
in vacuo. Flash chromatography (CH2Cl2) of the residue afforded tosylate 3-47 (5.42 g, 95% 
yield) as a colorless oil. Rf = 0.31 (CH2Cl2); [α]20D = +2.3 (c 3.55, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 0.91–0.96 (m, 21H, Si(CH(CH3)2), 1.84–1.87 (m, 1H, 3’-H), 1.98 (s, 1H, 
C≡CH), 2.18–2.28 (m, 2H, 4’-H), 2.42 (s, 3H, CH3 of Ts), 2.63–2.68 (m, 1H, 1’-H), 2.74–2.80 
(m, 1H, 1’-H), 3.77 (s, 6H, CO2CH3, OCH3), 3.85 (s, 3H, OCH3), 4.08–4.17 (m, 2H, 
CH2OTs), 4.32–4.36 (m, 1H, 2’-H), 6.32–6.33 (m, 2H, aryl H), 7.29 (d, J = 8.0 Hz, 2H, ar of 
Ts), 7.73 (d, J = 8.0 Hz, 2H, ar of Ts); 13C NMR (100 MHz, CDCl3): δ = 12.7 (CH(CH3)2), 
15.5 (CH2C≡CH), 18.0 (CH(CH3)2), 18.1 (CH(CH3)2), 21.6 (CH3 of Ts), 37.7 (C-1’), 42.1 (C-
3’), 52.2 (CO2CH3), 55.3 (OCH3), 56.0 (OCH3), 69.2 (CH2OTs), 70.0 (C≡CH), 71.5 (C-2’), 
81.8 (C≡CH), 97.3 (C-5), 106.5 (C-3), 116.9 (C-1), 128.0 (2 C, C-2, C-6 of Ts), 129.7 (2 C, C-
3, C-5 of Ts), 132.7 (C-1 of Ts), 137.9 (C-2), 144.6 (C-1 of Ts), 158.3 (C-4), 161.3 (C-6 ar), 
168.5 (CO2CH3); 
HRMS (ESI): [M+Na]+ calcd for C33H48NaO8SSi: 655.2731, found 655.2737. 
 
 
Methyl 2,4-dimethoxy-6-{(2R,3S)-3-methyl-2-[(triisopropylsilyl)oxy]hex-5-ynyl}benzoate (3-48) 
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A mixture of tosylate 3-47 (5.40 g, 8.5 mmol), NaI (12.75 g, 85 mmol), activated zinc dust 
(11.1 g, 170 mmol) and glyme (500 mL) was refluxed for 4 h under stirring. Then the reaction 
mixture was cooled to ambient temperature and filtered through a pad of celite. The filtrate 
was washed with H2O (100 mL) and the H2O fraction extracted with Et2O (2 × 300 mL). The 
combined organic layers were washed with saturated NaCl solution, dried over MgSO4, 
filtered, and concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc, 10:1) of 
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the residue afforded ester 3-48 (4.31 g, 97% yield) as colorless crystals. Rf = 0.38 (petroleum 
ether/EtOAc, 10:1); m.p. = 56–57 °C; [α]20D = +22.1 (c 5.8, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.97–1.05 (m, 24H, Si(CH(CH3)2), 3’-CH3), 1.87–1.90 (m, 1H, 3’-H), 1.93 (s, 1H, 
C≡CH), 2.04–2.10 (m, 1H, 4’-H), 2.19–2.24 (m, 1H, 4’-H), 2.61-2.66 (m, 1H, 1’-H), 2.72–
2.77 (m, 1H, 1’-H), 3.76 (s, 3H, CO2CH3), 3.78 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 4.10–4.13 
(m, 1H, 2’-H), 6.31 (s, 1H, aryl H), 6.40 (s, 1H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 
12.8 (CH(CH3)2), 15.0 (3’-CH3), 18.0 (CH(CH3)2), 18.1 (CH(CH3)2), 21.1 (C-4’), 37.1 (C-1’), 
37.9 (C-3’), 52.1 (CO2CH3), 55.3 (OCH3), 55.9 (OCH3), 69.0 (C≡CH), 75.8 (C-2’), 83.8 
(C≡CH), 96.9 (C-5), 107.3 (C-3), 117.0 (C-1), 139.3 (C-2), 158.2 (C-4), 161.0 (C-6), 168.7 
(CO2CH3); 
HRMS (ESI): [M+Na]+ calcd for C26H42NaO5Si: 485.2694, found 485.2692. 
 
 
2,4-Dimethoxy-6-{(2R,3S)-3-methyl-2-[(triisopropylsilyl)oxy]hex-5-ynyl}benzoic acid (3-49) 
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A solution of methyl ester 3-48 (3.1 g, 6.7 mmol) in a 10% solution of KOH in a mixture of 
ethanol/water (100 mL, 95:5) was refluxed for 20 h. After cooling, most of the ethanol was 
removed in vacuo. The residue was diluted with water (60 mL), acidified (pH ~ 3) by slow 
addition of aqueous hydrochloric acid (1N) and extracted with EtOAc (3 × 60 mL). The 
combined organic extracts were washed with saturated NaCl solution, dried over MgSO4, 
filtered, and concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc/HOAc, 
4:1:0.01) afforded acid 3-49 (2.85 g, 95% yield) as colorless crystals. Rf = 0.36 (petroleum 
ether/EtOAc, 4:1); m.p. = 106–107 °C; [α]20D = +74.3 (c 1.75, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.88–0.94 (m, 21H, Si(CH(CH3)2), 1.07 (d, J = 6.8 Hz, 3H, 3’-CH3), 2.04 (dd, J = 
2.5, 2.5 Hz, 1H, C≡CH), 2.08–2.14 (m, 1H, 3’-H), 2.18–2.29 (m, 2H, 4’-H), 2.80–2.88 (m, 
2H, 1’-H), 3.81 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 4.37–4.41 (m, 1H, 2’-H), 6.37 (d, J = 2.0 
Hz, 1H, aryl H), 6.40 (d, J = 2.0 Hz, 1H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 12.6 
(CH(CH3)2), 13.5 (3’-CH3), 17.7 (CH(CH3)2), 17.9 (CH(CH3)2), 22.7 (C-4’), 35.2 (C-1’), 38.2 
(C-3’), 55.4 (OCH3), 56.3 (OCH3), 69.8 (C≡CH), 77.2 (C-2’), 82.6 (C≡CH), 97.5 (C-5), 107.7 
(C-3), 116.2 (C-1), 141.2 (C-2), 159.5 (C-4), 162.1 (C-6), 166.5 (CO2H); 
HRMS (ESI): [M+Na]+ calcd for C25H40NaO5Si: 471.2537, found 471.2538. 
 
 
2,4-Dimethoxy-6-{(2R,3S)-3-methyl-2-[(triisopropylsilyl)oxy]hept-5-ynyl}benzoic acid (3-50) 
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A solution of acid 3-49 (1.02 g, 2.2 mmol) in THF (45 mL) was treated with nBuLi (2.64 mL, 
2.5 M in hexanes, 6.6 mmol, 3 equiv) in a dropwise fashion at –78 °C. After being stirred for 1 
h at –78 °C, methyl iodide (0.685 mL, 11 mmol) was added at –78 °C and the reaction mixture 
allowed to warm to room temperature over 5 h. After addition of H2O (10 mL), all volatiles 
were removed in vacuo. The residue was redissolved in H2O (30 mL), acidified (pH ~ 3) by 
slow addition of aqueous hydrochloric acid (1N) and extracted with EtOAc (3 × 40 mL). Flash 
chromatography (petroleum ether/EtOAc/HOAc, 4:1:0.01) afforded acid 3-50 (1.04 g, 98% 
yield) as a colorless solid. Rf = 0.38 (petroleum ether/EtOAc, 4:1); m.p. = 102–103 °C; [α]20D 
= +113.9 (c 2.1, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.87–0.93 (m, 21H, 
Si(CH(CH3)2), 1.02 (d, J = 6.8 Hz, 3H, 3’-CH3), 1.77 (s, 7’-CH3), 2.06–2.10 (m, 1H, 3’-H), 
2.11–2.21 (m, 2H, 4’-H), 2.75–2.81 (m, 2H, 1’-H), 3.79 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 
4.37–4.41 (m, 1H, 2’-H), 6.35 (d, J = 2.0 Hz, 1H, aryl H), 6.37 (d, J = 2.0 Hz, 1H, aryl H); 
13C NMR (100 MHz, CDCl3): δ = 3.4 (7’-CH3), 12.6 (CH(CH3)2), 13.5 (3’-CH3), 17.6 
(CH(CH3)2), 17.9 (CH(CH3)2), 23.0 (C-4’), 34.7 (C-1’), 38.5 (C-3’), 55.3 (OCH3), 56.1 
(OCH3), 77.0 (C≡C), 77.1 (C-2’), 77.1 (C≡C), 97.3 (C-5), 107.0 (C-3), 116.8 (C-1), 140.5 (C-
2), 159.3 (C-4), 161.9 (C-6), 167.4 (CO2H); 
HRMS (ESI): [M+Na]+ calcd for C26H42NaO5Si: 485.2694, found 485.2693. 
 
 
tert-Butyl[((1R,2R)-4-[(3,4-dimethoxybenzyl)oxy]-1-{(1R)-1-[(4R)-2,2-dimethyl-1,3-
dioxolan-4-yl]ethyl}-2-methylbutyl)oxy]dimethylsilane (3-51) 
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To a solution of alcohol 3-38 (2.92 g, 8.4 mmol) in CH2Cl2 (50 mL) were added 3,4-
dimethoxybenzyltrichloroacetimidate120b (7.86 g, 25.2 mmol) and PPTS (2.1 g, 8.4 mmol) at 0 
°C. The resultant mixture was stirred for 3 d before saturated aqueous NaHCO3 solution was 
added. After separation of the layers, the aqueous phase was extracted with CH2Cl2. The 
combined organic layers were washed with saturated NaCl solution, dried over MgSO4, 
filtered and concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc, 4:1) 
afforded ether 3-51 (4.05 g, 97% yield) as a colorless oil. Rf = 0.46 (petroleum ether/EtOAc, 
4:1); [α]20D = –1.9 (c 2.5, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.03 (s, 3H, Si(CH3)2), 
0.04 (s, 3H, Si(CH3)2), 0.86–0.92 (m, 12H, Si(C(CH3)3), 2’-H), 0.98 (d, J = 6.8 Hz, 3H, 2-
CH3), 1.31 (s, 3H, C(CH3)2), 1.37 (s, 3H, C(CH3)2), 1.64–1.82 (m, 4H, 1’-H, 3-H, 2-H), 3.40–
3.51 (m, 3H, 1-H), 4-H), 3.58 (dd, J = 7.3, 7.3 Hz, 1H, 5’’-H), 3.86 (s, 3H, OCH3), 3.87 (s, 
3H, OCH3), 4.03–4.17 (m, 2H, 5’’-H, 4’’-H), 4.41 (dd, J = 21.7, 11.6 Hz, 2H, CH2 of DMB), 
6.79–6.88 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ = –4.4 (Si(CH3)2), –3.8 
(Si(CH3)2), 11.6 (C-2’), 16.3 (2-CH3), 18.3 (Si(C(CH3)3)), 25.5 (C(CH3)2), 26.0 (Si(C(CH3)3)), 
26.7 (C(CH3)2), 32.6 (C-2), 35.4 (C-3), 39.3 (C-1’), 55.8 (OCH3), 55.9 (OCH3), 68.1 (C-5’’), 
68.6 (C-4), 72.8 (CH2 of DMB), 76.3 (C-1), 78.3 (C-4’’), 108.4 (C(CH3)2), 110.8, 110.9, 
120.1, 131.1, 148.5, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C27H48NaO6Si: 519.3112, found 519.3111. 
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(2S,3R,4R)-6-[(3,4-Dimethoxybenzyl)oxy]-2-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-4-
methylhexan-3-ol (3-52) 
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To a solution of silyl ether 3-51 (1.45 g, 2.9 mmol) in THF (5 mL) was added TBAF (8.7 mL, 
1M in THF, 8.7 mmol) at 0 °C (ice bath). The reaction mixture was allowed to warm to room 
temperature and stirred for 12 h. After addition of saturated NH4Cl solution the mixture was 
extracted with EtOAc (3 × 40 mL). The combined organic layers were washed with saturated 
NaCl solution (20 mL), dried over MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography (petroleum ether/EtOAc, 2:1→1:1) afforded alcohol 3-52 (1.05 g, 95% yield) 
as a colorless oil. Rf = 0.51 (petroleum ether/EtOAc, 1:1); [α]20D = +1.0 (c 2.0, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.82 (d, J = 6.8 Hz, 3H, 2’-H), 0.94 (d, J = 6.8 Hz, 3H, 2-
CH3), 1.33 (s, 3H, C(CH3)2), 1.39 (s, 3H, C(CH3)2), 1.48–1.58 (m, 1H, 3-H), 1.65–1.83 (m, 
2H, 3-H, 2-H), 1.87–1.98 (m, 1H, 1’-H), 3.23–3.30 (m, 2H, 1H, OH), 3.45–3.60 (m, 2H, 4-H), 
3.67 (dd, J = 7.6, 7.6 Hz, 1H, 5’’-H), 3.86 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 4.00–4.05 (m, 
1H, 5’’-H), 4.15–4.22 (m, 1H, 4’’-H), 4.43 (s, 2H, CH2 of DMB), 6.79–6.89 (m, 3H, aryl H); 
13C NMR (100 MHz, CDCl3): δ = 7.2 (C-2’), 16.7 (2-CH3), 25.3 (C(CH3)2), 26.5 (C(CH3)2), 
33.6 (C-2), 34.4 (C-3), 37.5 (C-1’), 55.7 (OCH3), 55.9 (OCH3), 67.6 (C-5’’), 68.3 (C-4), 72.8 
(CH2 of DMB), 77.6 (C-1), 79.7 (C-4’’), 108.8 (C(CH3)2), 110.8, 111.0, 120.2, 130.7, 148.5, 
149.0 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C21H34NaO6: 405.22531, found 405.22518. 
 
 
(4R)-4-{(1S,2R,3R)-5-[(3,4-Dimethoxybenzyl)oxy]-2-[(4-methoxybenzyl)oxy]-1,3-
dimethylpentyl}-2,2-dimethyl-1,3-dioxolane (3-53) 
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To a solution of alcohol 3-52 (0.96 g, 2.5 mmol) in DMF (5 mL) was added potassium hydride 
(0.86 g of (~35%) dispersion in mineral oil, 7.5 mmol) at 0 °C (ice bath). The reaction mixture 
was stirred at this temperature for 30 min and then treated with 4-methoxybenzylbromide 
(1.87 g, 10 mmol). After stirring for 2 h at 0 °C saturated NH4Cl solution was added and the 
mixture was extracted with EtOAc (3 × 40 mL). The combined organic layers were washed 
with saturated NaCl solution (20 mL), dried over MgSO4, filtered, and concentrated in vacuo. 
Flash chromatography (petroleum ether/EtOAc, 10:1→4:1) afforded compound 3-53 (1.10 g, 
88% yield) as a colorless oil. Rf = 0.92 (petroleum ether/EtOAc, 1:1); [α]20D = –5.6 (c 2.0, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.92 (d, J = 6.8 Hz, 3H, 2’-H), 1.03 (d, J = 6.8 Hz, 
3H, 2-CH3), 1.31 (s, 3H, C(CH3)2), 1.39 (s, 3H, C(CH3)2), 1.80–2.01 (m, 3H, 1’-H, 3-H, 2-H), 
3.05–3.09 (m, 1H, 1-H), 3.43–3.55 (m, 2H, 4-H), 3.61 (dd, J = 7.7, 7.7 Hz, 1H, 5’’-H), 3.78 (s, 
3H, OCH3), 3.86 (s, 6H, OCH3), 3.89–3.94 (m, 1H, 5’’-H), 4.02–4.09 (m, 1H, 4’’-H), 4.37–
4.43 (m, 4H, CH2 of DMB and PMB), 6.79–6.91 (m, 5H, aryl H), 7.24 (d, J = 8.3 Hz, 2H, aryl 
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H); 13C NMR (100 MHz, CDCl3): δ = 10.8 (C-2’), 16.6 (2-CH3), 25.3 (C(CH3)2), 26.7 
(C(CH3)2), 32.4 (C-2), 32.9 (C-3), 38.5 (C-1’), 55.3 (OCH3), 55.8 (OCH3), 55.9 (OCH3), 67.9 
(C-5’’), 68.5 (C-4), 72.8 (CH2 of DMB), 73.3 (CH2 of PMB), 78.3 (C-1), 83.7 (C-4’’), 108.5 
(C(CH3)2), 110.8, 110.9, 113.7, 113.9, 128.6, 129.0, 130.9, 131.1, 148.5, 149.0, 159.0 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C29H42NaO7: 525.28227, found 525.28224. 
 
 
(2R,3R,4R,5R)-7-[(3,4-Dimethoxybenzyl)oxy]-4-[(4-methoxybenzyl)oxy]-3,5-
dimethylheptane-1,2-diol (3-54) 
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CuCl2·2H2O (3.07 g, 18.0 mmol, 10 equiv) was added to a solution of acetal 3-53 (0.92 g, 1.8 
mmol) in CH3CN (50 mL) at –10 °C. The reaction mixture was stirred for 20 h at –5 °C, 
treated with saturated NH4Cl solution (20 mL), and extracted with EtOAc (3 × 50 mL). The 
combined organic layers were washed with water, saturated NH4Cl solution and saturated 
NaCl solution, and dried over MgSO4. After filtration, the solvent was removed under reduced 
pressure, and the residue purified by flash chromatography (petroleum ether/EtOAc, 
2:1→1:1→0:1) to give diol 3-54 (0.76 g, 91%) as a colorless oil. Rf = 0.38 (petroleum 
ether/EtOAc, 1:1); [α]20D = –4.1 (c 1.5, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.92–0.96 
(m, 6H, 3-CH3, 5-CH3), 1.40–1.51 (m, 1H, 6-H), 1.76–1.87 (m, 2H, 5-H, 6-H), 1.88–1.97 (m, 
1H, 3-H), 2.19 (br s, 1H, OH), 3.02 (br s, 1H, OH), 3.37–3.40 (m, 1H, 4-H), 3.43–3.55 (m, 4H, 
7-H, 1-H, 2-H), 3.75–3.83 (m, 4H, 1-H, OCH3), 3.83–3.87 (m, 6H, OCH3), 4.38–4.46 (m, 3H, 
CH2 of DMB, CH2 of PMB), 4.57 (d, J = 10.9 Hz, 1H, CH2 of PMB), 6.79–6.88 (m, 5H, aryl 
H), 7.24 (d, J = 8.6 Hz, 2H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 8.7 (3-CH3), 16.4 (5-
CH3), 32.4 (C-5), 32.4 (C-6), 36.7 (C-3), 55.2 (OCH3), 55.8 (OCH3), 55.9 (OCH3), 65.1 (C-1), 
68.3 (C-7), 72.8 (CH2 of DMB), 73.0 (CH2 of PMB), 86.2 (C-2), 110.8, 111.1, 113.8, 120.2, 
129.2, 130.3, 130.9, 148.5, 148.9, 159.2 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C26H38NaO7: 485.25097, found 485.25080. 
 
 
(2R)-2-{(1S,2R,3R)-5-[(3,4-Dimethoxybenzyl)oxy]-2-[(4-methoxybenzyl)oxy]-1,3-
dimethylpentyl}oxirane (3-55) 
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To a solution of diol 3-54 (694 mg, 1.5 mmol) in THF (20 mL) at 0 °C was added NaH (60% 
wt. in mineral oil, 180 mg, 4.5 mmol, 3.0 equiv). The resulting mixture was warmed to room 
temperature and stirred for 40 min. The mixture was cooled to 0 °C before N-(2,4,6-
triisopropylbenzenesulfonyl)imidazole (3-41) (552 mg, 1.65 mmol, 1.1 equiv) was added in 
one portion. The reaction mixture was then allowed to warm to room temperature and stirred 
for 1 h. The mixture was diluted with water (10 mL) and extracted with Et2O (3 × 50 mL). The 
combined organic layers were washed with saturated NaCl solution (30 mL), dried over 
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MgSO4, filtered, and concentrated in vacuo. Flash chromatography (ethyl acetate/petroleum 
ether, 1:10) provided epoxide 3-55 (612 mg, 2.58 mmol, 92% yield) as a colorless oil. Rf = 
0.21 (petroleum ether/EtOAc, 4:1); [α]20D = +2.0 (c 1.5, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.91 (d, J = 6.8 Hz, 3H, 2’-H), 1.09 (d, J = 6.8 Hz, 3H, 2-CH3), 1.38–1.53 (m, 2H, 
3-H, 1’-H), 1.88–2.01 (m, 2H, 3-H, 2-H), 2.53–2.57 (m, 1H, 3’’-H), 2.68–2.72 (m, 1H, 3’’-H), 
2.82–2.87 (m, 1H, 2’’-H), 3.17–3.21 (m, 1H, CH(OPMB)), 3.42–3.56 (m, 2H, CH2ODMB), 
3.78 (s, 3H, OCH3), 3.85–3.88 (m, 6H, OCH3), 4.41 (dd, J = 17.9, 11.6 Hz, 2H, CH2 of DMB), 
4.50 (dd, J = 17.7, 10.9 Hz, 2H, CH2 of DMB), 6.79–6.89 (m, 5H, aryl H), 7.25 (d, J = 8.6 Hz, 
2H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 12.1 (C-2’), 16.7 (2-CH3), 32.0 (C-3), 32.9 (C-
2), 39.2 (C-1’), 47.3 (C-3’’), 55.2 (C-2’’), 55.8 (OCH3), 55.9 (OCH3), 68.4 (CH2ODMB), 72.8 
(CH2 of DMB), 74.1 (CH2 of PMB), 85.6 (CH(OPMB)), 110.8, 110.9, 113.7, 120.1, 129.1, 
130.8, 131.1, 148.5, 148.9, 159.1 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C26H36NaO6: 467.24041, found 467.24024. 
 
 
(4S,5R,6R,7R)-9-[(3,4-Dimethoxybenzyl)oxy]-6-[(4-methoxybenzyl)oxy]-5,7-dimethyl-1-
(triisopropylsilyl)non-1-yn-4-ol (3-56) 
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nBuLi (0.73 mL, 2.5 M in hexane, 1.83 mmol) was added to a solution of 
(triisopropylsilyl)acetylene (0.43 mL, 1.91 mmol) in THF (2 mL) at –78 °C in a dropwise 
fashion. The acetylide solution was stirred at –78 °C for 1 h before a solution of BF3·OEt2 
(0.46 mL, 3.8 mmol) was added. Stirring was continued for 50 min at –78 °C. Then, a solution 
of epoxide 3-55 (0.28 g, 0.63 mmol) in THF (1 mL) was added dropwise. The reaction was 
stirred at –78 °C for 25 min and then quenched with saturated NH4Cl solution. The layers 
were separated and the aqueous layer was extracted twice with Et2O. The combined organic 
extracts were dried (MgSO4), filtered, and concentrated in vacuo to afford an oil, which was 
purified by flash chromatography (petroleum ether/EtOAc, 4:1) to furnish alcohol 3-56 (0.315 
g) in 80% yield. Rf = 0.63 (petroleum ether/EtOAc, 2:1); [α]20D = –20.9 (c 1.6, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.90–0.96 (m, 6H, 7-CH3, 5-CH3), 0.99–1.09 (m, 21H, 
Si(CH(CH3)2), 1.40–1.51 (m, 1H, 8-H), 1.91–2.01 (m, 1H, 8-H), 2.04–2.16 (m, 2H, 5-H, 7-H), 
2.33–2.52 (m, 2H, 3-H), 3.05 (br s, 1H, OH), 3.36–3.41 (m, 1H, 6-H), 3.45–3.58 (m, 2H, 9-H), 
3.77 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 3.88–3.94 (m, 1H, 4-H), 4.38–4.47 (m, 3H, CH2 of 
DMB, CH2 of PMB), 4.59 (d, J = 10.4 Hz, 1H, CH2 of PMB), 6.79–6.89 (m, 5H, aryl H), 7.24 
(d, J = 8.3 Hz, 2H, aryl H); 13C NMR (100 MHz, CDCl3): δ = 6.8 (5-CH3), 11.1 (CH(CH3)2), 
16.0 (7-CH3), 18.6 (CH(CH3)2), 25.9 (C-3), 32.5 (C-8), 32.6 (C-7), 37.1 (C-5), 55.2 (OCH3), 
55.7 (OCH3), 55.8 (OCH3), 68.2 (C-9), 72.7 (C-4), 73.1 (CH2 of DMB), 82.6 (C-6), 87.4 (C-
1), 105.2 (C-2), 110.8, 110.9, 113.8, 120.1, 129.3, 130.2, 131.0, 148.5, 148.9, 159.2 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C37H58NaO6Si: 649.38949, found 649.38966. 
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tert-Butyl[((1S)-1-{(1S,2R,3R)-5-[(3,4-dimethoxybenzyl)oxy]-2-[(4-methoxybenzyl)oxy]-
1,3-dimethylpentyl}but-3-ynyl)oxy]dimethylsilane (3-58) 
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a)  TIPS deprotection: To a solution of alcohol 3-56 (0.30 g, 0.48 mmol) in THF (1 mL) 
was added TBAF (1 mL, 1 M in THF, 1.0 mmol) at 0 °C (ice bath). The reaction mixture was 
allowed to warm to room temperature and stirred for 12 h. After addition of saturated NH4Cl 
solution the mixture was extracted with EtOAc (3 × 30 mL). The combined organic layers were 
washed with saturated NaCl solution (20 mL), dried over MgSO4, filtered, and concentrated in 
vacuo. Flash chromatography (petroleum ether/EtOAc, 4:1→2:1) afforded terminal alkyne 3-57 
(221 mg, 98% yield) which was used directly in the next step. TLC (petroleum ether/EtOAc, 
2:1), Rf = 0.46. 
b)  TBS protection: A solution of alkyne 3-57 (0.217 g, 0.46 mmol) in CH2Cl2 (4 mL) 
was cooled to –50 °C. Then 2,6-lutidine (0.214 mL, 1.84 mmol) followed by TBSOTf (0.211 
mL, 0.92 mmol) were added. The reaction mixture was allowed to warm to room temperature 
and stirred for 2 h. The mixture was treated with water and extracted with CH2Cl2. The 
combined organic extracts were washed with 1N HCI, saturated NaHCO3 and saturated NaCl 
solution, dried over MgSO4, filtered, and concentrated in vacuo. Flash chromatography 
(petroleum ether/EtOAc, 10:1) afforded silyl ether 3-58 (0.247 g, 92% yield) as a colorless oil. 
Rf = 0.57 (petroleum ether/EtOAc, 4:1); [α]20D = –1.8 (c 1.2, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.05 (m, 3H, Si(CH3)2), 0.07 (m, 3H, Si(CH3)2), 0.91 (s, 9H, 
Si(C(CH3)3)), 0.98–1.03 (m, 6H, 3-CH3, 5-CH3), 1.44–1.51 (m, 1H, 2-H), 1.89–2.13 (m, 4H, 
2-H, 3-H, 9-H, 5-H), 2.28–2.43 (m, 2H, 7-H), 3.25–3.31 (m, 1H, 4-H), 3.48–3.57 (m, 2H, 1-
H), 3.77–3.89 (m, 10H, 6-H, OCH3), 4.38–4.56 (m, 4H, CH2 of DMB and PMB), 6.80–6.91 
(m, 5H, aryl H), 7.26 (d, J = 8.6 Hz, 2H, aryl H); 13C NMR (100 MHz, CDCl3): δ = –4.7 
(Si(CH3)2), –4.2 (Si(CH3)2), 9.8 (5-CH3), 17.2 (3-CH3), 18.0 (Si(C(CH3)3)), 24.5 (C-7), 25.8 
(Si(C(CH3)3)), 30.8 (C-2), 32.3 (C-3), 39.7 (C-5), 55.2 (OCH3), 55.7 (OCH3), 55.8 (OCH3), 
68.4 (C-1), 70.2 (C-9), 71.8 (C-6), 72.5 (CH2 of DMB), 74.1 (CH2 of DMB), 81.8 (C-8), 84.3 
(C-4), 110.8, 110.9, 113.6, 120.0, 128.9, 131.2, 131.3, 148.3, 148.9, 158.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C34H52NaO6Si: 607.34254, found 607.34227. 
 
 
(5S,6R,7R,8R)-10-[(3,4-Dimethoxybenzyl)oxy]-7-[(4-methoxybenzyl)oxy]-6,8-
dimethyldec-2-yn-5-ol (3-60) 
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a)  Methylation: To a solution of alkyne 3-58 (210 mg, 0.36 mmol) in THF (5 mL) was 
added nBuLi (26 µL, 2.5 M solution in hexane, 0.65 mmol, 1.8 equiv) dropwise at –78 °C. 
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Stirring was continued for 1 h at –78 °C before methyl iodide (140 µL, 2.2 mmol) was added 
at –78 °C. The reaction mixture was allowed to warm to room temperature over 4 h. After 
quenching with water (3 mL), all volatiles were removed in vacuo and the residue was 
extracted with Et2O (3 × 30 mL). The combined organic layers were washed with saturated 
NaCl solution (20 mL), dried over MgSO4, filtered, and concentrated in vacuo to furnish the 
propyne derivative 3-59 (213 mg, 99% yield), which was used directly in the next step. TLC 
(petroleum ether/EtOAc, 4:1), Rf = 0.62. 
b)  TBS deprotection: To a solution of silyl ether 3-59 (209 mg, 0.35 mmol) in THF (1 
mL) was added TBAF (1.5 mL, 1 M in THF) at 0 °C (ice bath). The reaction mixture was 
allowed to warm to room temperature and stirred for 12 h. After addition of saturated NH4Cl 
solution the mixture was extracted with EtOAc (3 × 30 mL). The combined organic layers 
were washed with saturated NaCl solution (20 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc, 2:1→1:1) afforded 
alcohol 3-60 (166 mg, 98% yield) as a colorless oil. Rf = 0.54 (petroleum ether/EtOAc, 2:1); 
[α]20D = –20.0 (c 1.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.90–0.98 (m, 6H, 3-CH3, 6-
CH3), 1.42–1.53 (m, 1H, 2-H), 1.75–1.78 (m, 3H, 10-H), 1.90–2.08 (m, 3H, 2-H, 3-H, 5-H), 
2.21–2.39 (m, 2H, 7-H), 3.36–3.41 (m, 1H, 4-H), 3.49–3.59 (m, 2H, 1-H), 3.78 (s, 3H, OCH3), 
3.82–3.87 (m, 7H, 6-H, OCH3), 4.39–4.48 (m, 3H, CH2 of DMB and PMB), 4.57 (d, J = 10.6 
Hz, 1H, CH2 of PMB), 6.80–6.90 (m, 5H, aryl H), 7.24 (d, J = 7.1 Hz, 2H, aryl H); 13C NMR 
(100 MHz, CDCl3): δ = 3.5 (C≡CCH3), 7.4 (5-CH3), 16.3 (3-CH3), 25.0 (C-7), 32.3 (C-2), 32.6 
(C-3), 37.8 (C-5), 55.2 (OCH3), 55.8 (OCH3), 55.9 (OCH3), 68.4 (C-1), 72.8 (CH2 of DMB), 
73.1 (CH2 of DMB), 73.9 (C-6), 75.8 (C-8), 77.7 (C-9), 86.8 (C-4), 110.8, 111.0, 113.8,120.2, 
129.3, 130.4, 131.0, 148.5, 149.0, 159.2 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C29H40NaO6: 507.27171, found 507.27139. 
 
 
Ester 3-64 
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A solution of alcohol 3-60 (26 mg, 0.053 mmol) in anhydrous DMF (0.5 mL) was stirred in 
the presence of sodium hydride (60% wt. in mineral oil, 2.5 mg, 0.064 mmol, 1.2 equiv) at 0 
°C for 10 min and for a further 1 h at room temperature. In a separate flask, to a solution of 
acid 3-50 (42 mg, 0.09 mmol) in anhydrous DMF (0.7 mL) was added CDI (18 mg, 0.11 
mmol), and the reaction mixture allowed to stir for 4 h at 50 °C. Then, the solution of the 
imidazolide derivative of acid 3-63 (analyzed by LC-MS) was cooled to 0 °C and added to the 
above solution of the sodium salt of alcohol 3-60 at 0 °C. The mixture was allowed to warm to 
room temperature and stirred for 3 days. After addition of saturated NH4Cl solution the 
mixture was extracted with EtOAc (3 × 30 mL). The combined organic extracts were washed 
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with 1N HCI, saturated NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered and 
concentrated in vacuo to provide ester 3-64 (17 mg, 35% yield) as a colorless oil. Rf = 0.35 
(petroleum ether/EtOAc, 4:1); [α]20D = +6.8 (c 1.4, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
0.95–1.03 (m, 27H, 3’’’-CH3, 1’’’-CH3, Si(CH(CH3)2)3), 1.06 (d, J = 6.6 Hz, 3H, 3’-CH3), 
1.46–1.55 (m, 1H, 4’’’-H), 1.72 (s, 3H, C≡CCH3), 1.75 (s, 3H, C≡CCH3), 1.87–2.09 (m, 4H, 
4’’’-H, 3’’’-H, 3’-H, 4’-H), 2.12–2.22 (m, 1H, 4’-H), 2.30–2.39 (m, 1H, 1’’’-H), 2.57–2.74 
(m, 4H, 2’’-H, 1’-H), 3.28–3.33 (m, 1H, CH(OPMB)), 3.46–3.59 (m, 2H, CH2ODMB), 3.74 
(s, 3H, OCH3), 3.77–3.79 (m, 6H, OCH3), 3.85–3.88 (m, 6H, OCH3), 4.24–4.31 (m, 1H, 
CH(OTIPS)), 4.38–4.54 (m, 4H, CH2 of DMB and PMB), 5.10–5.16 (m, 1H, 1’’-H), 6.30 (s, 
1H, 5-H), 6.50 (s, 1H, 3-H), 6.79–6.90 (m, 5H, aryl H), 7.25 (d, J = 8.6 Hz, 2H, aryl H of 
PMB); 13C NMR (100 MHz, CDCl3): δ = 3.5 (C≡CCH3), 3.6 (C≡CCH3), 10.0 (1’’’-CH3), 12.9 
(CH(CH3)2), 14.6 (3’-CH3), 17.2 (3’’’-CH3), 18.1 (CH(CH3)2), 18.2 (CH(CH3)2), 22.1 
(C≡CCH2), 22.2 (C≡CCH2), 31.2 (C-4’’’), 32.9 (C-3’’’), 36.2 (C-1’), 37.5 (C-1’’’), 38.8 (C-
3’), 55.3 (OCH3), 55.6 (OCH3), 55.8 (OCH3), 55.9 (OCH3), 68.8 (C-5’’’), 72.6 (CH2 of DMB), 
74.1 (CH3C≡C), 74.6 (CH3C≡C), 75.3 (C-2’), 76.6 (CH2C≡C), 78.0 (CH2C≡C), 78.1 (C-1’’), 
83.9 (C-2’’’), 96.7 (C-3), 106.9 (C-5), 110.8 (ar of DMB), 110.9 (ar of DMB), 113.7, 117.7 
(C-1), 120.1 (ar of DMB),  128.9, 131.1, 131.3 (ar of DMB), 139.1 (C-6), 148.4 (ar of DMB), 
148.9 (ar of DMB), 157.8 (C-4), 159.0, 160.8 (C-2), 167.8 (CO2R); 
HRMS (ESI): [M+Na]+ calcd for C55H80NaO10Si: 951.54130, found 951.54063. 
 
 
(2R,3R,4R,5R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-7-[(3,4-dimethoxybenzyl)oxy]-3,5-
dimethylheptane-1,2-diol (3-65) 
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CuCl2·2H2O (7.31 g, 43.0 mmol, 10 equiv) was added to a solution of acetal 3-51 (2.14 g, 4.3 
mmol) in CH3CN (100 mL) at –10 °C. The reaction mixture was stirred for 20 h at –5 °C, 
treated with saturated NH4Cl solution (20 mL), and extracted with EtOAc (3 × 50 mL). The 
combined organic layers were washed with water, saturated NH4Cl solution and saturated 
NaCl solution, and dried over MgSO4. After filtration, the solvent was removed under reduced 
pressure, and the residue purified by flash chromatography (petroleum ether/EtOAc, 2:1→1:1) 
to give diol 3-65 (1.89 g, 96%) as a colorless oil. Rf = 0.61 (petroleum ether/EtOAc, 1:1); 
[α]20D = +1.5 (c 2.5, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.04 (s, 6H, Si(CH3)2), 0.84–
0.93 (m, 15H, Si(C(CH3)3), 3-CH3, 5-CH3), 1.26–1.38 (m, 1H, 6-H), 1.63–1.71 (m, 1H, 5-H), 
1.76–1.97 (m, 2H, 6-H, 3-H), 2.71 (br s, 2H, OH), 3.38–3.55 (m, 5H, 7-H, 4-H, 1-H, 2-H), 
3.61 (dd, J = 3.5, 3.5 Hz, 1H, 1-H), 3.86 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 4.41 (dd, J = 
20.7, 11.6 Hz, 2H, CH2 of DMB), 6.79–6.88 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ 
= –4.3 (Si(CH3)2), –3.9 (Si(CH3)2), 10.4 (3-CH3), 17.7 (5-CH3), 18.2 (Si(C(CH3)3)), 26.0 
(Si(C(CH3)3)), 32.6 (C-5), 34.1 (C-6), 38.8 (C-3), 55.8 (OCH3), 55.9 (OCH3), 65.4 (C-1), 68.4 
(C-7), 73.0 (CH2 of DMB), 78.0 (C-2), 110.8, 111.1, 120.3, 130.7, 148.6, 149.0 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C24H44NaO6Si: 479.2799, found 479.2801. 
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tert-Butyl[((1R,2R)-4-[(3,4-dimethoxybenzyl)oxy]-2-methyl-1-{(1R)-1-[(2R)-oxiran-2-
yl]ethyl}butyl)oxy]-dimethylsilane (3-66) 
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To a solution of diol 3-65 (1.23 g, 2.7 mmol) in THF (50 mL) at 0 °C was added NaH (60% 
wt. in mineral oil, 0.324 g, 8.1 mol, 3.0 equiv). The resulting mixture was warmed to room 
temperature and stirred for 40 min. The mixture was cooled to 0 °C before N-(2,4,6-
triisopropylbenzenesulfonyl)imidazole (3-41) (1.0 g, 3.0 mmol, 1.1 equiv) was added in one 
portion. The reaction mixture was then allowed to warm to room temperature and stirred for 1 
h. The mixture was diluted with water (20 mL) and extracted with Et2O (3 × 50 mL). The 
combined organic layers were washed with saturated NaCl solution (30 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. Flash chromatography (ethyl acetate/petroleum 
ether, 1:10) provided epoxide 3-66 (1.132 g, 2.58 mmol, 96% yield) as a colorless oil. Rf = 
0.49 (petroleum ether/EtOAc, 4:1); [α]20D = +4.4 (c 1.7, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.03 (s, 3H, Si(CH3)2), 0.05 (s, 3H, Si(CH3)2), 0.85–0.93 (m, 12H, Si(C(CH3)3), 
2’-H), 1.04 (d, J = 6.8 Hz, 3H, 2-CH3), 1.28–1.38 (m, 2H, 3-H, 1’-H), 1.76–1.85 (m, 2H, 3-H, 
2-H), 2.50–2.54 (m, 1H, 3’’-H), 2.69–2.73 (m, 1H, 3’’-H), 2.78–2.83 (m, 1H, 2’’-H), 3.38-
3.54 (m, 3H, CH2ODMB, CH(OTBS)), 3.85 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 4.41 (dd, J = 
20.0, 11.6 Hz, 2H, CH2 of DMB), 6.78–6.88 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ 
= –4.2 (Si(CH3)2), –3.8 (Si(CH3)2), 13.0 (C-2’), 16.8 (2-CH3), 18.3 (Si(C(CH3)3)), 26.0 
(Si(C(CH3)3)), 32.1 (C-3), 34.5 (C-2), 40.3 (C-1’), 47.6 (C-3’’), 55.7 (C-2’’), 55.9 (2C, 
OCH3), 68.5 (CH2ODMB), 72.8 (CH2 of DMB), 77.9 (CH(OTBS)), 110.8, 110.9, 120.1, 
131.1, 148.4, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C24H42NaO5Si: 461.2694, found 461.2696 
 
 
(4S,5R,6R,7R)-6-{[tert-Butyl(dimethyl)silyl]oxy}-9-[(3,4-dimethoxybenzyl)oxy]-5,7-
dimethyl-1-(trimethylsilyl)non-1-yn-4-ol (3-67) 
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nBuLi (0.96 mL, 2.5 M in hexane, 2.4 mmol) was added to a solution of 
(trimethylsilyl)acetylene (0.34 mL, 2.4 mmol) in THF (10 mL) at –78 °C in a dropwise 
fashion. The acetylide solution was stirred at –78 °C for 1 h before a solution of BF3·OEt2 
(0.304 mL, 2.4 mmol) was added. Stirring was continued for 50 min at –78 °C. Then, a 
solution of epoxide 3-66 (0.526 g, 1.2 mmol) in THF (1 mL) was added dropwise. The 
reaction was stirred at –78 °C for 10 min and then quenched with saturated NH4Cl solution. 
The layers were separated and the aqueous layer was extracted twice with Et2O. The combined 
organic extracts were dried (MgSO4), filtered, and concentrated in vacuo to afford an oil, 
which was purified by flash chromatography (petroleum ether/EtOAc, 4:1) to furnish alcohol 
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3-67 (0.532 g) in 83% yield. Rf = 0.64 (petroleum ether/EtOAc, 2:1); [α]20D = –8.1 (c 2.5, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.05 (s, 6H, Si(CH3)2), 0.12 (s, 9H, Si(CH3)3), 
0.85–0.93 (m, 15H, Si(C(CH3)3), 7-CH3, 5-CH3), 1.30–1.41 (m, 1H, 8-H), 1.72–1.81 (m, 1H, 
8-H), 1.85–1.93 (m, 2H, 5-H, 7-H), 2.38–2.42 (m, 2H, 3-H), 3.40–3.53 (m, 2H, 9-H), 3.63–
3.67 (m, 1H, 6-H), 3.78–3.84 (m, 1H, 4-H), 3.85 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 4.41 (dd, 
J = 21.2, 11.6 Hz, 2H, CH2 of DMB), 6.78–6.88 (m, 3H, aryl H); 13C NMR (100 MHz, 
CDCl3): δ = –4.4 (Si(CH3)2), –3.7 (Si(CH3)2), 0.0 (Si(CH3)3), 8.9 (5-CH3), 16.4 (7-CH3), 18.2 
(Si(C(CH3)3)), 26.0 (Si(C(CH3)3)), 26.4 (C-3), 32.7 (C-8), 35.0 (C-7), 39.0 (C-5), 55.7 
(OCH3), 55.8 (OCH3), 68.4 (C-9), 72.4 (C-4), 72.8 (CH2 of DMB), 78.1 (C-6), 87.0 (C-1), 
103.7 (C-2), 110.8, 110.9, 120.1, 131.0, 148.5, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C29H52NaO5Si2: 559.3246, found 559.3247. 
 
 
((4S,5R,6R,7R)-6-{[tert-Butyl(dimethyl)silyl]oxy}-9-[(3,4-dimethoxybenzyl)oxy]-5,7-
dimethylnon-1-yn-4-ol (3-68) 
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To a solution of alcohol 3-67 (0.53 g, 0.99 mmol) in methanol (20 mL) was added anhydrous 
K2CO3 (0.69 g, 5 mmol). The reaction mixture was stirred at room temperature for 3 h, then 
diluted with water (10 mL) and extracted with Et2O (3 × 50 mL). The combined organic layers 
were washed with saturated NaCl solution (20 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. Flash chromatography of the residue (ethyl acetate/petroleum ether, 
1:4) provided alcohol 3-68 (0.458 g, 99% yield) as a colorless oil. Rf = 0.58 (petroleum 
ether/EtOAc, 2:1); [α]20D = –5.9 (c 2.9, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.05 (s, 6H, 
Si(CH3)2), 0.86–0.94 (m, 15H, Si(C(CH3)3), 7-CH3, 5-CH3), 1.32–1.41 (m, 1H, 8-H), 1.73–
1.82 (m, 1H, 8-H), 1.83–1.94 (m, 2H, 5-H, 7-H), 1.98 (dd, J = 2.5, 2.5 Hz, 1H, 1-H), 2.28–
2.41 (m, 2H, 3-H), 2.55 (d, J = 3.0 Hz, 1H, OH), 3.39–3.54 (m, 2H, 9-H), 3.64–3.69 (m, 1H, 
6-H), 3.83–3.89 (m, 7H, 4-H, OCH3), 4.42 (dd, J = 22.2, 11.6 Hz, 2H, CH2 of DMB), 6.79–
6.88 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ = –4.4 (Si(CH3)2), –3.7 (Si(CH3)2), 8.9 
(5-CH3), 16.7 (7-CH3), 18.2 (Si(C(CH3)3)), 25.0 (C-3), 26.0 (Si(C(CH3)3)), 32.7 (C-8), 34.8 
(C-7), 39.3 (C-5), 55.8 (OCH3), 55.9 (OCH3), 68.4 (C-9), 70.3 (C-1), 72.2 (C-4), 72.9 (CH2 of 
DMB), 78.3 (C-6), 81.4 (C-2), 110.8, 111.0, 120.2, 130.9, 148.5, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C26H44NaO5Si: 487.2850, found 487.2849. 
 
 
4-[({(3R,4R,5R,6S)-4,6-Bis{[tert-butyl(dimethyl)silyl]oxy}-3,5-dimethyl-8-
nonynyl}oxy)methyl]-1,2-bis(methyloxy)benzene (3-69) 
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A solution of alcohol 3-68 (0.456 g, 0.98 mmol) in CH2Cl2 (5 mL) was cooled to –50 °C. Then 
2,6-lutidine (0.341 ml, 2.94 mmol) followed by TBSOTf (0.296 ml, 1.27 mmol) were added. 
The reaction mixture was allowed to warm to room temperature and stirred for 2 h. The 
mixture was treated with water and extracted with CH2Cl2. The combined organic extracts 
were washed with 1N HCI, saturated NaHCO3 and saturated NaCl solution, dried over 
MgSO4, filtered, and concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc, 
20:1) afforded bis-silyl ether 3-69 (0.538 g, 95% yield) as a colorless oil. Rf = 0.70 (petroleum 
ether/EtOAc, 4:1); [α]20D = +8.4 (c 2.2, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.01–0.09 
(m, 12H, Si(CH3)2), 0.86–0.95 (m, 24H, Si(C(CH3)3), 3-CH3, 5-CH3), 1.31–1.41 (m, 1H, 2-H), 
1.75–1.89 (m, 2H, 2-H, 3-H), 1.91 (dd, J = 2.5, 2.5 Hz, 9-H), 1.93–2.01 (m, 1H, 5-H), 2.27–
2.43 (m, 2H, 7-H), 3.40–3.55 (m, 3H, 1-H, 4-H), 3.74–3.81 (m, 1H, 6-H), 3.86 (s, 1H, OCH3), 
3.87 (s, 1H, OCH3), 4.43 (dd, J = 27.3, 11.6 Hz, 2H, CH2 of DMB), 6.79–6.90 (m, 3H, aryl 
H); 13C NMR (100 MHz, CDCl3): δ = –4.6 (Si(CH3)2), –4.2 (Si(CH3)2), –3.6 (Si(CH3)2), –3.4 
(Si(CH3)2), 10.4 (5-CH3), 17.5 (3-CH3), 18.1 (Si(C(CH3)3)), 18.5 (Si(C(CH3)3)), 25.4 (C-7), 
25.9 (Si(C(CH3)3)), 26.2 (Si(C(CH3)3)), 31.0 (C-2), 34.1 (C-3), 40.2 (C-5), 55.8 (OCH3), 55.9 
(OCH3), 68.8 (C-1), 70.3 (C-9), 71.8 (C-6), 72.6 (CH2 of DMB), 76.7 (C-4), 81.5 (C-8), 110.8, 
110.9, 120.1, 131.3, 148.4, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C32H58NaO5Si2: 601.3715, found 601.3718. 
 
 
4-[({(3R,4R,5R)-4,6-Bis{[tert-butyl(dimethyl)silyl]oxy}-3,5-dimethyl-8-
decynyl}oxy)methyl]-1,2-bis(methyloxy)benzene (3-70) 
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To a solution of alkyne 3-69 (0.508 g, 0.88 mmol) in THF (5 mL) was added nBuLi (0.63 mL, 
2.5 M solution in hexane, 1.58 mmol, 1.8 equiv) dropwise at –78 °C. Stirring was continued 
for 1 h at –78 °C before methyl iodide (0.274 mL, 4.4 mmol) was added at –78 °C. The 
reaction mixture was allowed to warm to room temperature over 4 h. After quenching with 
water (3 mL), all volatiles were removed in vacuo and the residue was extracted with Et2O (3 
× 30 mL). The combined organic layers were washed with saturated NaCl solution (20 mL), 
dried over MgSO4, filtered, and concentrated in vacuo to furnish the propyne derivative 3-70 
(0.532 g, 99% yield). Rf = 0.75 (petroleum ether/EtOAc, 4:1); [α]20D = +3.4 (c 2.6, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.01–0.08 (m, 12H, Si(CH3)2), 0.85–0.95 (m, 24H, 
Si(C(CH3)3), 3-CH3, 5-CH3), 1.32–1.45 (m, 1H, 2-H), 1.73 (dd, J = 2.3, 2.3 Hz, 3H, C≡CCH3), 
1.77–1.89 (m, 2H, 2-H, 3-H), 1.90–1.97 (m, 1H, 5-H), 2.21–2.35 (m, 2H, 7-H), 3.41–3.55 (m, 
3H, 1-H, 4-H), 3.68–3.76 (m, 1H, 6-H), 3.86 (s, 1H, OCH3), 3.87 (s, 1H, OCH3), 4.42 (dd, J = 
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24.5, 11.6 Hz, 2H, CH2 of DMB), 6.79–6.90 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ 
= –4.6 (Si(CH3)2), –4.2 (Si(CH3)2), –3.6 (Si(CH3)2), –3.4 (Si(CH3)2), 3.5 (C≡CCH3), 10.5 (5-
CH3), 17.6 (3-CH3), 18.1 (Si(C(CH3)3)), 18.5 (Si(C(CH3)3)), 25.7 (C-7), 25.9 (Si(C(CH3)3)), 
26.2 (Si(C(CH3)3)), 30.8 (C-2), 34.1 (C-3), 40.2 (C-5), 55.8 (OCH3), 55.9 (OCH3), 69.0 (C-1), 
72.4 (C-6), 72.6 (CH2 of DMB), 76.4 (C-8), 76.8 (C-4), 77.4 (C-9), 110.8, 110.9, 120.0, 131.3, 
148.4, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C33H60NaO5Si2: 615.3872, found 615.3870. 
 
 
(3R,4R,5R,6S)-1-[(3,4-Dimethoxybenzyl)oxy]-3,5-dimethyldec-8-yne-4,6-diol (3-71) 
 
HO OH
O
OMe
OMe
Me
146
8
9
 
 
To a solution of silyl ether 3-70 (0.517 mg, 0.87 mmol) in THF (3 mL) was added TBAF (4.35 
mL, 1 M in THF) at 0 °C (ice bath). The reaction mixture was allowed to warm to room 
temperature and stirred for 12 h. After addition of saturated NH4Cl solution the mixture was 
extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with saturated 
NaCl solution (20 mL), dried over MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography (petroleum ether/EtOAc, 2:1→1:1) afforded diol 3-71 (0.314 g, 99% yield) as 
a colorless oil. Rf = 0.37 (petroleum ether/EtOAc, 2:1); [α]20D = –10.0 (c 2.2, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.80–0.90 (m, 6H, 3-CH3, 6-CH3), 1.65–1.80 (m, 6H, 2-H, 
10-H, 3-H), 1.82–1.90 (m, 1H, 5-H), 2.20–2.43 (m, 2H, 7-H), 3.42–3.51 (m, 3H, 1-H, 4-H), 
3.84–3.93 (m, 7H, 6-H, OCH3), 4.44 (s, 2H, CH2 of DMB), 6.79–6.87 (m, 3H, aryl H); 
13C NMR (100 MHz, CDCl3): δ = 3.5 (C≡CCH3), 15.2 (5-CH3), 17.4 (3-CH3), 24.8 (C-7), 34.4 
(C-2), 35.5 (C-3), 36.5 (C-5), 55.8 (OCH3), 55.9 (OCH3), 68.2 (C-1), 73.2 (CH2 of DMB), 75.7 
(C-6), 75.9 (C-8), 77.3 (C-9), 80.9 (C-4), 110.9, 111.0, 120.4, 129.9, 148.7, 149.0 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C21H32NaO5: 387.2142, found 387.2145. 
 
 
Ester 3-73 
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A solution of diol 3-71 (296 mg, 0.81 mmol) in anhydrous DMF (1.5 mL) was stirred in the 
presence of sodium hydride (60% wt. in mineral oil, 81 mg, 2.03 mmol, 2.5 equiv) at 0 °C for 
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10 min and for a further 1 h at room temperature. In a separate flask, to a solution of acid 3-50 
(595 mg, 1.29 mmol) in anhydrous DMF (1.7 mL) was added CDI (260 mg, 1.55 mmol), and 
the reaction mixture allowed to stir for 4 h at 50 °C. Then, the solution of the imidazolide 
derivative of acid 3-63 (analyzed by LC-MS) was cooled to 0 °C and added to the above 
solution of the disodium salt of diol 3-71 at 0 °C. The mixture was allowed to warm to room 
temperature and stirred for 3 days. After addition of saturated NH4Cl solution the mixture was 
extracted with EtOAc (3 × 30 mL). The combined organic extracts were washed with 1N HCI, 
saturated NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered and concentrated 
in vacuo to provide 0.87 g of crude hydroxyester 3-72, which was used in the next step 
without further purification. 
A solution of crude hydroxyester 3-72 (0.87 g, 0.81 mmol) in CH2Cl2 (10 mL) was cooled to –
50 °C, then 2,6-lutidine (0.58 mL, 5.0 mmol) followed by TBSOTf (0.46 mL, 2.0 mmol) were 
added. The reaction mixture was allowed to warm to room temperature and stirred for 2 h 
before it was treated with water. After separation of the layers, the aqueous layer was extracted 
with CH2Cl2. The combined organic extracts were washed with 1N HCl, saturated NaHCO3 
and saturated NaCl solution, dried over MgSO4, filtered and concentrated in vacuo. Flash 
chromatography (petroleum ether/EtOAc, 10:1→4:1) afforded ester 3-73 (0.485 g, 65% yield 
for 2 steps) as a colorless oil. Besides ester 3-73 some unreacted imidazolide derivative of acid 
3-63 (307 mg, 30%) was isolated. Rf = 0.43 (petroleum ether/EtOAc, 4:1); [α]20D = +29.3 (c 
1.5, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.02–0.09 (m, 6H, Si(CH3)2), 0.86–1.04 (m, 
39H, 3’’’-CH3, 1’’’-CH3, 3’-CH3, Si(CH(CH3)2)3), 1.31–1.44 (m, 1H, 4’’’-H), 1.73 (s, 3H, 
C≡CCH3), 1.76 (s, 3H, C≡CCH3), 1.81–1.97 (m, 3H, 4’’’-H, 3’’’-H, 3’-H), 2.00-2.09 (m, 1H, 
4’-H), 2.12–2.24 (m, 2H, 1’’’-H, 4’-H), 2.54–2.74 (m, 4H, 2’’-H, 1’-H), 3.42–3.60 (m, 3H, 
CH2ODMB, CH(OTBS)), 3.74 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.84–3.89 (m, 6H, OCH3 
of DMB), 4.23–4.31 (m, 1H, CH(OTIPS)), 4.42 (dd, J = 20.5, 11.6, 2H, CH2 of DMB), 4.99–
5.07 (m, 1H, 1’’-H), 6.29 (s, 1H, 5-H), 6.49 (s, 1H, 3-H), 6.78–6.90 (m, 3H, aryl H of DMB); 
13C NMR (100 MHz, CDCl3): δ = –3.8 (Si(CH3)2), –3.6 (Si(CH3)2), 3.5 (C≡CCH3), 3.6 
(C≡CCH3),10.5 (1’’’-CH3), 12.9 (CH(CH3)2), 14.6 (3’-CH3), 16.9 (SiC(CH3)3), 18.0 
(CH(CH3)2), 18.1 (CH(CH3)2), 18.5 (3’’’-CH3), 22.1 (C≡CCH2), 22.2 (C≡CCH2), 26.2 
(Si(C(CH3)3)), 31.8 (C-4’’’), 34.8 (C-3’’’), 36.1 (C-1’), 37.8 (C-1’’’), 38.8 (C-3’), 55.2 
(OCH3), 55.6 (OCH3), 55.8 (OCH3), 55.9 (OCH3), 68.9 (C-5’’’), 72.7 (CH2 of DMB), 74.6 
(CH3C≡C), 74.8 (CH3C≡C), 75.2 (C-2’), 76.1 (CH2C≡C), 76.6 (CH2C≡C), 77.9 (C-2’’’), 78.1 
(C-1’’), 96.6 (C-3), 106.9 (C-5), 110.8 (ar of DMB), 110.9 (ar of DMB), 117.8 (C-1), 120.1 
(ar of DMB), 131.3 (ar of DMB), 139.0 (C-6), 148.4 (ar of DMB), 148.9 (ar of DMB), 157.8 
(C-4), 160.7 (C-2), 167.4 (CO2R); 
HRMS (ESI): [M+Na]+ calcd for C53H86NaO9Si2: 945.5703, found 945.5707. 
 
 
Macrolactone 3-7444 
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To a solution of ester 3-73 (269 mg, 0.29 mmol) in toluene (33 mL) was added a solution of 
(tBuO)3W≡CCMe3 (2-34)41 (13.8 mg, 0.029 mmol) in toluene (1.0 mL) and the mixture was 
stirred at 85 °C for 2 h. For workup, the solvent was evaporated and the residue purified by 
flash chromatography (petroleum ether/EtOAc, 10:1) to give macrolactone 3-74 as an 
amorphous solid (229 mg, 91%). Rf = 0.56 (petroleum ether/EtOAc, 4:1); [α]20D = –29.3 (c 
2.9, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.02–0.09 (m, 6H, Si(CH3)2), 0.82–1.00 (m, 
39H, 18-CH3, 16-CH3, 10-CH3, Si(CH(CH3)2)3), 1.28–1.39 (m, 1H, 19-H), 1.63–1.98 (m, 5H, 
19-H, 18-H, 10-H, 11-H, 16-H), 2.09–2.19 (m, 1H, 11-H), 2.35–2.45 (m, 4H, 14-H, 8-H), 
3.34–3.54 (m, 3H, 20-H, 17-H), 3.73 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 3.84–3.89 (m, 6H, 
OCH3 of DMB), 3.96–4.02 (m, 1H, 9-H), 4.37 (dd, J = 19.7, 11.6 Hz, 2H, CH2 of DMB), 
5.38–5.52 (m, 1H, 15-H), 6.30 (s, 1H, 6-H), 6.40 (s, 1H, 4-H), 6.78–6.90 (m, 3H, ar of DMB); 
13C NMR (100 MHz, CDCl3): δ = –4.0 (Si(CH3)2), –3.6 (Si(CH3)2), 11.3 (16-CH3), 13.0 
(CH(CH3)2), 17.2 (10-CH3), 17.8 (CH(CH3)2), 18.1 (CH(CH3)2), 18.4 (18-CH3), 23.3 
(C≡CCH2), 23.5 (C≡CCH2), 26.1 (Si(C(CH3)3)), 31.7 (C-19), 34.5 (C-18), 37.5 (C-16), 38.6 
(C-8), 40.3 (C-10), 55.2 (OCH3), 55.7 (OCH3), 55.8 (OCH3), 55.8 (OCH3), 68.6 (C-20), 72.7 
(CH2 of DMB), 76.0 (C-15), 77.2 (C-17), 79.7 (C-9), 81.2 (CH2C≡C), 96.6 (C-3), 108.2 (C-6), 
110.8 (ar of DMB), 110.9 (ar of DMB), 118.1 (C-2), 120.1 (ar of DMB), 131.2 (ar of DMB), 
139.4 (C-7), 148.4 (ar of DMB), 148.9 (ar of DMB), 157.2 (C-5), 160.2 (C-3), 167.4 (CO2R); 
HRMS (ESI): [M+Na]+ calcd for C49H80NaO9Si2: 891.5233, found 891.5231. 
 
 
Cycloalkene 3-75 
 
4
OMeO
MeO
TIPSO
O
TBSO
DMBO
9
15
20
 
 
A 50 mL round-bottom flask was charged with macrolactone 3-74 (229 mg, 0.265 mmol) and 
a stir bar. EtOAc (25.0 mL) and quinoline (86 mg, 0.672 mmol) were added with stirring. This 
was followed by the addition of Lindlar’s catalyst (5 wt% Pd on CaCO3, posioned with lead 
230 mg, 100 wt%). The reaction was placed under H2 atmosphere and stirred for 4 h. The 
reaction mixture was filtered through a pad of celite and the filtrate concentrated in vacuo. The 
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residue was purified by flash chromatography (petroleum ether/EtOAc, 10:1) to give lactone 
3-75 as an amorphous solid (218 mg, 95%). Rf = 0.58 (petroleum ether/EtOAc, 4:1); [α]20D = 
+14.4 (c 2.9, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = –0.07 (s, 3H, Si(CH3)2), –0.02 (s, 3H, 
Si(CH3)2), 0.81–0.99 (m, 39H, 18-CH3, 16-CH3, 10-CH3, Si(CH(CH3)2)3), 1.32–1.44 (m, 1H, 
19-H), 1.57–2.05 (m, 7H, 19-H, 18-H, 10-H, 11-H, 16-H, 14-H), 2.09–2.26 (m, 2H,11-H, 8-
H), 2.58–2.73 (m, 1H, 14-H), 3.07–3.16 (m, 1H, 8-H), 3.35–3.54 (m, 3H, 20-H, 17-H), 3.72 (s, 
3H, OCH3), 3.77 (s, 3H, OCH3), 3.84–3.90 (m, 6H, OCH3 of DMB), 3.92–3.99 (m, 1H, 9-H), 
4.38 (dd, J = 16.9, 11.4 Hz, 2H, CH2 of DMB), 5.19–5.27 (m, 1H, 15-H), 5.34 (dd, J = 11.1, 
11.1 Hz, 1H, 12-H), 5.51 (dd, J = 11.1, 11.1 Hz, 1H, 13-H), 6.29 (s, 1H, H-6), 6.32 (s, 1H, H-
4), 6.78–6.91 (m, 3H, ar of DMB); 13C NMR (100 MHz, CDCl3): δ = –4.0 (Si(CH3)2), –3.7 
(Si(CH3)2), 11.2 (16-CH3), 12.8 (CH(CH3)2), 13.9, 17.6 (10-CH3), 17.8 (CH(CH3)2), 18.0 
(CH(CH3)2), 18.4 (18-CH3), 26.1 (Si(C(CH3)3)), 31.1 (C-19), 32.15 (CH2C=C), 32.2 
(CH2C=C), 34.3 (C-8), 34.4 (C-18), 39.8 (C-10), 41.0 (C-16), 55.1 (OCH3), 55.8 (OCH3), 55.9 
(OCH3), 56.1 (OCH3), 68.9 (C-20), 72.8 (CH2 of DMB), 73.3 (C-9), 76.5 (C-15), 77.2 (C-17), 
97.2 (C-4), 109.2 (C-6), 110.8 (ar of DMB), 111.0 (ar of DMB), 116.7 (C-2), 120.2 (ar of 
DMB), 127.5 (C=C), 129.2 (C=C), 131.2 (ar of DMB), 140.5 (C-7), 148.4 (ar of DMB), 148.9 
(ar of DMB), 158.6 (C-5), 160.4 (C-3), 166.1 (CO2R); 
HRMS (ESI): [M+Na]+ calcd for C49H82NaO9Si2: 893.5390, found 893.5389. 
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To a cooled (0 °C) solution of DMB ether 3-75 (218 mg, 0.25 mmol) in a mixture of 
CH2Cl2/H2O (20:1, 21 mL) was added DDQ (74 mg, 0.325 mmol, 1.3 equiv). The mixture was 
allowed to warm to room temperature and stirred for 30 min. Then it was treated with 
saturated NaHCO3 solution and extracted with CH2Cl2. The combined organic extracts were 
washed with saturated NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered, and 
concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc, 4:1) afforded lactone 
3-76 (167 mg, 93% yield) as a colorless oil. Rf = 0.50 (petroleum ether/EtOAc, 4:1); [α]20D = 
+9.5 (c 1.2, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = –0.05 (s, 3H, Si(CH3)2), 0.00 (s, 3H, 
Si(CH3)2), 0.81–1.00 (m, 39H, 18-CH3, 16-CH3, 10-CH3, Si(CH(CH3)2)3), 1.45–1.68 (m, 2H, 
19-H), 1.86–2.05 (m, 4H, 18-H, 10-H, 16-H, 14-H), 2.08–2.26 (m, 3H, 11-H, 8-H), 2.62–2.78 
(m, 1H, 14-H), 3.10 (d, J = 13.1 Hz, 1H, 8-H), 3.41–3.47 (m, 1H, 17-H), 3.52–3.59 (m, 1 H, 20-
H), 3.64–3.72 (m, 1 H, 20-H), 3.73 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.95 (d, J = 10.8 Hz, 1H, 
9-H), 5.24–5.39 (m, 2H, 15-H, 12-H), 5.55 (dd, J = 11.1, 11.1 Hz, 1H, 13-H), 6.30 (s, 1H, H-6), 
6.33 (s, 1H, H-4); 13C NMR (100 MHz, CDCl3): δ = –3.9 (Si(CH3)2), –3.6 (Si(CH3)2), 11.3 
(16-CH3), 12.8 (CH(CH3)2), 13.9, 17.7 (10-CH3), 17.8 (CH(CH3)2), 18.0 (CH(CH3)2), 18.5 
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(18-CH3), 26.1 (Si(C(CH3)3)), 32.2 (CH2C=C), 32.4 (CH2C=C), 33.7 (C-18), 34.0 (C-19), 34.3 
(C-8), 39.8 (C-10), 41.3 (C-16), 55.2 (OCH3), 56.2 (OCH3), 60.3 (C-20), 73.3 (C-9), 74.2 (C-
15), 77.1 (C-17), 97.2 (C-4), 109.2 (C-6), 116.6 (C-2), 127.4 (C=C), 129.3 (C=C), 140.5 (C-
7), 158.5 (C-5), 160.4 (C-3), 166.3 (CO2R); 
HRMS (ESI): [M+Na]+ calcd for C40H72NaO7Si2: 721.4889, found 721.4888. 
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To a cooled (0 °C) solution of DMB ether 3-74 (491 mg, 0.56 mmol) in a mixture of 
CH2Cl2/pH = 7 phosphate buffer (20:1, 42 mL) was added DDQ (166 mg, 0.73 mmol, 1.3 
equiv). The mixture was allowed to warm to room temperature and stirred for 30 min. Then it 
was treated with saturated NaHCO3 solution and the layers were separated. The aqueous layer 
was extracted with CH2Cl2. The combined organic extracts were washed with saturated 
NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered, and concentrated in vacuo. 
Flash chromatography (petroleum ether/EtOAc, 4:1) afforded alcohol 3-77 (400 mg, 99% 
yield) as an amorphous solid. Rf = 0.44 (petroleum ether/EtOAc, 4:1); [α]20D = –30.5 (c 1.5, 
CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.04 (s, 3H, Si(CH3)2), 0.07 (s, 3H, Si(CH3)2), 0.86–0.99 (m, 
36H, 18-CH3, 16-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.04 (d, J = 7.1 Hz, 3H, 10-CH3), 1.43–
1.52 (m, 1H, 19-H), 1.59–1.70 (m, 1H, 19-H), 1.86–2.06 (m, 4H, 11-H, 10-H, 16-H), 2.10–
2.19 (m, 1H, 18-H), 2.34–2.53 (m, 4H, 8-H, 14-H), 3.51-3.58 (m, 2H, 20-H, 17-H), 3.63–3.71 
(m, 1H, 20-H), 3.76 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.98 (br d, J = 8.6 Hz, 1H, 9-H), 
5.43–5.56 (m, 1H, 15-H), 6.31 (d, J = 2.0 Hz, 1H, 6-H), 6.41 (s, J = 2.0 Hz, 1H, 4-H); 
13C NMR (100 MHz, CDCl3): δ = –3.9 (Si(CH3)2), –3.4 (Si(CH3)2), 11.5 (16-CH3), 13.0 
(CH(CH3)2), 15.3 (10-CH3), 17.5 (Si(C(CH3)3)), 17.9 (CH(CH3)2), 18.1 (CH(CH3)2), 18.4 (18-
CH3), 23.3 (C-14), 23.6 (C-11), 26.1 (Si(C(CH3)3)), 33.8 (C-18), 34.4 (C-19),37.6 (C-16), 38.6 
(C-8), 40.4 (C-10), 55.2 (OCH3), 55.9 (OCH3), 60.4 (C-20), 74.2 (C-15), 76.5 (C-17), 79.6 (C-
9), 81.3 (C-12), 96.7 (C-4), 108.3 (C-2), 118.0 (C-6), 139.5 (C-7), 157.2 (C-5), 160.3 (C-3), 
167.5 (C-1); 
HRMS (ESI): [M+Na]+ calcd for C40H70O7Si2Na 741.45523, found 741.45582. 
 
 
Alkyne 3-80 
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a) Preparation of 3-methylhexanal derivative 3-78: To a cooled (0 °C) solution of 
alcohol 3-77 (272 mg, 0.38 mmol) in CH2Cl2 (7 mL) was added a solution of Dess-Martin 
periodinane (15% wt, 1.25 mL, 0.61 mmol). After stirring for 0.5 h at 0 °C and for 2 h at room 
temperature, the reaction mixture was concentrated, loaded on a flash silica gel column, and 
eluted with petroleum ether/EtOAc, 4:1 to give 259 mg (95%) of aldehyde 3-78, which was 
used directly in the next reaction. TLC (petroleum ether/EtOAc, 4:1): Rf = 0.75. 
b) Alkyne 3-80: Diethyl-1-diazo-2-oxopropylphosphonate (3-79)130 (176 mg, 0.72 mmol, 
2 equiv) was added to a solution of aldehyde 3-78 obtained in the previous step (259 mg, 0.36 
mmol) and K2CO3 (170 mg, 1.22 mmol, 3.4 equiv) in MeOH (7 mL) followed by stirring of 
the mixture for 12 h at room temperature. The reaction mixture was diluted with Et2O (60 
mL), washed with an aqueous solution (5%) of NaHCO3 (20 mL). The layers were separated 
and the organic layer dried over Na2SO4. After filtration and evaporation of the solvent the 
residue was purified by flash chromatography (EtOAc/petroleum ether, 10:1) to give 247 mg 
(96%) of alkyne 3-80 as an amorphous solid. Rf = 0.78 (petroleum ether/EtOAc, 4:1); [α]20D = 
–24.1 (c 1.9, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.07–0.10 (m, 6H, Si(CH3)2), 0.86–
0.98 (m, 33H, 16-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 0.99–1.08 (m, 6H, 18-CH3, 10-CH3), 
1.76–1.87 (m, 1H, 16-H), 1.90–2.20 (m, 7H, 21-H, 19-H, 10-H, 11-H, 18-H), 2.33–2.48 (m, 
3H, 8-H, 14-H), 2.50–2.58 (m, 1H, 8-H), 3.54–3.59 (m, 1H, 17-H), 3.75 (s, 3H, OCH3), 3.78 
(s, 3H, OCH3), 4.01 (br d, J = 8.8 Hz, 1H, 9-H), 5.42–5.54 (m, 1H, 15-H), 6.32 (d, J = 1.8 Hz, 
1H, 6-H), 6.41 (s, J = 1.8 Hz, 1H, 4-H); 13C NMR (100 MHz, CDCl3): δ = –3.9 (Si(CH3)2), –
3.7 (Si(CH3)2), 11.1 (16-CH3), 13.0 (CH(CH3)2), 17.0 (10-CH3), 17.9 (CH(CH3)2), 18.1 
(CH(CH3)2), 18.4 (18-CH3), 21.7 (C-19), 23.3 (C-14), 23.8 (C-11), 26.2 (Si(C(CH3)3)), 36.7 
(C-18), 37.6 (C-16), 38.6 (C-8), 40.8 (C-10), 55.2 (OCH3), 55.7 (OCH3), 69.5 (C-21), 74.7 
(C≡C), 75.3 (C-15), 77.2 (C-17), 79.6 (C≡C), 81.3 (C≡C), 83.5 (C-9), 96.7 (C-4), 108.3 (C-2), 
118.1 (C-6), 139.4 (C-7), 157.2 (C-5), 160.3 (C-3), 167.4 (C-1); 
HRMS (ESI): [M+Na]+ calcd for C41H68O6Si2Na 735.44466, found 735.44503. 
 
 
Propargyl alcohol 3-81 
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To a solution of alkyne 3-80 (230 mg, 0.32 mmol) in THF (9 mL) was added tBuLi (0.32 mL, 
1.5 M solution in pentane, 0.48 mmol, 1.5 equiv) dropwise at –90 °C. Stirring was continued 
for 1 h at –90 °C before paraformaldehyde (96 mg, 3.2 mmol, 10 equiv) was added at –90 °C. 
The reaction mixture was allowed to warm to room temperature over 1 h and stirred for an 
additional 1 h. After quenching of the reaction with H2O (3 mL), the mixture was extracted 
with Et2O (3 × 30 mL). The combined organic layers were washed with saturated NaCl 
solution (20 mL), dried over MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography (petroleum ether/EtOAc, 10:1 → 4:1) of the residue afforded alcohol 3-81 
(202 mg, 85% yield) as an amorphous solid. Besides product 3-81 some unreacted alkyne 3-80 
(32 mg, 14%) was isolated. Rf = 0.59 (petroleum ether/EtOAc, 4:1); [α]20D = –21.3 (c 1.5, 
CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.07 (s, 6H, Si(CH3)2), 0.86–1.07 (m, 39H, 18-CH3, 10-CH3, 
16-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.55–1.62 (m, 1H, 19-H), 1.76–1.85 (m, 1H, 16-H), 
1.90–2.19 (m, 4H, 19-H, 10-H, 11-H, 18-H), 2.25–2.56 (m, 5H, 8-H, 11-H, 14-H), 3.53–3.60 
(m, 1H, 17-H), 3.75 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.96–4.03 (m, 1H, 9-H), 4.17–4.23 
(m, 2H, 22-H), 5.42–5.58 (m, 1H, 15-H), 6.32 (d, J = 2.0 Hz, 1H, 6-H), 6.41 (s, J = 2.0 Hz, 
1H, 4-H); 13C NMR (100 MHz, CDCl3): δ = –3.8 (Si(CH3)2), –3.8 (Si(CH3)2), 11.3 (16-CH3), 
13.0 (CH(CH3)2), 17.3 (10-CH3), 17.9 (CH(CH3)2), 18.1 (CH(CH3)2), 18.4 (18-CH3), 21.8 (C-
19), 23.3 (C-14), 23.7 (C-11), 26.1 (Si(C(CH3)3)), 36.9 (C-18), 37.5 (C-16), 38.6 (C-8), 40.7 
(C-10), 51.4 (C-22), 55.2 (OCH3), 55.7 (OCH3), 69.5 (C-21), 75.4 (C-15), 77.2 (C-17), 79.6 
(C≡C), 79.6 (C-9), 81.4 (C≡C), 85.4 (C≡C), 96.7 (C-4), 108.2 (C-2), 118.1 (C-6), 139.4 (C-7), 
157.3 (C-5), 160.3 (C-3), 167.5 (C-1); 
HRMS (ESI): [M+Na]+ calcd for C42H70O7Si2Na 765.45523, found 765.45592. 
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To a stirred 0 °C solution of alcohol 3-81 (192 mg, 0.26 mmol) in THF (5 mL) was added 
triphenylphosphine (341 mg, 1.3 mmol, 5 equiv), DEAD (0.6 mL, 40% wt solution in toluene, 
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1.3 mmol, 5 equiv), and diphenylphosphoryl azide (0.29 mL, 1.3 mmol, 5 equiv). After being 
stirred for 5 h at room temperature the solvent was removed under reduced pressure, and the 
residue purified by flash chromatography (petroleum ether/EtOAc, 10:1) to give 180 mg 
(90%) of azide 3-82 as an amorphous colorless solid. Rf = 0.77 (petroleum ether/EtOAc, 4:1); 
[α]20D = –21.7 (c 1.2, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.07–0.10 (m, 6H, Si(CH3)2), 
0.87–1.07 (m, 39H, 18-CH3, 10-CH3, 16-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.76–1.85 (m, 1H, 
16-H), 1.91–2.04 (m, 2H, 18-H, 19-H), 2.10–2.22 (m, 2H, 19-H, 10-H), 2.27–2.57 (m, 6H, 8-H, 
11-H, 14-H), 3.56–3.62 (m, 1H, 17-H), 3.75 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.81–3.87 (m, 
2H, 22-H), 3.96–4.04 (m, 1H, 9-H), 5.40–5.57 (m, 1H, 15-H), 6.32 (d, J = 2.0 Hz, 1H, 6-H), 
6.41 (s, J = 2.0 Hz, 1H, 4-H); 13C NMR (100 MHz, CDCl3): δ = –3.9 (Si(CH3)2), –3.7 
(Si(CH3)2), 11.1 (16-CH3), 13.0 (CH(CH3)2), 17.0 (10-CH3), 17.9 (CH(CH3)2), 18.1 
(CH(CH3)2), 18.4 (18-CH3), 22.0 (C-19), 23.3 (C-14), 23.7 (C-11), 26.1 (Si(C(CH3)3)), 36.8 
(C-18), 37.6 (C-16), 38.6 (C-8), 40.3 (C-22), 40.7 (C-10), 55.2 (OCH3), 55.7 (OCH3), 73.3 (C-
15), 75.1 (C-17), 77.2 (C≡C), 77.2 (C≡C), 79.6 (C-9), 81.3 (C≡C), 87.1 (C≡C), 96.6 (C-4), 
108.3 (C-2), 118.1 (C-6), 139.4 (C-7), 157.2 (C-5), 160.3 (C-3), 167.4 (C-1); 
HRMS (ESI): [M+Na]+ calcd for C42H69N3O6Si2Na 790.46171, found 790.46251. 
 
 
(4R)-4-Benzyl-3-[(2R,3S)-3-hydroxy-2-methylhexanoyl]-1,3-oxazolidin-2-one (3-85) 
 
N O
OOOH
Ph
1'
5
2
5' 3'
 
 
To a stirred solution of (4R)-4-benzyl-3-propionyl-1,3-oxazolidin-2-one (2-6) (0.49 g, 2.1 
mmol) in absolute CH2CI2 (10 mL) was added nBu2BOTf (2.3 mL, 1M in CH2Cl2) dropwise 
to maintain the internal temperature at –5 °C. After stirring for 5 min at –5 °C, NEt3 (0.37 ml, 
2.63 mmol) was added dropwise, while maintaining the internal temperature at –5 °C. The 
solution turned from dark orange to light yellow after this addition. The reaction mixture was 
stirred for 2 h at 0 °C and then cooled to –78 °C before a solution of freshly distilled 
butyraldehyde (0.21 ml, 2.4 mmol) in CH2CI2 (1 mL) was added at –78 °C. The reaction 
mixture was stirred at this temperature for 1 h and then allowed to warm to 0 °C. After stirring 
at 0 °C for 2 h, the reaction was quenched by addition of phosphate buffer pH = 7, (6 mL), and 
methanol (5 mL). The mixture was cooled to an internal temperature of –5 °C followed by the 
addition of 30% H2O2 (1 mL). The reaction mixture was stirred at 0 °C for 1 h. All volatiles 
were removed in vacuo and the residue was extracted with EtOAc (3 × 30 mL). The combined 
organic layers were washed with H2O (10 mL), saturated NaCl solution (10 mL), dried 
(MgSO4), and filtered. The filtrate was concentrated in vacuo to give the crude aldol product, 
which was purified by flash chromatography (petroleum ether/EtOAc, 3:2) affording the aldol 
product 3-85 (512 mg, 80% yield) as a colorless oil. Rf = 0.4 (petroleum ether/EtOAc, 3:2); 
[α]20D = –52.6 (c 0.4, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.92 (t, J = 7.0 Hz, 3H, 6’-H), 
1.24 (d, J = 7.2 Hz, 3H, 2’-CH3), 1.30–1.42 (m, 2H, 4’-H, 5’-H), 1.45–1.56 (m, 2H, 4’-H, 5’-H), 
2.55 (br s, 1H, 3’-OH), 2.72–2.80 (m, 1H, 5-H), 3.23 (dd, J = 13.4, 2.8 Hz, 1H, 5-H), 3.71–3.77 
(m, 1H, 2’-H), 3.92–3.97 (m, 1H, 3’-H), 4.15–4.23 (m, 2H, CH2Ph), 4.63-4.72 (m, 1H, 4-H), 
7.17–7.35 (m, 5H, Ph); 13C NMR (100 MHz, CDCl3): δ = 10.3 (2’-CH3), 14.0 (C-6’), 19.2 (C-
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5’), 35.9 (C-4’), 37.8 (CH2Ph), 42.1 (C-2’), 55.1 (C-4), 66.2 (C-5), 71.2 (C-3’), 127.4 (pCH ar 
Ph), 129.0 (mCH ar Ph), 129.4 (oCH ar Ph), 135.0 (iCH ar Ph), 153.0 (C-2), 177.6 (C-1’); 
HRMS (ESI): [M+Na]+ calcd for C17H23NO4Na: 328.1519, found 328.1516. 
 
 
(4R)-4-Benzyl-3-((2R,3S)-3-{[tert-butyl(dimethyl)silyl]oxy}-2-methylhexanoyl)-1,3-
oxazolidin-2-one (3-86) 
 
N O
OOTBSO
Ph
1'
5
2
5' 3'
 
 
A solution of the foregoing aldol adduct134 3-85 (0.48 g, 1.57 mmol) in CH2Cl2 (10 mL) was 
cooled to –50 °C. Then, 2,6-lutidine (0.73 mL, 6.3 mmol) followed by TBSOTf (0.51 mL, 2.2 
mmol) were added. The reaction mixture was allowed to warm to room temperature and 
stirred for 2 h. The mixture was treated with H2O and extracted with CH2Cl2. The combined 
organic extracts were washed with 1N HCI, saturated NaHCO3 and saturated NaCl solution, 
dried over MgSO4, filtered, and concentrated in vacuo. Flash chromatography (petroleum 
ether/EtOAc, 10:1) afforded the OH-protected compound 3-86 (0.63 g, 95% yield) as a 
colorless solid. Rf = 0.78 (petroleum ether/EtOAc, 4:1); m.p. = 112–113 °C; [α]20D = –57.1 (c 
1.5, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = –0.02 (s, 3H, Si(CH3)2), 0.02 (s, 3H, Si(CH3)2), 
0.84–0.94 (m, 12H, 6’-H, Si(C(CH3)3)), 1.19 (d, J = 6.8 Hz, 3H, 2’-CH3), 1.24–1.42 (m, 2H, 
4’-H, 5’-H), 1.44–1.55 (m, 2H, 4’-H, 5’-H), 2.70–2.80 (m, 1H, 5-H), 3.29 (dd, J = 13.4, 2.8 
Hz, 1H, 5-H), 3.80–3.89 (m, 1H, 2’-H), 3.96–4.03 (m, 1H, 3’-H), 4.12–4.19 (m, 2H, CH2Ph), 
4.55–4.64 (m, 1H, 3-H), 7.18–7.37 (m, 5H, Ph); 13C NMR (100 MHz, CDCl3): δ = –4.9 
(Si(CH3)2), –4.2 (Si(CH3)2), 11.4 (2’-CH3), 14.4 (C-6’), 18.0 (Si(C(CH3)3)), 18.4 (C-5’), 25.8 
(Si(C(CH3)3)), 37.6 (C-4’), 37.8 (CH2Ph), 42.8 (C-2’), 55.8 (C-4), 66.0 (C-5), 72.7 (C-3’), 
127.3 (pCH ar Ph), 128.9 (mCH ar Ph), 129.5 (oCH ar Ph), 135.2 (iCH ar Ph), 153.1 (C-2), 
175.3 (C-1’); 
HRMS (ESI): [M+Na]+ calcd for C23H37NNaO4Si: 442.2384, found 442.2384. 
 
 
(2R,3S)-3-{[tert-Butyl(dimethyl)silyl]oxy}-2-methylhexanoic acid (2-31) 
 
OH
OTBSO
15 3
 
 
To a stirred solution of oxazolidinone 3-86 (570 mg, 1.36 mmol) in a THF/H2O mixture (6:1, 
14 mL) were added 30% aqueous H2O2 (0.8 mL, 6.0 mmol) and a solution of LiOH·H2O (126 
mg, 3.0 mmol) in H2O (2 mL) sequentially at 0 °C. After 8 h, saturated aqueous Na2SO3 
solution (2 mL) was added, and stirring continued at 0 °C for a further 30 min. The solution 
was poured into a mixture of diethyl ether and 1N aqueous HCI. The organic phase was 
separated and washed with saturated NaCl solution, dried over MgSO4, filtered, and 
concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc/HOAc, 4:1:0.01) of the 
residue afforded acid 2-31 (313 mg, 89% yield) as a colorless oil. Rf = 0.71 (petroleum 
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ether/EtOAc, 4:1); [α]20D = –20.5 (c 2.2, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.06 (s, 
3H, Si(CH3)2), 0.08 (s, 3H, Si(CH3)2), 0.83–0.94 (m, 12H, 6-H, Si(C(CH3)3)), 1.11 (d, J = 7.1 
Hz, 3H, 2-CH3), 1.22–1.51 (m, 4H, 4-H, 5-H), 2.52–2.63 (m, 1H, 2-H), 3.92–4.02 (m, 1H, 3-
H); 13C NMR (100 MHz, CDCl3): δ = –4.8 (Si(CH3)2), –4.4 (Si(CH3)2), 11.1 (2-CH3), 14.1 
(C-6), 18.0 (Si(C(CH3)3)), 18.6 (C-5), 25.7 (Si(C(CH3)3)), 36.2 (C-4), 44.4 (C-2), 73.5 (C-3), 
179.0 (C-1); 
HRMS (ESI): [M+Na]+ calcd for C13H28O3SiNa: 283.1699, found 283.1697. 
 
 
Propargylamine 3-83 
 
O
O
TIPSO
MeO
MeO
TBSO
4
1
8
14
20
NH2
 
 
To a solution of the azide 3-82 (173 mg, 0.23 mmol) in THF (12 mL) were added 
triphenylphosphine (0.60 g, 2.30 mmol) and H2O (83 mg, 4.6 mmol). Then the mixture was 
refluxed for 8 h. Analysis of the reaction mixture by TLC (CH2Cl2/MeOH/NEt3, 9:1:0.01; 
detection, molibdate solution) showed complete conversion of starting material to a product at 
Rf 0.48. The solvent was removed in vacuo, and the resulting yellow oil (0.85 g) was purified 
by flash chromatography (CH2Cl2/MeOH/NH4OH, 9:1:0.01; detection molibdate solution) to 
afford amine 3-83 (154 mg, 89%) as a colorless amorphous solid, which was used directly in 
the next reaction. 
 
 
Hexanamide 3-84 
 
O
O
TIPSO
MeO
MeO
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N
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O
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To a solution of amine 3-83 (154 mg, 0.21 mmol, 1 equiv) in dry DMF (5 mL) were added the 
carboxylic acid 2-31 (87 mg, 0.34 mmol, 1.6 equiv), HBTU (159 mg, 0.42 mmol, 2 equiv), 
HOBt (57 mg, 0.42 mmol, 2 equiv), and N,N-diisopropylethylamine (0.36 mL, 2.1 mmol, 10 
equiv). After the mixture was stirred at room temperature for 4 h, H2O (10 mL) was added and 
the obtained emulsion was extracted with Et2O (3 × 30 mL). The combined organic layers 
were washed with saturated NaHCO3 solution (20 mL), dried over MgSO4, filtered, and 
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concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 10:1 → 4:1) to give 176 mg (85%) of amide 3-84 as a slightly yellow amorphous 
solid. Rf = 0.65 (petroleum ether/EtOAc, 4:1); [α]20D = –15.6 (c 4.3, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 0.07–0.10 (m, 12H, Si(CH3)2), 0.85–1.01 (m, 48H, 24-CH3, 28-H, 16-CH3, 
Si(C(CH3)3), Si(CH(CH3)2)3), 1.02–1.10 (m, 6H, 18-CH3, 10-CH3),1.15–1.46 (m, 4H, 26-H, 27-
H, 18-H), 1.72–1.83 (m, 1H, 16-H), 1.87–2.05 (m, 3H, 10-H, 11-H), 2.09–2.19 (m, 1H, 19-H), 
2.23–2.32 (m, 1H, 19-H), 2.33–2.56 (m, 5H, 8-H, 14-H, 24-H), 3.46–3.53 (m, 1H, 17-H), 3.68–
3.80 (m, 8H, OCH3, 25-H, 26-H), 3.94–4.04 (m, 3H, 9-H, 22-H), 5.39–5.57 (m, 1H, 15-H), 6.31 
(d, J = 2.0 Hz, 1H, 6-H), 6.41 (s, J = 2.0 Hz, 1H, 4-H), 6.59 (br s, 1H, NH); 13C NMR (100 
MHz, CDCl3): δ = –4.6 (Si(CH3)2), –3.9 (Si(CH3)2), –3.7 (Si(CH3)2), 11.1 (16-CH3), 12.6 (24-
CH3), 13.0 (CH(CH3)2), 14.2 (C-28), 17.2 (10-CH3), 17.8 (CH(CH3)2), 17.9 (Si(C(CH3)3)), 
18.1 (CH(CH3)2), 18.4 (18-CH3), 19.2 (C-27), 21.9 (C-19), 23.3 (C-14), 23.9 (C-11), 25.8 
(Si(C(CH3)3)), 26.1 (Si(C(CH3)3)), 29.4 (C-22), 34.8 (C-26), 36.8 (C-18), 37.6 (C-16), 38.6 
(C-8), 41.0 (C-10), 45.5 (C-24), 55.2 (OCH3), 55.7 (OCH3), 74.7 (C-17), 75.6 (C-9), 76.8 (C-
15), 77.1 (C-25), 77.2 (C≡C), 79.5 (C≡C), 81.3 (C≡C), 82.7 (C≡C), 96.7 (C-4), 108.3 (C-6), 
118.1 (C-2), 139.4 (C-7), 157.2 (C-5), 160.2 (C-3), 167.3 (C-1), 173.5 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C55H97NO8Si3Na 1006.64142, found 1006.64065. 
 
 
2-Hydroxy-4-methoxybenzoate (3-87a) and 2-hydroxy-4-methoxybenzoate (3-87b) 
 
O
O
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HO
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O
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3-87a  R = TBS (57%)
3-87b  R = H (42%)  
 
A solution of amide 3-84 (112 mg, 0.114 mmol) in CH2Cl2 (5 mL) was treated with BCl3 (0.46 
mL, 1.0 M in CH2Cl2, 0.46 mmol, 4 equiv) at –78 °C. The reaction was stirred for 2 h at –78 
°C before a saturated solution of NaOAc (5 mL) was added. After separation of the layers, the 
aqueous phase was extracted twice with CH2Cl2. The combined organic layers were washed 
with H2O, saturated NaCl solution, dried over MgSO4, filtered and concentrated in vacuo. 
Flash chromatography (CH2Cl2/EtOAc, 9:1 → 4:1) afforded phenol 3-87a (62.1 mg, 57% 
yield) and the phenol with additional TBS-deprotection 3-87b (40 mg, 41% yield). 
 
Compound 3-87a: 
Rf = 0.85 (CH2Cl2/EtOAc, 85:15); [α]20D = +14.0 (c 3.1, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.04–0.10 (m, 12H, Si(CH3)2), 0.85–1.10 (m, 54H, 24-CH3, 28-H, 16-CH3, 18-
CH3, 10-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.27–1.65 (m, 4H, 26-H, 27-H), 1.74–1.87 (m, 
1H, 16-H), 1.92–2.68 (m, 8H, 10-H, 11-H, 19-H, 8-H, 14-H, 24-H), 2.80–3.00 (m, 1H, 14-H), 
3.45–3.53 (m, 1H, 17-H), 3.68–3.81 (m, 5H, OCH3, 25-H, 26-H), 3.95–4.05 (m, 2H, 22-H), 
4.16–4.28 (m, 1H, 9-H), 5.10–5.30 (m, 1H, 15-H), 6.35 (s, 2H, 6-H, 4-H), 6.62 (br s, 1H, NH), 
11.26 (br s, 1H, 3-OH); 13C NMR (100 MHz, CDCl3): δ = –4.6 (Si(CH3)2), –3.9 (Si(CH3)2), –
3.9 (Si(CH3)2), 10.9 (16-CH3), 12.6 (24-CH3), 13.0 (CH(CH3)2), 14.2 (C-28), 16.5 (10-CH3), 
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17.9 (Si(C(CH3)3)), 18.2 (CH(CH3)2), 18.4 (18-CH3), 19.3 (C-27), 22.0 (C-19), 22.8 (C-14), 
23.9 (C-11), 25.9 (Si(C(CH3)3)), 26.1 (Si(C(CH3)3)), 29.4 (C-22), 29.7, 34.8 (C-26), 37.4 (C-
16), 38.6 (C-8), 45.5 (C-24), 55.2 (OCH3), 74.8 (C-25), 75.0 (C-15), 75.5 (C-9), 77.2 (C≡C), 
82.2 (C-9), 98.9 (C-4), 143.7 (C-7), 163.4 (C-5), 164.7 (C-3), 171.0 (C-1), 173.5 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C54H95NO8SiNa 992.62577, found 992.62514. 
 
Compound 3-87b: 
Rf = 0.36 (CH2Cl2/EtOAc, 85:15); [α]20D = +19.8 (c 2.0, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.07 (3, 6H, Si(CH3)2), 0.85–1.10 (m, 51H, , 28-H, 16-CH3, 18-CH3, 10-CH3, 
Si(C(CH3)3), Si(CH(CH3)2)3), 1.16 (d, J = 7.1 Hz, 3H, 24-CH3), 1.27–1.52 (m, 4H, 26-H, 27-
H), 1.75–1.90 (m, 1H, 18-H), 1.95–2.37 (m, 6H, 11-H, 19-H, 8-H, 24-H), 2.39–2.50 (m, 1H, 
14-H), 2.53–2.69 (m, 1H, 10-H), 2.85–2.98 (m, 1H, 14-H), 3.15 (d, 1H, 25-OH), 3.53–3.60 
(m, 1H, 17-H), 3.79 (s, 3H, OCH3), 3.83–3.90 (m, 1H, 25-H), 3.96–4.04 (m, 2H, 22-H), 4.15–
4.30 (m, 1H, 9-H), 5.14–5.29 (m, 1H, 15-H), 6.02 (br s, 1H, NH), 6.35 (s, 2H, 6-H, 4-H), 
11.23 (br s, 1H, 3-OH); 13C NMR (100 MHz, CDCl3): δ = –4.0 (Si(CH3)2), 11.0 (16-CH3), 11.0 
(24-CH3), 13.0 (CH(CH3)2), 14.0 (C-28), 16.5 (10-CH3), 17.9 (Si(C(CH3)3)), 18.2 (CH(CH3)2), 
18.4 (18-CH3), 19.2 (C-27), 22.0 (C-19), 22.7 (C-14), 25.9 (C-11), 26.0 (Si(C(CH3)3)), 29.5 (C-
22), 35.7 (C-26), 37.4 (C-16), 44.6 (C-24), 55.2 (OCH3), 71.7 (C-25), 74.6, 75.5 (C-9), 76.9 (C-
15), 77.2 (C≡C), 82.6 (C≡C), 98.9 (C-4), 143.7 (C-7), 163.4 (C-5), 164.6 (C-3), 171.1 (C-1), 
175.9 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C48H81NO8Si2Na 878.53929, found 878.53906. 
 
 
Deprotected macrolactone 3-88 
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To a stirred solution of the mixture of 3-87a (62 mg, 0.064 mmol) and 3-87b (40 mg, 0.046 
mmol) in THF (0.8 mL, in a plastic test tube) was added at –80 °C dropwise HF·pyridine 
complex (70% HF, 0.6 mL). The reaction mixture was allowed to warm to –5 °C. After 2 h the 
mixture was partioned between an ice-cooled mixture of EtOAc (20 mL) and saturated 
aqueous NaHCO3 solution (20 mL). The organic layer was separated and the H2O layer 
extracted with EtOAc (2 × 20 mL). The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
(CH2Cl2/MeOH, 95:5 → 9:1) to give 63 mg (97%) of tetraol 3-88. Rf = 0.52 (CH2Cl2/MeOH, 
9:1); [α]20D = +29.2 (c 0.65, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.86–0.95 (m, 9H, 16-
CH3, 18-CH3, 28-H), 1.01 (d, J = 6.8 Hz, 3H, 10-CH3), 1.12 (d, J = 7.1 Hz, 3H, 24-CH3), 
1.20–1.52 (m, 4H, 26-H, 27-H), 1.70–1.82 (m, 1H, 19-H), 1.84–1.94 (m, 1H, 18-H), 2.00–2.10 
(m, 1H, 19-H), 2.11–2.40 (m, 6H, 8-H, 11-H, 16-H, 24-H), 2.48–2.64 (m, 2H, 14-H, 17-OH), 
2.74–2.83 (m, 1H, 14-H), 2.84–2.95 (m, 1H, 10-H), 3.28 (br s, 1H, 25-OH), 3.55–3.63 (m, 1H, 
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17-H), 3.69–3.76 (m, 1H, 25-H), 3.79 (s, 3H, OCH3), 3.89–4.00 (m, 3H, 9-H, 22-H), 5.30–
5.38 (m, 1H, 15-H), 6.35–6.46 (m, 3H, 4-H, 6-H, NH), 10.97 (br s, 1H, 3-OH); 13C NMR (100 
MHz, CDCl3): δ = 8.44 (16-CH3), 11.1 (24-CH3), 14.0 (C-28), 16.1 (18-CH3), 16.4 (10-CH3), 
19.2 (C-27), 21.1 (C-19), 22.5 (C-14), 23.0 (C-11), 29.4 (C-22), 35.7 (C-26), 36.6 (C-18), 37.3 
(C-16), 38.3 (C-8), 44.7 (C-24), 55.3 (OCH3), 71.7 (C-25), 73.9 (C-17), 75.2 (C-9), 76.9 (C-
15), 77.5 (C≡C), 79.2 (C≡C), 81.7 (C≡C), 83.1 (C≡C), 99.5 (C-4), 106.7 (C-2), 111.3 (C-6), 
143.1 (C-7), 163.5 (C-5), 164.2 (C-3), 170.6 (C-1), 176.0 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C33H47NO8Na 608.31939, found 608.31943. 
 
 
Cruentaren A (1-1) 
 
OOH
MeO
HO
O
HO
N
H
O
HO
1
4
9
12
15
18 22
25
 
 
A 50 mL round-bottom flask was charged with diyne 3-88 (45 mg, 0.077 mmol) and a stir bar. 
EtOAc (18 mL) and quinoline (16 mg, 0.123 mmol) were added with stirring. This was 
followed by the addition of Lindlar’s catalyst (5 wt% Pd on CaCO3, posioned with lead, 45 
mg, 100 wt%). The reaction was placed under H2 atmosphere and stirred for 1 h. The reaction 
mixture was filtered through a pad of celite and the filtrate concentrated in vacuo. The residue 
was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give cruentaren A (1-1) 
as a colorless oil (43 mg, 95%). Rf = 0.44 (CH2Cl2/MeOH, 9:1); [α]20D = –3.3 (c 0.6, CH2Cl2); 
1H NMR (600 MHz, CDCl3): δ = 0.79 (d, J = 7.0 Hz, 3H, 18-CH3), 0.89 (d, J = 7.0 Hz, 3H, 
16-CH3), 0.92 (t, J = 7.1 Hz, 3H, 28-H), 1.02 (d, J = 6.8 Hz, 3H, 10-CH3), 1.14 (d, J = 7.2 Hz, 
3H, 24-CH3), 1.28–1.34 (m, 2H, 26-H, 27-H), 1.41–1.51 (m, 2H, 26-H, 27-H), 1.58 (br s, 1H, 
25-OH), 1.70 (qddd, J = 6.8, 6.8, 2.3, 2.0 Hz, 1H, 18-H), 1.92–2.06 (m, 3H, 10-H, 11-H, 16-
H), 2.19–2.30 (m, 4H, 8-H, 14-H, 19-H), 2.28 (dq, J = 7.2, 2.8 Hz, 1H, 24-H), 2.32 (dt, J = 
14.3, 11.7 Hz, 1H, 11-H), 2.73 (br s, 1H, 17-OH), 2.82 (dt, J = 14.3, 11.5 Hz, 1H, 14-H), 3.12 
(br s, 1H, 9-OH), 3.45 (dd, J = 9.2, 2.3 Hz, 1H, 17-H), 3.64 (d, J = 10.6 Hz, 1H, 9-H), 3.75 
(dd, J = 12.8, 1.8 Hz, 1H, 8-H), 3.80 (s, 3H, OCH3), 3.80–3.86 (m, 2H, 22-H, 25-H), 3.91 
(dddd, J = 14.8, 7.4, 5.8, 1.5 Hz, 1H, 22-H), 5.29 (ddd, J = 11.7, 5.6, 2.0 Hz, 1H, 15-H), 5.38–
5.42 (m , 1H, 21-H), 5.44 (ddd, J = 11.0, 4.5, 2.0 Hz, 1H, 13-H), 5.49 (ddd, J = 11.0, 2.9, 1.0 
Hz, 1H, 12-H), 5.53–5.59 (m, 1H, 20-H), 6.11 (br t, J = 5.2 Hz, 1H, NH), 6.30 (d, J = 2.6 Hz, 
1H, 6-H), 6.36 (d, J = 2.6 Hz, 1H, 4-H), 11.48 (br s, 1H, 3-OH); 13C NMR (100 MHz, CDCl3): 
δ = 8.6 (16-CH3), 11.2 (24-CH3), 14.0 (C-28), 14.1 (10-CH3), 16.1 (18-CH3), 19.2 (C-27), 29.8 (C-
14), 30.6 (C-19), 31.6 (C-11), 35.8 (C-26), 36.5 (C-22), 36.5 (C-8), 36.8 (C-18), 38.3 (C-10), 39.3 
(C-16), 44.8 (C-24), 55.4 (OCH3), 71.8 (C-25), 73.1 (C-9), 74.7 (C-17), 78.0 (C-15), 99.6 (C-4), 
104.9 (C-2), 112.3 (C-6), 125.8 (C-13), 126.7 (C-21), 130.9 (C-20), 132.1 (C-12), 143.7 (C-7), 
163.5 (C-5), 165.7 (C-3), 171.5 (C-1), 176.5 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C33H51NO8Na 612.35069, found 612.35108. 
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Deprotected macrolactone 3-89 
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To a stirred solution of the amide 3-84 (20 mg, 0.02 mmol) in THF (0.4 mL, in a plastic test 
tube) was added at –80 °C dropwise HF·pyridine complex (70% HF, 0.3 mL). The reaction 
mixture was allowed to warm to –5 °C. After 2 h the mixture was partioned between an ice-
cooled mixture of EtOAc (20 mL) and saturated aqueous NaHCO3 solution (20 mL). The 
organic layer was separated and the H2O layer extracted with EtOAc (2 × 20 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give 11.5 mg 
(96%) of triol 3-89. Rf = 0.50 (CH2Cl2/MeOH, 9:1); [α]20D = –2.0 (c 1.2, CH2Cl2); 1H NMR 
(400 MHz, CDCl3): δ = 0.88 (t, J = 7.0 Hz, 3H, 28-H), 0.92–0.96 (m, 6H, 16-CH3, 18-CH3), 
1.04 (d, J = 7.1 Hz, 3H, 10-CH3), 1.10 (d, J = 7.1 Hz, 3H, 24-CH3), 1.20–1.31 (m, 2H, 26-H, 
27-H), 1.35–1.48 (m, 2H, 26-H, 27-H), 1.74–1.83 (m, 1H, 19-H), 1.93–2.00 (m, 2H, 18-H, 19-
H), 2.05–2.13 (m, 1H, 11-H), 2.16–2.22 (m, 1H, 16-H), 2.23–2.32 (m, 2H, 11-H, 24-H), 2.38–
2.54 (m, 4H, 14-H, 8-H, OH), 2.59–2.81 (m, 2H, 14-H, 10-H), 3.31 (dd, J = 13.6, 2.3 Hz, 1H, 
17-H), 3.40 (br s, 1H, OH), 3.69 (dd, J = 8.2, 4.9 Hz, 1H, 25-H), 3.77–3.87 (m, 8H, 8-H, 9-H, 
OCH3), 3.89–4.06 (m, 2H, 22-H), 5.51–5.57 (m, 1H, 15-H), 6.36 (d, J = 1.8 Hz, 1H, 6-H), 
6.39–6.46 (m, 2H, 4-H, NH); 13C NMR (100 MHz, CDCl3): δ = 7.4 (16-CH3), 11.0 (24-CH3), 
14.0 (C-28), 15.6 (18-CH3), 16.2 (10-CH3), 19.1 (C-27), 22.5 (C-19), 22.7 (C-14), 22.7 (C-11), 
29.6 (C-22), 35.5 (C-26), 35.8, 36.0 (C-18), 38.1 (C-16), 38.1 (C-8), 44.5 (C-24), 55.5 (OCH3), 
55.7 (OCH3), 71.6 (C-25), 75.0 (C-17), 75.4 (C-9), 77.2 (C-15), 77.6 (C≡C), 79.8 (C≡C), 81.6 
(C≡C), 82.0 (C≡C), 96.7 (C-4), 106.6 (C-2), 117.8 (C-6), 138.8 (C-7), 157.0 (C-5), 161.3 (C-3), 
168.6 (C-1), 176.2 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C34H49NaNO8 622.33559, found 622.33581. 
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A 10 mL round-bottom flask was charged with diyne 3-89 (11.0 mg, 0.018 mmol) and a stir 
bar. EtOAc (4 mL) and quinoline (3.7 mg, 0.029 mmol) were added with stirring. This was 
followed by the addition of Lindlar’s catalyst (5 wt% Pd on CaCO3, poisoned with lead, 11 
mg, 100 wt%). The reaction was placed under H2 atmosphere and stirred for 1 h. The reaction 
mixture was filtered through a pad of celite and the filtrate concentrated in vacuo. The residue 
was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give 3-OMe-cruentaren 
(3-90) as a colorless oil (10.5 mg, 95%). Rf = 0.46 (CH2Cl2/MeOH, 9:1); [α]20D = +31.1 (c 
0.4, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.83–0.93 (m, 6H, 28-H, 18-CH3), 0.97 (m, J 
= 6.8 Hz, 3H, 16-CH3), 1.05 (d, J = 6.6 Hz, 3H, 10-CH3), 1.12 (d, J = 7.3 Hz, 3H, 24-CH3), 
1.17–1.34 (m, 2H, 26-H, 27-H), 1.37–1.50 (m, 2H, 26-H, 27-H), 1.70–1.99 (m, 5H, 19-H, 18-
H, 11-H, OH), 2.18–2.31 (m, 4H, 16-H, 8-H, 24-H), 2.35–2.52 (m, 2H, 14-H, 11-H), 2.65–
2.83 (m, 2H, 14-H, OH) 2.89–2.98 (m, 1H, 10-H), 3.36 (br s, 1H, OH), 3.42–3.49 (m, 1H, 17-
H), 3.71–3.78 (m, 4H, 25-H, OCH3), 3.79–3.99 (m, 6H, 9-H, 22-H, OCH3), 5.40 (dd, J = 9.7, 
5.2 Hz, 1H, 15-H), 5.44–5.53 (m, 3H, 12-H, 13-H, 21-H), 5.57–5.67 (m, 1H, 20-H), 6.23 (t, J 
= 5.2 Hz, 1H, NH), 6.31–6.37 (m, 2H, 6-H, 4-H); 13C NMR (100 MHz, CDCl3): δ = 8.0 (16-
CH3), 11.2 (24-CH3), 14.0 (C-28), 16.1 (18-CH3), 19.2 (C-27), 29.7 (C-14), 30.0 (C-19), 31.6 
(C-11), 35.7 (C-26), 36.3 (C-22), 36.4 (C-8), 37.5 (C-18), 38.0 (C-10), 39.5 (C-16), 44.6 (C-
24), 55.4 (OCH3), 55.9 (OCH3), 71.8 (C-25), 76.0 (C-17), 77.2 (C-9), 78.3 (C-15), 97.1 (C-4), 
106.7 (C-2), 116.8 (C-6), 126.7 (C-21), 131.1 (C-20), 131.4 (C-12), 139.3 (C-7), 158.4 (C-5), 
161.5 (C-3), 166.9 (C-1), 176.5 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C34H53NaNO8 626.36689, found 626.36668. 
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To a solution of amine 3-83 (20 mg, 0.027 mmol, 1 equiv) in dry DMF (2 mL) were added the 
E-cinnamic acid (3-91a) (6.4 mg, 0.043 mmol, 1.6 equiv), HBTU (20.5 mg, 0.054 mmol, 2 
equiv), HOBt (7.3 mg, 0.054 mmol, 2 equiv), and N,N-diisopropylethylamine (48 μL, 0.27 
mmol, 10 equiv). After the mixture was stirred at room temperature for 4 h, H2O (5 mL) was 
added and the obtained emulsion was extracted with Et2O (3 × 15 mL). The combined organic 
layers were washed with saturated NaHCO3 solution (10 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 10:1 → 4:1) to give 20.5 mg (87%) of amide 3-92a as a colorless amorphous 
solid. Rf = 0.39 (petroleum ether/EtOAc, 4:1); [α]20D = –13.1 (c 1.4, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 0.04 (s, 3H, Si(CH3)2), 0.06 (s, 3H, Si(CH3)2), 0.87–1.02 (m, 39H, 16-CH3, 
18-CH3, 10-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.72–1.83 (m, 1H, 16-H), 1.91–2.11 (m, 3H, 
19-H, 18-H), 2.12–2.20 (m, 1H, 11-H), 2.22–2.30 (m, 1H, 10-H), 2.33–2.55 (m, 4H, 8-H, 14-
H, 11-H), 3.60–3.65 (m, 1H, 17-H), 3.73 (s, 3H, OCH3), 3.75-3.83 (m, 4H, OCH3, 8-H), 4.00–
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4.18 (m, 3H, 9-H, 22-H), 5.47–5.59 (m, 1H, 15-H), 6.02 (br s, 1H, NH), 6.31 (d, J = 2.0 Hz, 
1H, 6-H), 6.40–6.46 (m, 2H, 4-H, 25-H), 7.29–7.34 (m, 3H, o-, p-CH of Ph), 7.41–7.47 (m, 
2H, m-CH of Ph), 7.62 (d, J = 15.7 Hz, 1H, 24-H); 13C NMR (100 MHz, CDCl3): δ = –3.9 
(Si(CH3)2), 11.4 (16-CH3), 13.0 (CH(CH3)2), 17.2 (10-CH3), 17.9 (CH(CH3)2), 18.1 (CH(CH3)2), 
18.4 (18-CH3), 21.7 (C-19), 23.1 (C-14), 23.7 (C-11), 26.1 (Si(C(CH3)3)), 30.0 (C-22), 37.2 (C-
18), 37.3 (C-16), 38.6 (C-8), 40.3 (C-10), 55.2 (OCH3), 55.7 (OCH3), 75.0 (C-17), 76.6 (C-9), 
77.2 (C-15), 79.6 (C≡C), 81.7 (C≡C), 83.2 (C≡C), 96.6 (C-4), 108.2 (C-6), 118.0 (C-2), 120.2 
(C-24), 127.8 (C-4’), 128.7 (C-3’), 129.6 (C-2’), 134.8 (C-1’), 139.4 (C-7), 141.2 (C-25), 157.4 
(C-5), 160.4 (C-3), 165.4 (C-1), 167.6 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C51H77NNaO7Si2 894.51308, found 894.51309. 
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A solution of amide 3-92a (18 mg, 0.02 mmol) in CH2Cl2 (3 mL) was treated with BCl3 (80 
μL, 1.0 M in CH2Cl2, 0.08 mmol, 4 equiv) at –80 °C. The reaction was stirred for 2 h at –80 °C 
before a saturated solution of NaOAc (3 mL) was added. After separation of the layers, the 
aqueous phase was extracted twice with CH2Cl2. The combined organic layers were washed 
with H2O, saturated NaCl solution, dried over MgSO4, filtered and concentrated in vacuo. 
Flash chromatography (petroleum ether/EtOAc, 4:1) afforded phenol 3-93a (15.8 mg, 92%) as 
a slightly yellow oil. Rf = 0.4 (petroleum ether/EtOAc, 4:1); [α]20D = +17.0 (c 0.7, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.05-0.08 (m, 6H, Si(CH3)2), 0.85–1.05 (m, 39H, 16-CH3, 
18-CH3, 10-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.67–1.91 (m, 2H, 16-H, 19-H), 1.94-2.20 (m, 
4H, 19-H, 18-H, 11-H), 2.23–2.35 (m, 2H, 10-H, 14-H), 2.44–2.52 (m, 1H, 8-H), 2.55-2.67 
(m, 1H, 14-H), 2.85–2.97 (m, 1H, 8-H), 3.56–3.62 (m, 1H, 17-H), 3.77 (s, 3H, OCH3), 4.10–
4.15 (m, 2H, 22-H), 4.17–4.25 (m, 1H, 9-H), 5.19–5.28 (m, 1H, 15-H), 5.81 (br s, 1H, NH), 
6.33–6.42 (m, 3H, 6-H, 4-H, 25-H), 7.32–7.39 (m, 3H, o-, p-CH of Ph), 7.47–7.53 (m, 2H, m-
CH of Ph), 7.64 (d, J = 15.7 Hz, 1H, 24-H), 11.22 (br s, 1H, 3-OH); 
13C NMR (100 MHz, CDCl3): δ = –4.0 (Si(CH3)2), 11.1 (16-CH3), 13.0 (CH(CH3)2), 16.6 (10-
CH3), 18.2 (CH(CH3)2), 18.2 (CH(CH3)2), 18.4 (18-CH3), 22.1 (C-19), 22.7 (C-14), 26.0 
(Si(C(CH3)3)), 30.0 (C-22), 36.7 (C-18), 37.4 (C-16), 55.2 (OCH3), 74.6 (C-17), 75.6 (C-9), 
76.9 (C≡C), 77.2 (C-15), 82.7 (C≡C), 83.2 (C≡C), 98.9 (C-4), 104.2 (C-6), 119.7 (C-2), 120.0 
(C-24), 127.8 (C-4’), 128.8 (C-3’), 129.8 (C-2’), 134.7 (C-1’), 141.6 (C-7), 143.3 (C-25), 
163.4 (C-3), 164.6 (C-5), 165.3 (C-1), 171.1 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C50H75NO7Si2Na 880.49743, found 880.49810. 
 
 
Deprotected macrolactone 3-94a 
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To a stirred solution of the phenol 3-93a (14 mg, 0.016 mmol) in THF (0.4 mL, in a plastic 
test tube) was added at –80 °C dropwise HF·pyridine complex (70% HF, 0.3 mL). The 
reaction mixture was allowed to warm to –5 °C. After 2 h, the mixture was partioned between 
an ice-cooled mixture of EtOAc (20 mL) and saturated aqueous NaHCO3 solution (20 mL). 
The organic layer was separated and the H2O layer extracted with EtOAc (2 × 20 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give 9.0 mg 
(95%) of triol 3-94a. Rf = 0.56 (CH2Cl2/MeOH, 9:1); [α]20D = +11.7 (c 0.8, CH2Cl2); 1H NMR 
(400 MHz, CDCl3): δ = 0.91–0.96 (m, 6H, 16-CH3, 18-CH3), 1.02 (d, J = 6.8 Hz, 3H, 10-CH3), 
1.74–1.85 (m, 2H, 16-H, 18-H), 2.00–2.10 (m, 2H, 19-H, 18-H), 2.15–2.27 (m, 4H, 19-H, 11-
H, OH), 2.28–2.37 (m, 2H, 11-H, 8-H), 2.38–2.46 (m, 1H), 2.57–2.65 (m, 1H, 14-H), 2.77–
2.85 (m, 1H, 14-H), 2.88–2.98 (m, 1H, 10-H), 3.63–3.69 (m, 1H, 17-H), 3.72-3.76 (m, 1H, 8-
H), 3.91-3.99 (m, 1H, 9-H), 4.11–4.16 (m, 2H, 22-H), 5.32–5.39 (m, 1H, 15-H), 5.97 (br s, 
1H, NH), 6.34–6.43 (m, 3H, 6-H, 4-H, 25-H), 7.33–7.40 (m, 3H, o-, p-CH of Ph), 7.46–7.52 
(m, 2H, m-CH of Ph), 7.63 (d, J = 15.7 Hz, 1H, 24-H), 11.00 (br s, 1H, 3-OH); 13C NMR (100 
MHz, CDCl3): δ = 8.5 (16-CH3), 14.1 (24-CH3), 16.2 (18-CH3), 16.5 (10-CH3), 21.1 (C-19), 
22.5 (C-14), 23.0 (C-11), 29.9 (C-22), 35.7 (C-26), 36.7 (C-18), 37.3 (C-16), 38.4 (C-8), 55.4 
(OCH3), 73.8 (C-17), 75.3 (C-9), 77.2 (C-15), 77.6 (C≡C), 79.3 (C≡C), 81.8 (C≡C), 83.3 
(C≡C), 99.5 (C-4), 106.5 (C-2), 111.5 (C-6), 120.0 (C-24), 127.8 (C-4’), 128.8 (C-3’), 129.8 
(C-2’), 134.7 (C-1’), 141.7 (C-7), 143.2 (C-25), 163.7 (C-5), 164.5 (C-3), 165.5 (C-1), 170.7 
(C-23); 
HRMS (ESI): [M+Na]+ calcd for C35H41NaNO7 610.27752, found 610.27802. 
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To a stirred solution of diyne 3-94a (4.2 mg, 0.007 mmol) in EtOAc (2 mL) containing 
quinoline (1.5 mg, 0.01 mmol) was added Lindlar’s catalyst (5 wt% Pd on CaCO3, poisoned 
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with lead, 4.2 mg, 100 wt%). The reaction was placed under H2 atmosphere and stirred for 1 h. 
The mixture was filtered through a pad of celite and the filtrate concentrated in vacuo. Flash 
chromatography of the residue (CH2Cl2/MeOH, 95:5 → 9:1) afforded cinnamide 3-95a (3.1 
mg, 74%) and phenylpropionamide 3-95e (1.0 mg, 24%). 
 
Compound 3-95a: 
Rf = 0.64 (CH2Cl2/MeOH, 9:1); [α]20D = +8.3 (c 0.3, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 0.80 (d, J = 6.8 Hz, 3H, 18-CH3), 0.92 (d, J = 7.1 Hz, 3H, 16-CH3), 0.97 (d, J = 6.8 Hz, 3H, 
10-CH3), 1.70–1.79 (m, 2H, 18-H, OH), 1.93–2.06 (m, 3H, 10-H, 11-H, 16-H), 2.16–2.26 (m, 
2H, 14-H, 19-H), 2.28–2.40 (m, 3H, 11-H, 8-H, 19-H), 2.79–2.96 (m, 1H, 14-H), 3.51 (dd, J = 
9.4, 1.8 Hz, 1H, 17-H), 3.61–3.67 (m, 1H, 9-H), 3.72–3.74 (m, 1H, 8-H), 3.75–3.80 (m, 4H, 
OCH3, OH), 3.87–3.95 (m, 1H, 22-H), 4.05-4.14 (m, 1H, 22-H), 5.27–5.35 (m, 1H, 15-H), 
5.42–5.52 (m, 3H, 21-H, 12-H, 13-H), 5.53–5.63 (m, 1H, 20-H), 6.02 (br s, 1H, NH), 6.30 (d, 
J = 2.6 Hz, 1H, 6-H), 6.35–6.41 (m, 2H, 4-H, 25-H), 7.32–7.39 (m, 3H, o-, p-CH of Ph), 7.46–
7.51 (m, 2H, m-CH of Ph), 7.62 (d, J = 15.7 Hz, 1H, 24-H), 11.50 (br s, 1H, 3-OH); 
HRMS (ESI): [M+Na]+ calcd for C35H45NaNO7 614.30882, found 614.30923. 
 
Compound 3-95e: 
Rf = 0.58 (CH2Cl2/MeOH, 9:1); [α]20D = +6.4 (c 0.1, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 0.77 (d, J = 6.8 Hz, 3H, 18-CH3), 0.90 (d, J = 7.1 Hz, 3H, 16-CH3), 1.00 (d, J = 6.6 Hz, 3H, 
10-CH3), 1.63–1.77 (m, 1H, 18-H), 1.90–2.50 (m, 12H, 10-H, 11-H, 16-H, 14-H, 19-H, 8-H, 
25-H, OH), 2.78–2.90 (m, 1H, 14-H), 2.91–2.99 (m, 2H, 24-H), 3.43–3.50 (m, 1H, 17-H), 
3.61–3.67 (m, 1H, 9-H), 3.72–3.82 (m, 5H, 8-H, 22-H, OCH3), 3.85–3.97 (m, 1H, 22-H), 
5.25–5.36 (m, 2H, 15-H, 21-H), 5.40–5.59 (m, 3H, 12-H, 13-H, 20-H), 5.7 (br s, 1H, NH), 
6.28–6.32 (m, 1H, 6-H), 6.34–6.39 (m, 1H, 4-H), 7.15–7.22 (m, 3H, m-, p-CH of Ph), 7.24–7.31 
(m, 2H, o-CH of Ph), 11.50 (br s, 1H, 3-OH); 
HRMS (ESI): [M+Na]+ calcd for C33H47NO8Na 616.32447, found 616.32467. 
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To a solution of amine 3-83 (20 mg, 0.027 mmol, 1 equiv) in dry DMF (2 mL) were added 
capronic acid (3-91b) (5.4 µl, 0.043 mmol, 1.6 equiv), HBTU (20.5 mg, 0.054 mmol, 2 equiv), 
HOBt (7.3 mg, 0.054 mmol, 2 equiv), and N,N-diisopropylethylamine (48 µL, 0.27 mmol, 10 
equiv). After the mixture was stirred at room temperature for 4 h, H2O (5 mL) was added and 
the obtained emulsion was extracted with Et2O (3 × 15 mL). The combined organic layers 
were washed with saturated NaHCO3 solution (10 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
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ether/EtOAc, 10:1 → 4:1) to give 20.0 mg (88%) of amide 3-92b as a colorless amorphous 
solid. Rf = 0.37 (petroleum ether/EtOAc, 4:1); [α]20D = –17.9 (c 1.2, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 0.06 ppm (s, 6H, Si(CH3)2), 0.84–1.01 (m, 39H, 16-CH3, 18-CH3, 28-H, 
Si(C(CH3)3), Si(CH(CH3)2)3), 1.04 (d, J = 6.8 Hz, 3H, 10-CH3), 1.25–1.44 (m, 4H, 26-H, 27-
H), 1.54–1.68 (m, 2H, 25-H), 1.72–1.86 (m, 2H, 16-H, 18-H), 1.89–2.04 (m, 3H, 10-H, 11-H), 
2.04–2.56 (m, 8H, 8-H, 14-H, 24-H, 19-H), 3.54–3.58 (m, 1H, 17-H), 3.75 (s, 3H, OCH3), 
3.78 (s, 3H, OCH3), 3.95–4.04 (m, 3H, 9-H, 22-H), 5.42–5.54 (m, 1H, 15-H), 5.62 (br s, 1H, 
NH), 6.32 (s, 1H, 6-H), 6.41 (s, 1H, 4-H); 13C NMR (100 MHz, CDCl3): δ = –3.8 (Si(CH3)2), –
3.8 (Si(CH3)2), 11.4 (16-CH3), 13.0 (CH(CH3)2), 13.9 (C-28), 17.3 (10-CH3), 17.9 
(Si(CH(CH3)2)3), 18.1 ((Si(CH(CH3)2)3), 18.4 (18-CH3), 21.7 (C-19), 22.4 (C-27), 23.3 (C-14), 
23.8 (C-11), 25.3 (C-25), 26.1 (Si(C(CH3)3), 29.7 (C-22), 31.5 (C-26), 36.5 (C-18), 36.9 (C-
16), 37.5 (C-10), 38.6 (C-8), 40.7 (C-24), 55.2 (OCH3), 55.7 (OCH3), 75.4 (C-9), 77.2 (C≡C), 
79.6 (C≡C), 81.4 (C≡C), 83.0 (C≡C), 96.7 (C-4), 108.3 (C-6), 118.1 (C-2), 139.4 (C-7), 157.3 
(C-5), 160.3 (C-3), 167.5 (C-1), 172.7 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C48H81NNaO7Si2: 862.54438, found 862.54445. 
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A solution of amide 3-92b (19 mg, 0.023 mmol) in CH2Cl2 (3 mL) was treated with BCl3 (92 
μL, 1.0 M in CH2Cl2, 0.092 mmol, 4 equiv) at –80 °C. The reaction was stirred for 2 h at –80 
°C before a saturated solution of NaOAc (3 mL) was added. After separation of the layers, the 
aqueous phase was extracted twice with CH2Cl2. The combined organic layers were washed 
with H2O, saturated NaCl solution, dried over MgSO4, filtered and concentrated in vacuo. 
Flash chromatography (petroleum ether/EtOAc, 4:1) afforded phenol 3-93b (16.3 mg, 86%). 
Rf = 0.40 (petroleum ether/EtOAc, 4:1); [α]20D = +15.0 (c 0.9, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.01–0.08 (m, 6H, Si(CH3)2), 0.85–1.06 (m, 42H, 10-CH3, 16-CH3, 18-CH3, 28-H, 
Si(C(CH3)3), Si(CH(CH3)2)3), 1.28–1.34 (m, 4H, 26-H, 27-H), 1.55–2.13 (m, 7H, 11-H, 16-H, 
18-H, 19-H, 25-H), 2.14–2.20 (m, 3H, 19-H, 24-H), 2.20–2.65 (m, 4H, 8-H, 10-H, 14-H), 
2.85–2.96 (m, 1H, 14-H), 3.58 (dd, J = 6.3, 2.0 Hz, 1H, 17-H), 3.78 (s, 3H, OCH3), 3.96–4.02 
(m, 2H, 22-H), 4.16–4.25 (m, 1H, 9-H), 5.17–5.24 (m, 1H, 15-H), 5.53–5.60 (m, 1H, NH), 
6.32–6.37 (m, 2H, 6-H, 4-H), 11.22 (br s, 1H, 3-OH); 13C NMR (100 MHz, CDCl3): δ = –3.9 
(Si(CH3)2), 11.1 (16-CH3), 13.0 (CH(CH3)2), 13.9 (C-28), 16.5 (10-CH3), 18.2 
(Si(CH(CH3)2)3), 18.2 (Si(CH(CH3)2)3), 18.4 (18-CH3), 22.0 (C-19), 22.4 (C-14), 22.8 (C-11), 
25.3 (C-25), 26.1 (Si(C(CH3)3)), 29.7 (C-22), 31.5 (C-26), 36.5 (C-18), 37.5 (C-8), 55.2 
(OCH3), 74.6 (C-17), 75.6 (C-9), 77.2 (C≡C), 82.4 (C≡C), 98.9 (C-4), 143.7 (C-7), 163.4 (C-
5), 164.6 (C-3), 171.1 (C-1), 172.6 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C47H79NNaO7Si2: 848.52873, found 848.52881. 
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Deprotected macrolactone 3-94b 
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To a stirred solution of the phenol 3-93b (16 mg, 0.019 mmol) in THF (0.4 mL, in a plastic 
test tube) was added at –80 °C dropwise HF·pyridine complex (70% HF, 0.3 mL). The 
reaction mixture was allowed to warm to –5 °C. After 2 h the mixture was partioned between 
an ice-cooled mixture of EtOAc (20 mL) and saturated aqueous NaHCO3 solution (20 mL). 
The organic layer was separated and the H2O layer extracted with EtOAc (2 × 20 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give 9.8 mg 
(93%) of triol 3-94b. Rf = 0.46 (CH2Cl2/MeOH, 9:1); [α]20D = +27.5 (c 0.5, CH2Cl2); 1H 
NMR (400 MHz, CDCl3): δ = 0.85–0.95 (m, 9H, 16-CH3, 18-CH3, 28-H), 1.02 (d, J = 6.8 Hz, 
3H, 10-CH3), 1.22–1.34 (m, 4H, 26-H, 27-H), 1.54–1.64 (m, 2H, 25-H), 1.65–1.71 (m, 1H, 
OH), 1.73–1.85 (m, 2H, 18-H, 19H), 1.98–2.08 (m, 1H, 19-H), 2.09–2.41 (m, 7H, 8-H, 11-H, 
16-H, 24-H, OH), 2.55–2.64 (m, 1H, 14-H), 2.76–2.85 (m, 1H, 14-H), 2.85–2.96 (m, 1H, 10-
H), 3.57–3.63 (m, 1H, 17-H), 3.73–3.82 (m, 4H, 8-H, OCH3), 3.91–4.01 (m, 3H, 9-H, 22-H), 
5.31–5.38 (m, 1H, 15-H), 5.77 (br s, 1H, NH), 6.38 (d, J = 2.5 Hz, 1H, 6-H), 6.41 (d, J = 2.5 
Hz, 1H, 4-H), 11.03 (s, 1H, 3-OH); 13C NMR (100 MHz, CDCl3): δ = 8.5 (16-CH3), 13.9 (C-
28), 16.1 (18-CH3), 16.5 (10-CH3), 21.1 (C-19), 22.4 (C-27), 22.5 (C-14), 23.0 (C-11), 25.3 
(C-25), 29.6 (C-22), 31.4 (C-26), 35.7 (C-18), 36.5 (C-16), 36.6 (C-24), 37.4 (C-10), 38.4 (C-
8), 55.4 (OCH3), 73.9 (C-17), 75.3 (C-9), 76.9 (C-15), 77.2 (C≡C), 77.4, 79.2 (C≡C), 81.6 
(C≡C), 83.2 (C≡C), 99.5 (C-4), 106.5 (C-2), 111.5 (C-6), 143.3 (C-7), 163.6 (C-5), 164.6 (C-
3), 170.6 (C-1), 172.8 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C32H45NNaO7 578.30882, found 578.30901. 
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A 5 mL round-bottom flask was charged with diyne 3-94b (9.1 mg, 0.016 mmol) and a stir bar. 
EtOAc (2 mL) and quinoline (3.3 mg, 0.026 mmol) were added with stirring. This was followed 
by the addition of Lindlar’s catalyst (5 wt% Pd on CaCO3, poisoned with lead, 9.1 mg, 100 
wt%). The reaction was placed under H2 atmosphere and stirred for 1 h. The mixture was filtered 
through a pad of celite and the filtrate concentrated in vacuo. Flash chromatography 
(CH2Cl2/MeOH, 95:5 → 9:1) afforded hexanoyl cruentaren 3-95b (8.6 mg, 96%). Rf = 0.55 
(CH2Cl2/MeOH, 9:1); [α]20D = +13.5 (c 0.5, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.77 
(d, J = 6.8 Hz, 3H, 18-CH3), 0.84–0.91 (m, 6H, 16-CH3, 28-H), 1.01 (d, J = 6.8 Hz, 3H, 10-
CH3), 1.23–1.32 (m, 4H, 26-H, 27-H), 1.54–1.65 (m, 2H, 25-H), 1.65–1.75 (m, 1H, 18-H), 
1.90–2.09 (m, 3H, 10-H, 11-H, 16-H), 2.13 (t, J = 7.7 Hz, 2H, 24-H), 2.16–2.41 (m, 6H, 8-H, 
11-H, 14-H, 19-H, OH), 2.77–2.89 (m, 1H, 14-H), 3.01 (br s, 1H, OH), 3.42–3.47 (m, 1H, 17-
H), 3.61–3.67 (m, 1H, 9-H), 3.72–3.82 (m, 5H, 8-H, 22-H, OCH3), 3.89–3.97 (m, 1H, 22-H), 
5.25–5.32 (m, 1H, 15-H), 5.33–5.58 (m, 4H, 21-H, 12-H, 13-H, 20-H), 5.68–5.76 (m, 1H, 
NH), 6.30 (d, J = 2.6 Hz, 1H, 6-H), 6.36 (d, J = 2.6 Hz, 1H, 4-H), 11.51 (s, 1H, 3-OH); 
13C NMR (100 MHz, CDCl3): δ = 8.7 (16-CH3), 13.9 (C-28), 14.2 (10-CH3), 16.0 (18-CH3), 
22.4 (C-27), 25.4 (C-25), 29.6 (C-14), 29.7 (C-19), 30.7 (C-26), 31.4 (C-11), 31.6 (C-14), 36.6 
(C-8), 36.8 (C-10), 38.2 (C-22), 39.1 (C-16), 55.4 (OCH3), 73.1 (C-17), 74.3 (C-9), 77.2 
(C≡C), 78.2 (C≡C), 99.6 (C-4), 105.0 (C-2), 112.3 (C-6), 126.0 (C-13), 127.0 (C-21), 130.6 
(C-20), 132.0 (C-12), 143.7 (C-7), 163.5 (C-5), 165.7 (C-3), 171.5 (C-1), 173.3 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C32H49NNaO7 582.34012, found 582.34061. 
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To a solution of amine 3-83 (20 mg, 0.027 mmol, 1 equiv) in dry DMF (2 mL) were added the 
isobutyric acid (3-91c) (4.0 µl, 0.043 mmol, 1.6 equiv), HBTU (20.5 mg, 0.054 mmol, 2 
equiv), HOBt (7.3 mg, 0.054 mmol, 2 equiv), and N,N-diisopropylethylamine (48 µL, 0.27 
mmol, 10 equiv). After the mixture was stirred at room temperature for 4 h, H2O (5 mL) was 
added and the obtained emulsion was extracted with Et2O (3 × 15 mL). The combined organic 
layers were washed with saturated NaHCO3 solution (10 mL), dried over MgSO4, filtered, and 
concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 10:1 → 4:1) to give 20 mg (91%) of amide 3-92c as a colorless amorphous solid. 
Rf = 0.36 (petroleum ether/EtOAc, 4:1); [α]20D = –20.0 (c 1.0, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.06 ppm (s, 6H, Si(CH3)2), 0.85–1.02 (m, 36H, 16-CH3, 18-CH3, Si(C(CH3)3), 
Si(CH(CH3)2)3), 1.04 (d, J = 6.8 Hz, 3H, 10-CH3), 1.15 (d, J = 6.8 Hz, 6H, 24-CH3), 1.60–1.73 (m, 
1H, 18-H), 1.77–1.87 (m, 1H, 16-H), 1.91–2.09 (m, 3H, 10-H, 11-H), 2.10–2.20 (m, 1H, 19-H), 
2.21–2.30 (m, 1H, 19-H), 2.31–2.55 (m, 5H, 8-H, 14-H, 24-H), 3,56 (t, J = 4.3 Hz, 1H, 17-H), 
3.75 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 3.95–4.04 (m, 3H, 9-H, 22-H), 5.42–5.55 (m, 1H, 15-H), 
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5.60 (br s, 1H, NH), 6.32 (d, J = 2.0 Hz, 1H, 6-H), 6.41 (d, J = 2.0 Hz, 1H, 4-H); 13C NMR (100 
MHz, CDCl3): δ = –3.8 (Si(CH3)2), –3.8 (Si(CH3)2), 11.4 (16-CH3), 13.0 (CH(CH3)2), 17.3 
(10-CH3), 17.9 (Si(CH(CH3)2)3), 18.1 (Si(CH(CH3)2)3), 18.4 (18-CH3), 19.5 (24-CH3), 21.7 
(C-19), 22.3 (C-14), 23.8 (C-11), 26.1 (Si(C(CH3)3)), 29.7 (C-22), 35.4 (C-18), 36.9 (C-16), 
37.6 (C-10), 38.6 (C-8), 40.7 (C-24), 55.2 (OCH3), 55.7 (OCH3), 75.4 (C-9), 76.8 (C-15), 77.2 
(C≡C), 79.6 (C≡C), 81.4 (C≡C), 83.0 (C≡C), 96.7 (C-4), 108.3 (C-6), 118.1 (C-2), 139.4 (C-
7), 157.3 (C-5), 160.3 (C-3), 167.5 (C-1), 176.4 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C46H77NNaO7Si2 834.51308 , found 834.51395. 
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A solution of amide 3-92c (18 mg, 0.022 mmol) in CH2Cl2 (3 mL) was treated with BCl3 (88 
µL, 1.0 M in CH2Cl2, 0.088 mmol, 4 equiv) at –80 °C. The reaction was stirred for 2 h at –80 
°C before a saturated solution of NaOAc (3 mL) was added. After separation of the layers, the 
aqueous phase was extracted twice with CH2Cl2. The combined organic layers were washed 
with H2O, saturated NaCl solution, dried over MgSO4, filtered and concentrated in vacuo. 
Flash chromatography (petroleum ether/EtOAc, 4:1) afforded phenol 3-93c (14.6 mg, 83%). 
Rf = 0.41 (petroleum ether/EtOAc, 4:1); [α]20D = +21.0 (c 0.7, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.07 (s, 6H, Si(CH3)2), 0.86–1.05 (m, 39H, 10-CH3, 16-CH3, 18-CH3, 
Si(C(CH3)3), Si(CH(CH3)2)3), 1.15 (d, J = 6.8 Hz, 6H, 24-CH3), 1.71–1.90 (m, 2H, 16-H, 18-
H), 1.94–2.20 (m, 3H, 10-H, 11-H, 19-H), 2.21–2.39 (m, 4H, 11-H, 19-H, 24-H, 8-H), 2.42–
2.50 (m, 1H, 8-H), 2.52–2.68 (m, 1H, 14-H), 2.85–2.97 (m, 1H, 14-H), 3.55–3.60 (m, 1H, 17-
H), 3.79 (s, 3H, OCH3), 3.97–4.01 (m, 2H, 22-H), 4.15–4.26 (m, 1H, 9-H), 5.17–5.26 (m, 1H, 
15-H), 5.57 (br s, 1H, NH), 6.33–6.37 (m, 2H, 4-H, 6-H), 11.22 (br s, 1H, 3-OH); 13C NMR 
(100 MHz, CDCl3): δ = –4.0 (Si(CH3)2), 11.1 (16-CH3), 13.0 (CH(CH3)2), 16.5 (10-CH3), 18.2 
(Si(CH(CH3)2)3), 18.2 (Si(CH(CH3)2)3), 18.4 (18-CH3), 19.5 (24-CH3), 22.1 (C-19), 22.9 (C-
14), 26.1 (Si(C(CH3)3)), 29.7 (C-22), 35.5 (C-18), 37.5 (C-8), 55.2 (OCH3), 74.6 (C-17), 75.6 
(C-9), 77.2 (C≡C), 82.5 (C≡C), 98.9 (C-4), 143.7 (C-7), 163.4 (C-5), 164.7 (C-3), 171.1 (C-1), 
176.3 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C45H75NNaO7Si2: 820.49743, found 820.49791. 
 
 
Deprotected macrolactone 3-94c 
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To a stirred solution of the phenol 3-93c (13.8 mg, 0.017 mmol) in THF (0.4 mL, in a plastic 
test tube) was added at –80 °C dropwise HF·pyridine complex (70% HF, 0.3 mL). The 
reaction mixture was allowed to warm to –5 °C. After 2 h the mixture was partioned between 
an ice-cooled mixture of EtOAc (20 mL) and saturated aqueous NaHCO3 solution (20 mL). 
The organic layer was separated and the H2O layer extracted with EtOAc (2 × 20 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give 7.6 mg 
(85%) of triol 3-94c. Rf = 0.57 (CH2Cl2/MeOH, 9:1); [α]20D = +24.0 (c 0.75, CH2Cl2); 1H 
NMR (400 MHz, CDCl3): δ = 0.89–0.95 (m, 6H, 16-CH3, 18-CH3), 1.03 (d, J = 6.8 Hz, 3H, 
10-CH3), 1.10–1.15 (m, 6H, 24-CH3), 1.73–1.87 (m, 2H, 18-H, 19-H), 2.04–2.10 (m, 1H, 19-
H), 2.13–2.39 (m, 5H, 8-H, 11-H, 16-H, 24-H), 2.55–2.64 (m, 1H, 14-H), 2.76–2.85 (m, 1H, 
14-H), 2.92 (dd, J = 13.4 Hz, 10.9 Hz, 1H, 10-H), 3.57–3.67 (m, 2H, 17-H, OH), 3.76 (dd, J = 
13.4 Hz, 3.5 Hz, 1H, 8-H), 3.80 (s, 3H, OCH3), 3.90–4.02 (m, 3H, 9-H, 22-H), 5.31–5.38 (m, 
1H, 15-H), 5.74 (br s, 1H, NH), 6.39 (d, J = 2.6 Hz, 1H, 6-H), 6.41 (d, J = 2.6, 1H, 4-H), 11.04 
(br s, 1H, 3-OH); 13C NMR (100 MHz, CDCl3): δ = 8.5 (16-CH3), 16.1 (18-CH3), 16.5 (10-
CH3), 19.5 (24-CH3), 21.1 (C-19), 22.5 (C-14), 23.0 (C-11), 29.7 (C-22), 35.4 (C-18), 35.8 (C-
16), 36.7 (C-24), 37.4 (C-10), 38.4 (C-8), 55.4 (OCH3), 73.9 (C-17), 75.3 (C-9), 76.9 (C-15), 
77.2 (C≡C), 77.8, 79.2 (C≡C), 81.6 (C≡C), 83.2 (C≡C), 99.5 (C-4), 106.4 (C-2), 111.5 (C-6), 
143.3 (C-7), 163.7 (C-5), 164.7 (C-3), 170.7 (C-1), 176.5 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C30H41NaNO7 550.27752, found 550.27757. 
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A 5 mL round-bottom flask was charged with diyne 3-94c (5.5 mg, 0.01 mmol) and a stir bar. 
EtOAc (2 mL) and quinoline (2.3 mg, 0.018 mmol) were added with stirring. This was 
followed by the addition of Lindlar’s catalyst (5 wt% Pd on CaCO3, poisoned with lead, 6.0 
mg, 100 wt%). The reaction was placed under H2 atmosphere and stirred for 1 h. The mixture 
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was filtered through a pad of celite and the filtrate concentrated in vacuo. Flash 
chromatography (CH2Cl2/MeOH, 95:5 → 9:1) afforded methylpropanoyl cruentaren 3-95c 
(4.6 mg, 87%). Rf = 0.6 (CH2Cl2/MeOH, 9:1); [α]20D = +10.4 (c 0.5, CH2Cl2); 1H NMR (400 
MHz, CDCl3): δ = 0.78 (d, J = 6.8 Hz, 3H, 16-CH3), 0.89 (d, J = 7.1 Hz, 3H, 18-CH3), 1.01 (d, 
J = 6.8 Hz, 3H, 10-CH3), 1.13 (d, J = 6.8 Hz, 6H, 24-CH3), 1.57 (br s, 1H, OH), 1.64–1.74 (m, 
1H, 18-H), 1.92–2.04 (m, 3H, 10-H, 11-H, 16-H), 2.17–2.40 (m, 6H, 8-H, 11-H, 14-H, 19-H, 
24-H), 2.76–2.87 (m, 1H, 14-H), 3.02 (br s, 1H, OH), 3.42–3.49 (m, 1H, 17-H), 3.61–3.67 (m, 
1H, 9-H), 3.73–3.82 (m, 5H, 8-H, 22-H, OCH3), 3.88–3.94 (m, 1H, 22-H), 5.26–5.33 (m, 1H, 
15-H), 5.34–5.59 (m, 4H, 12-H, 13-H, 21-H, 20-H), 5.66–5.75 (m, 1H, NH), 6.30 (d, J = 2.6 
Hz, 1H, 6-H), 6.36 (d, J = 2.6 Hz, 1H, 4-H), 11.51 (s, 1H, 3-OH); 13C NMR (100 MHz, 
CDCl3): δ = 8.7 (16-CH3), 14.1 (10-CH3), 16.1 (18-CH3), 19.6 (24-CH3), 29.6 (C-14), 30.7 (C-
19), 31.6 (C-11), 35.6 (C-22), 36.7 (C-8), 36.8 (C-18), 38.2 (C-16), 39.21 (C-24), 55.4 
(OCH3), 73.0 (C-17), 74.3 (C-9), 77.2 (C≡C), 78.2 (C≡C), 99.6 (C-4), 105.0 (C-2), 112.3 (C-
6), 126.0 (C-13), 127.0 (C-21), 130.6 (C-20), 132.0 (C-12), 143.7 (C-7), 163.5 (C-5), 165.7 
(C-3), 171.5 (C-1), 177.0 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C30H45NaNO7 554.30937, found 554.30964. 
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To a solution of amine 3-83 (22 mg, 0.03 mmol, 1 equiv) in dry DMF (2 mL) were added the 
(2Z)-hept-2-en-4-ynoic acid (3-91d)90b (6.0 mg, 0.048 mmol, 1.6 equiv), HBTU (22.8 mg, 
0.06 mmol, 2 equiv), HOBt (8.1 mg, 0.06 mmol, 2 equiv), and N,N-diisopropylethylamine 
(108 µL, 0.6 mmol, 10 equiv). After the mixture was stirred at room temperature for 4 h, H2O 
(5 mL) was added and the obtained emulsion was extracted with Et2O (3 × 15 mL). The 
combined organic layers were washed with saturated NaHCO3 solution (10 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
(petroleum ether/EtOAc, 10:1 → 4:1) to give 21.6 mg (85%) of amide 3-92d as a colorless 
amorphous solid. Rf = 0.23 (petroleum ether/EtOAc, 4:1); [α]20D = –21.6 (c 2.1, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.04–0.08 (m, 6H, Si(CH3)2), 0.87–0.97 (m, 33H, 18-CH3, 
Si(C(CH3)3), Si(CH(CH3)2)3), 0.98–1.07 (m, 6H, 16-CH3, 10-CH3), 1.24 (t, J = 7.3 Hz, 3H, 
29-H), 1.75–1.85 (m, 1H, 16-H), 1.90–2.07 (m, 3H, 10-H, 18-H, 11-H), 2.10–2.19 (m, 1H, 19-
H), 2.26–2.34 (m, 1H, 19-H), 2.35–2.54 (m, 7H, 8-H, 14-H, 28-H, 11-H), 3.49–3.54 (m, 1H, 
17-H), 3.74 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.96–4.03 (m, 1H, 9-H), 4.06–4.13 (m, 2H, 
22-H), 5.41–5.54 (m, 1H, 15-H), 5.95–6.07 (m, 2H, 24-H, 25-H), 6.31 (d, J = 2.0 Hz, 1H, 6-
H), 6.41 (d, J = 2.0 Hz, 1H, 4-H), 7.31 (br s, 1H, NH); 13C NMR (100 MHz, CDCl3): δ = –3.9 
(Si(CH3)2), –3.7 (Si(CH3)2), 11.3 (16-CH3), 13.0 (CH(CH3)2), 13.3 (C-29), 13.5 (C-28), 17.4 
(10-CH3), 17.9 (CH(CH3)2), 18.1 (CH(CH3)2), 18.4 (18-CH3), 21.8 (C-19), 23.3 (C-14), 23.9 
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(C-11), 26.1 (Si(C(CH3)3)), 29.7 (C-22), 36.7 (C-18), 37.6 (C-16), 38.6 (C-8), 41.0 (C-10), 
55.2 (OCH3), 55.7 (OCH3), 74.5 (C-17), 75.7 (C-9), 76.5 (C-15), 76.5 (C≡C), 77.2 (C-25), 
77.2 (C≡C), 79.5 (C≡C), 81.4 (C≡C), 83.1 (C≡C), 96.7 (C-4), 108.3 (C-6), 116.6 (C-25), 118.1 
(C-2), 132.5 (C-24), 139.4 (C-7), 157.2 (C-5), 160.3 (C-3), 164.4 (C-1), 167.4 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C49H77NNaO7Si2 870.51308, found 870.51317. 
 
 
2-Hydroxy-4-methoxybenzoate 3-93d 
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A solution of amide 3-92d (19 mg, 0.022 mmol) in CH2Cl2 (2 mL) was treated with BCl3 (89 
µL, 1.0 M in CH2Cl2, 0.089 mmol, 4 equiv) at –80 °C. The reaction was stirred for 2 h at –80 
°C before a saturated solution of NaOAc (3 mL) was added. After separation of the layers, the 
aqueous phase was extracted twice with CH2Cl2. The combined organic layers were washed 
with H2O, saturated NaCl solution, dried over MgSO4, filtered and concentrated in vacuo. 
Flash chromatography (petroleum ether/EtOAc, 4:1) afforded phenol 3-93d (16.3 mg, 89%). 
Rf = 0.38 (petroleum ether/EtOAc, 4:1); [α]20D = +18.4 (c 1.6, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.04–0.08 (m, 6H, Si(CH3)2), 0.87–1.05 (m, 39H, 18-CH3, 16-CH3, 10-CH3, 
Si(C(CH3)3), Si(CH(CH3)2)3)), 1.24 (t, J = 7.3 Hz, 3H, 29-H), 1.75–1.89 (m, 2H, 16-H, 18-H), 
1.95–2.18 (m, 3H, 10-H, 11-H, 19-H), 2.24–2.35 (m, 2H, 19-H, 14-H), 2.40–2.49 (m, 4H, 8-H, 
28-H), 2.50–2.62 (m, 1H, 11-H), 2.85–2.96 (m, 1H, 14-H), 3.49–3.54 (m, 1H, 17-H), 3.78 (s, 
3H, OCH3), 4.07–4.12 (m, 2H, 22-H), 4.17–4.26 (m, 1H, 9-H), 5.14–5.26 (m, 1H, 15-H), 
6.00–6.08 (m, 2H, 24-H, 25-H), 6.33–6.36 (m, 2H, 6-H, 4-H), 7.32 (br s, 1H, NH), 11.23 (br s, 
1H, 3-OH); 13C NMR (100 MHz, CDCl3): δ = –4.0 (Si(CH3)2), –3.9 (Si(CH3)2), 11.0 (16-CH3), 
13.0 (CH(CH3)2), 13.3 (C-29), 13.5 (C-28), 16.6 (10-CH3), 18.2 (CH(CH3)2), 18.2 
(CH(CH3)2), 18.4 (18-CH3), 22.0 (C-19), 22.8 (C-14), 26.1 (Si(C(CH3)3)), 29.6 (C-22), 34.3 
(C-18), 37.4 (C-16), 55.2 (OCH3), 75.0 (C-17), 75.4 (C-9), 76.5 (C-15), 76.9 (C≡C), 77.2 (C-
25), 82.6 (C≡C), 98.9 (C-4), 104.6 (C-6), 116.6 (C-25), 132.5 (C-24), 143.7 (C-7), 163.4 (C-
5), 164.4 (C-3), 164.7 (C-1), 171.1 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C48H75NNaO7Si2 856.49743, found 856.49761. 
 
 
Deprotected macrolactone 3-94d 
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To a stirred solution of the phenol 3-93d (15 mg, 0.018 mmol in THF (0.4 mL, in a plastic test 
tube) was added at –80 °C dropwise HF·pyridine complex (70% HF, 0.3 mL). The reaction 
mixture was allowed to warm to –5 °C. After 2 h the mixture was partioned between an ice-
cooled mixture of EtOAc (20 mL) and saturated aqueous NaHCO3 solution (20 mL). The 
organic layer was separated and the H2O layer extracted with EtOAc (2 × 20 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give 9.3 mg 
(92%) of triol 3-94d. Rf = 0.55 (CH2Cl2/MeOH, 9:1); [α]20D = +31.8 (c 0.9, CH2Cl2); 1H 
NMR (400 MHz, CDCl3): δ = 0.88–0.96 (m, 6H, 18-CH3, 16-CH3), 1.01 (d, J = 6.8 Hz, 3H, 
10-CH3), 1.24 (t, J = 7.3 Hz, 3H, 29-H), 1.65 (br s, 1H, OH), 1.68–1.72 (m, 1H, 16-H), 1.74–
1.82 (m, 1H, 18-H), 2.01–2.10 (m, 1H, 10-H), 2.12–2.39 (m, 5H, 11-H, 19-H, 14-H, OH), 
2.41–2.49 (m, 2H, 28-H), 2.53–2.61 (m, 1H, 11-H), 2.76–2.87 (m, 2H, 14-H, 8-H), 3.52–3.59 
(m, 1H, 17-H), 3.77–3.86 (m, 4H, OCH3, 8-H), 3.91–3.99 (m, 1H, 9-H), 4.07–4.13 (m, 2H, 22-
H), 5.31–5.38 (m, 1H, 15-H), 6.00–6.07 (m, 2H, 24-H, 25-H), 6.38 (d, J = 2.5 Hz, 1H, 6-H), 
6.41 (d, J = 2.5 Hz, 1H, 4-H), 7.37 (br s, 1H, NH), 11.05 (br s, 1H, 3-OH); 13C NMR (100 
MHz, CDCl3): δ = 8.5 (16-CH3), 13.3 (C-29), 13.5 (C-28), 16.1 (10-CH3), 21.2 (18-CH3), 22.6 
(C-19), 23.0 (C-14), 29.6 (C-22), 35.9, 36.6 (C-18), 37.5 (C-16), 38.2 (C-8), 55.4 (OCH3), 
74.1 (C-17), 74.9 (C-9), 76.5 (C-15), 76.8 (C≡C), 77.2 (C-25), 79.1 (C≡C), 81.9 (C≡C), 83.2 
(C≡C), 99.5 (C-4), 104.8 (C-2), 106.2 (C-6), 111.7, 116.7 (C-25), 132.4 (C-24), 143.3 (C-7), 
163.7 (C-5), 164.5 (C-3), 164.7 (C-1), 170.7 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C33H41NNaO7 586.27752, found 586.27737. 
 
 
Heptanoyl cruentaren 3-95f 
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A 5 mL round-bottom flask was charged with triol 3-94d (7.0 mg, 0.012 mmol) and a stir bar. 
EtOAc (2 mL) and quinoline (2.4 mg, 0.02 mmol) were added with stirring. This was followed 
by the addition of Lindlar’s catalyst (5 wt% Pd on CaCO3, poisoned with lead, 7.0 mg, 100 
wt%). The reaction was placed under H2 atmosphere and stirred for 2 h. The reaction mixture 
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was filtered through a pad of celite and the filtrate concentrated in vacuo. Flash 
chromatography (CH2Cl2/MeOH, 95:5 → 9:1) afforded heptanamide 3-95f (5.1 mg, 73%). Rf 
= 0.51 (CH2Cl2/MeOH, 9:1); [α]20D = +16.4 (c 0.5, CH2Cl2); 1H NMR (600 MHz, CDCl3): δ = 
0.78 (d, J = 6.8 Hz, 3H, 18-CH3), 0.83–0.92 (m, 6H, 16-CH3, 29-H), 1.01 (d, J = 6.8 Hz, 3H, 
10-CH3), 1.22–1.37 (m, 8H, 25-H, 26-H, 27-H, 28-H), 1.65–1.75 (m, 1H, 18-H), 1.90–2.07 
(m, 4H, 10-H, 11-H, 16-H, OH), 2.11–2.41 (m, 7H, 8-H, 14-H, 19-H, 24-H, 11-H), 2.77–2.88 
(m, 1H, 14-H), 2.97–3.04 (m, 1H), 3.41–3.49 (m, 1H, 17-H), 3.61–3.68 (m, 1H, 9-H), 3.71–
3.82 (m, 5H, 8-H, 22-H, OCH3), 3.90–3.99 (m, 1H, 22-H), 5.25–5.32 (m, 1H, 15-H), 5.34–
5.59 (m, 4H, 21-H, 13-H, 12-H, 20-H), 5.69 (br t, J = 5.3 Hz, 1H, NH), 6.30 (d, J = 2.5 Hz, 
1H, 6-H), 6.36 (d, J = 2.5 Hz, 1H, 4-H), 11.51 (br s, 1H, 3-OH); 
HRMS (ESI): [M+Na]+ calcd for C33H51NNaO7 596.35577, found 596.35590. 
 
 
(2R,3S)-3-{[tert-Butyl(dimethyl)silyl]oxy}-2-methylhexanamide (3-97) 
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The Ghosez chloroenamine (N-(1-chloro-2-methyl-1-propenyl)-N,N-dimethylamine) (3-61)140 
(123 µL, 0.92 mmol) was slowly added via syringe to a solution of acid 2-31 (120 mg, 0.46 
mmol) in CH2Cl2 (1 mL) at –5 °C followed by stirring of the mixture for 1 h at that 
temperature. After the solvent was evaporated in vacuo affording the acid chloride as slightly 
yellow oil. The crude acid chloride was redissolved in CH2Cl2 (5 mL) and gaseous ammonia 
was bubbled through this solution during 1 h. The reaction mixture was diluted with H2O and 
extracted trice with CH2Cl2. The combined organic extracts were washed with saturated NaCl 
solution, dried over MgSO4, filtered, and concentrated in vacuo. Flash chromatography 
(petroleum ether/EtOAc/NEt3, 4:1:0.01→2:1:0.01) afforded amide 3-97 (105 mg, 89%) as a 
colorless oil. Rf = 0.49 (petroleum ether/EtOAc/NEt3, 2:1:0.01); [α]20D = –44.0 (c 2.5, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = –0.02, 0.02 (2s, 6H, Si(CH3)2), 0.77–0.83 (m, 12H, 6-
H, Si(C(CH3)3)), 0.99 (d, J = 7.1 Hz, 3H, 2-CH3), 1.11–1.22 (m, 1H, 5-H), 1.31–1.40 (m, 3H, 4-H, 
5-H), 2.36–2.45 (m, 1H, 2-H), 3.65–3.71 (m, 1H, 3-H), 6.37 (br s, 1H, NH), 6.53 (br s, 1H, NH); 
13C NMR (100 MHz, CDCl3): δ = –4.8 (Si(CH3)2), –4.8 (Si(CH3)2), 12.6 (2-CH3), 14.0 (C-6), 
17.8 (Si(C(CH3)3)), 19.0 (C-5), 25.7 (Si(C(CH3)3)), 34.8 (C-4), 45.4 (C-2), 74.4 (C-3), 177.0 
(C-1); 
HRMS (ESI): [M+Na]+ calcd for C13H29NNaO2Si: 282.18598, found 282.18592. 
 
 
E-Vinyl iodide 3-96 
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[Cp2Zr(H)Cl] (31 mg, 0.12 mmol) was added to a solution of alkyne 3-80 (44 mg, 0.06 mmol) 
in THF (1.5 mL) at 0 °C and the resulting mixture was stirred for 2 h at that temperature. A 
solution of I2 (0.24 ml, 0.5M in THF, 0.12 mmol) was then added dropwise and stirring was 
continued for 2 h. The reaction was quenched with saturated aqueous Na2S2O3 solution (5 
mL). The mixture was repeatedly extracted with Et2O. The combined organic layers were 
dried (MgSO4), filtered and evaporated, and the residue was purified by flash chromatography 
(petroleum ether/EtOAc, 4:1) to give E-vinyl iodide 3-96 as an amorphous solid (52 mg, 92%) 
which was used directly in the next step. TLC (petroleum ether/EtOAc, 4:1): Rf = 0.74. 
 
 
Enamide 3-98 
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A Schlenk tube was charged with CuI (10.5 mg, 0.055 mmol, 1 equiv), amide 3-97 (28.5 mg, 
0.11 mmol, 2 equiv), and Cs2CO3 (46 mg, 0.14 mmol, 2.5 equiv). The tube was evacuated and 
backfilled with argon. N,N'-Dimethylethylenediamine (12.0 µL, 0.11 mmol, 2 equiv), vinyl 
iodide 3-96 (52 mg, 0.055 mmol) and THF (1.0 mL) were added under argon. The Schlenk 
tube was closed and immersed in an oil bath, preheated to 60 °C. The mixture was stirred for 
14 h. After the resulting pale blue suspension was allowed to reach room temperature, ethyl 
acetate (5 mL) was added. The reaction mixture was filtered through a pad of celite and the 
filtrate concentrated in vacuo. The residue was purified by flash chromatography (petroleum 
ether/EtOAc, 10:1→4:1) to give enamide 3-98 as an amorphous solid (44 mg, 82%). Rf = 0.66 
(petroleum ether/EtOAc, 4:1); [α]20D = –23.5 (c 1.6, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
0.03–0.07 (m, 6H, Si(CH3)2), 0.08–0.11 (m, 6H, Si(CH3)2), 0.84–0.98 (m, 48H, 24-CH3, 27-H, 
16-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.02–1.10 (m, 6H, 18-CH3, 10-CH3), 1.16–1.26 (m, 
1H, 26-H), 1.31–1.50 (m, 3H, 25-H, 26-H), 1.65–1.75 (m, 2H, 18-H, 16-H), 1.76–1.84 (m, 1H, 
11-H), 1.90–1.99 (m, 1H, 10-H), 2.10–2.27 (m, 2H, 19-H), 2.35–2.54 (m, 5H, 8-H, 14-H, 23-
H, 11-H), 3.45–3.49 (m, 1H, 17-H), 3.72–3.78 (m, 8H, OCH3, 24-H, 8-H), 3.97–4.03 (m, 1H, 
9-H), 4.92–5.01 (m, 1H, 20-H), 5.38–5.51 (m, 1H, 15-H), 6.31 (d, J = 2.0 Hz, 1H, 6-H), 6.41 
(d, J = 2.0 Hz, 1H, 4-H), 6.73 (dd, J = 14.0, 10.6 Hz, 1H, 21-H), 8.08 (br d, J = 10.6 Hz, 1H, 
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NH); 13C NMR (100 MHz, CDCl3): δ = –4.6 (Si(CH3)2), –4.6 (Si(CH3)2), –3.8 (Si(CH3)2), –3.7 
(Si(CH3)2), 11.3 (16-CH3), 12.4 (23-CH3), 13.0 (CH(CH3)2), 14.1 (C-27), 16.7 (10-CH3), 17.9 
(CH(CH3)2), 17.9 (Si(C(CH3)3)), 18.1 (CH(CH3)2), 18.4 (18-CH3), 19.4 (C-26), 23.3 (C-14), 
23.7 (C-11), 25.9 (Si(C(CH3)3)), 26.1 (Si(C(CH3)3)), 32.6 (C-19), 34.7 (C-25), 37.6 (C-18), 
38.1 (C-16), 38.6 (C-8), 40.7 (C-10), 45.6 (C-23), 55.2 (OCH3), 55.7 (OCH3), 74.9 (C-17), 
76.2 (C-9), 77.2 (C-24), 79.7 (C≡C), 81.2 (C≡C), 96.6 (C-4), 108.3 (C-6), 110.9 (C-20), 118.2 
(C-2), 123.4 (C-21), 139.4 (C-7), 157.2 (C-5), 160.2 (C-3), 167.4 (C-1), 170.9 (C-22); 
HRMS (ESI): [M+Na]+ calcd for C54H97NaNO8Si3 994.64142, found 994.64053. 
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To a stirred solution of the enamide 3-98 (10 mg, 0.01 mmol) in THF (0.4 mL, in a plastic test 
tube) was added at –80 °C dropwise HF·pyridine complex (70% HF, 0.3 mL). The reaction 
mixture was allowed to warm to –10 °C. After 2 h the mixture was partioned between an ice-
cooled mixture of EtOAc (20 mL) and saturated aqueous NaHCO3 solution (20 mL). The 
organic layer was separated and the H2O layer extracted with EtOAc (2 × 20 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give 4.4 mg 
(75%) of triol 3-99. Rf = 0.47 (CH2Cl2/MeOH, 9:1); [α]20D = –3.3 (c 0.4, CH2Cl2); 1H NMR 
(400 MHz, CDCl3): δ = 0.81 (d, J = 6.8 Hz, 3H, 18-CH3), 0.90–0.98 (m, 6H, 27-H, 10-CH3), 
1.10 (d, J = 7.1 Hz, 3H, 16-CH3), 1.16 (d, J = 7.3 Hz, 3H, 23-CH3), 1.28–1.39 (m, 2H, 25-H, 26-
H), 1.41–1.51 (m, 2H, 25-H, 26-H), 1.58–1.67 (m, 2H, 19-H, OH), 1.90–2.02 (m, 4H, 18-H, 19-
H, 11-H, OH), 2.05–2.14 (m, 1H, 16-H), 2.29–2.40 (m, 2H, 8-H, 10-H), 2.46–2.63 (m, 3H, 14-
H, 11-H), 2.71–2.79 (m, 1H, 23-H), 2.85 (br s, 1H, OH), 3.29–3.26 (m, 1H, 8-H), 3.45–3.49 (m, 
1H, 17-H), 3.78 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 3.83–3.90 (m, 2H, 9-H, 24-H), 5.10–5.19 
(m, 1H, 20-H), 5.46–5.52 (m, 1H, 15-H), 6.35 (d, J = 2.0 Hz,1H, 6-H), 6.41 (d, J = 2.0 Hz,1H, 
4-H), 6.75 (dd, J = 14.2, 10.4 Hz, 1H, 21-H), 7.52 (d, J = 10.4 Hz, 1H, NH); 
HRMS (ESI): [M+Na]+ calcd for C33H49NaNO8 610.33504, found 610.33433. 
 
 
Enamide analogue 3-100 
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To a stirred solution of diyne 3-99 (4.0 mg, 0.007 mmol) in EtOAc (2 mL) containing 
quinoline (1.4 mg, 0.011 mmol) was added Lindlar’s catalyst (5 wt% Pd on CaCO3, poisoned 
with lead, 4.0 mg, 100 wt%). The reaction was placed under H2 atmosphere and stirred for 1 h. 
The reaction mixture was filtered through a pad of celite and the filtrate concentrated in vacuo. 
The residue was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give 
enamide 3-100 as a colorless oil (3.4 mg, 85%). Rf = 0.52 (CH2Cl2/MeOH, 9:1); [α]20D = –4.3 
(c 0.3, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.83 (d, J = 6.8 Hz, 3H, 18-CH3), 0.93 (t, J 
= 6.8 Hz, 3H, 27-H), 0.98 (d, J = 6.8 Hz, 3H, 16-CH3), 1.05 (d, J = 6.8 Hz, 3H, 10-CH3), 1.16 
(d, J = 7.3 Hz, 3H, 23-CH3), 1.28–1.40 (m, 2H, 25-H, 26-H), 1.42–1.71 (m, 4H, 25-H, 26-H, 
19-H, OH), 1.88–1.99 (m, 4H, 18-H, 19-H, 11-H, 14-H), 2.07–2.21 (m, 1H, 16-H), 2.27–2.37 
(m, 2H, 8-H, 10-H), 2.37–2.50 (m, 1H, 11-H), 2.70–3.00 (m, 4H, 23-H, 14-H, 8-H, OH), 3.45–
3.52 (m, 1H, 17-H), 3.71–3.81 (m, 7H, OCH3, 24-H), 3.85–3.91 (m, 1H, 9-H), 5.09–5.19 (m, 
1H, 20-H), 5.40 (dd, J = 9.9, 4.0 Hz, 1H, 15-H), 5.48–5.54 (m, 2H, 12-H, 13-H), 6.33–6.36 
(m, 2H, 6-H, 4-H), 6.74 (dd, J = 14.2, 10.4 Hz, 1H, 21-H), 7.52 (d, J = 10.4 Hz, 1H, NH); 
HRMS (ESI): [M+Na]+ calcd for C33H51NaNO8 612.35069, found 612.35104. 
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a) ortho-demethylation: A solution of enamide 3-98 (16 mg, 0.016 mmol) in CH2Cl2 (2 mL) 
was treated with BCl3 (64 µL, 1.0 M in CH2Cl2, 0.064 mmol, 4 equiv) at –80 °C. The reaction 
was stirred for 2 h at –80 °C before a saturated solution of NaOAc (5 mL) was added. After 
separation of the layers, the aqueous phase was extracted twice with CH2Cl2. The combined 
organic layers were washed with H2O, saturated NaCl solution, dried over MgSO4, filtered and 
concentrated in vacuo to give 14 mg of crude 2-hydroxy-4-methoxybenzoate which was used 
in the next step without futher purification. 
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b) global deprotection: To a stirred solution of the crude 2-hydroxy-4-methoxybenzoate (14 
mg) in THF (0.8 mL, in a plastic test tube) was added at –80 °C dropwise HF·pyridine 
complex (70% HF, 0.6 mL). The reaction mixture was allowed to warm to –10 °C. After 2 h 
the mixture was partioned between an ice-cooled mixture of EtOAc (20 mL) and saturated 
aqueous NaHCO3 solution (20 mL). The organic layer was separated and the H2O layer 
extracted with EtOAc (2 × 20 mL). The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
(CH2Cl2/MeOH, 95:5 → 9:1) to give 7.6 mg (84% for 2 steps) of triol 3-101. Rf = 0.40 
(CH2Cl2/MeOH, 9:1); [α]20D = +11.5 (c 0.7, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.80 
(d, J = 6.6 Hz, 3H, 18-CH3), 0.88–0.96 (m, 6H, 27-H, 16-CH3), 1.01 (d, J = 6.8 Hz, 3H, 10-
CH3), 1.15 (d, J = 7.1 Hz, 3H, 23-CH3), 1.29–1.56 (m, 6H, 25-H, 26-H, 19-H, 20-H), 1.71–
1.87 (m, 3H, 18H, 19H, 11-H), 2.00–2.35 (m, 6H, 16-H, 8-H, 11-H, 23-H, OH), 2.58–2.85 (m, 
3H, 14-H, 10-H), 2.90 (br s, 1H, OH), 3.24 (dd, J = 9.6, 2.3 Hz, 1H, 24-H), 3.74–3.78 (m, 1H, 
17-H), 3.80 (s, 3H, OCH3), 3.83–3.90 (m, 1H, 8-H), 3.94–4.00 (m, 1H, 9-H), 5.02 (t, J = 8.6 
Hz, 1H, 21-H), 5.26–5.30 (m, 1H, 15-H), 6.20 (br d, J = 8.8 Hz, 1H, NH), 6.36–6.40 (m, 2H, 
4-H, 6-H), 11.2 (br s, 1H, 3-OH); 
HRMS (ESI): [M+Na]+ calcd for C32H47NaNO8 596.31994, found 596.31968. 
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To a stirred solution of alkyne 3-101 (6.0 mg, 0.01 mmol) in EtOAc (2.5 mL) containing 
quinoline (2.1 mg, 0.016 mmol) was added Lindlar’s catalyst (5 wt% Pd on CaCO3, poisoned 
with lead, 6.0 mg, 100 wt%). The reaction was placed under H2 atmosphere and stirred for 1 h. 
The mixture was filtered through a pad of celite and the filtrate concentrated in vacuo. The 
residue was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give analogue 
3-102 as a colorless oil (5.4 mg, 90%). Rf = 0.39 (CH2Cl2/MeOH, 9:1); [α]20D = –7.1 (c 0.5, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.66 (d, J = 6.6 Hz, 3H, 18-CH3), 0.89–0.95 (m, 6H, 
27-H, 16-CH3), 1.05 (d, J = 6.6 Hz, 3H, 10-CH3), 1.15 (d, J = 7.1 Hz, 3H, 23-CH3), 1.27–1.54 
(m, 8H, 25-H, 26-H, 19-H, 20-H), 1.71–1.99 (m, 5H, 18-H, 19-H, 16-H, OH), 2.11–2.21 (m, 2H, 
10-H, 11-H), 2.25–2.34 (m, 2H, 8-H, 14-H), 2.43–2.54 (m, 1H, 14-H), 2.84–2.96 (m, 1H, 11-H), 
3.01 (d, J = 2.5 Hz, 1-H, OH), 3.24 (dd, J = 9.9, 1.5 Hz, 1H, 24-H), 3.62–3.68 (m, 1H, 17-H), 
3.80 (s, 3H, OCH3), 3.82–3.91 (m, 2H, 8-H, 9-H), 5.02–5.09 (m, 1H, 21-H), 5.15 (dd, J = 10.7, 
6.2 Hz, 1H, 15-H), 5.32–5.40 (m, 1H, 13-H), 5.44–5.54 (m, 1H, 12-H), 6.19 (br d, J = 9.1 Hz, 
1H, NH), 6.33 (d, J = 2.5 Hz, 1H, 6-H), 6.36 (d, J = 2.5 Hz, 1H, 4-H), 11.7 (br s, 1H, 3-OH); 
HRMS (ESI): [M+Na]+ calcd for C32H49NaNO8 598.33504, found 598.33534. 
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(4R,5R,6R)-5-{[tert-Butyl(dimethyl)silyl]oxy}-6-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-4-
methylhept-2-yn-1-ol (3-103) 
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To a solution of alkyne 3-36 (2.03 g, 6.2 mmol) in THF (30 mL) was added nBuLi (3.72 mL, 
2.5 M solution in hexane, 9.3 mmol, 1.5 equiv) dropwise at –90 °C. Stirring was continued for 
1 h at –90 °C before paraformaldehyde (1.86 g, 62 mmol, 10 equiv) was added at –90 °C. The 
reaction mixture was allowed to warm to room temperature over 1 h and stirred for an 
additional 1 h. After quenching of the reaction with H2O (20 mL), the mixture was extracted 
with Et2O (3 × 80 mL). The combined organic layers were washed with saturated NaCl 
solution (50 mL), dried over MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography (petroleum ether/EtOAc, 4:1 → 2:1) of the residue afforded alcohol 3-103 
(1.92 g, 87%) as an amorphous solid. Rf = 0.47 (petroleum ether/EtOAc, 4:1); [α]20D = +3.7 (c 
2.3, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.05 (s, 3H, Si(CH3)2), 0.06 (s, 3H, Si(CH3)2), 
0.89 (s, 9H, Si(C(CH3)3)), 0.99 (d, J = 6.8 Hz, 3H, 7-H), 1.14 (d, J = 7.1 Hz, 3H, 4-CH3), 1.32 
(s, 3H, C(CH3)2), 1.39 (s, 3H, C(CH3)2), 1.89–1.98 (m, 1H, 6-H), 2.19 (t, J = 6.0 Hz, 1H, OH), 
2.62–2.70 (m, 1H, 4-H), 3.51–3.56 (m, 1H, 5-H), 3.71–3.77 (m, 1H, 5’-H), 4.00–4.13 (m, 2H, 
5’-H, 4’-H), 4.13–4.23 (m, 2H, 1-H); 13C NMR (100 MHz, CDCl3): δ[ppm] = –4.4 (Si(CH3)2), –
4.2 (Si(CH3)2), 12.0 (C-7), 16.7 (4-CH3), 18.2 (Si(C(CH3)3)), 25.5 (C(CH3)2), 25.7 (Si(C(CH3)3)), 
26.8 (C(CH3)2), 31.9 (C-4), 39.7 (C-6), 51.2 (C-1), 68.0 (C-5’), 75.0 (C-5), 78.3 (C-4’), 80.9 (C-2), 
88.5 (C-3), 108.5 (C(CH3)2); 
HRMS (ESI): [M+Na]+ calcd for C19H36NaO4Si 379.22751, found 349.22761. 
 
 
(4R,5R,6R)-5-{[tert-Butyl(dimethyl)silyl]oxy}-6-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-4-
methylheptan-1-ol (3-104) 
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A 250 mL round-bottom flask was charged with alcohol 3-103 (1.4 g, 3.9 mmol) and a stir bar. 
EtOAc (120 mL) and 10% Pd/C (0.7 g, 50 wt%) were added with stirring. The reaction was 
placed under H2 atmosphere and stirred for 5 h. The reaction mixture was filtered through a 
pad of celite and the filtrate concentrated in vacuo. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 4:1 → 2:1) to give primary alcohol 3-104 as a 
colorless oil (1.32 g, 94%). Rf = 0.66 (petroleum ether/EtOAc, 2:1); [α]20D = –1.5 (c 2.2, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.01, 0.05 (2s, 6H, Si(CH3)2), 0.86–0.92 (m, 12H, 
7-H, Si(C(CH3)3)), 0.97 (d, J = 6.8 Hz, 3H, 4-CH3), 1.03–1.14 (m, 1H, 2-H), 1.33 (s, 3H, 
C(CH3)2), 1.39 (s, 3H, C(CH3)2), 1.43–1.53 (m, 2H, 3-H, 2-H), 1.55–1.69 (m, 3H, 3-H, 4-H, 
OH), 1.72–1.78 (m, 1H, 6-H), 3.39–3.43 (m, 1H, 5-H), 3.55–3.65 (m, 3H, 5’-H, 1-H), 3.95–
4.02 (m, 1H, 5’-H), 4.09 (dd, J = 6.8, 6.8 Hz, 1H, 4’-H); 13C NMR (100 MHz, CDCl3): δ[ppm] 
= –4.3 (Si(CH3)2), –3.9 (Si(CH3)2), 11.4 (C-7), 16.3 (4-CH3), 18.3 (Si(C(CH3)3)), 25.5 (C(CH3)2), 
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26.0 (Si(C(CH3)3)), 26.7 (C(CH3)2), 28.6 (C-2), 30.6 (C-3), 37.8 (C-4), 39.3 (C-6), 62.9 (C-1), 68.2 
(C-5’), 76.3 (C-5), 77.9 (C-4’), 108.6 (C(CH3)2); 
HRMS (ESI): [M+Na]+ calcd for C19H40NaO4Si 383.25881, found 383.25916. 
 
 
tert-Butyl[((1R,2R)-5-[(3,4-dimethoxybenzyl)oxy]-1-{(1R)-1-[(4R)-2,2-dimethyl-1,3-
dioxolan-4-yl]ethyl}-2-methylpentyl)oxy]dimethylsilane (3-105) 
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To a solution of alcohol 3-104 (1.05 g, 2.9 mmol) in CH2Cl2 (15 mL) were added 3,4-
dimethoxybenzyltrichloroacetimidate (2.7 g, 8.7 mmol) and PPTS (1.1 g, 4.4 mmol) at 0 °C. 
The resultant mixture was stirred at room temperature for 3 d before saturated aqueous 
NaHCO3 solution was added. After separation of the layers, the aqueous phase was extracted 
with CH2Cl2. The combined organic layers were washed with saturated NaCl solution, dried 
over MgSO4, filtered and concentrated in vacuo. Flash chromatography (petroleum 
ether/EtOAc, 4:1) afforded DMB ether 3-105 (1.4 g, 95%) as a colorless oil. Rf = 0.49 
(petroleum ether/EtOAc, 4:1); [α]20D = –1.0 (c 4.1, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
0.00, 0.03 (2s, 6H, Si(CH3)2), 0.85–0.90 (m, 12H, Si(C(CH3)3), 2’-H), 0.97 (d, J = 6.8 Hz, 3H, 
2-CH3), 1.03–1.12 (m, 1H, 4-H), 1.31 (s, 3H, C(CH3)2), 1.37 (s, 3H, C(CH3)2), 1.64–1.82 (m, 
5H, 1’-H, 3-H, 2-H, 4-H), 3.35–3.44 (m, 3H, 1-H, 5-H), 3.54–3.61 (m, 1H, 5’’-H), 3.85 (s, 3H, 
OCH3), 3.86 (s, 3H, OCH3), 3.95–4.02 (m, 2H, 5’’-H, 4’’-H), 4.41 (s, 2H, CH2 of DMB), 
6.78–6.87 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ[ppm] = –4.4 (Si(CH3)2), –3.9 
(Si(CH3)2), 11.5 (C-2’), 15.9 (2-CH3), 18.3 (Si(C(CH3)3)), 25.5 (C(CH3)2), 26.0 (Si(C(CH3)3)), 
26.7 (C(CH3)2), 27.9 (C-4), 29.5 (C-3), 38.6 (C-2), 39.2 (C-1’), 55.7 (OCH3), 55.8 (OCH3), 
68.1 (C-5’’), 70.4 (C-5), 72.8 (CH2 of DMB), 76.0 (C-1), 78.4 (C-4’’), 108.3 (C(CH3)2), 
110.8, 110.9, 120.2, 131.1, 148.4, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C28H50NaO6Si 533.32689, found 533.32678. 
 
 
(2R,3R,4R,5R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-8-[(3,4-dimethoxybenzyl)oxy]-3,5-
dimethyloctane-1,2-diol (3-106) 
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CuCl2·2H2O (4.3 g, 24.5 mmol, 10 equiv) was added to a solution of acetal 3-105 (1.25 g, 2.45 
mmol) in CH3CN (100 mL) at –10 °C. The reaction mixture was stirred for 20 h at –5 °C, 
treated with saturated NH4Cl solution (20 mL), and extracted with EtOAc (3 × 50 mL). The 
combined organic layers were washed with water, saturated NH4Cl solution and saturated 
NaCl solution, and dried over MgSO4. After filtration, the solvent was removed under reduced 
pressure, and the residue purified by flash chromatography (petroleum ether/EtOAc, 2:1→1:2) 
to give diol 3-106 (1.07 g, 93%) as a colorless oil. Rf = 0.5 (petroleum ether/EtOAc, 1:2); 
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[α]20D = –2.5 (c 2.7, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.02, 0.05 (2s, 6H, Si(CH3)2), 
0.85–0.93 (m, 15H, Si(C(CH3)3), 3-CH3, 5-CH3), 1.05–1.15 (m, 1H, 7-H), 1.42–1.57 (m, 2H, 
6-H, 7-H), 1.63–1.75 (m, 3H, 5-H, 3-H, 6-H), 2.05 (br s, 1H, OH), 3.39–3.58 (m, 4H, 8-H, 4-
H, 1-H), 3.60–3.64 (m, 1H, 1-H), 3.67–3.73 (m, 1H, 2-H), 3.85 (s, 3H, OCH3), 3.86 (s, 3H, 
OCH3), 4.41 (s, 2H, CH2 of DMB), 6.79–6.88 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): 
δ[ppm] = –4.4 (Si(CH3)2), –3.7 (Si(CH3)2), 9.9 (3-CH3), 16.0 (5-CH3), 18.2 (Si(C(CH3)3)), 
26.0 (Si(C(CH3)3)), 27.8 (C-7), 29.3 (C-6), 37.5 (C-5), 38.1 (C-3), 55.8 (OCH3), 55.9 (OCH3), 
65.2 (C-1), 70.2 (C-8), 72.8 (CH2 of DMB), 74.9 (C-4), 77.8 (C-2), 110.8, 111.1, 120.3, 130.9, 
148.5, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C25H46NaO6Si 493.29559, found 493.29593. 
 
 
tert-Butyl[((1R,2R)-5-[(3,4-dimethoxybenzyl)oxy]-2-methyl-1-{(1R)-1-[(2R)-oxiran-2-
yl]ethyl}pentyl)oxy]dimethylsilane (3-107) 
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To a solution of diol 3-106 (0.94 g, 2.0 mmol) in THF (25 mL) at 0 °C was added NaH (60% 
wt. in mineral oil, 0. 24 g, 6.0 mol, 3.0 equiv). The resulting mixture was warmed to room 
temperature and stirred for 40 min. The mixture was cooled to 0 °C before N-(2,4,6-
triisopropylbenzenesulfonyl)imidazole (3-41) (0.74 g, 2.2 mmol, 1.1 equiv) was added in one 
portion. The reaction mixture was then allowed to warm to room temperature and stirred for 1 
h. The mixture was diluted with water (20 mL) and extracted with Et2O (3 × 50 mL). The 
combined organic layers were washed with saturated NaCl solution (30 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. Flash chromatography (EtOAc/petroleum ether, 
1:10) provided epoxide 3-107 (0.83 g, 1.82 mmol, 92%) as a colorless oil. Rf = 0.51 
(petroleum ether/EtOAc, 4:1); [α]20D = +3.0 (c 1.7, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
0.01, 0.05 (2s, 6H, Si(CH3)2), 0.86–0.91 (m, 12H, Si(C(CH3)3), 2’-H), 1.05 (d, J = 6.8 Hz, 3H, 
2-CH3), 1.30–1.37 (m, 1H, 3-H), 1.44–1.76 (m, 5H, 3-H, 2-H, 4-H, 1’-H), 2.70–2.76 (m, 1H, 
3’’-H), 2.80–2.85 (m, 1H, 3’’-H), 2.78–2.83 (m, 1H, 2’’-H), 3.39–3.45 (m, 2H, CH2ODMB), 
3.50–3.54 (m, 1H, CH(OTBS)), 3.86 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 4.42 (s, 2H, CH2 of 
DMB), 6.79–6.88 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ[ppm] = –4.2 (Si(CH3)2), –
3.8 (Si(CH3)2), 12.7 (C-2’), 16.2 (2-CH3), 18.3 (Si(C(CH3)3)), 26.0 (Si(C(CH3)3)), 27.9 (C-4), 
29.0 (C-3), 37.9 (C-2), 40.1 (C-1’), 47.6 (C-3’’), 55.8 (OCH3), 55.9 (OCH3), 56.3 (C-2’’), 70.5 
(CH2ODMB), 72.9 (CH2 of DMB), 77.5 (CH(OTBS)), 110.8, 111.0, 120.2, 131.1, 148.5, 
148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C25H44NaO5Si 475.28502, found 475.28542. 
 
 
(4S,5R,6R,7R)-6-{[tert-Butyl(dimethyl)silyl]oxy}-10-[(3,4-dimethoxybenzyl)oxy]-5,7-
dimethyl-1-(trimethylsilyl)dec-1-yn-4-ol (3-108) 
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A solution of nBuLi (2.1 mL, 2.5 M in hexane, 5.22 mmol) was added to a solution of 
(trimethylsilyl)acetylene (0.73 mL, 5.22 mmol) in THF (12 mL) at –80 °C in a dropwise 
fashion. The acetylide solution was stirred at –80 °C for 1 h before a solution of BF3·OEt2 
(0.66 mL, 5.22 mmol) was added. Stirring was continued for 50 min at –80 °C. Then, a 
solution of epoxide 3-107 (0.787 g, 1.74 mmol) in THF (3 mL) was added dropwise. The 
reaction was stirred at –80 °C for 20 min and then quenched with saturated NH4Cl solution. 
The layers were separated and the aqueous layer was extracted twice with Et2O. The combined 
organic extracts were dried (MgSO4), filtered, and concentrated in vacuo to afford an oil, 
which was purified by flash chromatography (petroleum ether/EtOAc, 4:1) to furnish alcohol 
3-108 (0.814 g, 85%) as colorless oil. Rf = 0.48 (petroleum ether/EtOAc, 4:1); [α]20D = –4.6 (c 
3.6, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.03, 0.06 (2s, 6H, Si(CH3)2), 0.11 (s, 9H, 
Si(CH3)3), 0.85–0.93 (m, 15H, Si(C(CH3)3), 7-CH3, 5-CH3), 1.05–1.25 (m, 1H, 9-H), 1.39–
1.59 (m, 2H, 8-H, 9-H), 1.62–1.75 (m, 2H, 7-H, 8-H), 1.85–1.93 (m, 1H, 5-H), 2.32 (d, J = 3.5 
Hz, 1H, OH), 2.38 (d, J = 6.6 Hz, 2H, 3-H), 3.41 (t, J = 6.6 Hz, 2H, 10-H), 3.63–3.67 (m, 1H, 
6-H), 3.70–3.76 (m, 1H, 4-H), 3.84 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 4.40 (dd, J = 21.2, 
11.6 Hz, 2H, CH2 of DMB), 6.78–6.89 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ[ppm] 
= –4.4 (Si(CH3)2), –3.6 (Si(CH3)2), 0.0 (Si(CH3)3), 8.6 (5-CH3), 15.6 (7-CH3), 18.2 
(Si(C(CH3)3)), 25.9 (Si(C(CH3)3)), 26.2 (C-3), 27.9 (C-9), 29.5 (C-8), 38.2 (C-7), 38.6 (C-5), 
55.7 (OCH3), 55.8 (OCH3), 70.3 (C-10), 72.8 (CH2 of DMB), 73.4 (C-4), 78.2 (C-6), 87.0 (C-1), 
103.6 (C-2), 110.8, 110.9, 120.2, 131.0, 148.4, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C30H54NaO5Si2 573.34020, found 573.34077. 
 
 
(5R,6R,7S)-5-{(1R)-4-[(3,4-Dimethoxybenzyl)oxy]-1-methylbutyl}-2,2,3,3,6,9,9,10,10-
nonamethyl-7-[3-(trimethylsilyl)prop-2-ynyl]-4,8-dioxa-3,9-disilaundecane (3-109) 
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A solution of alcohol 3-108 (0.80 g, 1.45 mmol) in CH2Cl2 (10 mL) was cooled to –50 °C. 
Then 2,6-lutidine (0.69 ml, 5.8 mmol) followed by TBSOTf (0.54 ml, 2.32 mmol) was added. 
The reaction mixture was allowed to warm to room temperature and stirred for 2 h. The 
mixture was treated with water and extracted with CH2Cl2. The combined organic extracts 
were washed with 1N HCI, saturated NaHCO3 and saturated NaCl solution, dried over MgSO4, 
filtered, and concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc, 20:1) 
afforded bis-silyl ether 3-109 (0.915 g, 95%) as a colorless oil. Rf = 0.74 (petroleum 
ether/EtOAc, 4:1); [α]20D = +4.6 (c 2.8, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.01-0.04 
(m, 9H, Si(CH3)2), 0.08 (s, 3H, Si(CH3)2), 0.11 (s, 9H, Si(CH3)3), 0.85–0.94 (m, 24H, 
Si(C(CH3)3), 7-CH3, 5-CH3), 1.07–1.17 (m, 1H, 9-H), 1.43–1.56 (m, 2H, 8-H, 9-H), 1.59–1.66 
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(m, 1H, 8-H), 1.68–1.77 (m, 1H, 7-H), 1.86–1.94 (m, 1H, 5-H), 2.38 (ddd, J = 30.8, 17.1, 5.7 
Hz, 2H, 3-H), 3.36–3.48 (m, 2H, 10-H), 3.50–3.54 (m, 1H, 6-H), 3.67–3.74 (m, 1H, 4-H), 3.86 
(s, 3H, OCH3), 3.87 (s, 3H, OCH3), 4.42 (s, 2H, CH2 of DMB), 6.79–6.89 (m, 3H, aryl H); 
13C NMR (100 MHz, CDCl3): δ[ppm] = –4.5 (Si(CH3)2), –4.1 (Si(CH3)2), –3.7 (Si(CH3)2), –
3.5 (Si(CH3)2), 0.02 (Si(CH3)3), 10.6 (5-CH3), 16.7 (7-CH3), 18.1 (Si(C(CH3)3)), 18.5 
(Si(C(CH3)3)), 25.9 (Si(C(CH3)3)), 26.2 (Si(C(CH3)3)), 26.7 (C-3), 28.1 (C-9), 28.2 (C-8), 37.8 
(C-7), 40.2 (C-5), 55.8 (OCH3), 55.9 (OCH3), 70.7 (C-10), 72.5 (C-4), 72.8 (CH2 of DMB), 
76.2 (C-6), 86.3 (C-1), 104.6 (C-2), 110.8, 111.0, 120.2, 131.2, 148.4, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C36H68NaO5Si3: 687.42668, found 687.42711. 
 
 
(5R,6R,7S)-5-{(1R)-4-[(3,4-Dimethoxybenzyl)oxy]-1-methylbutyl}-2,2,3,3,6,9,9,10,10-
nonamethyl-7-prop-2-ynyl-4,8-dioxa-3,9-disilaundecane (3-110) 
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To a solution of bis-silyl ether 3-109 (0.91 g, 1.37 mmol) in methanol (25 mL) was added 
anhydrous K2CO3 (1.89 g, 13.7 mmol). The reaction mixture was stirred at room temperature 
for 3 h, then diluted with water (10 mL) and extracted with Et2O (3 × 50 mL). The combined 
organic layers were washed with saturated NaCl solution (20 mL), dried over MgSO4, filtered, 
and concentrated in vacuo. Flash chromatography of the residue (ethyl acetate/petroleum 
ether, 1:4) provided compound 3-110 (0.803 g, 99%) as a colorless oil. Rf = 0.69 (petroleum 
ether/EtOAc, 4:1); [α]20D = +7.6 (c 2.8, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = –0.01–0.03 
(m, 9H, Si(CH3)2), 0.05 (s, 3H, Si(CH3)2), 0.85–0.94 (m, 24H, Si(C(CH3)3), 4-CH3, 6-CH3), 
1.05–1.16 (m, 1H, 2-H), 1.45–1.76 (m, 4H, 2-H, 3-H, 4-H), 1.89 (t, J = 2.3 Hz, 1H, 10-H), 
1.91–2.01 (m, 1H, 6-H), 2.25–2.42 (m, 2H, 8-H), 3.35–3.46 (m, 2H, 1-H), 3.49–3.55 (m, 1H, 
5-H), 3.72 (dd, J = 10.9, 5.1 Hz, 1H, 7-H), 3.83 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 4.40 (s, 
2H, CH2 of DMB), 6.76–6.87 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ[ppm] = –4.7 
(Si(CH3)2), –4.3 (Si(CH3)2), –3.8 (Si(CH3)2), –3.6 (Si(CH3)2), 10.4 (6-CH3), 16.8 (4-CH3), 
17.9 (Si(C(CH3)3)), 18.4 (Si(C(CH3)3)), 25.2 (C-8), 25.7 (Si(C(CH3)3)), 26.1 (Si(C(CH3)3)), 
27.9 (C-2), 28.0 (C-3), 37.5 (C-4), 39.9 (C-6), 55.6 (OCH3), 55.7 (OCH3), 70.2 (C-10), 70.5 
(C-1), 72.0 (C-7), 72.6 (CH2 of DMB), 76.2 (C-5), 81.3 (C-9), 110.7, 110.8, 120.0, 131.1, 
148.3, 148.8 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C33H60NaO5Si2: 615.38715, found 615.38703. 
 
 
(5S,6R,7R)-5-But-2-ynyl-7-{(1R)-4-[(3,4-dimethoxybenzyl)oxy]-1-methylbutyl}-
2,2,3,3,6,9,9,10,10-nonamethyl-4,8-dioxa-3,9-disilaundecane (3-111) 
 
TBSO OTBS
Me
5
9
O
OMe
OMe
2
 
  Experimental Section 200 
To a solution of alkyne 3-110 (0.79 g, 1.33 mmol) in THF (10 mL) was added nBuLi (0.96 
mL, 2.5 M solution in hexane, 2.40 mmol, 1.8 equiv) dropwise at –80 °C. Stirring was 
continued for 1 h at –80 °C before methyl iodide (0.38 mL, 6.65 mmol) was added at –80 °C. 
The reaction mixture was allowed to warm to room temperature over 4 h. After quenching 
with water (3 mL), all volatiles were removed in vacuo and the residue was extracted with 
Et2O (3 × 30 mL). The combined organic layers were washed with saturated NaCl solution (20 
mL), dried over MgSO4, filtered, and concentrated in vacuo to furnish the propyne derivative 
3-111 (0.80 g, 99%). Rf = 0.72 (petroleum ether/EtOAc, 4:1); [α]20D = +4.2 (c 2.0, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.00–0.04 (m, 9H, Si(CH3)2), 0.06 (s, 3H, Si(CH3)2), 0.84–
0.89 (m, 21H, Si(C(CH3)3), 4-CH3), 0.92 (d, J = 6.8 Hz, 3H, 6-CH3), 1.05–1.17 (m, 1H, 2-H), 
1.45–1.57 (m, 3H, 2-H, 3-H) 1.59–1.66 (m, 1H, 4-H), 1.72 (t, J = 2.0 Hz, 3H, 10-CH3), 1.89–
1.97 (m, 1H, 6-H), 2.20–2.36 (m, 2H, 8-H), 3.37–3.47 (m, 2H, 1-H), 3.50–3.54 (m, 1H, 5-H), 
3.69 (dd, J = 10.9, 5.1 Hz, 1H, 7-H), 3.86 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 4.42 (s, 2H, CH2 
of DMB), 6.79–6.89 (m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ[ppm] = –4.5 (Si(CH3)2), 
–4.2 (Si(CH3)2), –3.6 (Si(CH3)2), –3.5 (Si(CH3)2), 3.5 (10-CH3), 10.5 (6-CH3), 17.0 (4-CH3), 
18.1 (Si(C(CH3)3)), 18.5 (Si(C(CH3)3)), 25.6 (C-8), 25.9 (Si(C(CH3)3)), 26.2 (Si(C(CH3)3)), 
27.9 (C-2), 28.2 (C-3), 37.6 (C-4), 40.1 (C-6), 55.8 (OCH3), 55.9 (OCH3), 70.8 (C-1), 72.7 (C-
7), 72.8 (CH2 of DMB), 76.4 (C-9), 76.5 (C-5), 77.2 (C-10), 110.8, 110.9, 120.1, 131.2, 148.4, 
148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C34H62NaO5Si2: 629.40280, found 629.40278. 
 
 
(5S,6R,7R,8R)-11-[(3,4-Dimethoxybenzyl)oxy]-6,8-dimethylundec-2-yne-5,7-diol (3-112) 
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To a solution of silyl ether 3-111 (0.79 g, 1.30 mmol) in THF (2 mL) was added TBAF (6.5 
mL, 1 M in THF) at 0 °C (ice bath). The reaction mixture was allowed to warm to room 
temperature and stirred for 12 h. After addition of saturated NH4Cl solution the mixture was 
extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with saturated 
NaCl solution (20 mL), dried over MgSO4, filtered, and concentrated in vacuo. Flash 
chromatography (petroleum ether/EtOAc, 2:1→1:2) afforded diol 3-112 (0.486 g, 99%) as a 
colorless oil. Rf = 0.56 (petroleum ether/EtOAc, 1:2); [α]20D = +5.2 (c 1.8, CH2Cl2); 1H NMR 
(400 MHz, CDCl3): δ = 0.80 (d, J = 6.8 Hz, 3H, 6-CH3), 0.84 (d, J = 7.1 Hz, 3H, 4-CH3), 1.16–
1.29 (m, 1H, 2-H), 1.48–1.65 (m, 2H, 2-H, 3-H), 1.66–1.75 (m, 2H, 4-H, 3-H), 1.76 (t, J = 2.3 
Hz, 3H, 10-CH3), 1.81–1.88 (m, 1H, 6-H), 2.20–2.43 (m, 2H, 8-H), 3.20 (br s, 2H, OH), 3.40–
3.50 (m, 3H, 1-H, 5-H), 3.84–3.93 (m, 7H, 7-H, OCH3), 4.42 (s, 2H, CH2 of DMB), 6.79–6.88 
(m, 3H, aryl H); 13C NMR (100 MHz, CDCl3): δ[ppm] = 3.5 (10-CH3), 4.1 (6-CH3), 15.6 (4-
CH3), 25.3 (C-8), 26.4 (C-2), 29.2 (C-3), 36.0 (C-4), 36.7 (C-6), 55.8 (OCH3), 55.9 (OCH3), 
70.5 (C-1), 72.9 (CH2 of DMB), 75.5 (C-9), 75.7 (C-7), 77.9 (C-10), 80.7 (C-5), 110.8, 111.0, 
120.3, 130.9, 148.5, 148.9 (aryl C); 
HRMS (ESI): [M+Na]+ calcd for C22H34NaO5: 401.22985, found 401.22968. 
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A solution of diol 3-112 (470 mg, 1.24 mmol) in anhydrous DMF (2.5 mL) was stirred in the 
presence of sodium hydride (60% wt. in mineral oil, 124 mg, 3.1mmol, 2.5 equiv) at 0 °C for 
10 min and for a further 1 h at room temperature. In a separate flask, to a solution of acid 3-50 
(917 mg, 2.0 mmol) in anhydrous DMF (3.5 mL) was added CDI (390 mg, 2.4 mmol), and the 
reaction mixture allowed to stir for 4 h at 50 °C. Then, the solution of the imidazolide 
derivative 3-63 (analyzed by LC-MS) was cooled to 0 °C and added to the above solution of 
the disodium salt of diol 3-112 at 0 °C. The mixture was allowed to warm to room temperature 
and stirred for 3 days. After addition of saturated NH4Cl solution the mixture was extracted 
with EtOAc (3 × 30 mL). The combined organic extracts were washed with 1N HCI, saturated 
NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered and concentrated in vacuo to 
provide 1.01 g of crude hydroxyester 3-113, which was used in the next step without further 
purification.  
A solution of crude hydroxyester 3-113 (1.01 g, 1.23 mmol) in CH2Cl2 (10 mL) was cooled to 
–50 °C, then 2,6-lutidine (0.58 mL, 4.9 mmol) followed by TBSOTf (0.46 mL, 2.0 mmol) 
were added. The reaction mixture was allowed to warm to room temperature and stirred for 2 
h before it was treated with water. After separation of the layers, the aqueous layer was 
extracted with CH2Cl2. The combined organic extracts were washed with 1N HCl, saturated 
NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered and concentrated in vacuo. 
Flash chromatography (petroleum ether/EtOAc, 10:1→4:1) afforded ester 3-114 (0.778 g, 
67% for 2 steps, based on diol 3-112) as a colorless oil. Besides ester 3-114 some unreacted 
imidazolide derivative 3-63 (295 mg, 30%) was isolated. Rf = 0.46 (petroleum ether/EtOAc, 
4:1); [α]20D = +24.8 (c 2.4, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = –0.01, 0.02 (2s, 6H, 
Si(CH3)2), 0.83–0.89 (m, 12H, Si(C(CH3)3), 3’’’-CH3), 0.89 –0.97 (m, 27H, 1’’’-CH3, 3’-CH3, 
Si(CH(CH3)2)3), 1.04–1.11 (m, 1H, 5’’’-H), 1.45–1.58 (m, 3H, 4’’’-H, 5’’’-H), 1.66 (t, J = 2.3 
Hz, 3H, C≡CCH3), 1.71 (t, J = 2.3 Hz, 3H, C≡CCH3), 1.80–1.91 (m, 1H, 3’-H), 1.96–2.05 (m, 
2H, 3’’’-H, 4’-H), 2.07–2.20 (m, 2H, 1’’’-H, 4’-H), 2.49–2.71 (m, 4H, 2’’-H, 1’-H), 3.34–3.40 
(m, 2H, CH2ODMB), 3.50–3.54 (m, 1H, CH(OTBS)), 3.69 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 
3.80–3.84 (m, 6H, OCH3 of DMB), 4.21–4.36 (m, 1H, CH(OTIPS)), 4.37 (s, 2H, CH2 of DMB), 
4.93–5.00 (m, 1H, 1’’-H), 6.24 (d, J = 2.3 Hz, 1H, 5-H), 6.43 (d, J = 2.3 Hz, 3-H), 6.74–6.85 (m, 
3H, aryl H of DMB); 13C NMR (100 MHz, CDCl3): δ = –3.7 (Si(CH3)2), –3.6 (Si(CH3)2), 3.5 
(C≡CCH3), 3.5 (C≡CCH3), 10.3 (1’’’-CH3), 12.9 (CH(CH3)2), 14.6 (3’-CH3), 16.5 
(SiC(CH3)3), 18.0 (CH(CH3)2), 18.2 (CH(CH3)2), 18.5 (3’’’-CH3), 22.1 (C≡CCH2), 22.1 
(C≡CCH2), 26.1 (Si(C(CH3)3)), 28.0 (C-5’’’), 28.7 (C-4’’’), 36.2 (C-1’), 37.5 (C-3’’’), 37.8 
(C-1’’’), 38.8 (C-3’), 55.2 (OCH3), 55.6 (OCH3), 55.8 (OCH3), 55.9 (OCH3), 70.7 (C-6’’’), 
72.8 (CH2 of DMB), 74.6 (CH3C≡C), 74.9 (CH3C≡C), 75.2 (C-2’), 76.0 (CH2C≡C), 76.6 
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(CH2C≡C), 77.9 (C-2’’’), 78.1 (C-1’’), 96.7 (C-3), 107.0 (C-5), 110.8 (ar of DMB), 111.0 (ar 
of DMB), 117.9 (C-1), 120.2 (ar of DMB), 131.2 (ar of DMB), 139.0 (C-6), 148.4 (ar of 
DMB), 148.9 (ar of DMB), 157.8 (C-4), 160.7 (C-2), 167.7 (CO2R); 
HRMS (ESI): [M+Na]+ calcd for C54H88NaO9Si2 959.58591, found 959.58513. 
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To a solution of ester 3-114 (650 mg, 0.69 mmol) in toluene (81 mL) was added a solution of 
(tBuO)3W≡CCMe3 (2-34) (32.8 mg, 0.069 mmol) in toluene (1.0 mL) and the mixture was 
stirred at 85 °C for 3 h. For workup, the solvent was evaporated and the residue purified by 
flash chromatography (petroleum ether/EtOAc, 10:1) to give macrolactone 3-115 as an 
amorphous solid (553 mg, 90%). Rf = 0.63 (petroleum ether/EtOAc, 4:1); [α]20D = –19.0 (c 
2.4, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.01–0.06 (m, 6H, Si(CH3)2), 0.87–0.97 (m, 
36H, 18-CH3, 10-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.03 (d, J = 6.8 Hz, 3H, 16-CH3), 1.40–
1.52 (m, 2H, 20-H), 1.60–1.85 (m, 4H, 19-H, 11-H, 16-H), 1.89–1.98 (m, 1H, 18-H), 2.09–
2.19 (m, 1H, 11-H), 2.35–2.51 (m, 4H, 14-H, 8-H, 10-H), 3.37 (dd, J = 6.4, 6.4 Hz, 2H, 21-H), 
3.48 (dd, J = 4.3, 4.3 Hz, 1H, 17-H), 3.71–3.79 (m, 7H, 8-H, OCH3), 3.84–3.87 (m, 6H, OCH3 
of DMB), 3.98–4.02 (m, 1H, 9-H), 4.40 (s, 2H, CH2 of DMB), 5.35–5.50 (m, 1H, 15-H), 6.30 
(d, J = 2.0, 1H, 6-H), 6.40 (d, J = 2.0, 1H, 4-H), 6.78–6.88 (m, 3H, ar of DMB); 13C NMR 
(100 MHz, CDCl3): δ = –4.0 (Si(CH3)2), –3.7 (Si(CH3)2), 11.2 (16-CH3), 12.9 (CH(CH3)2), 16.7 
(10-CH3), 17.8 (CH(CH3)2), 18.0 (CH(CH3)2), 18.3 (18-CH3), 23.3 (C≡CCH2), 23.5 (C≡CCH2), 
26.1 (Si(C(CH3)3)), 27.7 (C-20), 28.4 (C-19), 37.4 (2C, C-16, C-18), 38.5 (C-8), 40.3 (C-10), 55.1 
(OCH3), 55.7 (OCH3), 55.7 (OCH3), 55.8 (OCH3), 70.3 (C-21), 72.7 (CH2 of DMB), 76.0 (C-15), 
77.2 (C-17), 79.6 (C-9), 81.2 (CH2C≡C), 96.6 (C-3), 108.2 (C-6), 110.8 (ar of DMB), 110.9 (ar of 
DMB), 118.1 (C-2), 120.1 (ar of DMB), 131.1 (ar of DMB), 139.3 (C-7), 148.4 (ar of DMB), 
148.9 (ar of DMB), 157.2 (C-5), 160.2 (C-3), 167.3 (CO2R); 
HRMS (ESI): [M+Na]+ calcd for C50H82NaO9Si2 905.53896, found 905.53829. 
 
 
Alcohol 3-116 
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To a cooled (0 °C) solution of DMB ether 3-115 (540 mg, 0.61 mmol) in a mixture of 
CH2Cl2/pH = 7 phosphate buffer (20:1, 32 mL) was added DDQ (194 mg, 0.85 mmol, 1.4 
equiv). The mixture was allowed to warm to room temperature and stirred for 40 min. Then it 
was treated with saturated NaHCO3 solution and the layers were separated. The aqueous layer 
was extracted with CH2Cl2. The combined organic extracts were washed with saturated 
NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered, and concentrated in vacuo. 
Flash chromatography (petroleum ether/EtOAc, 4:1) afforded alcohol 3-116 (435 mg, 97%) as 
an amorphous solid. Rf = 0.42 (petroleum ether/EtOAc, 4:1); [α]20D = –28.0 (c 4.0, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.02, 0.06 (2s, 6H, Si(CH3)2), 0.86–0.96 (m, 36H, 18-CH3, 
16-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.02 (d, J = 7.1 Hz, 3H, 10-CH3), 1.05–1.10 (m, 1H, 
20-H), 1.38–1.51 (m, 2H, 20-H, 19-H), 1.55–1.73 (m, 3H, 19-H, 11-H, OH), 1.76–1.82 (m, 
1H, 11-H), 1.86–1.97 (m, 1H, 16-H), 2.10–2.18 (m, 1H, 18-H), 2.34–2.51 (m, 4H, 8-H, 14-H, 
10-H), 3.50 (dd, J = 4.3, 4.3 Hz, 1H, 17-H), 3.55 (dd, J = 6.3, 6.3 Hz, 2H, 21-H), 3.70–3.78 
(m, 7H, 8-H, OCH3), 3.76 (s, 3H, OCH3), 3.96–4.02 (m, 1H, 9-H), 5.37–5.50 (m, 1H, 15-H), 
6.31 (d, J = 2.3 Hz, 1H, 6-H), 6.40 (s, J = 2.3 Hz, 1H, 4-H); 13C NMR (100 MHz, CDCl3): δ = 
–4.0 (Si(CH3)2), –3.7 (Si(CH3)2), 11.4 (16-CH3), 12.9 (CH(CH3)2), 16.7 (10-CH3), 17.8 
(Si(C(CH3)3)), 18.0 (CH(CH3)2), 18.3 (18-CH3), 23.2 (C-14), 23.4 (C-11), 26.1 (Si(C(CH3)3)), 
28.0 (C-20), 30.7 (C-19), 37.4 (C-16), 37.4 (C-18), 38.6 (C-8), 40.3 (C-10), 55.1 (OCH3), 55.8 
(OCH3), 62.9 (C-21), 76.0 (C-15), 76.7 (C-17), 77.3 (C≡C), 79.6 (C-9), 81.2 (C-12), 96.7 (C-
4), 108.3 (C-2), 118.1 (C-6), 139.4 (C-7), 157.2 (C-5), 160.2 (C-3), 167.4 (C-1); 
HRMS (ESI): [M+Na]+ calcd for C41H72NaO7Si2 755.47088, found 755.47080. 
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a) Aldehyde 3-117: To a cooled (0 °C) solution of alcohol 3-116 (198 mg, 0.27 mmol) in 
CH2Cl2 (6 mL) was added a solution of Dess-Martin periodinane (15% wt, 1.02 mL, 0.49 
mmol). After stirring for 0.5 h at 0 °C and for 2 h at room temperature, the reaction mixture 
was concentrated, loaded on a flash column, and eluted with petroleum ether/EtOAc, 4:1 to 
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give 188 mg (95%) of aldehyde 3-117, which was used directly in the next reaction. TLC 
(petroleum ether/EtOAc, 4:1): Rf = 0.69. 
b) Alkyne 3-118: Diethyl-1-diazo-2-oxopropylphosphonate (3-79) (124 mg, 0.52 mmol, 
2 equiv) was added to a solution of aldehyde 3-117 obtained in the previous step (188 mg, 
0.26 mmol) and K2CO3 (122 mg, 0.88 mmol, 3.4 equiv) in MeOH (5 mL) followed by stirring 
of the mixture for 12 h at room temperature. The reaction mixture was diluted with Et2O (50 
mL), washed with an aqueous solution (5%) of NaHCO3 (20 mL). The layers were separated 
and the organic layer dried over Na2SO4. After filtration and evaporation of the solvent the 
residue was purified by flash chromatography (EtOAc/petroleum ether, 1:10) to give 179 mg 
(97%) of alkyne 3-118 as an amorphous solid. Rf = 0.78 (petroleum ether/EtOAc, 4:1); [α]20D 
= –32.2 (c 2.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.03–0.07 (m, 6H, Si(CH3)2), 0.86–
0.99 (m, 36H, 16-CH3, 18-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.04 (d, J = 7.1 Hz, 3H, 10-
CH3), 1.20–1.32 (m, 1H, 20-H), 1.61–1.71 (m, 1H, 20-H), 1.75–1.84 (m, 1H, 16-H), 1.87–1.98 
(m, 3H, 19-H, C≡CH), 2.02–2.28 (m, 3H, 10-H, 11-H, 18-H), 2.36–2.47 (m, 4H, 8-H, 14-H, 
11-H), 3.52 (dd, J = 4.3, 4.3 Hz, 1H, 17-H), 3.71–3.79 (m, 7H, 8-H, OCH3), 3.78 (s, 3H, 
OCH3), 3.97–4.02 (m, 1H, 9-H), 5.40–5.52 (m, 1H, 15-H), 6.31 (d, J = 2.0 Hz, 1H, 6-H), 6.41 
(s, J = 2.0 Hz, 1H, 4-H); 13C NMR (100 MHz, CDCl3): δ = –4.0 (Si(CH3)2), –3.6 (Si(CH3)2), 
11.3 (16-CH3), 13.0 (CH(CH3)2), 16.4 (10-CH3), 16.5 (C-20), 17.8 (CH(CH3)2), 18.0 
(CH(CH3)2), 18.4 (18-CH3), 23.2 (C-14), 23.3 (C-11), 26.1 (Si(C(CH3)3)), 30.8 (C-19), 36.5 
(C-18), 37.5 (C-16), 38.6 (C-8), 40.4 (C-10), 55.1 (OCH3), 55.7 (OCH3), 68.4 (C-22), 74.8 
(C≡C), 75.6 (C-15), 77.2 (C-17), 79.6 (C≡C), 81.2 (C≡C), 84.5 (C-9), 96.6 (C-4), 108.2 (C-2), 
118.1 (C-6), 139.4 (C-7), 157.2 (C-5), 160.2 (C-3), 167.3 (C-1); 
HRMS (ESI): [M+Na]+ calcd for C42H70NaO6Si2 749.46031, found 749.46039. 
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[Cp2Zr(H)Cl] (38 mg, 0.14 mmol) was added to a solution of alkyne 3-118 (51 mg, 0.07 
mmol) in THF (1.5 mL) at 0 °C and the resulting mixture was stirred for 2 h at that 
temperature. A solution of I2 (0.28 ml, 0.5M in THF, 0.14 mmol) was then added dropwise 
and stirring was continued for 2 h. The reaction was quenched with saturated aqueous Na2S2O3 
solution (5 mL), and the mixture was repeatedly extracted with Et2O. The combined organic 
layers were dried (MgSO4), filtered and evaporated. The residue was purified by flash 
chromatography (petroleum ether/EtOAc, 4:1) to give E-vinyl iodide 3-119 as an amorphous 
solid (66 mg, 95%). Rf = 0.77 (petroleum ether/EtOAc, 4:1); [α]20D = –21.0 (c 3.6, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.03–0.07 (m, 6H, Si(CH3)2), 0.84–0.97 (m, 36H, 16-CH3, 
18-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.04 (d, J = 6.8 Hz, 3H, 10-CH3), 1.20–1.26 (m, 1H, 
20-H), 1.43–1.54 (m, 1H, 19-H), 1.64–1.72 (m, 1H, 20-H), 1.74–1.82 (m, 1H, 16-H), 1.87–
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1.98 (m, 2H, 19-H, 18-H), 2.02–2.20 (m, 2H, 10-H, 11-H), 2.37–2.48 (m, 4H, 8-H, 14-H, 11-
H), 3.52 (dd, J = 4.3, 4.3 Hz, 1H, 17-H), 3.72–3.81 (m, 7H, 8-H, OCH3), 3.97–4.02 (m, 1H, 9-
H), 5.39–5.44 (m, 1H, 15-H), 5.90 (d, J = 14.4 Hz, 1H, 22-H), 6.33 (d, J = 2.0 Hz, 1H, 6-H), 
6.36–6.45 (m, 2H, 4-H, 21-H); 13C NMR (100 MHz, CDCl3): δ = –4.0 (Si(CH3)2), –3.6 
(Si(CH3)2), 11.5 (16-CH3), 13.0 (CH(CH3)2), 16.4 (10-CH3), 16.5 (C-20), 17.9 (CH(CH3)2), 
18.1 (CH(CH3)2), 18.4 (18-CH3), 23.2 (C-14), 23.2 (C-11), 26.1 (Si(C(CH3)3)), 30.8 (C-19), 
34.1 (C-20), 37.4 (C-18), 37.5 (C-16), 38.6 (C-8), 40.0 (C-10), 55.2 (OCH3), 55.8 (OCH3), 
74.5 (C-22), 75.4 (C-15), 77.2 (C-17), 79.6 (C≡C), 81.4 (C-9), 96.6 (C-4), 108.4 (C-2), 118.0 
(C-6), 139.4 (C-7), 146.6 (C-21), 157.3 (C-5), 160.3 (C-3), 167.3 (C-1); 
HRMS (ESI): [M+Na]+ calcd for C42H71INaO6Si2 877.37261, found 877.37329. 
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A Schlenk tube was charged with CuI (14.0 mg, 0.075 mmol, 1 equiv), amide 3-97 (39 mg, 
0.15 mmol, 2 equiv), and Cs2CO3 (62 mg, 0.19 mmol, 2.5 equiv). The tube was evacuated and 
backfilled with argon. N,N'- Dimethylethylenediamine (16.0 µL, 0.15 mmol, 2eq), vinyl 
iodide 3-119 (64 mg, 0.075 mmol) and THF (1.0 mL) were added under argon. The Schlenk 
tube was closed with a glass stopper, immersed in a preheated to 60 °C oil bath and the 
reaction mixture was stirred for 14 h. After the resulting pale blue suspension was allowed to 
reach room temperature, ethyl acetate (5 mL) was added and the reaction mixture was filtered 
through a pad of celite and the filtrate concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (petroleum ether/EtOAc, 10:1→4:1) to give enamide 3-120 as an 
amorphous solid (63 mg, 85%). Rf = 0.72 (petroleum ether/EtOAc, 4:1); [α]20D = –23.9 (c 1.3, 
CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.02–0.07 (m, 6H, Si(CH3)2), 0.08–0.10 (m, 6H, 
Si(CH3)2), 0.85–1.01 (m, 48H, 24-CH3, 28-H, 16-CH3, Si(C(CH3)3), Si(CH(CH3)2)3), 1.02–
1.10 (m, 6H, 18-CH3, 10-CH3), 1.16–1.27 (m, 3H, 20-H, 27-H), 1.30–1.52 (m, 5H, 26-H, 27-
H, 18-H, 19-H), 1.74–1.83 (m, 1H, 16-H), 1.86–1.99 (m, 2H, 10-H, 11-H), 2.04–2.19 (m, 2H, 
19-H, 11-H), 2.36–2.55 (m, 5H, 8-H, 14-H, 24-H), 3.43–3.48 (m, 1H, 17-H), 3.71–3.79 (m, 
7H, OCH3, 25-H), 3.97–4.03 (m, 1H, 9-H), 4.94–5.03 (m, 1H, 21-H), 5.35–5.49 (m, 1H, 15-
H), 6.31 (d, J = 2.0 Hz, 1H, 6-H), 6.41 (d, J = 2.0 Hz, 1H, 4-H), 6.73 (dd, J = 14.2, 10.6 Hz, 
1H, 22-H), 8.08 (br d, J = 10.6 Hz, 1H, NH); 13C NMR (100 MHz, CDCl3): δ = –4.6 
(Si(CH3)2), –4.6 (Si(CH3)2), –3.8 (Si(CH3)2), –3.7 (Si(CH3)2), 11.2 (16-CH3), 12.6 (24-CH3), 
13.0 (CH(CH3)2), 14.1 (C-28), 16.5 (10-CH3), 17.9 (Si(C(CH3)3)), 17.9(CH(CH3)2), 18.1 
(CH(CH3)2), 18.4 (18-CH3), 19.3 (C-27), 23.3 (C-14), 23.6 (C-11), 25.9 (Si(C(CH3)3)), 26.2 
(Si(C(CH3)3)), 27.7 (C-20), 32.5 (C-19), 34.7 (C-26), 37.0 (C-18), 37.6 (C-16), 38.6 (C-8), 
40.6 (C-10), 45.6 (C-24), 55.2 (OCH3), 55.7 (OCH3), 75.0 (C-17), 76.1 (C-9), 76.8 (C-15), 
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77.2 (C-25), 79.6 (C≡C), 81.2 (C≡C), 96.7 (C-4), 108.3 (C-6), 112.2 (C-21), 118.2 (C-2), 
122.6 (C-22), 139.4 (C-7), 157.2 (C-5), 160.2 (C-3), 167.4 (C-1), 171.0 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C55H99NNaO8Si3 1008.65707, found 1008.65733. 
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To a stirred solution of the enamide 3-120 (12 mg, 0.012 mmol) in THF (0.4 mL, in a plastic 
test tube) was added at –80 °C dropwise HF·pyridine complex (70% HF, 0.3 mL). The 
reaction mixture was allowed to warm to –10 °C. After 2 h the mixture was partioned between 
an ice-cooled mixture of EtOAc (20 mL) and saturated aqueous NaHCO3 solution (20 mL). 
The organic layer was separated and the H2O layer extracted with EtOAc (2 × 20 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo. The 
residue was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give 6.1 mg 
(85%) of triol 3-121. Rf = 0.38 (CH2Cl2/MeOH, 9:1); [α]20D = –4.2 (c 1.2, CH2Cl2); 1H NMR 
(400 MHz, CDCl3): δ = 0.84 (d, J = 6.8 Hz, 3H, 18-CH3), 0.91 (t, J = 7.1 Hz, 3H, 28-H), 0.99 
(d, J = 7.1 Hz, 3H,10-CH3), 1.10 (d, J = 7.1 Hz, 3H, 16-CH3), 1.14 (d, J = 7.1 Hz, 3H, 24-
CH3), 1.24–1.50 (m, 5H, 26-H, 27-H, 20-H), 1.55–1.77 (m, 4H, 19-H, 20-H, OH), 1.89–2.02 
(m, 3H, 18-H, 19-H, 11-H), 2.05–2.20 (m, 3H, 16-H, 24-H, 11-H), 2.24–2.33 (m, 1H, 8-H), 
2.46–2.62 (m, 3H, 14-H, 10-H, OH), 2.73–2.82 (m, 1H, 14-H), 3.09 (br s, 1H, OH), 3.27 (dd, J 
= 13.8, 2.7 Hz, 1H, 8-H), 3.38–3.44 (m, 1H, 17-H), 3.75–3.89 (m, 8H, OCH3, 9-H, 25-H), 
5.01–5.10 (m, 1H, 21-H), 5.42–5.50 (m, 1H, 15-H), 6.34 (d, J = 2.0 Hz,1H, 6-H), 6.40 (d, J = 
2.0 Hz,1H, 4-H), 6.70 (dd, J = 14.2, 10.4 Hz, 1H, 22-H), 7.68 (d, J = 10.4 Hz, 1H, NH); 
HRMS (ESI): [M+Na]+ calcd for C34H51NNaO8 624.35069, found 624.35092. 
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A 5 mL round-bottom flask was charged with diyne 3-121 (3.0 mg, 0.005 mmol) and a stir 
bar. EtOAc (2 mL) and quinoline (1.0 mg, 0.08 mmol) were added with stirring. This was 
followed by the addition of Lindlar’s catalyst (5 wt% Pd on CaCO3, posioned with lead, 3 mg, 
100 wt%). The reaction was placed under H2 atmosphere and stirred for 1 h. The reaction 
mixture was filtered through a pad of celite and the filtrate concentrated in vacuo. The residue 
was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give enamide 3-122 as 
a colorless oil (2.7 mg, 90%). Rf = 0.41 (CH2Cl2/MeOH, 9:1); [α]20D = –5.6 (c 0.2, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.84–0.89 (m, 6H, 28-H, 18-CH3), 1.01–1.06 (m, 6H, 10-
CH3, 16-CH3), 1.14 (d, J = 7.1 Hz, 3H, 24-CH3), 1.21–1.31 (m, 4H, 26-H, 27-H, 20-H), 1.34–
1.49 (m, 2H, 26-H, 27-H), 1.57 (br s, 1H, OH), 1.63–1.75 (m, 2H, 18-H, 19-H), 1.81–2.07 (m, 
5H, 10-H, 11-H, 16-H, 19-H, 8-H), 2.15–2.24 (m, 1H, 14-H), 2.25–2.40 (m, 1H, 24-H), 2.58 
(br s, 1H, OH), 2.74–2.86 (m, 1H, 11-H), 2.92–3.00 (m, 1H, 8-H), 2.82 (dt, J = 14.3, 11.5 Hz, 
1H, 14-H), 3.29–3.39 (m, 2H, 17-H, OH), 3.69–3.76 (m, 4H, 25-H, OCH3), 3.77–3.83 (m, 4H, 
9-H, OCH3), 5.10–5.19 (m, 1H, 21-H), 5.36 (dd, J = 10.2, 3.2 Hz, 1H, 15-H), 5.41–5.56 (m, 
2H, 12-H, 13-H), 6.32–6.36 (m, 2H, 6-H, 4-H), 6.76 (dd, J = 14.2, 10.6 Hz, 1H, 22-H), 7.69 
(d, J = 10.4 Hz, 1H, NH); 
HRMS (ESI): [M+Na]+ calcd for C34H53NO8Na 626.36689, found 626.36672. 
 
 
Oxazinane-4-one 3-123 
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a) ortho-demethylation: A solution of enamide 3-120 (18 mg, 0.018 mmol) in CH2Cl2 (2 
mL) was treated with BCl3 (72 µL, 1.0 M in CH2Cl2, 0.072 mmol, 4 equiv) at –80 °C. The 
reaction was stirred for 2 h at –80 °C before a saturated solution of NaOAc (5 mL) was added. 
After separation of the layers, the aqueous phase was extracted twice with CH2Cl2. The 
combined organic layers were washed with H2O, saturated NaCl solution, dried over MgSO4, 
filtered and concentrated in vacuo to give 17 mg of crude 2-hydroxy-4-methoxybenzoate 
which was used in the next step without futher purification. 
b) global deprotection: To a stirred solution of the crude 2-hydroxy-4-methoxybenzoate 
(17 mg) in THF (0.8 mL, in a plastic test tube) was added at –80 °C dropwise HF·pyridine 
complex (70% HF, 0.6 mL). The reaction mixture was allowed to warm to –10 °C. After 2 h 
the mixture was partioned between an ice-cooled mixture of EtOAc (20 mL) and saturated 
aqueous NaHCO3 solution (20 mL). The organic layer was separated and the H2O layer 
extracted with EtOAc (2 × 20 mL). The combined organic layers were dried over MgSO4, 
filtered, and concentrated in vacuo. The residue was purified by flash chromatography 
(CH2Cl2/MeOH, 95:5 → 9:1) to give 9.2 mg (87% for 2 steps) of triol 3-123. Rf = 0.38 
(CH2Cl2/MeOH, 9:1); [α]20D = +14.0 (c 0.4, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.82 
(d, J = 6.6 Hz, 3H, 18-CH3), 0.91–0.97 (m, 6H, 28-H, 16-CH3), 1.04 (d, J = 7.1 Hz, 3H, 10-
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CH3), 1.19 (d, J = 7.3 Hz, 3H, 24-CH3), 1.27–1.75 (m, 10H, 19-H, 26-H, 27-H, 20-H, 21-H), 
1.95–2.21 (m, 4H, 18-H, 16-H, 11-H, OH), 2.28–2.36 (m, 3H, 8-H, 24-H, OH), 2.54–2.73 (m, 
3H, 14-H, 10-H, 11-H), 2.78–2.86 (m, 1H, 14-H), 3.53 (d, J = 8.8 Hz, 1H, 17-H), 3.69–3.78 
(m, 2H, 25-H, 8-H), 3.80 (s, 3H, OCH3), 3.91–3.99 (m, 1H, 9-H), 4.79 (t, J = 5.6 Hz, 1H, 22-
H), 5.37–5.43 (m, 1H, 15-H), 6.38–6.40 (m, 2H, 4-H, 6-H), 6.76 (br s, 1H, NH), 11.1 (br s, 
1H, 3-OH); 13C NMR (100 MHz, CDCl3): δ = 7.9 (16-CH3), 12.0 (24-CH3), 14.0 (C-28), 16.4 
(18-CH3), 16.7 (10-CH3), 18.8 (C-27), 20.9, 21.7 (C-14), 22.3 (C-11), 29.7 (C-20), 32.5 (C-
19), 33.3 (C-21), 35.6 (C-26), 36.0, 36.3 (C-18), 37.8 (C-16), 38.2 (C-8), 40.0 (C-24), 55.4 
(OCH3), 71.0 (C-25), 75.1 (C-9), 76.2 (C-15), 77.2 (C≡C), 79.0 (C≡C), 83.0 (C-22), 84.0, 99.4 
(C-4), 110.2 (C-6), 142.0 (C-7), 162.0 (C-5), 163.0 (C-3), 170.2 (C-1), 175.0 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C33H49NaNO8 610.33504, found 610.33543. 
 
 
Oxazinan-4-one analogue 3-124 
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A 10 mL round-bottom flask was charged with alkyne 3-123 (9.0 mg, 0.015 mmol) and a stir 
bar. EtOAc (5 mL) and quinoline (3.0 mg, 0.024 mmol) were added with stirring. This was 
followed by the addition of Lindlar’s catalyst (5 wt% Pd on CaCO3, posioned with lead, 9 mg, 
100 wt%). The reaction was placed under H2 atmosphere and stirred for 1 h. The reaction 
mixture was filtered through a pad of celite and the filtrate concentrated in vacuo. The residue 
was purified by flash chromatography (CH2Cl2/MeOH, 95:5 → 9:1) to give analogue 3-124 as 
a colorless oil (8.4 mg, 93%). Rf = 0.38 (CH2Cl2/MeOH, 9:1); [α]20D = –9.4 (c 0.8, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.78 (d, J = 6.6 Hz, 3H, 18-CH3), 0.89–0.96 (m, 6H, 28-H, 
16-CH3), 1.01 (d, J = 6.8 Hz, 3H, 10-CH3), 1.17 (d, J = 7.3 Hz, 3H, 24-CH3), 1.27–1.60 (m, 
10H, 19-H, 26-H, 27-H, 20-H, 21-H), 1.82 (br s, 1H, OH), 1.93–2.10 (m, 3H, 18-H, 11-H, 16-
H), 2.17–2.42 (m, 5H, 10-H, 14-H, 11-H, 8-H), 2.78–2.89 (m, 1H, 24-H), 3.38–3.47 (m, 1H, 
17-H), 3.62–3.75 (m, 3H, 9-H, 8-H, 25-H), 3.79 (s, 3H, OCH3), 4.71 (t, J = 4.6 Hz, 1H, 22-H), 
5.23 (dd, J = 11.0, 4.2 Hz, 1H, 15-H), 5.38–5.54 (m, 2H, 12-H, 13-H), 6.30 (d, J = 2.5 Hz, 1H, 
6-H), 6.36 (d, J = 2.5 Hz, 1H, 4-H), 6.40 (br s, 1H, NH), 11.6 (br s, 1H, 3-OH); 13C NMR (100 
MHz, CDCl3): δ = 9.0 (16-CH3), 12.0 (24-CH3), 14.0 (C-28), 14.2 (18-CH3), 15.8 (10-CH3), 
18.9 (C-27), 20.8 (C-20), 29.4 (C-14), 29.7 (C-11), 31.6 (C-19), 32.0 (C-21), 33.3 (C-26), 36.3, 
36.7, 37.1 (C-18), 37.8 (C-16), 38.3 (C-8), 38.8 (C-24), 40.1 (C-10), 55.4 (OCH3), 72.9 (C-25), 
75.5 (C-9), 78.0 (C-15), 83.8 (C-22), 99.7 (C-4), 104.8 (C-2), 112.4 (C-6), 125.6 (C-13), 132.3 
(C-12), 143.6 (C-7), 163.6 (C-5), 165.9 (C-3), 171.5 (C-1), 174.6 (C-23); 
HRMS (ESI): [M+Na]+ calcd for C33H51NaNO8 612.35069, found 612.35076. 
 
 
Methyl (3S)-3-hydroxyhexanoate (8-15)184 
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A 100-mL, dry Schlenk tube was charged with methyl 3-oxobutanoate (8-7) (21.6 g, 0.15 mol) 
and degassed methanol (50 mL). The resulting solution was further degassed and then 
transferred by cannula to a dry, argon-filled, 500 mL Parr hydrogenation vessel. To this 
mixture was added the in situ prepared [(S)-2,2'-Bis(diphenylphosphino)-1,1'-
binaphthyl]ruthenium(II) complex (120 mg, 0.14 mmol, 0.09 mol%) in degassed methanol (5 
mL) under a stream of argon. The hydrogenation vessel was attached to a hydrogen source and 
hydrogen was introduced into the reaction vessel until the pressure gauge indicates 2 atm. The 
pressure was carefully released to 1 atm by opening the stop valve. This procedure was 
repeated three times, and finally hydrogen was pressurized to 5 atm. The yellowish orange 
solution was vigorously shaked at 90 °C for 24 h during which time the hydrogen cylinder was 
kept connected. After the reaction mixture was allowed to cool to room temperature, the stop 
valve was opened, excess hydrogen was carefully bled off, and the apparatus was 
disassembled. The resulting orange solution was poured into a 250 mL, round-bottomed flask, 
and the hydrogenation vessel was rinsed with dichloromethane (3 × 25 mL). The solvent was 
removed by a rotary evaporator, and the residue was distilled to give 20.45 g (0.14 mol, 93% 
yield) of methyl (3S)-3-hydroxyhexanoate (8-15) (98% ee, bp 65 °C, 1 mm Hg). Rf = 0.56 
(petroleum ether/EtOAc, 2:1); [α]20D = +24.3 (c 3.5, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 
0.91 (t, J = 7.1 Hz, 3H, 5-CH3), 1.30–1.55 (m, 4H, 4-H, 5-H), 2.35–2.54 (m, 2H, 2-H), 2.88 (d, J = 
3.3 Hz, 1H, OH), 3.69 (s, 3H, OCH3), 3.94–4.06 (m, 1H, 3-H); 13C NMR (100 MHz, CDCl3): δ = 
13.9 (5-CH3), 18.6 (C-5), 38.6 (C-4), 41.1 (C-2), 51.7 (OCH3), 67.7 (C-3), 173.5 (C-1); 
HRMS (ESI): calcd for C7H14NaO3 [M+Na]+: 169.08352, found 169.08335. 
 
 
Methyl (3S)-3-{[tert-butyl(diphenyl)silyl]oxy}hexanoate (8-16) 
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To a solution of methyl (3S)-3-hydroxyhexanoate (8-15) (7.30 g, 50.0 mmol) in anhydrous 
DMF (70 mL) were added imidazole (6.80 g, 100 mmol), DMAP (122 mg, 1 mmol), and 
TBDPS-chloride (16.44 g, 15.6 mL, 60 mmol) at 0 °C. The mixture was stirred for 12 h while 
it warmed to room temperature, and then diluted with water (100 mL). The product was 
extracted with CH2CI2 (3 × 75 mL). The combined organic extracts were washed with 1N HCI, 
saturated NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered, and concentrated 
in vacuo. Flash chromatography of the residue (petroleum ether/EtOAc, 20:1) afforded silyl 
ether 8-16 (19.26 g, 99% yield) as a colorless oil. Rf = 0.49 (petroleum ether/EtOAc, 10:1); 
[α]20D = +16.3 (c 1.6, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.71 (t, J = 7.3 Hz, 3H, 5-
CH3), 1.03 (s, 9H, Si(C(CH3)3)), 1.16–1.30 (m, 2H, 5-H), 1.39–1.46 (m, 2H, 4-H), 2.38–2.53 
(m, 2H, 2-H), 3.54 (s, 3H, OCH3), 4.15–4.23 (m, 1H, 3-H), 7.33–7.45 (m, 6H, mCH, pCH ar 
Ph), 7.64–7.71 (m, 4H, oCH ar Ph); 13C NMR (100 MHz, CDCl3): δ = 13.9 (5-CH3), 17.9 (C-
5), 19.3 (Si(C(CH3)3)), 26.9 (Si(C(CH3)3)), 39.3 (C-4), 41.9 (C-2), 51.3 (OCH3), 70.2 (C-3), 
127.5, 129.5, 134.0, 134.2, 135.9, 135.9 (C of SiPh2), 172.0 (C-1); 
HRMS (ESI): calcd for C23H32NaO3Si [M+Na]+: 407.20129, found 407.20119. 
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(3S)-3-{[tert-Butyl(diphenyl)silyl]oxy}hexanal (8-17)252 
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To a solution of ester 8-16 (14.3 g, 37.2 mmol) in dry dichloromethane (200 mL), at –80 °C, 
was added dropwise diisobutylaluminium hydride (1M in hexanes, 39.0 mL, 39.0 mmol, 1.05 
equiv). The solution was stirred at –80 °C for 30 min, quenched with saturated aqueous NH4Cl 
solution and warmed up to room temperature. It was then treated with saturated potassium 
sodium tartrate solution (Rochelle salt)/Et2O (400:400 ml) and the mixture was vigorously 
stirred for 10 min. After the layers were separated, the water layer was extracted with Et2O (3 
× 100 mL). The combined organic extracts were washed with saturated NaCl solution, dried 
over MgSO4, filtered, and concentrated in vacuo. Flash chromatography of the residue 
(petroleum ether/EtOAc, 10:1) afforded aldehyde 8-17 (12.91 g, 98% yield) as a colorless oil. 
Rf = 0.53 (petroleum ether/EtOAc, 10:1); [α]20D = +5.8 (c 1.2, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.74 (t, J = 7.3 Hz, 3H, 5-CH3), 1.04 (s, 9H, Si(C(CH3)3)), 1.16–1.30 (m, 2H, 5-
H), 1.46–1.54 (m, 2H, 4-H), 2.47 (dd, J = 5.6, 2.5 Hz, 2H, 2-H), 4.17–4.24 (m, 1H, 3-H), 
7.35–7.46 (m, 6H, mCH, pCH ar Ph), 7.64–7.70 (m, 4H, oCH ar Ph), 9.70 (t, J = 2.5 Hz, 1H, 
CHO); 13C NMR (100 MHz, CDCl3): δ = 13.8 (5-CH3), 18.1 (C-5), 19.3 (Si(C(CH3)3)), 26.9 
(Si(C(CH3)3)), 39.5 (C-4), 50.2 (C-2), 69.1 (C-3), 127.6, 127.7, 129.7, 129.8, 133.7, 133.9, 
135.8, 135.9 (C of SiPh2), 202.2 (C-1); 
HRMS (ESI): calcd for C22H30NaO2Si [M+Na]+: 377.19073, found 377.19095. 
 
 
(4S,6S)-6-{[tert-Butyl(diphenyl)silyl]oxy}non-1-en-4-ol (8-18) 
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To a cooled (–20 °C) solution of (R,R)-6-82 (17.7 g, 32.0 mmol, 1.1 equiv) in CH2Cl2 (160 
mL) was added a solution of aldehyde 8-17 (10.3 g, 29.1 mmol, 1.0 equiv) in CH2Cl2 (20 mL). 
The mixture was then placed in a freezer (–10 °C) and maintained at that temperature for 24 h 
(without stirring). The reaction was quenched, while still cold, with 1N HCl (100 mL) and 
EtOAc (100 mL) and the mixture was vigorously stirred at room temperature for 15 min. The 
resulting white precipitate of (R,R)-N,N’-bis-(4-bromo-benzyl)-cyclohexane-1,2-diamine 
dihydrochloride was filtered off, washed with Et2O (3 × 50 mL) and dried in vacuo (recovered 
15.2 g, 91% of (R,R)-diamine dihydrochloride). The combined filtrates were poured into a 
separatin funnel, and the layers were separated. The aqueous layer was extracted with Et2O (3 
× 100 mL). The combined organic extracts were washed with H2O (100 mL), saturated NaCl 
solution (100 mL), dried (MgSO4), and filtered. The filtrate was concentrated in vacuo to give 
the crude product, which was purified by flash chromatography (petroleum ether/EtOAc, 20:1 
to 10:1) to give homoallylic alcohol 8-18 (10.03 g, 87%) as a colorless oil. Rf = 0.47 
(petroleum ether/EtOAc, 10:1); [α]20D = +11.1 (c 2.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 0.67 (t, J = 7.3 Hz, 3H, 8-CH3), 0.98–1.19 (m, 11H, Si(C(CH3)3), 8-H), 1.38–1.48 (m, 1H, 7-
H), 1.55–1.73 (m, 3H, 7-H, 5-H), 2.11–2.28 (m, 2H, 3-H), 3.16 (d, J = 1.5 Hz, 1H, OH), 3.96–
4.05 (m, 2H, 4-H, 6-H), 5.04–5.07 (m. 1H, 1-H), 5.08–5.12 (m, 1H, 1-H), 5.74–5.87 (m, 1H, 
2-H), 7.36–7.47 (m, 6H, mCH, pCH ar Ph), 7.69–7.76 (m, 4H, oCH ar Ph); 13C NMR (100 
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MHz, CDCl3): δ = 13.8 (8-CH3), 18.4 (C-8), 19.2 (Si(C(CH3)3)), 27.0 (Si(C(CH3)3)), 38.0 (C-
7), 40.5 (C-5), 42.2 (C-3), 67.6 (C-4), 72.2 (C-6), 117.2 (C-1), 127.5, 127.6, 129.7, 129.7, 
133.5, 133.8 (C of SiPh2), 134.9 (C-2), 135.9 (C of SiPh2); 
HRMS (ESI): calcd for C25H36NaO2Si [M+Na]+: 419.23768, found 419.23775. 
 
 
tert-Butyl{[(1S,3S)-3-methoxy-1-propylhex-5-enyl]oxy}diphenylsilane (8-19) 
 
MeO OTBDPS
1 3 5 7
 
 
To a solution of alcohol 8-18 (6.25 g, 15.8 mmol) in CH2Cl2 (200 mL), protected from light, 
were added Me3OBF4 (8.2 g, 55.3 mmol) and proton sponge (16.9 g, 79.0 mmol) at room 
temperature, followed by stirring of the mixture for 48 h. After complete reaction (monitoring 
by TLC), water was added (50 ml) and the mixture extracted with CH2Cl2. The combined 
organic extracts were washed with 1N HCI, saturated NaHCO3 and saturated NaCl solution, 
dried over MgSO4, filtered, and concentrated in vacuo. Flash chromatography of the residue 
(petroleum ether/EtOAc, 40:1 to 20:1) afforded methyl ether 8-19 (5.66 g, 87% yield) as a 
colorless oil. Rf = 0.63 (petroleum ether/EtOAc, 10:1); [α]20D = +14.9 (c 3.0, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.75 (t, J = 7.3 Hz, 3H, 8-CH3), 1.09 (s, 9H, Si(C(CH3)3)), 
1.19–1.38 (m, 2H, 8-H), 1.40–1.47 (m, 2H, 7-H), 1.59–1.65 (m, 2H, 5-H), 2.15–2.22 (m, 2H, 
3-H), 3.13 (s, 3H, OCH3), 3.33–3.41 (m, 1H, 4-H), 3.97–4.05 (m, 1H, 6-H), 5.01–5.05 (m. 1H, 
1-H), 5.06–5.08 (m. 1H, 1-H), 5.67–5.79 (m, 1H, 2-H), 7.36–7.47 (m, 6H, mCH, pCH ar Ph), 
7.71–7.76 (m, 4H, oCH ar Ph); 13C NMR (100 MHz, CDCl3): δ = 14.0 (8-CH3), 17.7 (C-8), 
19.4 (Si(C(CH3)3)), 27.1 (Si(C(CH3)3)), 37.6 (C-3), 39.8 (C-7), 41.6 (C-5), 56.0 (OCH3), 70.5 
(C-6), 76.9 (C-4), 117.0 (C-1), 127.4, 127.4, 129.4, 134.4, 134.5 (C of SiPh2), 134.8 (C-2), 
135.9, 136.0 (C of SiPh2); 
HRMS (ESI): calcd for C26H38NaO2Si [M+Na]+: 433.25333, found 433.25319. 
 
 
(3R,5S)-5-{[tert-Butyl(diphenyl)silyl]oxy}-3-methoxyoctanal (8-20) 
 
MeO OTBDPS
O 2 4 6
 
 
To a solution of methyl ether 8-19 (5.56 g, 13.6 mmol) in a mixture of THF/tBuOH (180/40 
mL) was added 4-methyl-morpholine-N-oxide (3.70 g, 27.0 mmol) and an aqueous solution of 
OsO4 (10 mL of a 0.027 M solution, 0.27 mmol, 2 mol%, prepared from K2OsO4·2H2O (100 
mg, 0.27 mmol)) at 0 °C. After being stirred at room temperature for 20 h, 100 ml of 10% 
Na2S2O3 solution was added to the mixture. After 30 min, the diol was extracted with EtOAc 
and the combined organic extracts were washed with water, saturated NaCl solution, dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was filtered through a short pad 
of silica gel followed by rinsing the pad with EtOAc. Removal of the solvent from the 
combined filtrate gave the crude diol.  
NaIO4 (4.4 g, 21.0 mmol, 1.5 equiv) was added to a solution of crude diol in 90% MeOH (200 
mL). After stirring at room temperature for 1 h, most of the methanol was removed in vacuo 
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and the residue extracted with Et2O (3 × 150 mL). The combined organic extracts were 
washed with water, saturated NaCl solution, dried over MgSO4, and filtered. After 
concentration, the residue was purified by flash chromatography (petroleum ether/EtOAc, 
10:1→5:1) to give aldehyde 8-20 as a colorless oil (5.10 g, 93% over 2 steps). Rf = 0.35 
(petroleum ether/EtOAc, 10:1); [α]20D = +5.1 (c 1.6, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 0.72 (t, J = 7.1 Hz, 3H, 7-CH3), 1.05 (s, 9H, Si(C(CH3)3)), 1.16–1.36 (m, 2H, 7-H), 1.37–1.45 
(m, 2H, 6-H), 1.52–1.61 (m, 1H, 4-H), 1.71–1.80 (m, 1H, 4-H), 2.30–2.44 (m, 2H, 2-H), 3.09 (s, 
3H, OCH3), 3.69–3.77 (m, 1H, 3-H), 3.87–3.94 (m, 1H, 5-H), 7.34–7.45 (m, 6H, mCH, pCH ar 
Ph), 7.66–7.72 (m, 4H, oCH ar Ph), 9.65 (t, J = 2.5 Hz, 1H, CHO); 13C NMR (100 MHz, 
CDCl3): δ = 14.0 (7-CH3), 17.7 (C-7), 19.4 (Si(C(CH3)3)), 27.0 (Si(C(CH3)3)), 39.6 (C-6), 42.2 
(C-4), 48.0 (C-2), 56.3 (OCH3), 70.2 (C-5), 73.3 (C-3), 127.5, 127.5, 129.6, 129.6, 134.3, 
134.5, 135.9, (C of SiPh2), 201.3 (C-1); 
HRMS (ESI): calcd for C26H40NaO4Si [M+CH3OH+Na]+: 467.25881, found 467.25872. 
 
 
S-Ethyl (2E,5S,7S)-7-{[tert-butyl(diphenyl)silyl]oxy}-5-methoxydec-2-enethioate (8-22) 
 
MeO OTBDPS
EtS
O
2 6
 
 
A solution of the aldehyde 8-20 (3.46 g, 8.40 mmol) and ylide 8-21 (16.8 mmol, 6.11 g) in 
CH2Cl2 (160 mL) was heated at reflux for 10 h. The solution was concentrated under reduced 
pressure and purified by column flash chromatography (petroleum ether/EtOAc, 40:1→20:1) 
to afford the desired α,β-unsaturated thioester 8-22 as a colorless oil (3.84 g, 92% ). Rf = 0.47 
(petroleum ether/EtOAc, 10:1); [α]20D = +2.0 (c 2.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 0.71 (t, J = 7.3 Hz, 3H, 9-CH3), 1.05 (s, 9H, Si(C(CH3)3)), 1.14–1.33 (m, 5H, 9-H, 
SCH2CH3), 1.36–1.43 (m, 2H, 8-H), 1.49–1.65 (m, 2H, 6-H), 2.20–2.26 (m, 2H, 4-H), 2.95 (q, 
J = 14.9 Hz, 2H, SCH2CH3), 3.06 (s, 3H, OCH3), 3.33–3.41 (m, 1H, 5-H), 3.89–3.97 (m, 1H, 
7-H), 6.08 (d, J = 15.7 Hz, 1H, 2-H), 6.75–6.84 (m, 1H, 3-H), 7.33–7.44 (m, 6H, mCH, pCH 
ar Ph), 7.66–7.70 (m, 4H, oCH ar Ph); 13C NMR (100 MHz, CDCl3): δ = 14.0 (9-CH3), 14.8 
(SCH2CH3), 17.7 (C-9), 19.4 (Si(C(CH3)3)), 23.0 (SCH2CH3), 27.1 (Si(C(CH3)3)), 36.3 (C-4), 
39.8 (C-8), 42.0 (C-6), 56.3 (OCH3), 70.4 (C-7), 76.4 (C-5), 127.4, 127.5, 129.5, 129.5 (C of 
SiPh2), 130.7 (C-2), 134.3, 134.5, 135.9 (C of SiPh2), 141.0 (C-3), 189.8 (C-1); 
HRMS (ESI): calcd for C29H42NaO3SSi [M+Na]+: 521.25161, found 521.25138. 
 
 
S-Ethyl (3S,5S,7S)-7-{[tert-butyl(diphenyl)silyl]oxy}-5-methoxy-3-methyldecanethioate (8-23) 
 
MeO OTBDPS
EtS
O
2 6
 
 
CuBr·Me2S (27.0 mg, 0.130 mmol, 3.4 mol%) and (S,R)-Josiphos ent-6-87 (100.0 mg, 0.156 
mmol, 4.1 mol%) were dissolved in tBuOMe (34 mL) and stirred at room temperature for 30 
min under nitrogen. The mixture was cooled to –75 °C and MeMgBr (3M solution in Et2O, 1.67 
ml, 5.0 mmol, 1.3 equiv) was added dropwise. After stirring for 10 min, a solution of thioester 8-
22 (1.90 g, 3.81 mmol, 1 equiv) in tBuOMe (4.20 mL) was added via a syringe pump over 3 h. 
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The reaction mixture was stirred at –75 °C for 12 h, then quenched by the addition of MeOH 
and allowed to warm to room temperature. Saturated aqueous NH4Cl solution was then added, 
the phases were separated and the aqueous layer extracted with Et2O (3 × 60 mL). The 
combined organic phases were dried over MgSO4, concentrated under reduced pressure and 
purified by column flash chromatography (petroleum ether/EtOAc, 30:1→20:1) to afford the 
desired 1,4-addition adduct 8-23 as a colorless oil (1.82 g, 93% ). Rf = 0.52 (petroleum 
ether/EtOAc, 10:1); [α]20D = –4.5 (c 2.8, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.71 (t, J = 
7.3 Hz, 3H, 9-CH3), 0.88 (d, J = 6.6 Hz, 3H, 3-CH3), 0.93–1.02 (m, 1H, 9-H), 1.04 (s, 9H, 
Si(C(CH3)3)), 1.17–1.42 (m, 8H, 4-H, 9-H, SCH2CH3, 8-H), 1.42–1.50 (m, 1H, 6-H), 1.63–
1.72 (m, 1H, 6-H), 2.04–2.16 (m, 1H, 3-H), 2.25–2.32 (m, 1H, 2-H), 2.47 (dd, J = 14.4, 5.7 
Hz, 1H, 2-H), 2.86 (q, J = 14.9 Hz, 2H, SCH2CH3), 3.09 (s, 3H, OCH3), 3.25–3.34 (m, 1H, 5-
H), 3.82–3.89 (m, 1H, 7-H), 7.33–7.44 (m, 6H, mCH, pCH ar Ph), 7.65–7.71 (m, 4H, oCH ar 
Ph); 13C NMR (100 MHz, CDCl3): δ = 14.0 (9-CH3), 14.8 (SCH2CH3), 17.8 (C-9), 19.4 
(Si(C(CH3)3)), 19.6 (3-CH3), 23.2 (SCH2CH3), 27.1 (Si(C(CH3)3)), 27.9 (C-3), 39.5 (C-8), 
41.0 (C-4), 41.9 (C-6), 51.5 (C-2), 55.6 (OCH3), 70.5 (C-7), 75.4 (C-5), 127.4, 127.5, 129.4, 
129.4, 134.4, 134.6, 135.9 (C of SiPh2), 198.8 (C-1); 
HRMS (ESI): calcd for C30H46NaO3SSi [M+Na]+: 537.28291, found 537.28303. 
 
 
(3S,5S,7S)-7-{[tert-Butyl(diphenyl)silyl]oxy}-5-methoxy-3-methyldecanal (8-24) 
 
MeO OTBDPS
H
O
2 6
 
 
To a stirred mixture of the thioester 8-23 (904 mg, 1.76 mmol) and Pd/C (90.0 mg, 10% wt) in 
CH2Cl2 (15 mL) was added Et3SiH (840 μL, 5.30 mmol, 3 equiv) at 0 °C under nitrogen. The 
reaction mixture was warmed to room temperature and stirred for 30 min. The catalyst was 
filtered off through a pad of Celite and washed with CH2Cl2. The filtrate was concentrated 
under reduced pressure and purified by flash chromatography (petroleum ether/EtOAc, 10:1 to 
5:1) to give the pure aldehyde 8-24 (759 mg, 95%) as a slightly yellow oil. Rf = 0.29 
(petroleum ether/EtOAc, 10:1); [α]20D = –11.7 (c 2.4, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 0.73 (t, J = 7.3 Hz, 3H, 9-CH3), 0.88 (d, J = 6.3 Hz, 3H, 3-CH3), 0.97–1.01 (m, 1H, 9-H), 
1.03 (s, 9H, Si(C(CH3)3)), 1.17–1.35 (m, 3H, 4-H, 9-H), 1.36–1.49 (m, 3H, 6-H, 8-H), 1.66–
1.74 (m, 1H, 6-H), 2.06–2.19 (m, 2H, 2-H, 3-H), 2.24–2.33 (m, 1H, 2-H), 3.09 (s, 3H, OCH3), 
3.21–3.29 (m, 1H, 5-H), 3.79–3.87 (m, 1H, 7-H), 7.33–7.44 (m, 6H, mCH, pCH ar Ph), 7.64–
7.70 (m, 4H, oCH ar Ph), 9.66 (s, 1H, CHO); 13C NMR (100 MHz, CDCl3): δ = 14.0 (9-CH3), 
17.8 (C-9), 19.4 (Si(C(CH3)3)), 20.0 (3-CH3), 24.9 (C-3), 27.0 (Si(C(CH3)3)), 39.5 (C-8), 41.4 
(C-6), 41.9 (C-4), 51.3 (C-2), 55.7 (OCH3), 70.5 (C-7), 75.6 (C-5), 127.4, 127.5, 129.5, 134.3, 
134.6, 135.9 (C of SiPh2), 202.6 (C-1); 
HRMS (ESI): calcd for C29H46NaO4Si [M+MeOH+Na]+: 509.30576, found 509.30549. 
 
 
3-(Benzyloxy)propanal (8-8) 
 
OH
O  
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Dibal-H (1M in hexane, 21 mL, 21 mmol) was added to a solution of 3-
(benzyloxy)propanenitrile (8-25)256 (2.41 g, 15.0 mmol) in toluene (40 mL) at –80 °C, under 
nitrogen atmosphere. The solution was allowed to warm to 0 °C and stirred at this temperature 
for 2 h. After the mixture was partioned between an ice-cooled mixture of Et2O (100 mL) and 
saturated potassium sodium tartrate (Rochelle salt) (100 mL) it was stirred until the layers 
became clear. The organic layer was separated and the H2O layer extracted with Et2O (2 × 100 
mL). The combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo. The residue was purified by flash chromatography (petroleum ether/EtOAc, 4:1) to 
give aldehyde 8-8 (1.92 g, 78%) as a colorless oil. Rf = 0.38 (petroleum ether/EtOAc, 4:1); 
1H NMR (400 MHz, CDCl3): δ = 2.69 (dt, J = 6.1, 1.8 Hz, 2H, CH2CHO), 3.81 (t, J = 6.1 Hz, 2H, 
BnOCH2), 4.53 (s, 2H, PhCH2O), 7.27–7.37 (m, 5H, ar H of Ph), 9.79 (t, J = 1.8 Hz, 1H, CHO); 
13C NMR (100 MHz, CDCl3): δ = 43.8 (CH2CHO), 63.8 (BnOCH2), 73.2 (PhCH2O), 127.7, 
127.7, 128.4, 137.8 (C of Ph), 201.1 (CHO). 
 
 
(3R)-1-(Benzyloxy)hex-5-en-3-ol (8-26) 
 
O
OH
26
 
 
To a cooled (–20 °C) solution of (S,S)-6-82 (1.18 g, 2.19 mmol, 1.06 equiv) in CH2Cl2 (11 
mL) was added aldehyde 8-8 (340 mg, 2.07 mmol, 1.0 equiv). The reaction mixture was then 
placed into a freezer (–10 °C) and maintained at that temperature for 24 h (without stirring). 
The reaction was quenched, while still cold, with 1N HCl (10 mL) and EtOAc (10 mL) and the 
mixture was vigorously stirred at room temperature for 15 min. The obtained white precipitate 
of (S,S)-N,N’-bis-(4-bromo-benzyl)-cyclohexane-1,2-diamine dihydrochloride was filtered off, 
washed with Et2O (3 × 10 mL) and dried in vacuo (recovered 1.06 g, 92% of (S,S)-diamine 
dihydrochloride). The combined filtrates were poured into a separating funnel, the layers were 
separated, and the aqueous layer was extracted with EtOAc (3 × 30 mL). The combined 
organic extracts were washed with H2O (40 mL), saturated NaCl solution (40 mL), dried 
(MgSO4), and filtered. The filtrate was concentrated in vacuo to give the crude product, which 
was purified by flash chromatography (petroleum ether/EtOAc, 4:1 to 2:1) to give homoallylic 
alcohol 8-26 (358 mg, 84%) as a colorless oil. Rf = 0.42 (petroleum ether/EtOAc, 4:1); [α]20D 
= −4.2 (c 1.3, CH2Cl2), lit.270 [α]20D = −4.8 (c 2.31, CHCl3); 1H NMR (400 MHz, CDCl3): δ = 
1.65–1.73 (m, 2H, 2-H), 2.14–2.20 (m, 2H, 4-H), 2.78 (d, J = 3.0 Hz, 1H, OH), 3.53–3.67 (m, 
2H, 1-H), 3.75–3.85 (m, 1H, 3-H), 4.44 (s, 2H, PhCH2O), 4.99–5.06 (m, 2H, 6-H), 5.70–5.82 
(m, 1H, 5-H), 7.18–7.30 (m, 5H, ar H of Ph); 13C NMR (100 MHz, CDCl3): δ = 35.8 (C-2), 
41.9 (C-4), 68.9 (C-1), 70.3 (C-3), 73.3 (PhCH2O), 117.5 (C-6), 127.6, 127.7, 128.4 (C of Ph), 
134.8 (C-5), 137.9 (C of Ph); 
HRMS (ESI): calcd for C13H18NaO2 [M+Na]+: 229.11990, found 229.11982. 
 
 
Trifluoroacetate 8-27 
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Trifluoroacetic acid (0.85 mL, 8.9 mmol) was added to a solution of alcohol 8-26 (330 mg, 1.6 
mmol) and aldehyde 8-24 (404 mg, 0.89 mmol) in CH2Cl2 (8 mL) at –5 °C under a nitrogen 
atmosphere. The reaction mixture was stirred for 1 h at this temperature before saturated 
aqueous NaHCO3 solution (10 mL) was added dropwise. The layers were separated and the 
aqueous phase was extracted with CH2Cl2 (3 × 30 mL). The combined organic extracts were 
washed with brine (20 mL), dried over MgSO4, filtered, concentrated in vacuo. The residue 
was purified by flash chromatography (petroleum ether/EtOAc, 15:1 to 10:1) to afford 
trifluoroacetate 8-27 as a colorless oil (485 mg, 72%). Rf = 0.69 (petroleum ether/EtOAc, 4:1); 
[α]20D = –3.5 (c 2.2, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.71 (t, J = 7.3 Hz, 3H, 8-CH3), 
0.83 (d, J = 6.6 Hz, 3H, 2-CH3), 0.87–0.99 (m, 1H, 8-H), 1.05 (s, 9H, Si(C(CH3)3)), 1.08–1.14 
(m, 1H, 8-H), 1.16–1.41 (m, 7H, 7-H, 5’-H, 1-H, BnOCH2CH2), 1.45–1.70 (m, 3H, 
BnOCH2CH2, 3-H), 1.73–1.88 (m, 3H, 5-H, 2-H), 1.95–2.08 (m, 2H, 3’-H), 3.09 (s, 3H, OCH3), 
3.29–3.44 (m, 2H, 6’-H, 2’-H), 3.51–3.66 (m, 3H, 4-H, BnOCH2CH2), 3.85–3.92 (m, 1H, 6-H), 
4.48 (s, 2H, PhCH2O), 5.04–5.14 (m, 1H, 4’-H), 7.27–7.44 (m, 11H, mCH, pCH ar SiPh2, Ph of 
Bn), 7.66–7.73 (m, 4H, oCH ar SiPh2); 13C NMR (100 MHz, CDCl3): δ = 14.0 (8-CH3), 17.8 
(C-8), 19.4 (Si(C(CH3)3)), 19.5 (2-CH3), 25.7 (C-2), 26.5, 27.1 (Si(C(CH3)3)), 36.1 
(BnOCH2CH2), 36.7 (C-3’), 37.2 (C-3), 39.6 (C-5’), 42.1 (C-5), 43.5 (C-1), 55.8 (OCH3), 66.4 
(BnOCH2CH2), 70.4 (C-6), 71.9 (C-4), 72.6 (C-6’), 73.2 (PhCH2O), 75.4 (C-4’), 75.5 (C-2’), 
114.5 (q, J = 286 Hz, CF3), 127.4, 127.4, 127.6, 127.6, 127.7, 128.4, 129.5, 129.6, 134.4, 
134.7, 134.8, 135.9, 136.0, 138.4 (C of SiPh2 and Ph of Bn), 156.9 (q, J = 42 Hz, COCF3); 
HRMS (ESI): calcd for C43H59F3NaO6Si [M+Na]+: 779.39252, found 779.39261. 
 
 
Tetrahydropyran 8-28271 
 
O
MeO OTBDPS
OH
BnO H H 1 5 9
3' 5'
 
 
To a solution of triflouroacetate 8-27 (452 mg, 0.60 mmol) in methanol (6 mL) was added 
K2CO3 (166 mg, 1.2 mmol) and water (0.3 mL). The reaction mixture was stirred at room 
temperature for 30 min, then diluted with water (5 mL) and extracted with Et2O (3 × 40 mL). 
The combined organic layers were washed with saturated NaCl solution (20 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. Flash chromatography of the residue (petroleum 
ether/EtOAc, 3:1 to 2:1) provided alcohol 8-28 (361 mg, 91% yield) as a colorless oil. Rf = 
0.36 (petroleum ether/EtOAc, 2:1); [α]20D = –7.0 (c 2.0, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.70 (t, J = 7.3 Hz, 3H, 8-CH3), 0.83 (d, J = 6.6 Hz, 3H, 2-CH3), 0.87–0.98 (m, 
1H, 8-H), 1.04 (s, 9H, Si(C(CH3)3)), 1.07–1.31 (m, 4H, 7-H, 8-H, BnOCH2CH2), 1.32–1.41 
(m, 3H, 5’-H, 1-H), 1.46–1.57 (m, 3H, 1-H, 5-H), 1.59–1.66 (m, 1H, 5-H), 1.71–1.82 (m, 3H, 
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2-H, BnOCH2CH2), 1.82–1.95 (m, 2H, 3’-H), 3.08 (s, 3H, OCH3), 3.26–3.37 (m, 2H, 6’-H, 4-
H), 3.43–3.47 (m, 1H, 2’-H), 3.53–3.65 (m, 2H, BnOCH2CH2), 3.72–3.83 (m, 1H, 4’-H), 
3.85–3.91 (m, 1H, 6-H), 4.48 (s, 2H, PhCH2O), 7.26–7.43 (m, 11H, mCH, pCH ar SiPh2, Ph of 
Bn), 7.65–7.71 (m, 4H, oCH ar SiPh2); 13C NMR (100 MHz, CDCl3): δ = 14.0 (8-CH3), 17.7 
(C-8), 19.4 (Si(C(CH3)3)), 19.6 (2-CH3), 25.8 (C-2), 27.1 (Si(C(CH3)3)), 36.2 (BnOCH2CH2), 
39.6 (C-3), 41.4 (C-3’), 41.8 (C-5’), 42.1 (C-7), 42.2 (C-5), 43.6 (C-1), 55.8 (OCH3), 66.8 
(BnOCH2CH2), 68.3 (C-6), 70.4 (C-4’), 72.2 (C-4), 73.0 (C-6’), 73.1 (PhCH2O), 75.5 (C-2’), 
127.4, 127.4, 127.5, 127.6, 128.3, 129.4, 134.4, 134.8, 135.9, 136.0, 138.5 (C of SiPh2 and Ph 
of Bn); 
HRMS (ESI): calcd for C41H60NaO5Si [M+Na]+: 683.41022, found 683.41020. 
 
 
Methoxy-methyl ether 8-29272 
 
O
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O
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To a stirred, cooled (0 °C) solution of alcohol 8-28 (350 mg, 0.53 mmol) in DMF 
 
(3 mL) were 
added N,N-diisopropylethylamine (0.91 mL, 5.3 mmol), chloromethylmethyl ether273 (250 μL, 
3.2 mmol), and tetrabutylammonium iodide (20 mg, 0.05 mmol). The reaction mixture was 
warmed to room temperature. After stirring for 5 h, saturated aqueous NaHCO3 solution (5 
mL) was added followed by Et2O (20 mL). After separation of the layers, the aqueous phase 
was extracted with Et2O (3 × 30 mL). The combined organic extracts were washed with 
saturated NaHCO3, saturated NaCl solution, dried over MgSO4, filtered and concentrated 
under reduced pressure. Flash chromatography (petroleum ether/EtOAc, 5:1) afforded MOM 
ether 8-29 (423 mg, 99% yield) as a colorless oil. Rf = 0.70 (petroleum ether/EtOAc, 2:1); 
[α]20D = –4.3 (c 2.3, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.69 (t, J = 7.3 Hz, 3H, 8-
CH3), 0.83 (d, J = 6.6 Hz, 3H, 2-CH3), 0.88–0.99 (m, 1H, 8-H), 1.04 (s, 9H, Si(C(CH3)3)), 
1.07–1.41 (m, 8H, 7-H, 8-H, 5’-H, 1-H, BnOCH2CH2), 1.47–1.67 (m, 3H, 1-H, BnOCH2CH2, 
3-H) 1.73–1.85 (m, 3H, 5-H, 2-H), 1.87–1.98 (m, 2H, 3’-H), 3.08 (s, 3H, CHOCH3), 3.28–
3.39 (m, 5H, 6’-H, 4-H, CH2OCH3), 3.41–3.51 (m, 1H, 2’-H), 3.52–3.66 (m, 2H, 
BnOCH2CH2), 3.67–3.77 (m, 1H, 4’-H), 3.84–3.92 (m, 1H, 6-H), 4.48 (s, 2H, PhCH2O), 4.68 
(s, 2H, CH2OCH3), 7.26–7.43 (m, 11H, mCH, pCH ar SiPh2, Ph of Bn), 7.66–7.71 (m, 4H, 
oCH ar SiPh2); 13C NMR (100 MHz, CDCl3): δ = 14.0 (8-CH3), 17.7 (C-8), 19.4 
(Si(C(CH3)3)), 19.6 (2-CH3), 25.8 (C-2), 27.1 (Si(C(CH3)3)), 36.3 (BnOCH2CH2), 38.7 (C-3’), 
39.2 (C-3), 39.6 (C-5’), 42.1 (C-7), 42.1 (C-5), 43.8 (C-1), 55.2 (CH2OCH3), 55.7 (CHOCH3), 
66.8 (BnOCH2CH2), 70.4 (C-6), 72.3 (C-4), 73.0 (C-6’), 73.1 (PhCH2O), 73.2 (C-4’), 75.5 (C-
2’), 94.4 (CH2OCH3), 127.4, 127.4, 127.5, 127.6, 128.3, 129.4, 129.4, 134.4, 134.8, 135.9, 
136.0, 138.6 (C of SiPh2 and Ph of Bn); 
HRMS (ESI): calcd for C43H64NaO6Si [M+Na]+: 727.43644, found 727.43653. 
 
 
Alcohol 8-30 
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A hydrogenation vessel was charged with MOM ether 8-29 (371 mg, 0.53 mmol), Pd/C (110 
mg), ethanol (20 mL), and attached to a hydrogen source. Hydrogen was introduced into the 
reaction vessel until the pressure gauge indicated 2 atm. The pressure was carefully released to 
1 atm by opening the stop valve. This procedure was repeated three times, and finally 
hydrogen was pressurized to 5 atm. The reaction mixture was vigorously shaken at room 
temperature for 10 h during which time the hydrogen cylinder was kept connected. After the 
stop valve was opened, excess hydrogen was carefully bled off, and the apparatus was 
disassembled. The catalyst was filtered off through a pad of Celite and washed with EtOAc. 
The filtrate was concentrated under reduced pressure and purified by flash chromatography 
(petroleum ether/EtOAc, 2:1) to give the alcohol 8-30 (304 mg, 92%) as a colorless oil. Rf = 
0.30 (petroleum ether/EtOAc, 2:1); [α]20D = –1.6 (c 1.7, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.69 (t, J = 7.3 Hz, 3H, 8-CH3), 0.82 (d, J = 6.6 Hz, 3H, 2-CH3), 0.86–0.96 (m, 1-
H, 8-H), 1.04 (s, 9H, Si(C(CH3)3)), 1.08–1.40 (m, 8H, 7-H, 8-H, 5’-H, HOCH2CH2, 3-H), 
1.41–1.59 (m, 2H, 1-H), 1.61–1.81 (m, 4H, 5-H, 2-H, HOCH2CH2), 1.87–1.97 (m, 2H, 3’-H), 
2.55 (br s, 1H, OH), 3.09 (s, 3H, CHOCH3), 3.27–3.41 (m, 5H, 6’-H, 4-H, CH2OCH3), 3.47–
3.56 (m, 1H, 2’-H), 3.65–3.87 (m, 4H, HOCH2CH2, 4’-H, 6-H), 4.68 (s, 2H, CH2OCH3), 7.32–
7.43 (m, 6H, mCH, pCH ar SiPh2), 7.65–7.71 (m, 4H, oCH ar SiPh2); 13C NMR (100 MHz, 
CDCl3): δ = 14.0 (8-CH3), 17.8 (C-8), 19.4 (Si(C(CH3)3)), 19.6 (2-CH3), 26.1 (C-2), 27.1 
(Si(C(CH3)3)), 37.9 (C-3’), 38.6 (C-3), 38.9 (CH2CH2OH), 39.5 (C-5’), 42.1 (C-7), 42.3 (C-5), 
43.6 (C-1), 55.3 (CH2OCH3), 55.5 (CHOCH3), 61.2 (HOCH2CH2), 70.5 (C-6), 72.8 (C-4’), 
73.8 (C-4), 75.6 (C-6’), 75.8 (C-2’), 94.4 (CH2OCH3), 127.4, 127.4, 129.4, 129.4, 134.4, 
134.7, 136.0 (C of SiPh2); 
HRMS (ESI): calcd for C36H58NaO6Si [M+Na]+: 637.38949, found 637.38973. 
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a) Preparation of aldehyde: To a cooled (0 °C) solution of alcohol 8-30 (260 mg, 0.42 
mmol) in CH2Cl2 (4 mL) was added a solution of Dess-Martin periodinane (15% wt, 1.5 mL, 
0.71 mmol). After stirring for 0.5 h at 0 °C and for 1.5 h at room temperature, the reaction 
mixture was concentrated, loaded on a flash silica gel column, and eluted with petroleum 
ether/EtOAc, 4:1 to give 253 mg (96%) of the corresponding aldehyde, which was used 
directly in the next reaction. TLC (petroleum ether/EtOAc, 2:1): Rf = 0.64. 
b) Acid (152):257 The obtained aldehyde (250 mg, 0.41 mmol) was dissolved in tBuOH (4 
mL) and 2,3-dimethyl-2-butene (1.4 mL). A solution of NaClO2 (140 mg, 1.23 mmol) and 
NaH2PO4·2H2O (620 mg, 3.7 mmol) in water (3 mL) was added slowly at 0 °C. After stirring 
for 30 min at room temperature, the mixture was diluted with water (5 mL), extracted with 
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EtOAc (4 x 20 mL), washed with brine, dried (Na2SO4), filtered, and concentrated under 
reduced pressure. Flash chromatography of the residue (petroleum ether/EtOAc/HOAc, 
2:1:0.01 to 1:1:0.01) provided acid 8-31 (253 mg, 98% yield) as a colorless oil. Rf = 0.43 
(petroleum ether/EtOAc, 2:1); [α]20D = –3.3 (c 2.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
0.69 (t, J = 7.3 Hz, 3H, 8-CH3), 0.81 (d, J = 6.6 Hz, 3H, 2-CH3), 0.86–0.96 (m, 1H, 8-H), 1.04 
(s, 9H, Si(C(CH3)3)), 1.08–1.41 (m, 8H, 7-H, 8-H, 5’-H, 1-H, 2-H), 1.42–1.58 (m, 2H, 3-H), 
1.59–1.78 (m, 2H, 5-H), 1.89–1.98 (m, 1H, 3’-H), 1.99–2.07 (m, 1H, 3’-H), 2.44–2.62 (m, 2H, 
CH2COOH), 3.09 (s, 3H, CHOCH3), 3.29–3.44 (m, 5H, 6’-H, 4-H, CH2OCH3), 3.68–3.78 (m, 
2H, 2’-H, 4’-H), 3.81–3.89 (m, 1H, 6-H), 4.68 (s, 2H, CH2OCH3), 7.31–7.43 (m, 6H, mCH, 
pCH ar SiPh2), 7.65–7.70 (m, 4H, oCH ar SiPh2); 13C NMR (100 MHz, CDCl3): δ = 14.0 (8-
CH3), 17.8 (C-8), 19.4 (Si(C(CH3)3)), 19.6 (2-CH3), 25.9 (C-2), 27.1 (Si(C(CH3)3)), 38.0 (C-
3’), 38.7 (C-3), 39.5 (C-5’), 40.8 (C-7), 42.0 (CH2COOH), 42.1 (C-5), 43.5 (C-1), 55.3 
(CH2OCH3), 55.8 (CHOCH3), 70.5 (C-6), 72.0 (C-4’), 72.6 (C-2’), 74.0 (C-6’), 75.6 (C-4), 
94.5 (CH2OCH3), 127.4, 127.5, 129.4, 129.5, 134.4, 134.7, 136.0, 136.0 (C of SiPh2), 174.1 
(COOH); 
HRMS (ESI): calcd for C36H56NaO7Si [M+Na]+: 651.36875, found 651.36843. 
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To a solution of acid 8-31 (214 mg, 0.34 mmol) in THF (1.5 mL) was added TBAF·3H2O 
(1.07 g, 3.40 mmol) at room temperature. The reaction mixture was stirred for 36 h. After 
addition of saturated NH4Cl solution the mixture was extracted with EtOAc (3 × 25 mL). The 
combined organic layers were washed with water (10 ml), saturated NaCl solution (20 mL), 
dried over MgSO4, filtered, and concentrated in vacuo. Flash chromatography (petroleum 
ether/EtOAc/HOAc, 1:1:0.01 to 0:1:0.01) afforded seco-acid 8-32 (134 mg, 99% yield) as a 
colorless oil. Rf = 0.3 (petroleum ether/EtOAc/HOAc, 1:1); [α]20D = +8.1 (c 1.8, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.86–0.94 (m, 6H, 8-CH3, 2-CH3), 1.03–1.14 (m, 1-H, 8-H), 
1.18–1.58 (m, 9H, 7-H, 8-H, 5’-H, 1-H, 3-H), 1.70–1.82 (m, 2H, 5-H), 1.86–1.95 (m, 2H, 3’-
H, 2-H), 1.97–2.04 (m, 1H, 3’-H), 2.42–2.53 (m, 2H, CH2COOH), 3.31–3.45 (m, 7H, 
CHOCH3, 6’-H, CH2OCH3), 3.48–3.55 (m, 1H, 4-H), 3.68–3.80 (m, 2H, 2’-H, 4’-H), 3.93–
4.00 (m, 1H, 6-H), 4.67 (s, 2H, CH2OCH3), 6.52 (br s, 2H, OH, COOH); 
13C NMR (100 MHz, CDCl3): δ = 14.1 (8-CH3), 18.6 (C-8), 20.7 (2-CH3), 27.8 (C-2), 38.0 
(C-3’), 38.6 (C-3), 39.1 (C-5’), 40.0 (C-7), 40.6 (CH2COOH), 41.2 (C-5), 43.7 (C-1), 55.3 
(CH2OCH3), 56.8 (CHOCH3), 68.8 (C-4’), 72.5 (C-6), 72.8 (C-4), 75.4 (C-6’), 78.2 (C-2’), 
94.5 (CH2OCH3), 173.6 (COOH); 
HRMS (ESI): calcd for C20H38NaO7 [M+Na]+: 413.25097, found 413.25082. 
 
 
Macrolactone 8-33a and 8-33b 
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To an ice-cooled solution of seco-acid 8-32 (102 mg, 0.26 mmol, 1.0 equiv) in THF (2.5 mL) 
was added Et3N (236 μl, 1.56 mmol, 6.0 equiv) followed by 2,4,6-trichlorobenzoyl chloride 
(203 μl, 1.3 mmol, 5.0 equiv). The mixture was stirred at 0 °C for 1 h and was then allowed to 
warm to room temperature, whereupon toluene (7.0 mL) was added. This solution was added 
over 8 h by syringe pump to a solution of DMAP (793 mg, 6.5 mmol, 25 equiv) in toluene 
(200 mL). Upon complete addition, stirring was continued for additional 2 h. The mixture was 
concentrated to dryness and filtered over silica gel (using petroleum ether /EtOAc 2:1 as 
eluant). The filtrate was concentrated under reduced pressure. Purification by flash 
chromatography (petroleum ether/EtOAc, 4:1) afforded lactone 8-33a (81 mg, 83% yield) and 
its 5-epi isomer 8-33b (8.7 mg, 9% yield). 
 
Macrolactone 8-33a: 
Rf = 0.26 (petroleum ether/EtOAc, 4:1); [α]20D = +19.4 (c 1.6, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.89 (t, J = 7.3 Hz, 3H, 15-CH3), 0.96 (d, J = 6.8 Hz, 3H, 9-CH3), 1.07–1.15 (m, 
1H, 6-H), 1.17–1.61 (m, 11H, 6-H, 10-H, 12-H, 8-H, 14-H, 15-H, 9-H), 1.80–1.90 (m, 2H, 4-H, 
12-H), 1.94–2.01 (m, 1H, 4-H), 2.37–2.45 (m, 1H, 2-H), 2.56–2.63 (m, 1H, 2-H), 3.11–3.19 (m, 
1H, 7-H), 3.30 (s, 3H, CHOCH3), 3.35 (s, 3H, CH2OCH3), 3.51–3.60 (m, 1H, 11-H), 3.65–3.76 
(m, 2H, 3-H, 5-H), 4.67 (s, 2H, CH2OCH3), 5.09–5.18 (m, 1H, 13-H); 13C NMR (100 MHz, 
CDCl3): δ = 13.9 (15-CH3), 19.0 (C-15), 25.5 (9-CH3), 31.2 (C-9), 36.9 (C-4), 38.1 (C-14), 
39.2 (C-6), 40.0 (C-10), 42.2 (C-2), 42.3 (C-12), 44.1 (C-8), 55.3 (CH2OCH3), 56.3 
(CHOCH3), 72.4 (C-3), 73.0 (C-5), 73.2 (C-13), 75.5 (C-11), 78.7 (C-7), 94.5 (CH2OCH3), 
170.8 (C-1); 
HRMS (ESI): calcd for C20H36NaO6 [M+Na]+: 395.24041, found 395.24064. 
 
Macrolactone 8-33b: 
Rf = 0.20 (petroleum ether/EtOAc, 4:1); [α]20D = +7.1 (c 0.8, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.84–0.93 (m, 6H, 15-CH3, 9-CH3), 1.08–1.43 (m, 9H, 6-H, 10-H, 8-H, 15-H, 9-
H), 1.44–1.56 (m, 2H, 14-H), 1.57–2.05 (m, 4H, 4-H, 12-H), 2.32–2.39 (m, 1H, 2-H), 2.42–
2.50 (m, 1H, 2-H), 2.98–3.07 (m, 1H, 7-H), 3.30 (s, 3H, CHOCH3), 3.33–3.45 (m, 4H, 
CH2OCH3, 11-H), 3.55 (apt, J = 11.0, 1H, 3-H), 3.69–3.80 (m, 1H, 5-H), 4.67 (s, 2H, 
CH2OCH3), 5.02–5.10 (m, 1H, 13-H); 13C NMR (100 MHz, CDCl3): δ = 13.9 (15-CH3), 18.9 
(C-15), 24.3 (9-CH3), 24.4 (C-9), 36.8 (C-4), 38.3 (C-14), 39.3 (C-6), 39.3 (C-12), 39.7 (C-
10), 42.4 (C-2), 45.2 (C-8), 55.3 (CH2OCH3), 57.0 (CHOCH3), 72.8 (C-3), 72.9 (C-5), 74.1 
(C-13), 74.9 (C-11), 76.8 (C-7), 94.5 (CH2OCH3), 172.7 (C-1); 
HRMS (ESI): calcd for C20H36NaO6 [M+Na]+: 395.24041, found 395.24030. 
 
 
Neopeltolide core 6-14 
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To a cooled (0 °C) solution of compound 8-33a (73.0 mg, 0.196 mmol) in MeOH (3 mL) was 
added concentrated HCI (100 µL). After stirring for 0.5 h at 0 °C and for 24 h at ambient 
temperature, the reaction mixture was quenched with saturated aqueous NaHCO3 solution (5 
mL), extracted with EtOAc (4 × 20 mL), washed with brine, dried (MgSO4), filtered, and 
concentrated under reduced pressure. Flash chromatography of the residue (petroleum 
ether/EtOAc/HOAc, 2:1 to 1:1) afforded neopeltolide macrolactone 6-14 (62.4 mg, 97% yield) 
as a colorless oil. Rf = 0.20 (petroleum ether/EtOAc, 2:1); [α]20D = +18.4 (c 0.1, CHCl3); 
1H NMR (400 MHz, CDCl3): δ = 0.90 (t, J = 7.3 Hz, 3H, 15-CH3), 0.97 (d, J = 6.8 Hz, 3H, 9-
CH3), 1.08–1.25 (m, 3H, 6-H, 8-H), 1.26–1.73 (m, 10H, 10-H, 8-H, 9-H, 12-H, 14-H, 15-H, 
OH), 1.80–1.88 (m, 2H, 14-H, 4-H), 1.92–1.98 (m, 1H, 4H), 2.41 (dd, J = 14.4, 10.9 Hz, 1H, 2-
H), 2.60 (dd, J = 14.6, 4.2 Hz, 1H, 2-H), 3.16 (apt, J = 10.1 Hz, 1H, 11-H), 3.30 (s, 3H, 
CHOCH3), 3.56 (apt, J = 10.1 Hz, 1H, 7-H), 3.68–3.84 (m, 2H, 3-H, 5-H), 5.09–5.18 (m, 1H, 
13-H); 13C NMR (100 MHz, CDCl3): δ = 13.9 (15-CH3), 19.0 (C-15), 25.5 (9-CH3), 31.2 (C-
9), 36.9 (C-4), 40.0 (C-14), 40.7 (C-6), 41.9 (C-12), 42.2 (C-2), 42.2 (C-10), 44.1 (C-8), 56.2 
(CHOCH3), 68.0 (C-5), 72.3 (C-13), 73.3 (C-3), 75.6 (C-11), 78.6 (C-7), 170.8 (C-1); 
HRMS (ESI): calcd for C18H32NaO5 [M+Na]+: 351.21420, found 351.21414. 
 
 
Ethyl 2-{[(trifluoromethyl)sulfonyl]oxy}-1,3-oxazole-4-carboxylate (8-12) 
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A solution of oxazolone 8-14251 (2.01 g, 12.8 mmol, 1 equiv) in CH2Cl2 (70 mL) was cooled to 
–80 °C, before 2,6-Lutidine (3.0 mL, 25.6 mmol, 2 equiv) was added via syringe followed by 
the addition of Tf2O (3.21 mL, 19.2 mmol, 1.5 equiv). The reaction mixture was then allowed 
to warm to ambient temperature with stirring for 40 min. The reaction was diluted with water 
(150 mL) and extracted with CH2Cl2 (3 × 100 mL). The combined organic layers were washed 
with brine, dried with MgSO4, filtered, and concentrated in vacuo. The residue was purified by 
flash chromatography (petroleum ether/EtOAc, 4:1) to give 3.30 g of 8-12 (88%) as a slightly 
yellow amorphous solid. Triflate 8-12 was used immediately after preparation. Rf = 0.52 
(petroleum ether/EtOAc, 4:1); 1H NMR (400 MHz, CDCl3): δ = 1.31 (t, J = 7.2 Hz, 3H, CH3), 
4.33 (q, J = 7.2 Hz, 2H, CH2), 8.09 (s, 1H, 5-H); 13C NMR (100 MHz, CDCl3): δ = 14.0 
(CH3), 61.7 (CH2), 118.3 (q, J = 322.0 Hz, CF3), 133.8 (C-4), 142.9 (C-5), 150.0 (C-2), 159.4 
(CO2Et). 
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Ethyl 2-{3-[(methoxycarbonyl)amino]prop-1-ynyl}-1,3-oxazole-4-carboxylate (8-11) 
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Triflate 8-12 (3.25 g, 11.1 mmol) and 2,6-lutidine (6.3 mL, 54.4 mmol) were dissolved in 
degased 1,4-dioxane (45.0 mL) and alkyne 8-13 (2.51 g, 22.2 mmol), Pd(PPh3)4 (1.27 g, 1.11 
mmol), and CuI (422 mg, 2.22 mmol) were added. The reaction mixture was stirred at ambient 
temperature for 12 h, diluted with EtOAc (200 mL), filtered through a thin pad of SiO2 and 
concentrated in vacuo. Flash chromatography (petroleum ether/EtOAc, 7:3→1:1) afforded 
alkyne 8-11 (2.21 g, 79% yield) as a slightly yellow oil which was crystallized upon standing 
in the fridge (–20 °C). Rf = 0.35 (CH2Cl2/EtOAc, 85:15); m.p. = 76–78 °C; 1H NMR (400 
MHz, CDCl3): δ = 1.33 (t, J = 7.2 Hz, 3H, CH2CH3), 3.66 (s, 3H, OCH3), 4.19 (d, J = 5.6 Hz, 2H, 
CH2NH), 4.33 (q, J = 7.2 Hz, 2H, CH2CH3), 5.36 (br s, 1H, NH), 8.14 (s, 1H, 5-H); 13C NMR 
(100 MHz, CDCl3): δ = 14.1 (CH2CH3), 31.1 (CH2NH), 52.5 (OCH3), 61.4 (CH2CH3), 70.1 
(C≡CCH2), 89.7 (C≡CCH2), 134.1 (C-4), 144.2 (C-5), 146.3 (C-2), 156.5 (CO2CH3), 160.3 
(CO2Et); 
HRMS (ESI): calcd for C11H12NaN2O5 [M+Na]+: 275.06384, found 275.06386. 
 
 
Ethyl 2-{(1Z)-3-[(methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazole-4-carboxylate (8-10) 
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Alkyne 8-11 (1.21 g, 4.8 mmol, 1 equiv) and quinoline (0.94 mL, 7.7 mmol, 1.6 equiv) were 
dissolved in EtOAc (280 mL), which was followed by the addition of Lindlar’s catalyst (5 
wt% Pd on CaCO3, posioned with lead (Fluka, № 62145), 940 mg, 100 wt%). The reaction 
was placed under H2 atmosphere and stirred until HPLC-MS analysis showed complete 
consumption of the starting material (ca. 5–6 h). The reaction mixture was filtered through a 
pad of celite and the filtrate was concentrated in vacuo. Obtained oil was triturated with 
hexane (50 mL), resulting in the crystalization of product. Hexane was decanted and this 
procedure was repeated one more time. Flash chromatography of the obtained residue 
(CH2Cl2/EtOAc, 9:1→85:15→4:1) afforded ester 8-10 (1.085 g, 89% yield) as a slightly 
yellow solid. Rf = 0.36 (CH2Cl2/EtOAc, 85:15); m.p. = 92–93 °C; 1H NMR (400 MHz, 
CDCl3): δ = 1.33 (t, J = 7.1 Hz, 3H, CH2CH3), 3.62 (s, 3H, OCH3), 4.28–4.37 (m, 4H, CH2NH, 
CH2CH3), 5.47 (br s, 1H, NH), 6.10–6.19 (m, 1H, HC=CHCH2), 6.30 (d, J = 11.9 Hz, 1H, 
HC=CHCH2), 8.14 (s, 1H, 5-H); 13C NMR (100 MHz, CDCl3): δ = 14.1 (CH2CH3), 39.6 
(CH2NH), 52.1 (OCH3), 61.2 (CH2CH3), 115.2 (HC=CHCH2), 134.3 (C-4), 139.3 
(HC=CHCH2), 143.1 (C-5), 157.1 (CO2CH3), 160.6 (CO2Et), 161.0 (C-2); 
HRMS (ESI): calcd for C11H14NaN2O5 [M+Na]+: 277.07949, found 277.07937. 
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Methyl (2Z)-3-(4-formyl-1,3-oxazol-2-yl)prop-2-enylcarbamate (8-34) 
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To a solution of ester 8-10 (0.72 g, 2.83 mmol) in dry CH2Cl2 (15 mL), at –80 °C, was added 
dropwise Dibal-H (1M in hexanes, 7.1 mL, 7.1 mmol, 2.5 equiv). The solution was stirred at –
80 °C for 90 min, quenched with saturated aqueous NH4Cl solution and warmed up to room 
temperature. It was then treated with saturated potassium and sodium tartrate (Rochelle 
salt)/EtOAc (100:100 mL) and the mixture was vigorously stirred for 10 min. After the layers 
were separated, the aqueous layer was extracted with EtOAc (3 × 100 mL). The combined 
organic extracts were washed with saturated NaCl solution, dried over MgSO4, filtered, and 
concentrated in vacuo. Flash chromatography of the residue (CH2Cl2/MeOH, 97:3→95:5) 
afforded aldehyde 8-34 (415 mg, 70% yield) as a colorless solid. Besides aldehyde 8-34 some 
overreducted alcohol 8-35 (85 mg, 14%) was isolated. Rf = 0.61 (CH2Cl2/MeOH, 9:1); m.p. = 
75–76 °C; 1H NMR (400 MHz, CDCl3): δ = 3.66 (s, 3H, OCH3), 4.32–4.42 (m, 2H, CH2NH), 
5.39 (br s, 1H, NH), 6.20–6.29 (m, 1H, HC=CHCH2), 6.33 (d, J = 11.6 Hz, 1H, HC=CHCH2), 
8.21 (s, 1H, 5-H), 9.93 (s, 1H, CHO); 13C NMR (100 MHz, CDCl3): δ = 39.7 (CH2NH), 52.2 
(OCH3), 115.0 (HC=CHCH2), 140.4 (C-4), 141.5 (HC=CHCH2), 143.5 (C-5), 157.1 
(CO2CH3), 161.1 (C-2), 184.1 (CHO). 
 
 
Methyl (2Z)-3-[4-(hydroxymethyl)-1,3-oxazol-2-yl]prop-2-enylcarbamate (8-35) 
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To a cooled (0 °C) solution of aldehyde 8-34 (380 mg, 1.81 mmol) in the mixture of 
THF/MeOH (6:2 mL) was added sodium borohydride (87 mg, 2.35 mmol) and the reaction 
mixture was stirred at this temperature for 1 h. Then it was treated with saturated NH4Cl 
solution and the layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 40 
mL), and the combined organic extracts were washed with saturated NaCl solution, dried over 
MgSO4, filtered and concentrated in vacuo. Flash chromatography (CH2Cl2/MeOH, 95:5) 
afforded alcohol 8-35 (364 mg, 95% yield) as a colorless solid. Rf = 0.42 (CH2Cl2/MeOH, 
9:1); m.p. = 125–126 °C, Lit.146a m.p. = 124–125 °C; 1H NMR (400 MHz, CDCl3): δ = 3.53 (s, 
3H, OCH3), 4.16–4.22 (m, 2H, CH2NH), 4.38 (d, J = 5.1 Hz, 2H, CH2OH), 5.21 (t, J = 5.1 Hz, 
1H, OH), 5.92–6.01 (m, 1H, HC=CHCH2), 6.28 (dt, J = 11.9, 2.0 Hz, 1H, HC=CHCH2), 7.46 
(t, J = 5.2 Hz, 1H, NH), 7.89 (s, 1H, 5-H); 13C NMR (100 MHz, CDCl3): δ = 39.8 (CH2NH), 
51.4 (OCH3), 55.7(CH2OH), 114.5 (HC=CHCH2), 135.3 (C-4), 138.4 (HC=CHCH2), 142.7 
(C-5), 156.8 (CO2CH3), 159.6 (C-2); 
HRMS (ESI): calcd for C11H14NaN2O5 [M+Na]+: 235.06948, found 235.06952. 
 
 
Methyl (2Z)-3-[4-(bromomethyl)-1,3-oxazol-2-yl]prop-2-enylcarbamate (8-39)265 
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A solution of alcohol 8-35 (62 mg, 0.29 mmol) and PPh3 (152 mg, 0.58 mmol) in CH3CN (3 
mL) was treated with 2,6-lutidine (17 mL, 0.15 mmol) and CBr4 (Fluka, № 86770) (192 mg, 
0.58 mmol). After 1 h the reaction mixture was partioned between 5% solution of NaHCO3 
(10 mL) and Et2O (20 mL). The organic layer was separated and the aqueous layer extracted 
with Et2O (3 × 40 mL). The combined organic layers were dried over MgSO4, filtered, and 
concentrated in vacuo. The crude product was purified by flash chromatography 
(EtOAc:hexane = 2:1→1:1→1:2) to give bromide 8-39 (64 mg, 81%) as a white solid. Rf = 
0.62 (hexane:EtOAc, 1:2); m.p. = 85–86 °C, Lit.146a m.p. = 86–87 °C; 1H NMR (400 MHz, 
CDCl3): δ = 3.67 (s, 3H, OCH3), 4.28–4.36 (m, 2H, CH2NH), 4.37 (s, 2H, CH2Br), 5.42 (br s, 
1H, NH), 6.10–6.20 (m, 1H, HC=CHCH2), 6.29 (d, J = 11.6 Hz, 1H, HC=CHCH2), 7.60 (s, 
1H, 5-H); 13C NMR (100 MHz, CDCl3): δ = 39.8 (CH2NH), 51.4 (OCH3), 55.7 (CH2OH), 
114.5 (HC=CHCH2), 135.3 (C-4), 138.4 (HC=CHCH2), 142.7 (C-5), 156.8 (CO2CH3), 159.6 
(C-2); 
HRMS (ESI): calcd for C9H11BrNaN2O3 [M+Na]+: 296.98453, found 296.98477. 
 
 
Methyl (2Z)-3-[4-(3-oxopropyl)-1,3-oxazol-2-yl]prop-2-enylcarbamate (8-9)146d 
 
N
O
NH
OMe
O
O
 
 
A solution of diethylamine (52.4 µL, 0.51 mmol, 2.2 equiv) in THF (0.5 mL) was cooled to –
78 °C, and treated with nBuLi (2.5M solution in hexane, 204.0 µL, 0.51 mmol, 2.2 equiv). 
After 15 min, a solution of imine 8-40264 (66.1 mg, 0.53 mmol, 2.3 equiv) in THF (0.5 mL) 
was added to the reaction mixture, immediately followed by HMPA (68.2 mL, 0.393 mmol). 
The reaction was warmed to 0 °C, stirred for 10 min and then cooled to –78 °C. The resulting 
yellow solution of the enolate was transferred via canula over a period of 5 min into a stirring 
solution of bromide 8-39 (63 mg, 0.23 mmol) in THF (0.5 mL) at –30 °C. After 20 min at –30 
°C, the reaction was quenched with 10% solution of tartaric acid (2 mL), and allowed to warm 
to room temperature. After the mixture was extracted with EtOAc (3 × 25 mL), the combined 
organic layers were washed with saturated NaCl solution (10 mL), dried over MgSO4, filtered, 
and concentrated in vacuo. Flash chromatography (CH2Cl2/MeOH, 98:2→95:5) afforded 
aldehyde 8-9 (43 mg, 78% yield) which was used immediately in the next step. TLC 
(CH2Cl2/MeOH, 9:1): Rf = 0.48. 
 
 
Methyl (2Z)-5-(2-{(1Z)-3-[(methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazol-4-yl)pent-2-
enoate (8-42)267 
 
N
O
NH
OMe
O
CO2Me 2''
5''
2
4
2'
3'
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A solution of 18-crown-6, freshly recrystallized from acetonitrile, (269 mg, 1.02 mmol, 6 
equiv) and bis(2,2,2-trifluoroethyl)(metoxycarbonylmethyl) phosphonate (8-41)267 (86 µL, 
0.41 mmol, 2.4 equiv) in THF (2.5 mL) was cooled to –78 °C, and treated with KHMDS 
(0.5M solution in toluene, 0.75 mL, 0.37 mmol, 2.2 equiv). After 1 h, the solution of aldehyde 
8-9 (41 mg, 0.17 mmol, 1 equiv) in THF (0.5 mL) was added over a period of 5 min. After 1 h, 
TLC indicated complete consumption of aldehyde; the reaction was quenched with saturated 
NH4Cl and warmed to room temperature. After the mixture was extracted with EtOAc (3 × 20 
mL), the combined organic layers were washed with saturated NaCl solution (10 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. Flash chromatography (CH2Cl2/MeOH, 
98:2) afforded ester 8-42 (32 mg, 65% yield, 11:1 mixture of Z:E isomers by 1H NMR 
analysis) as a colorless oil. Rf = 0.55 (CH2Cl2/MeOH, 9:1); 1H NMR (400 MHz, CDCl3): δ = 
2.68 (t, J = 7.2 Hz, 2H, 5-H), 2.96–3.03 (m, 2H, 4-H), 3.66 (s, 3H, OCH3), 3.69 (s, 3H, 
CCO2CH3), 4.25–4.32 (m, 2H, 3’-H), 5.59 (br s, 1H, NH), 5.80 (d, J = 11.6 Hz, 1H, 2-H), 
6.03–6.13 (m, 1H, 2’-H), 6.21–6.30 (m, 2H, 3-H, 1’-H), 7.36 (s, 1H, 5’’-H); 13C NMR (100 
MHz, CDCl3): δ = 25.6 (C-5), 27.5 (C-4), 39.3 (C-3’), 51.1 (OCH3), 52.1 (OCH3), 116.7 (C-
1’), 120.2 (C-2), 133.9 (C-5’’), 136.2 (C-4’’), 141.1 (C-2’), 148.9 (C-5’’), 157.1 (CO2CH3), 
159.9 (C-2’’), 166.7 (C-1); 
HRMS (ESI): calcd for C14H18NaN2O5 [M+Na]+: 317.11079, found 317.11086. 
 
 
Acid 6-15 
 
N
O
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O
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2
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A solution of ester 8-42 (15 mg, 0.05 mmol) in THF (0.5 mL) was treated with LiOH (1N 
solution in water, 0.5 mL, 0.5 mmol) at ambient temperature and the reaction mixture was 
vigorously stirred until TLC indicated complete consumption of the starting material (ca. 7 h). 
The reaction was cooled to 0 °C and neutralized with aqueous HCl (1N, 0.5 mL, 0.5 mmol). 
After the mixture was extracted with EtOAc (4 × 20 mL), the combined organic layers were 
washed with saturated NaCl solution (10 mL), dried over MgSO4, filtered, and concentrated in 
vacuo. Flash chromatography (CH2Cl2/MeOH, 95:5→9:1) afforded acid 6-15 (12.7 mg, 91% 
yield) as a colorless oil. Rf = 0.36 (CH2Cl2/MeOH, 9:1); 1H NMR (400 MHz, CDCl3): δ = 2.69 
(t, J = 7.3 Hz, 2H, 5-H), 2.98 (m, 2H, 4-H), 3.66 (s, 3H, OCH3), 4.25–4.32 (m, 2H, 3’-H), 5.52 
(br s, 1H, NH), 5.81 (d, J = 11.5 Hz, 1H, 2-H), 6.03–6.10 (m, 1H, 2’-H), 6.25–6.32 (m, 2H, 3-
H, 1’-H), 7.34 (s, 1H, 5’’-H); 13C NMR (100 MHz, CDCl3): δ = 25.5 (C-5), 27.4 (C-4), 39.3 
(C-3’), 52.1 (OCH3), 116.6 (C-1’), 120.2 (C-2), 133.9 (C-5’’), 136.4 (C-4’’), 141.0 (C-2’), 
148.9 (C-5’’), 157.1 (CO2CH3), 159.9 (C-2’’), 166.7 (C-1); 
HRMS (ESI): calcd for C13H16NaN2O5 [M+Na]+: 303.09514, found 303.09511. 
 
 
Neopeltolide (5-1) 
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To a solution of alcohol 6-14 (8.3 mg, 0.025 mmol, 1 equiv), acid 6-15 (11.2 mg, 0.04 mmol, 
1.6 equiv) and PPh3 (11.5 mg, 0.044 mmol, 1.76 equiv) in absolute benzene (1 mL) was added 
diisopropyl azodicarboxylate (88 μL of 0.5M solution in benzene, 0.044 mmol, 1.76 equiv). 
After stirring for 1 h at ambient temperature the reaction mixture was concentrated in vacuo 
and the residue was purified by flash column chromatography (hexane/EtOAC, 
2:1→1:1→1:2) to afford neopeltolide (5-1) (12.0 mg, 80%) as a colorless oil. Rf = 0.36 
(petroleum ether/EtOAc, 1:1); [α]20D = +23.8 (c 0.24, MeOH); 1H NMR (400 MHz, CD3OD): 
δ = 0.93 (t, J = 7.3 Hz, 3H, 16-H), 0.96 (d, J = 6.6 Hz, 3H, 17-H), 1.06–1.14 (m, 1H, 10-H), 
1.20–1.42 (m, 6H, 8-H, 9-H, 12-H, 15-H), 1.45–1.60 (m, 4H, 10-H, 4-H, 6-H, 14-H), 1.63–
1.75 (m, 2H, 6-H, 14-H), 1.78–1.89 (m, 2H, 4-H, 12-H), 2.28 (dd, J = 14.8, 11.0 Hz, 1H, 2-H), 
2.65–2.74 (m, 3H, 2-H, 22-H), 2.96–3.04 (m, 2H, 21-H), 3.27 (s, 3H, 11-OCH3), 3.55 (apt, J = 
9.9 Hz, 1H, 7-H), 3.62–3.70 (m, 4H, 29-OCH3, 11-H), 4.02–4.11 (m, 1H, 3-H), 4.29 (d, J = 
4.6 Hz, 2H, 28-H), 5.12–5.21 (m, 2H, 13-H, 5-H), 5.87 (d, J = 11.4 Hz, 1H, 19-H), 5.98–6.07 
(m, 1H, 27-H), 6.26 (dt, J = 11.9, 2.0 Hz, 1H, 26-H), 6.36 (dt, J = 11.6, 7.4 Hz, 1H, 20-H), 
7.65 (s, 1H, 24-H); 13C NMR (100 MHz, CD3OD): δ = 14.1 (C-16), 20.0 (C-15), 26.0 (C-17), 
26.4 (C-22), 29.0 (C-21), 32.6 (C-9), 36.2 (C-4), 37.4 (C-6), 37.9 (C-14), 41.0 (C-12), 43.2 (C-
2), 43.5 (C-10), 45.2 (C-8), 52.6 (29-OCH3), 56.4 (11-OCH3), 69.2 (C-5), 71.3 (C-3), 73.9 (C-
13), 77.0 (C-7), 77.1 (C-11), 115.9 (C-26), 121.7 (C-19), 135.9 (C-24), 139.2 (C-27), 142.3 
(C-23), 150.0 (C-20), 159.6 (C-29), 161.9 (C-25), 166.9 (C-18), 173.0 (C-1); 
HRMS (ESI): calcd for C31H46NaN2O9 [M+Na]+: 613.30955, found 613.31039. 
 
 
(4R,6S)-6-{[tert-Butyl(diphenyl)silyl]oxy}non-1-en-4-ol (8-43) 
 
OH OTBDPS
1 5
 
 
To a cooled (–20 °C) solution of (S,S)-6-82 (22.3 g, 40.4 mmol, 1.1 equiv) in CH2Cl2 (190 
mL) was added aldehyde 8-17 (13.0 g, 36.7 mmol, 1.0 equiv). The reaction mixture was then 
placed into a freezer (–10 °C) and maintained at that temperature for 24 h (without stirring). 
The reaction was quenched while cold with 1N HCl (100 mL) and EtOAc (100 mL) and the 
mixture was vigorously stirred at room temperature for 15 min. The obtained white precipitate 
of (S,S)-N,N’-bis-(4-bromo-benzyl)-cyclohexane-1,2-diamine dihydrochloride was filtered, 
washed with Et2O (3 × 50 mL) and dried in vacuo (recovered 18.6 g, 91% of (S,S)-diamine 
dihydrochloride). The filtrate layers were separated and the aqueous layer was extracted with 
Et2O (3 × 100 mL). The combined organic extracts were washed with H2O (100 mL), 
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saturated NaCl solution (100 mL), dried (MgSO4), and filtered. The filtrate was concentrated 
in vacuo to give the crude product, which was purified by flash chromatography (petroleum 
ether/EtOAc, 20:1→10:1) to give homoallylic alcohol 8-43 (12.30 g, 85%) as a colorless oil. 
Rf = 0.41 (petroleum ether/EtOAc, 10:1); [α]20D = +6.7 (c 3.0, CH2Cl2); 1H NMR (400 MHz, 
CDCl3): δ = 0.62 (t, J = 7.3 Hz, 3H, 8-CH3), 1.06 (s, 9H, Si(C(CH3)3)), 1.13–1.45 (m, 4H, 7-H, 
8-H), 1.59–1.67 (m, 2H, 5-H), 2.08–2.21 (m, 2H, 3-H), 2.66 (d, J = 3.0 Hz, 1H, OH), 3.80–
3.90 (m, 1H, 4-H), 3.93–4.02 (m, 1H, 6-H), 5.03–5.07 (m, 1H, 1-H), 5.08–5.10 (m, 1H, 1-H), 
5.70–5.84 (m, 1H, 2-H), 7.35–7.47 (m, 6H, mCH, pCH ar Ph), 7.69–7.74 (m, 4H, oCH ar Ph); 
13C NMR (100 MHz, CDCl3): δ = 13.8 (8-CH3), 18.0 (C-8), 19.3 (Si(C(CH3)3)), 27.0 
(Si(C(CH3)3)), 39.4 (C-7), 42.0 (C-3), 42.6 (C-5), 69.4 (C-4), 73.3 (C-6), 117.6 (C-1), 127.5, 
127.6, 129.6, 129.7, 133.7, 134.4 (C of SiPh2), 134.7 (C-2), 134.8, 135.9 (C of SiPh2); 
HRMS (ESI): calcd for C25H36NaO2Si [M+Na]+: 419.23768, found 419.23758. 
 
 
tert-Butyl{[(1S,3R)-3-methoxy-1-propylhex-5-enyl]oxy}diphenylsilane (8-44) 
 
MeO OTBDPS
1 5
 
 
To a solution of alcohol 8-43 (8.51 g, 21.4 mmol) in CH2Cl2 (220 mL) in the dark at room 
temperature was added Me3OBF4 (11.1 g, 74.9 mmol) and proton sponge (22.9 g, 107 mmol) 
and the mixture was allowed to stir for 48 h. After complete reaction (monitoring by TLC) 
H2O was added (50 mL) and the mixture extracted with CH2Cl2 (3 × 100 mL). The combined 
organic extracts were washed with 1N HCI, saturated NaHCO3 and saturated NaCl solution, 
dried over MgSO4, filtered, and concentrated in vacuo. Flash chromatography of the residue 
(petroleum ether/EtOAc, 40:1→20:1) afforded methyl ether 8-44 (7.64 g, 87% yield) as a 
colorless oil. Rf = 0.57 (petroleum ether/EtOAc, 10:1); [α]20D = –7.9 (c 2.1, CH2Cl2); 1H NMR 
(400 MHz, CDCl3): δ = 0.74 (t, J = 7.3 Hz, 3H, 8-CH3), 1.08 (s, 9H, Si(C(CH3)3)), 1.15–1.36 
(m, 2H, 8-H), 1.37–1.60 (m, 3H, 7-H, 5-H), 1.74–1.82 (m, 1H, 5-H), 1.99–2.08 (m, 1H, 3-H), 
2.10–2.19 (m, 1H, 3-H), 3.23 (s, 3H, OCH3), 3.34–3.42 (m, 1H, 4-H), 3.81–3.89 (m, 1H, 6-H), 
4.92–5.02 (m. 2H, 1-H), 5.64–5.77 (m, 1H, 2-H), 7.35–7.46 (m, 6H, mCH, pCH ar Ph), 7.68–
7.74 (m, 4H, oCH ar Ph); 
13C NMR (100 MHz, CDCl3): δ = 14.0 (8-CH3), 17.9 (C-8), 19.4 (Si(C(CH3)3)), 27.1 
(Si(C(CH3)3)), 37.6 (C-3), 39.1 (C-7), 40.1 (C-5), 56.0 (OCH3), 70.6 (C-6), 77.2 (C-4), 116.8 
(C-1), 127.4, 127.5, 129.4, 129.5, 134.4, 134.6 (C of SiPh2), 134.7 (C-2), 135.9 (C of SiPh2); 
HRMS (ESI): calcd for C26H38NaO2Si [M+Na]+: 433.25333, found 433.25335. 
 
 
(3S,5S)-5-{[tert-Butyl(diphenyl)silyl]oxy}-3-methoxyoctanal (8-45) 
 
MeO OTBDPS
O
2 6
 
 
To a solution of methyl ether 8-44 (6.50 g, 15.9 mmol) in a mixture of THF/tBuOH (200/40 
mL) was added 4-methyl-morpholine-N-oxide (4.30 g, 31.8 mmol) and an aqueous solution of 
OsO4 (10 mL of a 0.032 M solution, 0.32 mmol, 2 mol%, prepared from K2OsO4·2H2O (118 
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mg, 0.32 mmol)) at 0 ºC. After being stirred at room temperature for 20 h, 10% Na2S2O3 
solution (50 mL) was added to the mixture. After 30 min, the diol was extracted with EtOAc 
and the combined organic extracts were washed with water, saturated NaCl solution, dried 
over MgSO4, filtered, and concentrated in vacuo. The residue was filtered through a short pad 
of silica gel followed by rinsing the pad with EtOAc. Removal of the solvent from the 
combined filtrate gave the crude diol. 
NaIO4 (5.1 g, 24.0 mmol, 1.5 equiv) was added to a solution of crude diol in 90% MeOH (200 
mL). After stirring at room temperature for 1 h, most of the methanol was removed in vacuo 
and the residue extracted with Et2O (3 × 150 mL). The combined organic extracts were 
washed with water, saturated NaCl solution, dried over MgSO4, and filtered. After 
concentration, the residue was purified by flash chromatography (petroleum ether/EtOAc, 
10:1→5:1) to give aldehyde 8-45 as a colorless oil (6.11 g, 93% for 2 steps). Rf = 0.37 
(petroleum ether/EtOAc, 10:1); [α]20D = –3.6 (c 1.4, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 
0.75 (t, J = 7.3 Hz, 3H, 7-CH3), 1.05 (s, 9H, Si(C(CH3)3)), 1.14–1.33 (m, 2H, 7-H), 1.38–1.60 
(m, 3H, 6-H, 4-H), 1.86–1.94 (m, 1H, 4-H), 2.15–2.30 (m, 2H, 2-H), 3.21 (s, 3H, OCH3), 
3.72–3.82 (m, 2H, 3-H, 5-H), 7.33–7.44 (m, 6H, mCH, pCH ar Ph), 7.63–7.69 (m, 4H, oCH ar 
Ph), 9.54–9.57 (m, 1H, CHO); 13C NMR (100 MHz, CDCl3): δ = 14.0 (7-CH3), 17.9 (C-7), 
19.3 (Si(C(CH3)3)), 27.1 (Si(C(CH3)3)), 39.2 (C-6), 40.1 (C-4), 47.9 (C-2), 56.3 (OCH3), 70.2 
(C-5), 73.5 (C-3), 127.5, 127.6, 129.6, 129.7, 134.0, 134.3, 135.9, 135.9 (C of SiPh2), 201.5 
(C-1); 
HRMS (ESI): calcd for C25H36NaO3Si [M+Na]+: 435.23259, found 435.23257. 
 
 
S-Ethyl (2E,5R,7S)-7-{[tert-butyl(diphenyl)silyl]oxy}-5-methoxydec-2-enethioate (8-46) 
 
MeO OTBDPS
EtS
O
2 6
 
 
A solution of the aldehyde 8-45 (6.10 g, 14.8 mmol) and ylide 8-21 (22.2 mmol, 8.1 g) in 
CH2Cl2 (250 mL) was heated at reflux for 10 h. The solution was concentrated under reduced 
pressure and purified by flash chromatography (petroleum ether/EtOAc, 40:1→20:1) to afford 
the desired α,β-unsaturated thioester 8-46 as a colorless oil (6.71 g, 91% ). Rf = 0.51 
(petroleum ether/EtOAc, 10:1); [α]20D = –22.3 (c 3.2, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ 
= 0.74 (t, J = 7.3 Hz, 3H, 9-CH3), 1.05 (s, 9H, Si(C(CH3)3)), 1.14–1.33 (m, 5H, 9-H, 
SCH2CH3), 1.38–1.52 (m, 3H, 6-H, 8-H), 1.76–1.84 (m, 1H, 6-H), 1.99–2.08 (m, 1H, 4-H), 
1.99–2.08 (m, 1H, 4-H), 2.13–2.20 (m, 1H, 4-H), 2.93 (q, J = 14.7 Hz, 2H, SCH2CH3), 3.21 (s, 
3H, OCH3), 3.37–3.43 (m, 1H, 5-H), 3.75–3.80 (m, 1H, 7-H), 5.96 (d, J = 15.7 Hz, 1H, 2-H), 
6.70–6.79 (m, 1H, 3-H), 7.34–7.46 (m, 6H, mCH, pCH ar Ph), 7.64–7.70 (m, 4H, oCH ar Ph); 
13C NMR (100 MHz, CDCl3): δ = 14.0 (9-CH3), 14.8 (SCH2CH3), 18.0 (C-9), 19.3 
(Si(C(CH3)3)), 23.0 (SCH2CH3), 27.1 (Si(C(CH3)3)), 36.2 (C-4), 39.2 (C-8), 40.3 (C-6), 56.3 
(OCH3), 70.3 (C-7), 76.5 (C-5), 127.4, 127.6, 129.5, 129.7 (C of SiPh2), 130.5 (C-2), 134.1, 
134.4, 135.9 (C of SiPh2), 141.3 (C-3), 189.8 (C-1); 
HRMS (ESI): calcd for C29H42NaO3SSi [M+Na]+: 521.25161, found 521.25170. 
 
 
S-Ethyl (3S,5R,7S)-7-{[tert-butyl(diphenyl)silyl]oxy}-5-methoxy-3-methyldecanethioate (8-47) 
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CuBr·Me2S (7.1 mg, 0.034 mmol, 3 mol%) and (S,R)-Josiphos ent-6-87 (26.0 mg, 0.04 mmol, 
3.6 mol%) were dissolved in tBuOMe (10 mL) and stirred at room temperature for 30 min 
under nitrogen. The mixture was cooled to –75 °C and MeMgBr (3M solution in Et2O, 465 
µL, 1.4 mmol, 1.2 equiv) was added dropwise. After stirring for 10 min, a solution of thioester 
8-46 (572 mg, 1.15 mmol, 1 equiv) in tBuOMe (1.2 mL) was added via a syringe pump over 2 
h. The reaction mixture was stirred at –75 °C for 12 h, then quenched by the addition of 
MeOH and allowed to warm to room temperature. Saturated aqueous NH4Cl solution was then 
added, the phases were separated and the aqueous layer extracted with Et2O (2 × 50 mL). The 
combined organic phases were dried over MgSO4, concentrated under reduced pressure and 
purified by flash chromatography (petroleum ether/EtOAc, 30:1→20:1) to afford the desired 
1,4-addition adduct 8-47 as a colorless oil (501 mg, 85%). Rf = 0.57 (petroleum ether/EtOAc, 
10:1); [α]20D = –6.8 (c 1.5, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.72 (t, J = 7.3 Hz, 3H, 9-
CH3), 0.86 (d, J = 6.6 Hz, 3H, 3-CH3), 1.04 (s, 9H, Si(C(CH3)3)), 1.14–1.31 (m, 7H, 4-H, 9-H, 
SCH2CH3), 1.34–1.53 (m, 3H, 6-H, 8-H), 1.72–1.81 (m, 1H, 6-H), 2.00–2.12 (m, 1H, 3-H), 2.13–
2.21 (m, 1H, 2-H), 2.48 (dd, J = 14.4, 4.8 Hz, 1H, 2-H), 2.86 (q, J = 14.9 Hz, 2H, SCH2CH3), 3.16 
(s, 3H, OCH3), 3.24–3.30 (m, 1H, 5-H), 3.76–3.82 (m, 1H, 7-H), 7.33–7.44 (m, 6H, mCH, pCH ar 
Ph), 7.64–7.69 (m, 4H, oCH ar Ph); 13C NMR (100 MHz, CDCl3): δ = 14.0 (9-CH3), 14.8 
(SCH2CH3), 17.9 (C-9), 19.4 (Si(C(CH3)3)), 20.2 (3-CH3), 23.2 (SCH2CH3), 27.1 
(Si(C(CH3)3)), 27.8 (C-3), 39.0 (C-8), 40.6 (C-6), 41.2 (C-4), 50.8 (C-2), 55.7 (OCH3), 70.6 
(C-7), 75.9 (C-5), 127.4, 127.5, 129.5, 129.5, 134.3, 134.6, 136.0 (C of SiPh2), 199.0 (C-1); 
HRMS (ESI): calcd for C30H46NaO3SSi [M+Na]+: 537.28291, found 537.28327. 
 
 
(3S,5R,7S)-7-{[tert-Butyl(diphenyl)silyl]oxy}-5-methoxy-3-methyldecanal (8-48) 
 
MeO OTBDPS
H
O
2 6
 
 
To a stirred mixture of the thioester 8-47 (470 mg, 0.92 mmol) and Pd-C (47.0 mg, 10% wt) in 
CH2Cl2 (5 mL) was added Et3SiH (438 μL, 2.76 mmol, 3 equiv) at room temperature under 
nitrogen. The reaction mixture was stirred at room temperature for 30 min. The catalyst was 
filtered off through a pad of celite and washed with CH2Cl2. The filtrate was concentrated 
under reduced pressure and purified by flash chromatography (petroleum ether/EtOAc, 
10:1→5:1) to give the pure aldehyde 8-48 (397 mg, 95%). Rf = 0.36 (petroleum ether/EtOAc, 
10:1); [α]20D = –3.0 (c 1, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.73 (t, J = 7.3 Hz, 3H, 9-
CH3), 0.87 (d, J = 6.3 Hz, 3H, 3-CH3), 1.04 (s, 9H, Si(C(CH3)3)), 1.14–1.30 (m, 4H, 4-H, 9-H), 
1.37–1.52 (m, 3H, 6-H, 8-H), 1.73–1.83 (m, 1H, 6-H), 1.98–2.09 (m, 2H, 2-H, 3-H), 2.25–2.32 
(m, 1H, 2-H), 3.14 (s, 3H, OCH3), 3.25–3.32 (m, 1H, 5-H), 3.76–3.81 (m, 1H, 7-H), 7.33–7.44 
(m, 6H, mCH, pCH ar Ph), 7.64–7.70 (m, 4H, oCH ar Ph), 9.61–9.64 (m, 1H, CHO); 
13C NMR (100 MHz, CDCl3): δ = 14.0 (9-CH3), 18.0 (C-9), 19.4 (Si(C(CH3)3)), 20.8 (3-CH3), 
24.7 (C-3), 27.1 (Si(C(CH3)3)), 39.2 (C-8), 40.3 (C-6), 41.1 (C-4), 50.5 (C-2), 55.4 (OCH3), 70.6 
(C-7), 75.7 (C-5), 127.4, 127.5, 129.5, 129.6, 134.3, 134.5, 136.0 (C of SiPh2), 202.9 (C-1); 
HRMS (ESI): calcd for C28H42NaO3Si [M+Na]+: 477.28009, found 477.27978. 
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Trifluoroacetic acid (0.78 ml, 8.2 mmol, 10 equiv) was added to a solution of alcohol 8-26 
(220 mg, 1.07 mmol, 1.3 equiv) and aldehyde 8-48 (372 mg, 0.82 mmol) in CH2Cl2 (8 mL) at 
–5 °C under a nitrogen atmosphere. The reaction mixture was stirred for 1 h at this 
temperature and then saturated aqueous NaHCO3 solution (10 mL) was added dropwise. The 
layers were separated and the aqueous phase was extracted with CH2Cl2 (3 × 30 mL). The 
combined organic extracts were washed with brine (20 mL), dried over MgSO4, filtered, 
concentrated in vacuo and purified by column flash chromatography (petroleum ether/EtOAc, 
15:1→10:1) to afford trifluoracetate 8-49 as a colorless oil (437 mg, 71%). Rf = 0.75 
(petroleum ether/EtOAc, 4:1); 
[α]20D = –2.7 (c 3.8, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.65 (t, J = 7.3 Hz, 3H, 8-
CH3), 0.76 (d, J = 6.8 Hz, 3H, 2-CH3), 0.98 (s, 9H, Si(C(CH3)3)), 1.03–1.54 (m, 12H, 7-H, 8-
H, 5’-H, 1-H, BnOCH2CH2, 3-H), 1.64–1.82 (m, 3H, 5-H, 2-H), 1.84–2.00 (m, 2H, 3’-H), 3.10 
(s, 3H, OCH3), 3.19–3.37 (m, 2H, 6’-H, 2’-H), 3.41–3.60 (m, 3H, 4-H, BnOCH2CH2), 3.70–
3.79 (m, 1H, 6-H), 4.40 (s, 2H, PhCH2O), 4.96–5.07 (m, 1H, 4’-H), 7.18–7.37 (m, 11H, mCH, 
pCH ar SiPh2, Ph of Bn), 7.59–7.67 (m, 4H, oCH ar SiPh2); 13C NMR (100 MHz, CDCl3): δ = 
14.0 (8-CH3), 17.9 (C-8), 19.4 (Si(C(CH3)3)), 19.9 (2-CH3), 25.6 (C-2), 26.5, 27.1 
(Si(C(CH3)3)), 36.1 (BnOCH2CH2), 36.7 (C-3’), 37.3 (C-3), 39.0 (C-5’), 40.9 (C-7), 42.3 (C-
5), 42.9 (C-1), 55.7 (OCH3), 66.4 (BnOCH2CH2), 70.6 (C-6), 71.9 (C-4), 72.5 (C-6’), 73.1 
(PhCH2O), 75.4 (C-4’), 76.0 (C-2’), 114.5 (q, J = 286 Hz, CF3), 127.4, 127.4, 127.6, 127.6, 
127.7, 128.4, 129.5, 129.6, 134.4, 134.5, 135.9, 138.3 (C of SiPh2 and Ph of Bn), 156.9 (q, J = 
42 Hz, COCF3); 
HRMS (ESI): calcd for C43H59F3NaO6Si [M+Na]+: 779.39252, found 779.39261. 
 
 
Tetrahydropyran 8-50 
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To a solution of trifluoracetate 8-49 (360 mg, 0.476 mmol) in methanol (5 mL) was added 
K2CO3 (131 mg, 0.95 mmol) and water (0.2 ml). The reaction mixture was stirred at room 
temperature for 1 h, then diluted with water (5 mL) and extracted with Et2O (3 × 30 mL). The 
combined organic layers were washed with saturated NaCl solution (20 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. Flash chromatography of the residue (petroleum 
ether/EtOAc, 3:1→2:1) provided alcohol 8-50 (290 mg, 92% yield) as a colorless oil. Rf = 
0.30 (petroleum ether/EtOAc, 2:1); [α]20D = –19.1 (c 1.8, CH2Cl2); 1H NMR (400 MHz, 
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CDCl3): δ = 0.65 (t, J = 7.3 Hz, 3H, 8-CH3), 0.76 (d, J = 6.6 Hz, 3H, 2-CH3), 0.98 (s, 9H, 
Si(C(CH3)3)), 1.02–1.54 (m, 12H, 7-H, 8-H, 5’-H, 1-H, BnOCH2CH2, 3-H), 1.62–1.80 (m, 5H, 
5-H, 2-H, 3’-H, BnOCH2CH2), 1.83–1.89 (m, 1H, 3’-H), 3.10 (s, 3H, OCH3), 3.20–3.30 (m, 
2H, 6’-H, 4-H), 3.34–3.42 (m, 1H, 2’-H), 3.47–3.58 (m, 2H, BnOCH2CH2), 3.64–3.81 (m, 2H, 
4’-H, 6-H), 4.41 (s, 2H, PhCH2O), 7.18–7.34 (m, 11H, mCH, pCH ar SiPh2, Ph of Bn), 7.59–
7.64 (m, 4H, oCH ar SiPh2); 13C NMR (100 MHz, CDCl3): δ = 14.0 (8-CH3), 17.8 (C-8), 19.4 
(Si(C(CH3)3)), 19.9 (2-CH3), 25.8 (C-2), 27.1 (Si(C(CH3)3)), 36.2 (BnOCH2CH2), 38.9 (C-3), 
41.0 (C-3’), 41.4 (C-5’), 41.9 (C-7), 42.4 (C-5), 43.2 (C-1), 55.7 (OCH3), 66.8 (BnOCH2CH2), 
68.3 (C-6), 70.7 (C-4’), 72.2 (C-4), 72.9 (C-6’), 73.1 (PhCH2O), 76.1 (C-2’), 127.4, 127.4, 
127.5, 127.6, 128.3, 129.4, 129.4, 134.4, 134.6, 135.9, 135.9, 138.5 (C of SiPh2 and Ph of Bn); 
HRMS (ESI): calcd for C41H60NaO5Si [M+Na]+: 683.41022, found 683.41103. 
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To a stirred, cooled (0 °C) solution of alcohol 8-50 (278 mg, 0.44 mmol) in DMF (2 mL) were 
added N,N-diisopropylethylamine (0.68 mL, 4.0 mmol), chloromethylmethyl ether (182 µL, 
2.4 mmol), and tetrabutylammonium iodide (15 mg, 0.04 mmol). The reaction mixture was 
warmed to room temperature. After stirring for 4 h, saturated aqueous NaHCO3 solution (5 
mL) was added followed by Et2O (20 mL). After separation of the layers, the aqueous phase 
was extracted with Et2O (3 × 20 mL). The combined organic extracts were washed with 1N 
HCl, saturated NaHCO3 and saturated NaCl solution, dried over MgSO4, filtered and 
concentrated under reduced pressure. Flash chromatography (petroleum ether/EtOAc, 5:1) 
afforded MOM ether 8-51 (304 mg, 98% yield) as a colorless oil. Rf = 0.58 (petroleum 
ether/EtOAc, 4:1); [α]20D = –6.5 (c 3.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.65 (t, J = 
7.3 Hz, 3H, 8-CH3), 0.76 (d, J = 6.6 Hz, 3H, 2-CH3), 0.99 (s, 9H, Si(C(CH3)3)), 1.03–1.55 (m, 
11H, 7-H, 8-H, 5’-H, 1-H, BnOCH2CH2, 3-H), 1.64–1.94 (m, 6H, 5-H, 2-H, 3’-H, 
BnOCH2CH2), 3.10 (s, 3H, CHOCH3), 3.20–3.28 (m, 2H, 6’-H, 4-H), 3.31 (s, 3H, CH2OCH3), 
3.35–3.43 (m, 1H, 2’-H), 3.46–3.59 (m, 2H, BnOCH2CH2), 3.61–3.71 (m, 1H, 4’-H), 3.73–3.81 
(m, 1H, 6-H), 4.41 (s, 2H, PhCH2O), 4.63 (s, 2H, CH2OCH3), 7.17–7.37 (m, 11H, mCH, pCH ar 
SiPh2, Ph of Bn), 7.57–7.65 (m, 4H, oCH ar SiPh2); 13C NMR (100 MHz, CDCl3): δ = 14.0 (8-
CH3), 17.8 (C-8), 19.4 (Si(C(CH3)3)), 19.9 (2-CH3), 25.8 (C-2), 27.1 (Si(C(CH3)3)), 36.3 
(BnOCH2CH2), 38.7 (C-3’), 38.9 (C-3), 39.3 (C-5’), 41.0 (C-7), 42.5 (C-5), 43.3 (C-1), 55.2 
(CH2OCH3), 55.8 (CHOCH3), 66.8 (BnOCH2CH2), 70.7 (C-6), 72.3 (C-4), 72.9 (C-6’), 73.1 
(PhCH2O), 73.2 (C-4’), 76.1 (C-2’), 94.3 (CH2OCH3), 127.4, 127.4, 127.5, 127.6, 128.3, 129.4, 
129.4, 134.4, 134.7, 135.9, 138.5 (C of SiPh2 and Ph of Bn); 
HRMS (ESI): calcd for C43H64NaO6Si [M+Na]+: 727.43644, found 727.43571. 
 
 
Alcohol 8-52 
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The Parr hydrogenation vessel was charged with MOM ether 8-51 (195 mg, 0.276 mmol), Pd-
C (20 mg), methanol (20 mL), attached to a hydrogen source and hydrogen was introduced 
into the reaction vessel until the pressure gauge indicates 2 atm. The pressure was carefully 
released to 1 atm by opening the stop valve. This procedure was repeated three times, and 
finally hydrogen was pressurized to 5 atm. The reaction mixture was vigorously shaked at 
room temperature for 10 h during which time the hydrogen cylinder was kept connected. After 
the stop valve was opened, excess hydrogen was carefully bled off, and the apparatus was 
disassembled. The catalyst was filtered off through a pad of Celite and washed with EtOAc. 
The filtrate was concentrated under reduced pressure and purified by flash chromatography 
(petroleum ether/EtOAc, 2:1) to give the alcohol 8-52 (158 mg, 93%). Rf = 0.27 (petroleum 
ether/EtOAc, 2:1); [α]20D = +6.0 (c 2.0, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.70 (t, J = 
7.3 Hz, 3H, 8-CH3), 0.82 (d, J = 6.6 Hz, 3H, 2-CH3), 1.04 (s, 9H, Si(C(CH3)3)), 1.06–1.60 (m, 
11H, 7-H, 8-H, 5’-H, 1-H, HOCH2CH2, 3-H), 1.65–1.80 (m, 4H, 5-H, 2-H, HOCH2CH2), 
1.84–1.97 (m, 2H, 3’-H), 2.58 (br s, 1H, OH), 3.14 (s, 3H, CHOCH3), 3.26–3.40 (m, 5H, 6’-H, 
4-H, CH2OCH3), 3.46–3.55 (m, 1H, 2’-H), 3.65–3.84 (m, 4H, HOCH2CH2, 4’-H, 6-H), 4.69 
(s, 2H, CH2OCH3), 7.31–7.43 (m, 6H, mCH, pCH ar SiPh2), 7.64–7.70 (m, 4H, oCH ar SiPh2); 
13C NMR (100 MHz, CDCl3): δ = 14.0 (8-CH3), 17.9 (C-8), 19.4 (Si(C(CH3)3)), 20.1 (2-CH3), 
25.8 (C-2), 27.1 (Si(C(CH3)3)), 37.9 (C-3’), 38.6 (C-3), 39.0 (CH2CH2OH), 39.0 (C-5’), 40.8 
(C-7), 42.4 (C-5), 43.0 (C-1), 55.3 (CH2OCH3), 55.5 (CHOCH3), 61.3 (HOCH2CH2), 70.7 (C-
6), 72.9 (C-4’), 73.6 (C-4), 75.7 (C-6’), 75.9 (C-2’), 94.4 (CH2OCH3), 127.4, 127.4, 129.4, 
129.5, 134.4, 134.6, 135.9 (C of SiPh2); 
HRMS (ESI): calcd for C36H58NaO6Si [M+Na]+: 637.38949, found 637.38926. 
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a) Preparation of aldehyde: To a cooled (0 °C) solution of alcohol 8-52 (155 mg, 0.25 
mmol) in CH2Cl2 (3 mL) was added a solution of Dess-Martin periodinane (15% wt, 0.83 mL, 
0.4 mmol). After stirring for 0.5 h at 0 °C and for 2 h at room temperature, the reaction 
mixture was concentrated, loaded on a flash silica gel column, and eluted with petroleum 
ether/EtOAc, 4:1 to give 147 mg (96%) of the corresponding aldehyde, which was used 
directly in the next reaction. TLC (petroleum ether/EtOAc, 4:1): Rf = 0.76 
b) Acid 180: The aldehyde obtained in the previous step (147 mg, 0.24 mmol) was 
dissolved in tBuOH (4 mL) and 2,3-dimethyl-2-butene (0.8 mL). A solution of NaClO2 (65 
mg, 0.72 mmol) and NaH2PO4·2H2O (336 mg, 2.16 mmol) in water (3 mL) was added slowly 
at 0 °C. After stirring for 30 min at room temperature the mixture was diluted with water (5 
mL), extracted with EtOAc (4 × 20 mL), washed with saturated NaCl solution, dried (Na2SO4) 
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and concentrated under reduced pressure. Flash chromatography of the residue (petroleum 
ether/EtOAc/HOAc, 2:1:0.01→1:1:0.01) provided acid 8-53 (151 mg, 98% yield) as a 
colorless oil. Rf = 0.54 (petroleum ether/EtOAc, 2:1); [α]20D = –2.3 (c 1.3, CH2Cl2); 1H NMR 
(400 MHz, CDCl3): 0.70 (t, J = 7.3 Hz, 3H, 8-CH3), 0.80 (d, J = 6.6 Hz, 3H, 2-CH3), 1.04 (s, 9H, 
Si(C(CH3)3)), 1.06–1.60 (m, 12H, 7-H, 8-H, 5’-H, 1-H, 2-H, 3-H), 1.69–1.81 (m, 2H, 5-H), 1.85–1.93 
(m, 1H, 3’-H), 2.01–2.08 (m, 1H, 3’-H), 2.42–2.62 (m, 2H, CH2COOH), 3.15 (s, 3H, CHOCH3), 3.26–
3.43 (m, 5H, 6’-H, 4-H, CH2OCH3), 3.66–3.84 (m, 3H, 2’-H, 4’-H, 6-H), 4.69 (s, 2H, CH2OCH3), 
7.31–7.43 (m, 6H, mCH, pCH ar SiPh2), 7.65–7.70 (m, 4H, oCH ar SiPh2); 13C NMR (100 MHz, 
CDCl3): δ = 14.0 (8-CH3), 17.9 (C-8), 19.4 (Si(C(CH3)3)), 20.1 (2-CH3), 25.7 (C-2), 27.1 
(Si(C(CH3)3)), 37.9 (C-3’), 38.9 (C-3), 39.0 (C-5’), 40.8 (C-7), 40.9 (CH2COOH), 42.3 (C-5), 42.9 (C-
1), 55.3 (CH2OCH3), 55.7 (CHOCH3), 70.7 (C-6), 71.9 (C-4’), 72.7 (C-2’), 73.7 (C-6’), 76.0 (C-4), 
94.5 (CH2OCH3), 127.4, 127.5, 129.4, 129.5, 134.4, 134.6, 135.9 (C of SiPh2), 174.5 (COOH); 
HRMS (ESI): calcd for C36H56NaO7Si [M+Na]+: 651.36875, found 651.36884. 
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To a solution of acid 8-53 (149 mg, 0.237 mmol) in THF (1 mL) was added TBAF·3H2O (450 
mg, 1.44 mmol) at room temperature. The reaction mixture was stirred for 48 h. After addition 
of saturated NH4Cl solution the mixture was extracted with EtOAc (3 × 25 mL). The combined 
organic layers were washed with water (10 ml), saturated NaCl solution (20 mL), dried over 
MgSO4, filtered, and concentrated in vacuo. Flash chromatography (petroleum 
ether/EtOAc/HOAc, 1:1:0.01→0:1:0.01) afforded seco-acid 8-54 (92 mg, 99% yield) as a 
colorless oil. Rf = 0.2 (petroleum ether/EtOAc/HOAc, 2:1:0.01); [α]20D = –18.8 (c 1.2, CH2Cl2); 
1H NMR (400 MHz, CDCl3): δ = 0.84–0.94 (m, 6H, 8-CH3, 2-CH3), 1.12–1.75 (m, 14H, 7-H, 8-
H, 5’-H, 1-H, 2-H, 3-H, 5-H), 1.86–1.94 (m, 1H, 3’-H), 2.00–2.07 (m, 1H, 3’-H), 2.42–2.60 (m, 
2H, CH2COOH), 3.31–3.47 (m, 8H, CHOCH3, 6’-H, 4-H, CH2OCH3), 3.68–3.83 (m, 3H, 2’-H, 
4’-H, 6-H), 4.67 (s, 2H, CH2OCH3), 6.42 (br s, 2H, OH, COOH); 13C NMR (100 MHz, CDCl3): 
δ = 14.1 (8-CH3), 18.6 (C-8), 19.6 (2-CH3), 26.3 (C-2), 38.0 (C-3’), 38.8 (C-3), 39.7 (C-5’), 40.8 
(C-7), 40.9 (CH2COOH), 41.3 (C-5), 43.8 (C-1), 55.3 (CH2OCH3), 56.1 (CHOCH3), 71.4 (C-
4’), 72.1 (C-6), 72.7 (C-4), 74.0 (C-6’), 80.5 (C-2’), 94.5 (CH2OCH3), 174.4 (COOH); 
HRMS (ESI): calcd for C20H38NaO7 [M+Na]+: 413.25097, found 413.25110. 
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To an ice-cooled solution of seco-acid 8-54 (85 mg, 0.21 mmol, 1.0 equiv) in THF (2.5 mL) 
was added Et3N (177 μL, 1.26 mmol, 6.0 equiv) followed by 2,4,6-trichlorobenzoyl chloride 
(164 μL, 1.05 mmol, 5.0 equiv). The mixture was stirred at 0 °C for 1 h and then allowed to 
warm to room temperature, whereupon toluene (7.5 mL) was added. This solution was added 
over 8 h by syringe pump to a solution of DMAP (51 mg, 4.2 mmol, 20 equiv) in toluene (150 
mL). Upon completion, stirring was maintained for an additional 2 h. The mixture was 
concentrated to dryness and filtered over silica gel (using petroleum ether/EtOAc 2:1 as 
eluant). The filtrate was concentrated under reduced pressure. Purification by flash 
chromatography (petroleum ether/EtOAc, 4:1) afforded lactone 8-55 (69 mg, 85% yield) and 
its 5-epi isomer (7.0 mg, 9% yield). Rf = 0.33 (petroleum ether/EtOAc, 2:1); [α]20D = +10.8 (c 
1.2, CH2Cl2); 1H NMR (600 MHz, CDCl3): δ = 0.84–0.90 (m, 6H, 15-CH3, 9-CH3), 1.07 (t, J = 
11.7 Hz, 1H, 6-H), 1.14–1.50 (m, 8H, 6-H, 10-H, 12-H, 8-H, 14-H, 15-H), 1.56–1.64 (m, 1H, 
14-H), 1.77–1.89 (m, 3H, 4-H, 8-H, 9-H), 1.96–2.01 (m, 1H, 4-H), 2.01–2.07 (m, 1H, 12-H), 
2.31–2.38 (m, 1H, 2-H), 2.58–2.63 (m, 1H, 2-H), 3.18–3.25 (m, 1H, 7-H), 3.28–3.36 (m, 7H, 
11-H, CHOCH3, CH2OCH3), 3.63–3.73 (m, 2H, 3-H, 5-H), 4.65 (s, 2H, CH2OCH3), 4.86–4.94 
(m, 1H, 13-H); 13C NMR (150 MHz, CDCl3): δ = 14.0 (15-CH3), 18.4 (C-15), 24.6 (9-CH3), 
28.9 (C-9), 37.2 (C-4), 37.9 (C-14), 38.1 (C-6), 39.3 (C-12), 40.2 (C-10), 42.6 (C-2), 44.2 (C-
8), 55.2 (CH2OCH3), 56.1 (CHOCH3), 71.3 (C-13), 71.5 (C-5), 72.7 (C-3), 76.7 (C-11), 77.0 
(C-7), 94.4 (CH2OCH3), 170.2 (C-1); 
HRMS (ESI): calcd for C20H36NaO6 [M+Na]+: 395.24041, found 395.24036. 
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To a cooled (0 °C) solution of MOM-ether 8-55 (57.4 mg, 0.154 mmol) in MeOH (3 mL) was 
added concentrated HCl (100 µL). After stirring for 0.5 h at 0 °C and for 24 h at room 
temperature, the reaction mixture was quenched with saturated aqueous NaHCO3 solution (5 
mL), extracted with EtOAc (4 × 20 mL), washed with brine, dried (MgSO4) and concentrated 
under reduced pressure. Flash chromatography of the residue (petroleum ether/EtOAc/HOAc, 
2:1→1:1) provided alcohol 8-56 (48.6 mg, 96% yield) as a colorless oil. Rf = 0.24 (petroleum 
ether/EtOAc, 2:1); [α]20D = +9.1 (c 0.8, CH2Cl2); 1H NMR (600 MHz, CD3OD): δ = 0.82–0.89 
(m, 6H, 15-CH3, 9-CH3), 0.94–1.14 (m, 3H, 6-H, 8-H), 1.17–1.33 (m, 3H, 10-H, 9-H), 1.36–
1.61 (m, 4H, 12-H, 14-H, 15-H), 1.69–1.86 (m, 3H, 14-H, 8-H, 4-H), 1.86–1.95 (m, 1H, 4H), 
1.97–2.07 (m, 1H, 12-H), 2.16–2.24 (m, 1H, 2-H), 2.64–2.71 (m, 1H, 2-H), 3.23–3.35 (m, 5H, 
7-H, 11-H, CHOCH3), 3.61–3.72 (m, 2H, 3-H, 5-H), 4.83–4.93 (m, 1H, 13-H); 13C NMR (150 
MHz, CD3OD): δ = 14.4 (15-CH3), 19.5 (C-15), 24.9 (9-CH3), 30.5 (C-9), 38.1 (C-4), 39.1 (C-
14), 41.3 (C-6), 41.6 (C-12), 42.9 (C-2), 43.5 (C-10), 45.4 (C-8), 56.5 (CHOCH3), 68.4 (C-5), 
72.3 (C-13), 72.9 (C-3), 78.2 (C-11), 78.5 (C-7), 172.5 (C-1); 
HRMS (ESI): calcd for C18H32NaO5 [M+Na]+: 351.21420, found 351.21413. 
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11-epi neopeltolide (8-57) 
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To a solution of alcohol 8-56 (7.6 mg, 0.023 mmol, 1 equiv), acid 6-15 (10.3 mg, 0.037 mmol, 
1.6 equiv) and PPh3 (10.5 mg, 0.040 mmol, 1.74 equiv) in absolute benzene (1 mL) was added 
diisopropyl azodicarboxylate (80 μL of 0.5M solution in benzene, 0.040 mmol, 1.74 equiv). 
After stirring for 1 h at ambient temperature the reaction mixture was concentrated in vacuo 
and the residue was purified by flash chromatography (hexane/EtOAC, 2:1→1:1→1:2) to 
afford 11-epi neopeltolide (8-57) (11.7 mg, 86%) as a colorless oil. Rf = 0.5 (petroleum 
ether/EtOAc, 1:1); [α]20D = +19.4 (c 0.8, CH2Cl2); 1H NMR (400 MHz, CD3OD): δ = 0.88 (d, 
J = 6.8 Hz, 3H, 17-H), 0.92 (t, J = 7.3 Hz, 3H, 16-H), 1.02–1.10 (m, 1H, 10-H), 1.20–1.42 (m, 
5H, 8-H, 9-H, 15-H), 1.43–1.70 (m, 7H, 10-H, 4-H, 6-H, 14-H), 1.75–1.93 (m, 3H, 4-H, 14-H, 
12-H), 2.06 (ddd, J = 14.1, 10.9, 3.0 Hz, 1H, 12-H), 2.21 (dd, J = 14.4, 11.1 Hz, 1H, 2-H), 
2.66–2.73 (m, 3H, 2-H, 22-H), 2.96–3.04 (m, 2H, 21-H), 3.32–3.40 (m, 4H, 11-OCH3, 7-H), 
3.64 (s, 3H, 29-OCH3), 3.75 (apt, J = 9.9 Hz, 1H, 11-H), 3.98–4.08 (m, 1H, 3-H), 4.29 (d, J = 
5.1 Hz, 2H, 28-H), 4.90–4.98 (m, 1H, 13-H), 5.17–5.21 (m, 1H, 5-H), 5.85 (d, J = 11.4 Hz, 
1H, 19-H), 5.98–6.07 (m, 1H, 27-H), 6.27 (dt, J = 11.9, 2.0 Hz, 1H, 26-H), 6.36 (dt, J = 11.5, 
7.6 Hz, 1H, 20-H), 7.65 (s, 1H, 24-H); 13C NMR (100 MHz, CD3OD): δ = 14.3 (C-16), 19.5 
(C-15), 24.8 (C-17), 26.4 (C-22), 29.0 (C-21), 30.5 (C-9), 36.2 (C-4), 37.3 (C-6), 38.1 (C-14), 
39.1 (C-10), 41.2 (C-12), 43.5 (C-2), 45.1 (C-8), 52.6 (29-OCH3), 56.4 (11-OCH3), 69.2 (C-5), 
70.4 (C-3), 72.4 (C-13), 75.1 (C-7), 78.5 (C-11), 115.9 (C-26), 121.6 (C-19), 135.9 (C-24), 
139.2 (C-27), 142.3 (C-23), 150.1 (C-20), 159.6 (C-29), 161.9 (C-25), 166.8 (C-18), 172.6 (C-
1); 
HRMS (ESI): calcd for C31H46NaN2O9 [M+Na]+: 613.30955, found 613.30863. 
 
 
Deprotected macrolactone 8-58 
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To a cooled (0 °C) solution of MOM-ether 8-33b (6.8 mg, 0.018 mmol) in MeOH (2 mL) was 
added concentrated HCl (70 µL). After stirring for 0.5 h at 0 °C and for 24 h at room 
temperature, the reaction mixture was quenched with saturated aqueous NaHCO3 solution (5 
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mL), extracted with EtOAc (4 × 10 mL), washed with brine, dried (MgSO4) and concentrated 
under reduced pressure. Flash chromatography of the residue (petroleum ether/EtOAc/HOAc, 
2:1→1:1) provided alcohol 8-58 (5.2 mg, 88% yield) as a colorless oil. Rf = 0.31 (petroleum 
ether/EtOAc, 1:1); [α]20D = +7.2 (c 0.5, CH2Cl2); 1H NMR (400 MHz, CDCl3): δ = 0.87–0.94 
(m, 6H, 15-CH3, 9-CH3), 1.11–1.22 (m, 3H, 6-H, 8-H), 1.23–1.44 (m, 6H, 10-H, 12-H, 8-H, 9-
H), 1.45–1.80 (m, 6H, 10-H, 12-H, 14-H, 15-H, OH), 1.84–1.92 (m, 1H, 14-H), 1.92–2.02 (m, 
2H, 4-H), 2.36 (dd, J = 12.1, 2.0 Hz, 1H, 2-H), 2.47 (dd, J = 12.1 Hz, 1H, 2-H), 3.00–3.07 (m, 
1H, 11-H), 3.30 (s, 3H, CHOCH3), 3.35–3.44 (m, 1H, 7-H), 3.55 (apt, J = 10.9 Hz, 1H, 3-H), 
3.78–3.89 (m, 1H, 5-H), 5.04–5.12 (m, 1H, 13-H); 13C NMR (100 MHz, CDCl3): δ = 13.9 (15-
CH3), 18.9 (C-15), 24.3 (9-CH3), 24.4 (C-9), 36.9 (C-4), 39.3 (C-14), 39.7 (C-6), 40.8 (C-12), 
42.0 (C-2), 42.4 (C-10), 45.1 (C-8), 56.9 (CHOCH3), 67.9 (C-5), 72.8 (C-13), 74.1 (C-3), 74.8 
(C-11), 76.9 (C-7), 172.7 (C-1); 
HRMS (ESI): calcd for C18H32NaO5 [M+Na]+: 351.21420, found 351.21429. 
 
 
5-epi neopeltolide (8-59) 
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To a solution of alcohol 8-58 (4.0 mg, 0.012 mmol, 1 equiv), acid 6-15 (5.4 mg, 0.019 mmol, 
1.6 equiv) and PPh3 (5.5 mg, 0.021 mmol, 1.75 equiv) in absolute benzene (0.7 mL) was 
added diisopropyl azodicarboxylate (42 μL of 0.5M solution in benzene, 0.021 mmol, 1.75 
equiv). After stirring for 1 h at ambient temperature the reaction mixture was concentrated in 
vacuo and the residue was purified by flash chromatography (hexane/EtOAC, 2:1→1:1→1:2) 
to afford 5-epi neopeltolide (8-59) (5.4 mg, 76%) as a colorless oil. Rf = 0.57 (petroleum 
ether/EtOAc, 1:1); [α]20D = –3.3 (c 0.4, CH2Cl2); 1H NMR (400 MHz, CD3OD): δ = 0.90–
0.96 (m, 6H, 16-H, 17-H), 1.11 (apt, J = 12.1 Hz, 1H, 10-H), 1.24–1.42 (m, 6H, 8-H, 9-H, 12-
H, 15-H), 1.44–1.57 (m, 3H, 10-H, 4-H, 14-H), 1.57–1.93 (m, 8H, 6-H, 14-H, 4-H, 12-H), 
2.28–2.37 (m, 2H, 2-H), 2.69 (t, J = 7.3 Hz, 2H, 22-H), 2.94–3.02 (m, 2H, 21-H), 3.12–3.20 
(m, 1H, 11-H), 3.64 (s, 3H, 29-OCH3), 3.71–3.81 (m, 1H, 7-H), 3.89–4.01 (m, 1H, 3-H), 4.29 
(d, J = 4.6 Hz, 2H, 28-H), 4.95–5.03 (m, 1H, 13-H), 5.19–5.23 (m, 1H, 5-H), 5.82 (d, J = 11.6 
Hz, 1H, 19-H), 5.99–6.07 (m, 1H, 27-H), 6.27 (dt, J = 11.9, 2.0 Hz, 1H, 26-H), 6.34 (dt, J = 
11.6, 7.3 Hz, 1H, 20-H), 7.65 (s, 1H, 24-H); 13C NMR (100 MHz, CD3OD): δ = 14.2 (C-16), 
20.0 (C-15), 24.6 (C-17), 25.4 (C-9), 26.4 (C-22), 29.0 (C-21), 36.5 (C-4), 37.5 (C-6), 37.9 (C-
14), 40.4 (C-12), 40.6, (C-10), 43.2 (C-2), 46.4 (C-8), 52.6 (29-OCH3), 57.2 (11-OCH3), 69.0 
(C-5), 71.2 (C-3), 73.4 (C-13), 75.4 (C-7), 78.3 (C-11), 116.0 (C-26), 121.5 (C-19), 136.0 (C-
24), 139.1 (C-27), 142.2 (C-23), 150.2 (C-20), 161.9 (C-29), 166.8 (C-18), 174.8 (C-1); 
HRMS (ESI): calcd for C31H46NaN2O9 [M+H]+: 591.32761, found 591.32815. 
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Methyl (2E)-5-(2-{(1Z)-3-[(methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazol-4-yl)pent-2-
enoate (8-60) 
 
N
O
NH
OMe
O
2''
5''
2
4
2'
3'
MeO2C
 
 
To a solution of aldehyde 8-9 (7 mg, 0.029 mmol, 1 equiv) in CH2Cl2 (1 mL) at ambient 
temperature was added (methoxycarbonylmethylene)triphenylphosphorane (8-36) (19.4 mg, 
0.058 mmol, 2 equiv). The reaction mixture was stirred for 2 h, concentrated in vacuo and 
purified by flash column chromatography (CH2Cl2/MeOH, 98:2) to afford unsaturated ester 8-
60 (7.9 mg, 93%) as a colorless oil. Rf = 0.57 (CH2Cl2/MeOH, 9:1); 1H NMR (400 MHz, 
CDCl3): δ = 2.57 (q, J = 7.4 Hz, 2H, 4-H), 2.70 (t, J = 7.3 Hz, 2H, 5-H), 3.67 (s, 3H, OCH3), 
3.71 (s, 3H, CCO2CH3), 4.30 (d, J = 4.3 Hz, 2H, 3’-H), 5.52 (br s, 1H, NH), 5.86 (d, J = 15.7 
Hz, 1H, 2-H), 6.05–6.14 (m, 1H, 2’-H), 6.29 (d, J = 11.6 Hz, 1H, 1’-H), 6.97 (dt, J = 15.7, 6.8 
Hz, 1H, 3-H), 7.35 (s, 1H, 5’’-H); 13C NMR (100 MHz, CDCl3): δ = 24.8 (C-5), 30.7 (C-4), 
39.4 (C-3’), 51.5 (OCH3), 52.2 (OCH3), 116.6 (C-1’), 121.8 (C-2), 133.9 (C-5’’), 136.5 (C-
4’’), 140.6 (C-2’), 147.8 (C-5’’), 157.2 (CO2CH3), 160.1 (C-2’’), 166.9 (C-1); 
HRMS (ESI): calcd for C14H18NaN2O5 [M+Na]+: 317.11079, found 317.11064. 
 
 
(2E)-5-(2-{(1Z)-3-[(Methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazol-4-yl)pent-2-enoic 
acid (8-61) 
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A solution of ester 8-60 (6.5 mg, 0.022 mmol) in THF (0.5 mL) was treated with LiOH (1N 
solution in water, 0.22 mL, 0.22 mmol) at ambient temperature and the reaction mixture was 
vigorously stirred until TLC indicated complete consumption of the starting material (ca. 6 h). 
The reaction was cooled to 0 °C and neutralized with aqueous HCl (1N, 0.22 mL, 0.22 mmol). 
After the mixture was extracted with EtOAc (4 × 10 mL), the combined organic layers were 
washed with saturated NaCl solution (5 mL), dried over MgSO4, filtered, and concentrated in 
vacuo. Flash chromatography (CH2Cl2/MeOH, 95:5→9:1) afforded acid 8-61 (5.7 mg, 92% 
yield) as a white solid. Rf = 0.38 (CH2Cl2/MeOH, 9:1); m.p. = 108–110 °C; 1H NMR (400 
MHz, CDCl3): δ = 2.60 (q, J = 7.2 Hz, 2H, 4-H), 2.72 (t, J = 7.1 Hz, 2H, 5-H), 3.67 (s, 3H, 
OCH3), 4.26–4.34 (m, 2H, 3’-H), 5.51 (br s, 1H, NH), 5.87 (d, J = 15.7 Hz, 1H, 2-H), 6.05-
6.14 (m, 1H, 2’-H), 6.29 (d, J = 11.9 Hz, 1H, 1’-H), 7.08 (dt, J = 15.5, 6.8 Hz, 1H, 3-H), 7.36 
(s, 1H, 5’’-H); 13C NMR (100 MHz, CDCl3): δ = 24.6 (C-5), 30.9 (C-4), 39.4 (C-3’), 52.2 
(OCH3), 116.5 (C-1’), 121.4 (C-2), 133.9 (C-5’’), 136.5 (C-4’’), 140.5 (C-2’), 150.1 (C-5’’), 
157.2 (CO2CH3), 160.1 (C-2’’), 170.4 (C-1); 
HRMS (ESI): calcd for C14H18NaN2O5 [M+Na]+: 303.09514, found 303.09516. 
 
 
2-{(1Z)-3-[(Methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazole-4-carboxylic acid (8-62) 
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A solution of ester 8-10 (21 mg, 0.08 mmol) in MeOH (1 mL) was treated with LiOH (1N 
solution in water, 0.8 mL, 0.8 mmol) at ambient temperature and the reaction mixture was 
stirred until TLC indicated complete consumption of the starting material (ca. 2 h). The 
reaction was cooled to 0 °C and neutralized with aqueous HCl (1N, 0.8 mL, 0.8 mmol). After 
the mixture was extracted with EtOAc (4 × 20 mL), the combined organic layers were washed 
with saturated NaCl solution (5 mL), dried over MgSO4, filtered, and concentrated in vacuo to 
afford acid 8-62 (18 mg, 94%) as a slightly yellow solid. Rf = 0.2 (CH2Cl2/MeOH, 9:1); m.p. 
= 153–155 °C; 1H NMR (400 MHz, CD3OD): δ = 3.64 (s, 3H, OCH3), 4.32 (d, J = 4.8 Hz, 
2H, CH2NH), 6.12–6.22 (m, 1H, HC=CHCH2), 6.34 (d, J = 11.9 Hz, 1H, HC=CHCH2), 8.47 
(s, 1H, 5-H); 13C NMR (100 MHz, CD3OD): δ = 40.9 (CH2NH), 52.6 (OCH3), 115.3 
(HC=CHCH2), 135.5 (C-4), 141.6 (HC=CHCH2), 145.4 (C-5), 159.6 (CO2CH3), 162.4 (C-2), 
164.0 (CO2H); 
HRMS (ESI): calcd for C9H10NaN2O5 [M+Na]+: 249.04819, found 249.04838. 
 
 
Methyl (2E)-3-(2-{(1Z)-3-[(methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazol-4-yl)acrylate 
(8-37) 
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To a solution of aldehyde 8-34 (67 mg, 0.32 mmol, 1 equiv) in CH2Cl2 (5 mL) at ambient 
temperature was added (methoxycarbonylmethylene)triphenylphosphorane (8-36) (213.8 mg, 
0.64 mmol, 2 equiv). The reaction mixture was stirred for 3 h, concentrated in vacuo and 
purified by flash column chromatography (CH2Cl2/MeOH, 98:2) to afford unsaturated ester 8-
37 (78.3 mg, 92%) as a colorless solid. Rf = 0.59 (CH2Cl2/MeOH, 9:1); m.p. = 117–118 °C; 
1H NMR (400 MHz, CDCl3): δ = 3.67 (s, 3H, 4’-OCH3), 3.71 (s, 3H, 1-OCH3), 4.33–4.40 (m, 
2H, 3’-H), 5.49 (br s, 1H, NH), 6.13–6.24 (m, 1H, 2’-H), 6.30 (d, J = 11.9 Hz, 1H, 1’-H), 6.63 
(d, J = 15.4 Hz, 1H, 2-H), 7.48 (d, J = 15.4 Hz, 1H, 3-H), 7.72 (s, 1H, 5’’-H); 13C NMR (100 
MHz, CDCl3): δ = 39.4 (C-3’), 51.7 (OCH3), 52.2 (OCH3), 115.6 (C-1’), 120.0 (C-2), 132.1 
(C-5’’), 138.1 (C-4’’), 138.5 (C-3), 139.0 (C-2’), 157.2 (CO2CH3), 160.7 (C-2’’), 167.1 (C-1); 
HRMS (ESI): calcd for C12H14NaN2O5 [M+Na]+: 289.07949, found 289.07953. 
 
 
(2E)-3-(2-{(1Z)-3-[(Methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazol-4-yl)acrylic acid (8-63) 
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A solution of ester 8-37 (16.0 mg, 0.06 mmol) in THF (0.6 mL) was treated with LiOH (1N 
solution in water, 0.6 mL, 0.6 mmol) at ambient temperature and the reaction mixture was 
vigorously stirred until TLC indicated complete consumption of the starting material (ca 7 h). 
The reaction was cooled to 0 °C and neutralized with aqueous HCl (1N, 0.6 mL, 0.6 mmol). 
After the mixture was extracted with EtOAc (4 × 15 mL), the combined organic layers were 
washed with saturated NaCl solution (5 mL), dried over MgSO4, filtered, and concentrated in 
vacuo. Flash chromatography (CH2Cl2/MeOH, 95:5→9:1) afforded acid 8-63 (14.4 mg, 92% 
yield) as a colorless solid. Rf = 0.30 (CH2Cl2/MeOH, 9:1); m.p. = 134–136 °C; 1H NMR (400 
MHz, CDCl3): δ = 3.65 (s, 3H, OCH3), 4.36 (d, J = 4.3 Hz, 2H, 3’-H), 6.10–6.18 (m, 1H, 2’-
H), 6.32 (dt, J = 11.9, 2.0 Hz, 1H, 1’-H), 6.56 (d, J = 15.4 Hz, 1H, 2-H), 7.52 (d, J = 15.4 Hz, 
1H, 3-H), 8.10 (s, 1H, 5’’-H); 13C NMR (100 MHz, CDCl3): δ = 41.1 (C-3’), 52.6 (OCH3), 115.4 
(C-1’), 121.4 (C-2), 133.9 (C-5’’), 139.4 (C-4’’), 140.9 (C-3), 141.2 (C-2’), 159.7 (CO2CH3), 162.5 
(C-2’’), 170.0 (C-1); 
HRMS (ESI): calcd for C11H12NaN2O5 [M+Na]+: 275.06384, found 275.06377. 
 
 
Methyl (2Z)-3-{4-[(1E)-3-oxoprop-1-enyl]-1,3-oxazol-2-yl}prop-2-enylcarbamate (8-64) 
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a) Reduction to alcohol: To a solution of ester 8-37 (46 mg, 0.17 mmol) in CH2Cl2 (3 
mL), at –78 °C, was added dropwise Dibal-H (1M in hexanes, 0.43 mL, 0.43 mmol, 2.5 
equiv). The reaction was stirred at –78 °C for 1 h, quenched with saturated aqueous NH4Cl 
solution and warmed up to room temperature. It was then treated with saturated potassium and 
sodium tartrate (Rochelle salt)/EtOAc (20:20 mL) and the mixture was vigorously stirred for 
10 min. After the layers were separated, water layer was extracted with EtOAc (3 × 20 mL). 
The combined organic extracts were washed with saturated NaCl solution, dried over MgSO4, 
filtered, and concentrated in vacuo. Flash chromatography of the residue (CH2Cl2/MeOH, 
97:3→95:5) afforded corresponding alcohol (37.2 mg, 92% yield) which was subjected to 
Dess-Martin periodinane oxidation. TLC (CH2Cl2/MeOH, 9:1): Rf = 0.38. 
b) Preparation of aldehyde 8-64: To a cooled (0 °C) solution of alcohol obtained in the 
previous step (37.2 mg, 0.16 mmol) in the mixture CH2Cl2 (2 mL) and CH3CN (0.8 mL) was 
added a solution of Dess-Martin periodinane (15% wt, 0.66 mL, 0.32 mmol), followed by 
addition of pyridine (26 µL, 0.32 mmol). After stirring for 10 min at 0 °C and for 1.5 h at 
room temperature, the reaction mixture was concentrated, loaded on a flash silica gel column, 
and eluted with petroleum ether/EtOAc, 4:1 to give 34 mg (93%) of aldehyde 8-64, which was 
used directly in the next reaction. Rf = 0.47 (CH2Cl2/MeOH, 9:1); 1H NMR (400 MHz, 
CDCl3): δ = 3.67 (s, 3H, OCH3), 4.37 (dd, J = 5.9 Hz, 2H, 3’-H), 5.45 (br s, 1H, NH), 6.18–6.27 
(m, 1H, 2’-H), 6.32 (d, J = 11.9 Hz, 1H, 1’-H), 6.86 (dd, J = 15.5 Hz, 8.0 Hz, 1H, 2-H), 7.31 (d, 
J = 15.6 Hz, 1H, 3-H), 7.85 (s, 1H, 5’’-H), 9.68 (d, J = 7.8 Hz, 1H, CHO); 13C NMR (100 MHz, 
CDCl3): δ = 39.6 (C-3’), 52.2 (OCH3), 115.4 (C-1’), 125.9 (C-2), 130.3 (C-5’’), 135.1 (C-4’’), 139.1 
(C-3), 139.3 (C-2’), 157.1 (CO2CH3), 161.0 (C-2’’), 193.0 (C-1). 
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Methyl (2Z,4E)-5-(2-{(1Z)-3-[(methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazol-4-
yl)penta-2,4-dienoate (8-65) 
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A solution of 18-crown-6, freshly recrystallized from acetonitrile, (100 mg, 0.38 mmol, 6 
equiv) and bis(2,2,2-trifluoroethyl)(methoxycarbonylmethyl) phosphonate (8-41) (32 µL, 0.15 
mmol, 2.4 equiv) in THF (2.0 mL) was cooled to –78 °C, and treated with KHMDS (0.5M 
solution in toluene, 260 µL, 0.13 mmol, 2.2 equiv). After 1 h, the solution of aldehyde 8-64 
(15 mg, 0.063 mmol, 1 equiv) in THF (0.5 mL) was added over a period of 5 min. After 1 h, 
TLC indicated complete consumption of aldehyde; the reaction was quenched with saturated 
NH4Cl and warmed to room temperature. After the mixture was extracted with EtOAc (3 × 15 
mL), the combined organic layers were washed with saturated NaCl solution (5 mL), dried 
over MgSO4, filtered, and concentrated in vacuo. Flash chromatography (CH2Cl2/MeOH, 
98:2) afforded ester 8-65 (12.6 mg, 68% yield) as a colorless oil. Rf = 0.65 (CH2Cl2/MeOH, 
9:1); 1H NMR (400 MHz, CDCl3): δ = 3.68 (s, 3H, 4’-OCH3), 3.75 (s, 3H, 1-OCH3), 4.37 (dd, 
J = 5.9 Hz, 2H, 3’-H), 5.55 (br s, 1H, NH), 5.74 (d, J = 11.1 Hz, 1H, 2-H), 6.14–6.23 (m, 1H, 
2’-H), 6.30 (d, J = 11.9 Hz, 1H, 1’-H), 6.61–6.72 (m, 2H, 3-H, 5-H), 7.67 (s, 1H, 5’’-H), 8.13 
(dd, J = 15.4, 11.9 Hz, 1H, 4-H); 13C NMR (100 MHz, CDCl3): δ = 39.4 (C-3’), 51.3 (1-
OCH3), 52.2 (4’-OCH3), 116.1 (C-1’), 118.2 (C-5), 127.0 (C-2), 128.5 (C-4), 136.4 (C-5’’), 
138.1 (C-4’’), 139.7 (C-2’), 143.7 (C-3), 157.2 (C-4’), 160.4 (C-2’’), 166.7 (C-1); 
HRMS (ESI): calcd for C14H16NaN2O5 [M+Na]+: 315.09514, found 315.09542. 
 
 
(2Z,4E)-5-(2-{(1Z)-3-[(Methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazol-4-yl)penta-2,4-
dienoic acid (8-67) 
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A solution of ester 8-65 (11.2 mg, 0.038 mmol) in THF (0.5 mL) was treated with LiOH (1N 
solution in water, 0.5 mL, 0.5 mmol) at ambient temperature and the reaction mixture was 
vigorously stirred until TLC indicated complete consumption of the starting material (ca. 8 h). 
The reaction was cooled to 0 °C and neutralized with aqueous HCl (1N, 0.5 mL, 0.5 mmol). 
After the mixture was extracted with EtOAc (4 × 15 mL), the combined organic layers were 
washed with saturated NaCl solution (5 mL), dried over MgSO4, filtered, and concentrated in 
vacuo. Flash chromatography (CH2Cl2/MeOH, 95:5→9:1) afforded acid 8-67 (9.8 mg, 93% 
yield) as a colorless solid. Rf = 0.47 (CH2Cl2/MeOH, 9:1); m.p. = 158–160 °C; 1H NMR (400 
MHz, CDCl3): δ = 3.64 (s, 3H, 4’-OCH3), 4.36 (d, J = 5.8 Hz, 2H, 3’-H), 5.72 (d, J = 11.4 Hz, 
1H, 2-H), 6.06–6.14 (m, 1H, 2’-H), 6.30 (d, J = 11.9 Hz, 1H, 1’-H), 6.72–6.80 (m, 2H, 3-H, 5-
H), 7.95 (s, 1H, 5’’-H), 8.13 (dd, J = 15.4, 11.9 Hz, 1H, 4-H); 13C NMR (100 MHz, CDCl3): δ = 
41.1 (C-3’), 52.6 (4’-OCH3), 115.6 (C-1’), 119.9 (C-5), 128.1 (C-2), 129.3 (C-4), 138.9 (C-5’’), 
140.6 (C-2’), 141.0 (C-4’’), 144.9 (C-3), 159.7 (C-4’), 162.3 (C-2’’), 170.0 (C-1); 
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HRMS (ESI): calcd for C13H14NaN2O5 [M+Na]+: 301.07949, found 301.07988. 
 
 
Methyl (2E,4E)-5-(2-{(1Z)-3-[(methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazol-4-
yl)penta-2,4-dienoate (8-66) 
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To a solution of aldehyde 8-64 (14.2 mg, 0.06 mmol, 1 equiv) in CH2Cl2 (1 mL) at ambient 
temperature was added (methoxycarbonylmethylene)triphenylphosphorane (8-36) (40.0 mg, 
0.12 mmol, 2 equiv). The reaction mixture was stirred for 4 h, concentrated in vacuo and 
purified by flash chromatography (CH2Cl2/MeOH, 98:2) to afford unsaturated ester 8-66 (15.2 
mg, 87%) as a colorless solid. Rf = 0.67 (CH2Cl2/MeOH, 9:1); m.p. = 132–134 °C; 1H NMR 
(400 MHz, CDCl3): δ = 3.68 (s, 3H, 4’-OCH3), 3.75 (s, 3H, 1-OCH3), 4.35–4.42 (m, 2H, 3’-H), 
5.47 (br s, 1H, NH), 6.02 (d, J = 15.4 Hz, 1H, 2-H), 6.12–6.20 (m, 1H, 2’-H), 6.30 (d, J = 11.9 
Hz, 1H, 1’-H), 6.69 (d, J = 15.2 Hz, 1H, 5-H), 7.04 (dd, J = 15.2, 11.6 Hz, 1H, 4-H), 7.38 (dd, 
J = 15.2, 11.5 Hz, 1H, 3-H) 7.62 (s, 1H, 5’’-H); 13C NMR (100 MHz, CDCl3): δ = 39.6 (C-3’), 
51.6 (1-OCH3), 52.2 (4’-OCH3), 115.9 (C-1’), 121.8 (C-5), 127.3 (C-4), 128.3 (C-2), 136.6 (C-
5’’), 138.3 (C-4’’), 139.4 (C-2’), 143.9 (C-3), 157.2 (C-4’), 160.5 (C-2’’), 167.4 (C-1); 
HRMS (ESI): calcd for C14H16NaN2O5 [M+Na]+: 315.09514, found 315.09519. 
 
 
(2E,4E)-5-(2-{(1Z)-3-[(Methoxycarbonyl)amino]prop-1-enyl}-1,3-oxazol-4-yl)penta-2,4-
dienoic acid (8-68) 
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A solution of ester 8-66 (12.1 mg, 0.04 mmol) in THF (0.5 mL) was treated with LiOH (1N 
solution in water, 0.5 mL, 0.5 mmol) at ambient temperature and the reaction mixture was 
vigorously stirred until TLC indicated complete consumption of the starting material (ca. 7 h). 
The reaction was cooled to 0 °C and neutralized with aqueous HCl (1N, 0.5 mL, 0.5 mmol). 
After the mixture was extracted with EtOAc (4 × 15 mL), the combined organic layers were 
washed with saturated NaCl solution (5 mL), dried over MgSO4, filtered, and concentrated in 
vacuo. Flash chromatography (CH2Cl2/MeOH, 95:5→9:1) afforded acid 8-68 (10.2 mg, 92% 
yield) as a colorless solid. Rf = 0.51 (CH2Cl2/MeOH, 9:1); m.p. = 177–179 °C; 1H NMR (400 
MHz, CDCl3): δ = 3.65 (s, 3H, 4’-OCH3), 4.37 (d, J = 5.3 Hz, 2H, 3’-H), 6.01 (d, J = 15.4 Hz, 
1H, 2-H), 6.07–6.15 (m, 1H, 2’-H), 6.31 (d, J = 11.9 Hz, 1H, 1’-H), 6.85 (d, J = 15.2 Hz, 1H, 
5-H), 7.08 (dd, J = 15.2, 11.4 Hz, 1H, 4-H), 7.40 (dd, J = 15.0, 11.2 Hz, 1H, 3-H), 7.96 (s, 1H, 
5’’-H); 13C NMR (100 MHz, CDCl3): δ = 41.1 (C-3’), 52.6 (4’-OCH3), 115.5 (C-1’), 123.3 (C-
5), 129.0 (C-4), 129.3 (C-2), 139.0 (C-5’’), 140.7 (C-2’), 145.7 (C-3), 159.7 (C-4’), 162.3 (C-
2’’), 170.4 (C-1); 
HRMS (ESI): calcd for C13H14NaN2O5 [M+Na]+: 279.09755, found 279.09812. 
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19-trans Neopeltolide 8-69 
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To a solution of alcohol 6-14 (4.1 mg, 0.0125 mmol, 1 equiv), acid 8-61 (5.6 mg, 0.02 mmol, 
1.6 equiv) and PPh3 (5.8 mg, 0.022 mmol, 1.76 equiv) in absolute benzene (0.7 mL) was 
added diisopropyl azodicarboxylate (44 μL of 0.5M solution in benzene, 0.022 mmol, 1.76 
equiv). After stirring for 1 h at ambient temperature the reaction mixture was concentrated in 
vacuo and the residue was purified by flash column chromatography (hexane/EtOAC, 
2:1→1:1→1:2) to afford 19-trans neopeltolide (8-69) (5.6 mg, 76%) as a colorless oil. Rf = 
0.44 (petroleum ether/EtOAc, 1:1); [α]20D = +31.0 (c 0.4, CH2Cl2); 1H NMR (400 MHz, 
CD3OD): δ = 0.93 (t, J = 7.3 Hz, 3H, 16-H), 0.99 (d, J = 6.8 Hz, 3H, 17-H), 1.08–1.15 (m, 1H, 
10-H), 1.23–1.42 (m, 6H, 8-H, 9-H, 12-H, 15-H), 1.44–1.62 (m, 4H, 10-H, 4-H, 6-H, 14-H), 
1.64–1.76 (m, 2H, 6-H, 14-H), 1.78–1.93 (m, 2H, 4-H, 12-H), 2.28 (dd, J = 14.9, 11.1 Hz, 1H, 
2-H), 2.60 (q, J = 7.2 Hz, 2H, 21-H), 2.66–2.77 (m, 3H, 2-H, 22-H), 3.27 (s, 3H, 11-OCH3), 
3.58 (apt, J = 10.0 Hz, 1H, 7-H), 3.62–3.72 (m, 4H, 29-OCH3, 11-H), 4.03–4.12 (m, 1H, 3-H), 
4.30 (d, J = 4.6 Hz, 2H, 28-H), 5.13–5.21 (m, 2H, 13-H, 5-H), 5.95 (d, J = 15.7 Hz, 1H, 19-H), 
5.99–6.07 (m, 1H, 27-H), 6.28 (dt, J = 11.9, 2.0 Hz, 1H, 26-H), 7.03 (dt, J = 15.5, 6.8 Hz, 1H, 
20-H), 7.65 (s, 1H, 24-H); 13C NMR (100 MHz, CD3OD): δ = 14.1 (C-16), 20.0 (C-15), 25.5 
(C-22), 26.0 (C-17), 31.8 (C-21), 32.6 (C-9), 36.2 (C-4), 37.4 (C-6), 38.0 (C-14), 41.1 (C-12), 
43.2 (C-2), 43.5 (C-10), 45.3 (C-8), 52.6 (29-OCH3), 56.4 (11-OCH3), 69.4 (C-5), 71.2 (C-3), 
74.0 (C-13), 77.1 (C-7), 77.1 (C-11), 115.9 (C-26), 123.2 (C-19), 136.1 (C-24), 139.3 (C-27), 
141.9 (C-23), 149.7 (C-20), 161.9 (C-25), 167.2 (C-18), 173.1 (C-1); 
HRMS (ESI): calcd for C31H46NaN2O9 [M+Na]+: 613.30955, found 613.31007. 
 
 
Neopeltolide analogue 8-70 
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To a solution of alcohol 6-14 (5.3 mg, 0.016 mmol, 1 equiv), acid 8-62 (7.7 mg, 0.032 mmol, 
2.0 equiv) and PPh3 (9.2 mg, 0.035 mmol, 2.2 equiv) in a mixture of absolute benzene (0.8 
mL) and THF (1.5 mL) was added diisopropyl azodicarboxylate (70 μL of 0.5M solution in 
benzene, 0.035 mmol, 2.2 equiv). After stirring for 1 h at ambient temperature the reaction 
mixture was concentrated in vacuo and the residue was purified by flash column 
chromatography (hexane/EtOAC, 2:1→1.5:1→1:1) to afford neopeltolide analogue 8-70 (7.5 
mg, 88%) as a colorless oil. Rf = 0.58 (petroleum ether/EtOAc, 1:1); [α]20D = +28.8 (c 0.7, 
CH2Cl2); 1H NMR (400 MHz, CD3OD): δ = 0.93 (t, J = 7.3 Hz, 3H, 16-H), 0.99 (d, J = 6.6 Hz, 
3H, 17-H), 1.08–1.16 (m, 1H, 10-H), 1.22–1.44 (m, 6H, 8-H, 9-H, 12-H, 15-H), 1.45–1.64 (m, 
4H, 10-H, 4-H, 6-H, 14-H), 1.65–1.83 (m, 2H, 6-H, 14-H), 1.86–1.97 (m, 2H, 4-H, 12-H), 
2.31 (dd, J = 14.8, 11.0 Hz, 1H, 2-H), 2.73 (dd, J = 14.7, 4.3 Hz, 1H, 2-H), 3.28 (s, 3H, 11-
OCH3), 3.59–3.75 (m, 5H, 7-H, 29-OCH3, 11-H), 4.15–4.24 (m, 1H, 3-H), 4.34 (d, J = 4.8 Hz, 
2H, 24-H), 5.14–5.22 (m, 1H, 13-H), 5.36–5.41 (m, 1H, 5-H), 6.15–6.23 (m, 1H, 23-H), 6.37 
(dt, J = 11.9, 2.0 Hz, 1H, 22-H), 8.62 (s, 1H, 20-H); 13C NMR (100 MHz, CD3OD): δ = 14.1 
(C-16), 20.0 (C-15), 26.0 (C-17), 32.5 (C-9), 36.2 (C-4), 37.4 (C-6), 37.9 (C-14), 41.1 (C-12), 43.2 
(C-2), 43.6 (C-10), 45.3 (C-8), 52.6 (25-OCH3), 56.4 (11-OCH3), 70.7 (C-5), 71.2 (C-3), 73.9 (C-
13), 76.9 (C-7), 77.1 (C-11), 115.2 (C-22), 135.2 (C-20), 141.9 (C-23), 145.8 (C-19), 159.6 (C-
25), 161.8 (C-21), 162.5 (C-18), 173.1 (C-1); 
HRMS (ESI): calcd for C27H40NaN2O9 [M+Na]+: 559.26260, found 559.26265. 
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To a solution of alcohol 6-14 (4.1 mg, 0.0125 mmol, 1 equiv), acid 8-63 (5.6 mg, 0.02 mmol, 
1.6 equiv) and PPh3 (5.8 mg, 0.022 mmol, 1.76 equiv) in absolute benzene (0.7 mL) was 
added diisopropyl azodicarboxylate (44 μL of 0.5M solution in benzene, 0.022 mmol, 1.76 
equiv). After stirring for 1 h at ambient temperature the reaction mixture was concentrated in 
vacuo and the residue was purified by flash column chromatography (hexane/EtOAC, 
2:1→1:1→1:2) to afford neopeltolide analogue 8-71 (5.6 mg, 76%) as a colorless oil. Rf = 
0.57 (petroleum ether/EtOAc, 1:1); [α]20D = +20.5 (c 0.4, CH2Cl2); 1H NMR (400 MHz, 
CD3OD): δ = 0.93 (t, J = 7.3 Hz, 3H, 16-H), 0.99 (d, J = 6.6 Hz, 3H, 17-H), 1.07–1.14 (m, 1H, 
10-H), 1.21–1.42 (m, 6H, 8-H, 9-H, 12-H, 15-H), 1.44–1.61 (m, 4H, 10-H, 4-H, 6-H, 14-H), 
1.67–1.79 (m, 2H, 6-H, 14-H), 1.84–1.95 (m, 2H, 4-H, 12-H), 2.31 (dd, J = 14.7, 10.9 Hz, 1H, 
2-H), 2.72 (dd, J = 14.7, 4.3 Hz, 1H, 2-H), 3.28 (s, 3H, 11-OCH3), 3.62–3.74 m, 5H, 7-H, 27-
OCH3, 11-H), 4.10–4.19 (m, 1H, 3-H), 4.38 (d, J = 4.6 Hz, 2H, 26-H), 5.14–5.22 (m, 1H, 13-H), 
5.23–5.28 (m, 1H, 5-H), 6.11–6.19 (m, 1H, 25-H), 6.34 (dt, J = 11.9, 2.0 Hz, 1H, 24-H), 6.65 (d, 
J = 15.7 Hz, 1H, 19-H), 7.59 (d, J = 15.4 Hz, 1H, 20-H), 8.15 (s, 1H, 22-H); 13C NMR (100 
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MHz, CD3OD): δ = 14.1 (C-16), 20.0 (C-15), 26.0 (C-17), 32.5 (C-9), 36.3 (C-4), 37.4 (C-6), 
37.9 (C-14), 41.1 (C-12), 43.3 (C-2), 43.5 (C-10), 45.3 (C-8), 52.6 (27-OCH3), 56.4 (11-
OCH3), 69.8 (C-5), 71.3 (C-3), 74.0 (C-13), 77.1 (C-7), 77.1 (C-11), 115.3 (C-24), 121.0 (C-
19), 134.1 (C-22), 139.3 (C-25), 141.2 (C-20), 141.3 (C-21), 159.7 (C-27), 162.5 (C-23), 
167.4 (C-18), 173.1 (C-1); 
HRMS (ESI): calcd for C29H42NaN2O9 [M+Na]+: 585.27825, found 585.27827. 
 
 
Neopeltolide analogue 8-72 
 
O
O
OMe
O
O 1
3
5
7
10
12
15
N
O
NH
OMe
O
O
18
20 22 24
26
28
 
 
To a solution of alcohol 6-14 (4.6 mg, 0.014 mmol, 1 equiv), acid 8-67 (7.8 mg, 0.028 mmol, 
2.0 equiv) and PPh3 (8.1 mg, 0.031 mmol, 2.2 equiv) in a mixture of absolute benzene (1.0 
mL) and THF (1.0 mL) was added diisopropyl azodicarboxylate (62 μL of 0.5M solution in 
benzene, 0.031 mmol, 2.2 equiv). After stirring for 1 h at ambient temperature the reaction 
mixture was concentrated in vacuo and the residue was purified by flash column 
chromatography (hexane/EtOAC, 2:1→1.5:1→1:1) to afford neopeltolide analog 8-72 (7.0 
mg, 85%) as a colorless oil. Rf = 0.61 (petroleum ether/EtOAc, 1:1); [α]20D = +30.5 (c 0.6, 
CH2Cl2); 1H NMR (400 MHz, CD3OD): δ = 0.92 (t, J = 7.3 Hz, 3H, 16-H), 0.97 (d, J = 6.8 Hz, 
3H, 17-H), 1.08–1.15 (m, 1H, 10-H), 1.26–1.42 (m, 6H, 8-H, 9-H, 12-H, 15-H), 1.44–1.62 (m, 
4H, 10-H, 4-H, 6-H, 14-H), 1.63–1.76 (m, 2H, 6-H, 14-H), 1.84–1.92 (m, 2H, 4-H, 12-H), 
2.30 (dd, J = 14.8, 11.0 Hz, 1H, 2-H), 2.71 (dd, J = 14.8, 4.2 Hz, 1H, 2-H), 3.27 (s, 3H, 11-
OCH3), 3.56–3.72 (m, 5H, 7-H, 29-OCH3, 11-H), 4.07–4.16 (m, 1H, 3-H), 4.36 (dd, J = 4.6 
Hz, 2H, 28-H), 5.12–5.20 (m, 1H, 13-H), 5.21–5.25 (m, 1H, 5-H), 5.81 (d, J = 11.4 Hz, 1H, 
19-H), 6.06–6.14 (m, 1H, 27-H), 6.32 (d, J = 11.9 Hz, 1H, 26-H), 6.77–6.87 (m, 2H, 20-H, 22-
H), 7.98 (s, 1H, 24-H), 8.15 (dd, J = 15.5, 11.8 Hz, 1H, 21-H); 13C NMR (100 MHz, CD3OD): 
δ = 14.1 (C-16), 20.0 (C-15), 25.9 (C-17), 32.5 (C-9), 36.3 (C-4), 37.4 (C-6), 37.9 (C-14), 41.0 
(C-12), 43.2 (C-2), 43.5 (C-10), 45.3 (C-8), 52.6 (29-OCH3), 56.4 (11-OCH3), 69.2 (C-5), 71.3 
(C-3), 74.0 (C-13), 77.0 (C-7), 77.1 (C-11), 115.7 (C-26), 119.1 (C-22), 127.8 (C-19), 130.1 
(C-24), 139.1 (C-27), 140.6 (C-23), 141.0 (C-21), 145.6 (C-20), 159.7 (C-29), 162.3 (C-25), 
167.0 (C-18), 173.1 (C-1); 
HRMS (ESI): calcd for C31H44NaN2O9 [M+Na]+: 611.29390, found 611.29403. 
 
 
Neopeltolide analogue 8-73 
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To a solution of alcohol 6-14 (4.4 mg, 0.013 mmol, 1 equiv), acid 8-68 (7.2 mg, 0.026 mmol, 
2.0 equiv) and PPh3 (7.6 mg, 0.029 mmol, 2.2 equiv) in a mixture of absolute benzene (1.0 
mL) and THF (1.0 mL) was added diisopropyl azodicarboxylate (58 μL of 0.5M solution in 
benzene, 0.029 mmol, 2.2 equiv). After stirring for 1 h at ambient temperature the reaction 
mixture was concentrated in vacuo and the residue was purified by flash column 
chromatography (hexane/EtOAC, 2:1→1.5:1→1:1) to afford neopeltolide analogue 8-73 (6.6 
mg, 86%) as a colorless oil. Rf = 0.64 (petroleum ether/EtOAc, 1:1); [α]20D = +47.5 (c 0.6, 
CH2Cl2); 1H NMR (400 MHz, CD3OD): δ = 0.93 (t, J = 7.3 Hz, 3H, 16-H), 0.99 (d, J = 6.6 Hz, 
3H, 17-H), 1.08–1.17 (m, 1H, 10-H), 1.26–1.43 (m, 6H, 8-H, 9-H, 12-H, 15-H), 1.45–1.62 (m, 
4H, 10-H, 4-H, 6-H, 14-H), 1.67–1.77 (m, 2H, 6-H, 14-H), 1.83–1.95 (m, 2H, 4-H, 12-H), 
2.30 (dd, J = 14.8, 11.0 Hz, 1H, 2-H), 2.71 (dd, J = 14.9, 4.3 Hz, 1H, 2-H), 3.28 (s, 3H, 11-
OCH3), 3.59–3.72 (m, 5H, 7-H, 29-OCH3, 11-H), 4.07–4.16 (m, 1H, 3-H), 4.38 (d, J = 4.6 Hz, 
2H, 28-H), 5.14–5.24 (m, 2H, 13-H, 5-H), 6.07–6.16 (m, 2H, 19-H, 27-H), 6.31 (dt, J = 11.9, 
2.0 Hz, 1H, 26-H), 6.91 (d, J = 15.2 Hz, 1H, 22-H), 7.11 (dd, J = 15.2, 11.4 Hz, 1H, 21-H), 
7.46 (dd, J = 15.2, 11.1 Hz, 1H, 20-H), 7.97 (s, 1H, 24-H); 13C NMR (100 MHz, CD3OD): δ = 
14.1 (C-16), 20.0 (C-15), 26.0 (C-17), 32.5 (C-9), 36.3 (C-4), 37.4 (C-6), 38.0 (C-14), 41.1 (C-
12), 43.3 (C-2), 43.5 (C-10), 45.3 (C-8), 52.6 (29-OCH3), 56.4 (11-OCH3), 69.6 (C-5), 71.2 
(C-3), 74.0 (C-13), 77.0 (C-7), 77.1 (C-11), 115.5 (C-26), 122.9 (C-22), 129.2 (C-21), 129.5 
(C-19), 139.2 (C-24), 140.7 (C-27), 140.7 (C-23), 145.8 (C-20), 159.7 (C-29), 162.3 (C-25), 
167.8 (C-18), 173.1 (C-1); 
HRMS (ESI): calcd for C31H46NaN2O9 [M+H]+: 589.31196, found 589.31195. 
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11 Appendix 
 
11.1 NMR-Spectra for important compounds 
Additional spectra are included in the supporting information of the published papers from 
this work and are available free of charge via Internet at http://pubs.acs.org, 
http://www.angewandte.org and http://www.chemeurj.org. 
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3-27
  Appendix 250 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 -0.5
ppm
Chloroform-d
 
 
Chloroform-d
168.70
160.96
158.19
139.52
116.84
107.88
96.83
83.70
75.25
69.07
55.97
55.31
52.15
38.16
37.16
25.85
21.23
17.95
14.96
-4.97
-5.04
 
CO2Me
OMe
MeO
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3
5 1
2' 4'
3-30
Appendix 251
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
ppm
Chloroform-d
 
 
Chloroform-d
159.08
130.66
129.19
113.70
77.86
72.55
68.48
56.00
55.25
47.72
40.32
34.63
32.14
26.03
18.32
16.80
13.12
-3.81
-4.13
 
 
OTBS
O
OMe
1
41'
2'
2''
3''
O
3-42
  Appendix 252 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 -0.5
ppm
Chloroform-d
 
 
Chloroform-d
168.68
160.88
159.07
158.14
139.65
130.57
129.19
116.78
113.69
108.05
96.75
81.40
77.93
77.73
75.27
72.52
68.41
55.93
55.27
55.21
52.07
39.38
38.83
36.98
35.11
32.63
26.03
25.85
25.47
21.84
18.28
17.93
16.38
14.76
9.20
-3.66
-4.97
 
CO2Me
OMe
MeO
14
8
166
4
11
TBSO
OH
OTBS
O
OMe
193-43
Appendix 253
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Chloroform-d
 
 
Chloroform-d
159.03
148.95
148.47
131.12
130.93
129.02
128.63
120.14
113.93
113.68
110.94
110.81
108.52
83.74
78.29
77.20
73.31
72.76
68.52
67.94
55.89
55.77
55.25
38.49
32.85
32.35
26.68
25.34
16.56
10.80
 
O
O OPMB
O
OMe
OMe1
2
4
1'
2'
1''
3''
4''5''
3-53
  Appendix 254 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Chloroform-d
 
 
Chloroform-d
159.07
148.93
148.45
131.11
130.79
129.09
120.11
113.69
110.92
110.80
85.64
74.11
72.75
68.43
55.76
55.23
47.27
39.24
32.92
31.97
16.86
12.13
 
OPMB
O
OMe
OMe1
2 41'
2'
2''
3''
O
3-55
Appendix 255
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Chloroform-d
 
 
Chloroform-d
159.18
148.97
148.50
131.03
130.37
129.26
120.18
113.83
110.95
110.82
86.84
77.65
77.20
75.81
73.85
73.09
72.80
68.42
55.89
55.78
55.24
37.77
32.57
32.34
25.00
16.33
7.41
3.52
 
HO OPMB
O
OMe
OMe
Me
146
8
9 3-60
  Appendix 256 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Chloroform-d
 
 
Chloroform-d
167.75
160.76
158.99
157.78
148.93
148.38
139.14
131.31
131.05
128.92
120.07
117.69
113.70
110.91
110.81
106.89
96.67
83.92
78.13
76.56
75.28
74.61
74.14
72.59
68.77
55.89
55.78
55.59
55.25
38.81
37.53
36.22
32.86
31.24
22.17
18.06
17.22
14.56
12.91
10.00
3.50
 
O
OPMB
DMBO
OMeO
MeO
Me
TIPSO
5
3 1 Me
1'
3' 5'
1'' 3''
1'''
3'''
5'''
3-64
Appendix 257
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
ppm
Chloroform-d
 
 
Chloroform-d
167.35
160.20
157.20
148.92
148.38
139.40
131.15
120.11
118.10
110.88
110.76
108.21
96.60
81.15
79.68
77.23
75.95
72.72
68.63
55.84
55.75
55.15
40.29
38.57
37.53
34.48
31.68
26.11
23.45
23.26
18.37
18.05
17.84
17.21
12.95
11.33
-3.58
-4.00
 
 
O
O
TIPSO
OMe
MeO
TBSO
DMBO
4
1
8
12
15
18
3-74
  Appendix 258 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
ppm
Chloroform-d
 
Chloroform-d
-4.6
-3.9
-3.7
12.6
12.9
14.2
17.8
18.0
18.4
19.2
25.8
26.1
29.4
34.8
36.8
38.6
41.0
45.5
55.2
55.7
74.7
75.6
76.8
77.1
79.5
81.3
82.7
96.7
108.3
118.1
139.4
157.2
160.2
167.3
173.5  
 
O
O
TIPSO
OMe
MeO
TBSO
N
H
O
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4
8
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15
18
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25
Appendix 259
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
ppm
Chloroform-d
 
 
Chloroform-d
8.6
11.2
14.1
16.1
19.2
29.8
30.6
31.6
35.8
36.5
36.8
38.3
39.3
44.8
55.4
71.8
73.1
74.6
78.0
99.6
104.9
112.3
125.8
126.7
130.8
132.1
143.7
163.5
165.6
171.5
176.5  
OOH
MeO
HO
O
HO
N
H
O
HO
1
4
9
15
18 22
cruentaren A (1-1)
25
  Appendix 260 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
ppm
Chloroform-d
 
 
 
11 10 9 8 7 6 5 4 3 2 1 0
ppm
Chloroform-d
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O
HO
4
9
15
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O
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O
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Appendix 261
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0
ppm
Chloroform-d
 
 
Chloroform-d
9.00
11.96
13.97
15.77
18.86
20.77
29.42
29.68
33.27
36.15
37.11
38.27
38.82
40.06
55.38
72.92
75.48
77.20
77.97
83.83
99.66
104.78
112.39
125.62
132.29
143.64
163.58
165.86
171.45
174.64  
OOH
MeO
HO
O
HO
1
4
9
15
18
3-124
O
N
O
24
26
H
  Appendix 262 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
ppm
Chloroform-d
 
 
Chloroform-d
14.02
17.74
19.41
19.62
25.79
27.09
36.24
39.61
41.39
41.80
42.07
43.64
55.76
66.82
68.32
70.43
72.15
72.95
73.11
75.53
127.37
127.43
127.62
128.34
129.42
134.41
134.77
135.94
138.52  
 
O
MeO OTBDPS
OH
BnO H H 1 5
3' 5'
8-28
Appendix 263
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Chloroform-d
 
 
Chloroform-d
14.11
18.64
20.65
27.80
37.98
38.64
39.10
40.00
40.64
41.24
43.72
55.29
56.84
68.79
72.51
72.78
75.41
78.16
94.51
173.60  
 
O
MeO OH
O
HO H H 1 5 9
3' 5'
O
O
8-32
  Appendix 264 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Chloroform-d
 
 
Chloroform-d
13.87
18.96
25.53
31.22
36.89
39.99
40.70
41.90
42.23
44.05
56.23
68.04
72.29
73.25
75.55
78.60
170.84  
 
O
O
OMe
OH
O 1
3
5
7
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15
6-14
Appendix 265
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5
ppm
Chloroform-d
 
 
Chloroform-d
14.14
39.60
52.07
61.16
115.19
134.27
139.34
143.13
157.07
160.61
160.99  
 
N
O
O
EtO
NH
OMe
O
2
5
8-10
  Appendix 266 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0
ppm
Chloroform-d
 
 
Chloroform-d
25.59
27.47
39.26
51.06
52.10
116.65
120.18
133.87
136.21
141.12
148.87
157.14
159.94
166.65  
 
 
N
O
NH
OMe
O
CO2Me 2''
5''
2
4
2'
3'
8-42
Appendix 267
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Methanol-d4
 
 
Methanol-d4
173.04
166.85
161.88
159.59
149.99
142.29
139.18
135.92
121.69
115.93
77.13
77.04
73.94
71.31
69.18
56.40
52.56
45.24
43.47
43.21
41.03
37.94
37.39
36.21
32.56
28.96
26.39
25.96
20.00
14.14
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O
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O
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Neopeltolide (5-1)
  Appendix 268 
 
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Methanol-d4
 
 
Methanol-d4
172.50
78.52
78.23
72.92
72.33
68.36
56.47
45.42
43.49
42.93
41.57
41.31
39.09
38.11
30.52
24.90
19.49
14.36
 
 
O
O
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3
5
7
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8-56
Appendix 269
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Methanol-d4
 
 
Methanol-d4
172.55
166.79
161.87
159.59
150.05
142.25
139.16
135.93
121.63
115.93
78.53
75.10
72.36
70.41
69.23
56.43
52.56
45.05
43.54
41.23
41.01
39.12
38.05
37.30
36.17
30.52
28.98
26.38
24.79
19.52
14.34
 
 
O
O
OMe
O
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3
5
7
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O
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27
11-epi neopeltolide (8-57)
  Appendix 270 
 
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Chloroform-d
 
 
Chloroform-d
172.74
76.85
74.81
74.09
72.75
67.94
56.92
45.11
42.37
41.98
40.83
39.71
39.29
36.86
24.42
24.27
18.88
13.90
 
 
O
O
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3
5
7
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8-58
Appendix 271
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Methanol-d4
 
 
Methanol-d4
174.79
166.76
161.88
150.18
142.18
139.13
135.99
121.52
115.95
78.26
75.40
73.41
71.24
69.04
57.15
52.56
46.40
43.20
40.99
40.60
40.40
37.92
37.49
36.46
29.00
26.33
25.35
24.63
19.99
14.15
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O
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O
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O
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5-epi neopeltolide (8-59)
  Appendix 272 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Methanol-d4
 
 
Methanol-d4
173.09
167.19
161.93
149.70
141.91
139.26
136.05
123.15
115.87
77.05
73.96
71.24
69.41
56.40
52.56
45.28
43.52
43.22
41.06
37.95
37.39
36.24
32.56
31.81
25.98
25.51
20.01
14.14
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Appendix 273
 
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Methanol-d4
 
 
Methanol-d4
173.09
162.52
161.84
159.62
145.78
141.91
135.23
115.22
77.09
76.94
73.93
71.17
70.65
56.41
52.59
45.28
43.55
43.24
41.09
40.96
37.94
37.36
36.24
32.46
25.98
20.02
14.12
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O
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8-70
  Appendix 274 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Methanol-d4
 
 
Methanol-d4
173.13
167.38
162.52
159.67
141.34
141.24
139.32
134.06
120.96
115.33
77.08
73.95
71.25
69.76
56.41
52.60
45.32
43.54
43.25
41.06
37.94
37.42
36.29
32.52
26.00
20.01
14.14
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Appendix 275
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Methanol-d4
 
 
Methanol-d4
173.10
166.95
162.34
159.65
145.61
140.96
140.64
139.12
130.07
127.82
119.08
115.65
77.08
73.95
71.26
69.23
56.40
52.58
45.28
43.50
43.24
41.04
37.94
37.44
36.32
32.50
25.93
19.96
14.14
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  Appendix 276 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
ppm
Methanol-d4
 
 
Methanol-d4
173.11
167.76
162.31
159.67
145.78
140.69
139.15
129.46
129.17
122.90
115.50
77.08
73.98
71.24
69.55
56.41
52.59
45.32
43.54
43.25
41.06
37.95
37.44
36.32
32.52
25.98
20.01
14.14
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